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1.1	  Vertebrate	  skeletal	  muscle	  Vertebrate	  skeletal	  muscle	   is	  composed	  of	  two	  distinct	  types	  of	   fibre	  that	  are	  adapted	  to	  perform	   distinct	   functions	   through	   differences	   in	   their	   physiological	   and	   metabolic	  properties	   (Schiaffino	   and	   Reggiani,	   2011).	   Slow-­‐twitch	   fibres	   have	   a	   low	   contraction	  velocity	  but	  are	  rich	   in	  mitochondria	  and	  are	  therefore	  more	  efficient	  at	  using	  oxygen	  to	  generate	  ATP,	  resulting	  in	  a	  high	  endurance	  capability.	  Fast-­‐twitch	  fibres,	  by	  contrast,	  are	  more	  suited	  to	  generating	  short	  bursts	  of	  strength	  or	  speed,	  but	  they	  fatigue	  more	  rapidly	  than	   slow-­‐twitch	   fibres	   due	   to	   their	   high	   contraction	   velocity.	   Differing	   proportions	   of	  fibre	   types	   underpin	   the	   behavioural	   characteristics	   of	   many	   species.	   Most	   fish,	   for	  example,	  have	  a	  higher	  proportion	  of	  fast-­‐twitch	  muscle,	  which	  allows	  them	  to	  dart	  away	  quickly	   from	   predators,	   whereas	   terrestrial	   herbivores,	   such	   as	   cows,	   have	   a	   large	  proportion	  of	   slow-­‐twitch	  muscle	   that	   facilitates	   the	  sustained	   load-­‐bearing	  necessitated	  by	   their	   grazing	   life-­‐style.	   Significant	   fibre-­‐type	   variation	   also	   occurs	   within	   species,	  reflecting	  adaptation	  to	  different	  environments	  and/or	  activities.	  In	  humans,	  for	  instance,	  variation	   in	   the	  proportion	  of	   slow-­‐twitch	  muscle	   fibres	  underlies	  differences	   in	  athletic	  prowess;	   marathon	   runners	   have	   significantly	   more	   slow-­‐twitch	   fibres	   than	   sprinters,	  allowing	   them	   to	   run	   for	   long	   distances	   without	   experiencing	   overwhelming	   muscle	  fatigue	   (Costill	   et	   al.,	   1976,	  Gollnick	   et	   al.,	   1972).	   Indeed,	   genetic	   differences	   in	   the	   fast-­‐muscle-­‐specific	   gene	   α-­‐actinin-­‐3,	   found	   to	   be	   mutated	   in	   one	   billion	   of	   the	   world’s	  population	   of	   seven	   billion	   (North	   et	   al.,	   1999),	   may	   be	   a	   useful	   predictor	   of	   athletic	  performance.	   Although	   mutations	   in	   α-­‐actinin-­‐3	   do	   not	   cause	   any	   disease	   in	   humans,	  homozygosity	  for	  mutations	  in	  this	  gene	  are	  prevalent	  in	  endurance	  athletes,	  while	  at	  least	  one	   wild-­‐type	   allele	   is	   usually	   present	   in	   Olympic	   sprint	   athletes	   (Yang	   et	   al.,	   2003).	  Moreover,	   the	   varying	   frequency	   of	   this	   mutation	   in	   different	   ethnic	   groups	   has	   led	   to	  speculation	   about	   whether	   these	   variations	   have	   evolved	   to	   accommodate	   the	   differing	  energy	   expenditure	   requirements	   of	   particular	   environments,	   due	   to	   the	   existence	   of	  different	  selection	  pressures	  in	  these	  environments	  (North	  et	  al.,	  1999).	  Experiments	   investigating	   the	   effects	   of	   electrical	   stimulation,	   mechanical	   loading,	  exercise	   and	  disease	   states	   have	   provided	  us	  with	   good	   evidence	   that	  muscle	   fibres	   are	  plastic	  and	  can	  adapt	  to	  changing	  functional	  demands.	  For	  instance,	  in	  several	  fish	  species,	  forced	   swimming	   against	   a	   water	   current,	   results	   in	   a	   series	   of	   changes	   that	   include	  increases	  in	  the	  number	  and	  size	  of	  slow	  muscle	  fibres	  (for	  review	  see	  (Davison,	  1997)).	  These	  changes	  are	  bought	  about	  by	  activation	  of	   intracellular	  signalling	  pathways	  which	  respond	  to	  changes	  in	  intracellular	  calcium	  concentrations,	  leading	  to	  a	  reprogramming	  of	  gene	   expression	   and	   changes	   in	   mass,	   contractile	   properties,	   and	   metabolic	   states	   of	  muscle	  (for	  review	  see	  Bassel-­‐Duby	  and	  Olson,	  2006).	  For	  example,	  overexpression	  of	  the	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calcium-­‐binding	   protein	   calcineurin,	   both	   in	   vitro	   and	   in	   vivo,	   induces	   the	   de-­‐phosphorylation	   of	   the	   Nuclear	   Factor	   of	   Activated	   T	   cells	   (NFAT)	   transcription	   factor,	  causing	   its	   translocation	   to	   the	   nucleus,	  where	   it	   activates	   a	   subset	   of	   genes	   associated	  with	  slow-­‐twitch	  myofibres,	  leading	  to	  a	  fast	  to	  slow	  myofibre	  transformation	  (Chin	  et	  al.,	  1998,	  Naya	  et	  al.,	  2000).	  Interestingly,	  recent	  studies	  have	  begun	  to	  establish	  the	  zebrafish	  as	  a	  model	  for	  studying	  the	  changes	  in	  muscle	  physiology	  in	  response	  to	  exercise,	  creating	  an	  emerging	  field	  in	  zebrafish	  in	  the	  study	  of	  exercise	  physiology	  (Palstra	  et	  al.,	  2010).	  	  The	  importance	  of	  understanding	  the	  basis	  of	  fibre	  type	  specification	  is	  underlined	  by	  the	  propensity	   of	   certain	   muscle	   wasting	   diseases	   to	   affect	   particular	   fibre	   types	  preferentially.	  For	  example,	  in	  Duchenne	  Muscular	  Dystrophy	  and	  Sarcopenia	  (age-­‐related	  muscle	  wasting),	   fast-­‐twitch	   fibres	   are	  preferentially	   involved	   in	   the	  dystrophic	  process,	  exhibiting	   more	   deterioration	   and	   atrophy	   than	   slow-­‐twitch	   fibres	   (Lee	   et	   al.,	   2006,	  Webster	  et	  al.,	  1988).	  A	  fuller	  understanding	  of	  the	  progression	  of	  these	  diseases	  and	  the	  development	   of	   effective	   therapies	   will	   be	   predicated	   on	   developing	   a	   comprehensive	  knowledge	  of	  fibre-­‐type	  ontogeny.	  In	  contrast	  to	  the	  adult	  fibre-­‐type	  switching	  programme,	  the	  developmental	  pathways	  that	  allocate	  muscle	   progenitors	   to	   a	   particular	   fibre	   type	   have	   been	   less	  well	   characterised,	  with	  some	   fibre	   types	  able	   to	  differentiate	   in	   the	  complete	  absence	  of	   innervation	   in	   the	  developing	   embryo	   (Butler	   et	   al.,	   1982).	   The	   extent	   to	   which	   the	   developmental	   and	  physiological	   control	   of	   fibre	   type	   identity	   share	   common	  mechanisms	   remains	   elusive,	  but	   it	   appears	   that	   many	   of	   the	   signalling	   pathways	   activated	   during	   adult	   fibre-­‐type	  switching	   are	   distinct	   from	   those	   deployed	   during	   embryonic	   development.	   The	  availability	  of	  immunological	  and	  molecular	  genetic	  probes	  (Bormioli	  et	  al.,	  1980,	  Cantini	  et	   al.,	   1980,	  Lyons	  et	   al.,	   1990)	  has	   facilitated	   the	   identification	  of	  molecular	  differences	  between	   fibres	   and	   hence	   the	   analysis	   of	   changes	   in	   fibre	   type	   during	   embryonic	  development	  and	  adult.	  
1.2	  Myogenesis	  in	  the	  zebrafish	  embryo	  The	   zebrafish	   has	   emerged	   as	   a	   powerful	   model	   system	   for	   the	   genetic	   analysis	   of	  vertebrate	   myogenesis;	   not	   only	   are	   their	   rapidly	   developing	   embryos	   optically	  transparent,	   but	   in	   contrast	   to	   amniotes,	   the	   embryonic	   myotome	   shows	   a	   discrete	  temporal	  and	  spatial	  separation	  of	  fibre	  type	  ontogeny	  that	  facilitates	  its	  analysis	  (Devoto	  et	   al.,	   1996,	   van	   Raamsdonk	   et	   al.,	   1982).	   Furthermore,	   unlike	   amniotes,	   the	   fish	  sclerotome	   is	   small;	   therefore	   the	   somites	  mainly	   give	   rise	   to	   the	  muscle,	  which	   allows	  clear	  visualisation	  of	  the	  fibres.	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The	   process	   of	  mesoderm	   segmentation	   and	   differentiation	   follows	   a	   similar	   path	   in	   all	  vertebrates,	  although	  the	  relative	  timing	  and	  order	  of	  specific	  events	  may	  differ	  between	  species.	  During	  gastrulation,	   the	  mesoderm	  subdivides	   into	   the	  axial	  mesoderm,	  derived	  from	  dorsally	   located	   cells,	   and	   the	  paraxial	  mesoderm,	  derived	   from	   the	  more	   laterally	  located	  cells	  of	   the	  mesoderm.	  The	  axial	  mesoderm	  gives	   rise	   to	   the	  notochord	  whereas	  the	   paraxial	   mesoderm	   will	   form	   the	   somites.	   The	   paraxial	   mesoderm	   consists	   of	   two	  blocks	  of	  tissue,	  which	  flank	  the	  developing	  notochord	  that	  occupies	  the	  midline	  (Stickney	  et	  al.,	  2000).	   	  Mesodermal	  precursors	  commit	  to	  becoming	  myoblasts	  as	  indicated	  by	  the	  activation	   of	   the	  Myogenic	   Regulatory	   Factors	   (MRFs),	  myoD	  and	  myf5,	  members	   of	   the	  basic	  helix	   loop	  helix	   family	  of	   transcription	   factors	   (Blagden	  et	  al.,	  1997,	  Coutelle	  et	  al.,	  2001,	  Hammond	  et	  al.,	  2007,	  Weinberg	  et	  al.,	  1996).	   Inactivation	  of	  either	  myoD	  or	  myf5	  alone	   has	   no	   major	   effect	   on	   trunk	   muscle	   differentiation	   in	   zebrafish,	   although	  myoD	  mutants	  lack	  some	  head	  muscles	  (Hinits	  et	  al.,	  2011).	  However,	  simultaneous	  inactivation	  of	  both	  myoD	  and	  myf5	  causes	  a	  loss	  of	  muscle	  formation,	   implying	  significant	  functional	  overlap	  between	  the	  two	  encoded	  proteins	  (Hammond	  et	  al.,	  2007).	  In	  contrast	  to	  higher	  vertebrates,	   myogenesis	   in	   the	   zebrafish	   initiates	   prior	   to	   somite	   formation	   in	   a	  subpopulation	   of	   the	   presomitic	   mesoderm	   located	   immediately	   adjacent	   to	   the	  notochord,	   the	   so-­‐called	   adaxial	   cells.	   Consistent	  with	   these	   observations,	   expression	   of	  
myoD	   in	  the	  adaxial	  cells	  (Figure	  1.1A)	  begins	  prior	  to	  somite	   formation,	   indicating	  their	  commitment	   to	   the	  myogenic	   fate	   (Coutelle	   et	   al.,	   2001,	  Weinberg	   et	   al.,	   1996).	   During	  adaxial	   cell	   differentiation,	   the	   majority	   of	   these	   cells	   elongate	   and	   migrate	   radially	  outwards	  to	  form	  a	  subcutaneous	  layer	  of	  mononucleated	  slow-­‐twitch	  muscle	  fibre	  named	  the	   superficial	   slow-­‐twitch	   fibres	   (SSF),	   (Devoto	   et	   al.,	   1996),	   (Figure	   1.1B	   and	   D).	   A	  specialized	  subpopulation	  of	  adaxial	  cells,	  the	  muscle	  pioneers	  (MPs),	  retain	  their	  medial	  location	  and	  are	   characterised	  by	   their	   expression	  of	   the	  Engrailed	   transcription	   factors	  (Devoto	   et	   al.,	   1996,	   Felsenfeld	   et	   al.,	   1991,	   Hatta	   et	   al.,	   1991).	   The	  MPs	   later	   form	   the	  horizontal	  myoseptum	   that	   subdivides	   the	   somites	   into	   the	   dorsal	   (epaxial)	   and	   ventral	  (hypaxial)	  compartments.	  A	  second	  wave	  of	  myoD	  expression	  subsequently	  occurs	  in	  the	  posterior	   half	   of	   each	   newly	   formed	   somite	   (Figure	   1.1A)	   lateral	   to	   the	   adaxial	   cells	  (Weinberg	   et	   al.,	   1996).	   These	   cells	   give	   rise	   to	   the	   medially	   located	   fast-­‐twitch	   fibres	  (Stellabotte	  et	  al.,	  2007),	  which	  form	  the	  bulk	  of	  the	  myotome	  and	  begin	  to	  differentiate	  in	  the	   wake	   of	   the	   migrating	   adaxial	   cells	   (Henry	   and	   Amacher,	   2004)	   (Figure	   1.1D).	  Additional	   laterally	   located	   fast-­‐twitch	   fibres	   derive	   from	   the	   Pax3/7	   expressing	  dermomyotome	   cells	   (Stellabotte	   et	   al.,	   2007).	   The	   fast	  muscle	   progenitors	  mature	   and	  fuse	  with	  each	  other	  to	   form	  a	  multinucleated	  array	  of	  syncytial	   fibres	  (Roy	  et	  al.,	  2001)	  (Figure	  1.1C).	  By	  24	  hours	  post	   fertilization,	   clear,	   chevron-­‐shaped	  blocks	  of	  muscle	   are	  visible	  in	  the	  embryo.	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Figure	  1.1:	  Zebrafish	  myogenesis.	  myoD	  expression	  reveals	   that	   the	  adaxial	   cells	  are	   the	  
first	  cells	  to	  become	  committed	  to	  the	  myogenic	  programme,	  differentiating	  into	  slow-­‐twitch	  
muscle	  cells.	  The	  posterior	  half	  of	  each	  somite	  subsequently	  activates	  myoD,	  differentiating	  
into	   fast-­‐twitch	  muscle	   (A).	   Lateral	   view	   of	   the	   zebrafish	   trunk	   shows	   the	  mononucleated	  
(green)	   slow-­‐twitch	   fibres	   (red)	   running	  parallel	   to	   the	  notochord	  (B).	   In	  contrast,	   the	   fast	  
twitch	   fibres	   (outlined	   in	   green)	   lie	   at	   an	   angle	   to	   the	   notochord	   and	   are	  multinucleated	  
(blue)	  (C).	  A	  schematic	  representing	  a	  transverse	  section	  through	  the	  trunk	  of	  the	  developing	  
myotome	  at	  four	  stages	  of	  development	  (D).	  Adaxial	  cells	  (green)	  migrate	  laterally	  through	  
the	   myotome,	   followed	   by	   the	   differentiation	   of	   the	   fast-­‐twitch	   myoblasts	   (yellow),	   which	  
subsequently	   fuse	   to	   form	   multinucleated	   fibres.	   Panel	   A	   is	   from	   Dr.	   Wang	   Xingang	   and	  
panels	  B-­‐D	  are	  my	  own	  images.	  	  	  The	  slow-­‐twitch	   fibres	  are	   the	   first	   to	  undergo	   the	  spontaneous	  contractions	  seen	   in	   the	  embryo	   as	   early	   as	   17	   hours	   post	   fertilisation	   (hpf),	   and	   that	   by	   21	   hpf	   mediate	   the	  stereotypic	  coiling	  behaviour	  that	  is	  exhibited	  by	  embryos	  in	  response	  to	  touch	  (Hirata	  et	  al.,	   2012,	   Pietri	   et	   al.,	   2009,	   Saint-­‐Amant	   and	  Drapeau,	   1998,	   Saint-­‐Amant	   and	  Drapeau,	  2000,	   Saint-­‐Amant	   and	   Drapeau,	   2001).	   	   By	   48	   hpf	   the	   embryo	   is	   able	   to	   propel	   itself	  forward,	   and	   will	   display	   a	   darting	   behaviour	   in	   response	   to	   touch.	   	   This	   behaviour	   is	  primarily	  reliant	  on	  fast	  muscle	  contraction,	  as	  knockdown	  of	  the	  fast-­‐specific	  Ca2+	  release	  channel,	  ryanodine	  receptor	  1b,	  which	  is	  essential	  for	  fast	  muscle	  contraction,	  results	  in	  a	  significant	   reduction	   in	  burst	   swimming,	  whilst	   coiling	   remains	  unperturbed	   (Naganawa	  and	  Hirata,	  2011).	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notochord	   and	   floorplate	   of	   the	   neural	   tube	   (Krauss	   et	   al.,	   1993),	   whereas	   indian	  
hedgehog-­‐b	  (ihh-­‐b;	  formerly	  echidna	  hedgehog,	  ehh)	  and	  shh-­‐b	  (formerly	   	  tiggy-­‐winkle	  hh,	  
twhh)	   are	   expressed	   in	   the	   notochord	   and	   floorplate	   respectively	   (Currie	   and	   Ingham,	  1996,	   Ekker	   et	   al.,	   1995).	   In	   zebrafish,	   several	   lines	   of	   evidence	   have	   indicated	   that	   Hh	  signalling	   is	   required	   for	   the	   commitment	   of	  muscle	   precursors	   to	   the	   slow	  muscle	   fate	  (Barresi	  et	  al.,	  2000,	  Baxendale	  et	  al.,	  2004,	  Blagden	  et	  al.,	  1997,	  Du	  et	  al.,	  1997,	  Hirsinger	  et	   al.,	   2004,	  Lewis	   et	   al.,	   1999,	  Roy	  et	   al.,	   2001).	  A	   small	   group	  of	  mutants	   that	   failed	   to	  display	   a	   recognisable	   horizontal	   myoseptum	  were	   originally	   identified	   in	   a	   large-­‐scale	  ENU	  mutagenesis	  screen	  (Haffter	  et	  al.,	  1996,	  van	  Eeden	  et	  al.,	  1996).	  The	  genes	  affected	  in	  this	   group	   of	   mutants	   were	   termed	   the	   you-­‐type	   genes,	   due	   to	   their	   U-­‐shaped	   somites.	  These	  genes	  appeared	  to	  play	  no	  role	  in	  the	  formation	  of	  the	  notochord,	  yet	  interestingly	  they	   exhibited	   defects	   that	   were	   very	   similar	   to	   those	   observed	   in	  mutants	   lacking	   the	  notochord	  e.g.	  fewer	  or	  no	  adaxial	  cells	  and	  MPs.	  It	  was	  therefore	  hypothesised	  that	  these	  genes	  may	   be	   involved	   in	   a	   signalling	   pathway	   between	   the	   notochord	   and	   the	   somites	  (van	  Eeden	  et	  al.,	  1996).	  Indeed,	  the	  mapping	  of	  these	  mutants	  lead	  to	  the	  discovery	  that	  most	   of	   these	   mutants	   harboured	   mutations	   in	   genes	   encoding	   components	   of	   the	   Hh	  pathway,	   including	  shh-­‐a	   itself,	  as	  well	  as	  essential	   transducers/effectors	  of	   the	  pathway	  such	  as	  smoothened	  (smo),	  scube2	  (you)	  dispatched-­‐1	  (con)	  and	  gli2a	  (yot).	  These	  mutants	  displayed	   a	   dramatic	   reduction	   of	   slow	  muscle	   fibres,	   as	   assessed	   by	   slow	  myosin	   heavy	  
chain	   1	   (smyhc1)	   and	   prox1a	   expression	   (Barresi	   et	   al.,	   2000,	   Hollway	   et	   al.,	   2006,	  Karlstrom	   et	   al.,	   1999,	   Kawakami	   et	   al.,	   2005,	   Lewis	   et	   al.,	   1999,	   Nakano	   et	   al.,	   2004,	  Schauerte	   et	   al.,	   1998,	   van	   Eeden	   et	   al.,	   1996,	   Woods	   and	   Talbot,	   2005).	   Conversely,	  ectopic	   pathway	   activation,	   caused	   by	  mutation	   of	   the	   genes	   encoding	   the	  Hh	   receptors	  Ptch1	  and	  Ptch2	  (Koudijs	  et	  al.,	  2005,	  Koudijs	  et	  al.,	  2008)	  or	  by	  injection	  of	  shh	  mRNA	  or	  dominant	   negative	   PKA	   mRNA,	   a	   common	   negative	   regulator	   of	   Hh	   signalling	   in	  vertebrates	   (Hammerschmidt	   et	   al.,	   1996),	   was	   sufficient	   to	   induce	   most	   muscle	  precursors	  to	  form	  slow	  muscle	  at	  the	  expense	  of	  fast	  muscle	  (Blagden	  et	  al.,	  1997,	  Du	  et	  al.,	  1997,	  Kim	  et	  al.,	  2010).	  
1.4	  Prdm1	  One	  of	  the	  you-­‐type	  mutants,	  ubo,	  also	  exhibited	  a	  slow-­‐	  to	  fast-­‐twitch	  fibre	  transformation	  phenotype	   (Baxendale	   et	   al.,	   2004,	   Liew	   et	   al.,	   2008,	   Roy	   et	   al.,	   2001,	   van	   Eeden	   et	   al.,	  1996,	   von	  Hofsten	   et	   al.,	   2008),	   yet	  patched	   (ptc)	   (a	   key	   regulator	   and	   target	   of	   the	  Hh	  pathway)	  expression	  was	  unaffected	  in	  homozygous	  ubo	  mutant	  embryos,	  demonstrating	  that	   the	   capacity	   of	   ubo	   mutant	   embryonic	   cells	   to	   receive	   a	   Hh	   signal	   was	   not	  compromised.	  The	  ability	  of	  Ubo	   to	  rescue	  mutants	  with	  compromised	  Hh	  signalling,	   i.e.	  
smo	  mutants,	  suggested	  that	  Ubo	  activity	  is	  sufficient	  for	  slow-­‐muscle	  development	  in	  the	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zebrafish	  (Baxendale	  et	  al.,	  2004).	  Furthermore,	  the	  ubo	  mutation	  acts	  cell	  autonomously	  (Roy	  et	  al.,	  2001),	  indicating	  that	  ubo	  is	  required	  for	  the	  responding	  cells	  to	  interpret	  the	  Hh	  signal	  to	  become	  slow	  muscle.	  	  
Positional	   cloning	  revealed	   that	   the	  protein	  encoded	  by	  ubo	  has	  substantial	   similarity	   to	  the	   mammalian	   SET	   domain-­‐containing	   zinc-­‐finger	   transcription	   factor	   B	   lymphocyte	  induced	   maturation	   protein	   1	   (Blimp-­‐1)	   (Baxendale	   et	   al.,	   2004,	   Liew	   et	   al.,	   2008).	  Transient	   expression	   of	   Blimp1	   (also	   known	   as	   Prdm1)	   is	   activated	   exclusively	   in	   the	  adaxial	  cells	  in	  response	  to	  Hh	  and	  was	  identified	  as	  the	  first	  slow	  lineage-­‐specific	  marker	  to	   be	   expressed	   (Liew	   et	   al.,	   2008).	   Immunohistochemistry	   revealed	   that	   in	   the	   slow	  muscle	   precursors	   of	   anterior	   somites,	   there	   is	   reduced	   Prdm1a	   expression	   although	  expression	  of	  Prox1a	  remains	  abundant,	  whereas	  in	  the	  more	  posterior	  somites	  there	  are	  high	   levels	  of	  Prdm1a	  with	  Prox1a	  expression	  barely	  detectable	   (Liew	  et	   al.,	   2008).	  The	  zebrafish	   mutant	   narrowminded	   (nrd)	  was	   also	   found	   to	   result	   from	   a	   mutation	   in	   the	  
prdm1a	   gene	   (Hernandez-­‐Lagunas	   et	   al.,	   2005).	   Both	   ubo	   and	   nrd	   homozygous	   mutant	  zebrafish	   lack	  a	  horizontal	  myoseptum	  and	  have	  a	   reduced	  number	  of	  neural	   crest	   cells	  and	  their	  derivatives,	  Rohon-­‐Beard	  neurons	  (Hernandez-­‐Lagunas	  et	  al.,	  2005,	  Roy	  and	  Ng,	  2004).	  The	  latter	  phenotype	  appears	  to	  be	  more	  severe	  in	  nrd	  than	  that	  of	  ubo,	  which	  can	  be	   explained	   by	   the	   differences	   in	   the	   DNA	   sequence	   changes	   caused	   by	   these	   two	  mutations.	  While	  nrd	   is	   a	  null	   allele,	   resulting	   from	  a	   truncation	  of	   the	  protein	  at	   amino	  acid	  154	  within	  the	  SET	  domain	  (Hernandez-­‐Lagunas	  et	  al.,	  2005),	  ubo	  is	  predicted	  to	  be	  a	  hypomorphic	  allele	  resulting	  from	  a	  missense	  mutation	  in	  the	  second	  zinc-­‐finger	  domain	  (Baxendale	  et	  al.,	  2004).	  Blimp1	   is	   a	   member	   of	   the	   PR	   domain	   zinc	   finger	   protein	   family,	   hence	   its	   alternative	  name	  Prdm1.	  Prdm	   family	  members	  are	   characterized	  by	   the	  presences	  of	   a	  PR	  domain	  and	  variable	  numbers	  of	   zinc	   fingers	   (Fumasoni	  et	   al.,	  2007).	  The	  PR	  domain	   is	  20-­‐30%	  identical	  to	  the	  SET	  domain	  (Fumasoni	  et	  al.,	  2007),	  a	  methyltransferase	  catalytic	  domain,	  however	  Prdm1	  appears	   to	   lack	   this	  activity	  and	   instead	  recruits	  chromatin-­‐remodelling	  enzymes	   to	   modulate	   transcriptional	   activity	   (Gyory	   et	   al.,	   2004).	   Prdm1	   contains	   five	  DNA	  binding	  zinc	  fingers,	  two	  acidic	  regions,	  a	  proline	  rich	  region	  and	  PEST	  sequences	  (a	  peptide	  sequence	  rich	   in	  proline,	  glutamic	  acid,	  serine	  and	  threonine)	  (John	  and	  Garrett-­‐Sinha,	  2009).	  In	  mammals,	  the	  role	  of	  Prdm1	  as	  a	  key	  regulator	  of	  various	  non-­‐muscle	  cell	  types	  is	  well	  established	  (John	  and	  Garrett-­‐Sinha,	  2009).	  For	  example	  in	  the	  B-­‐lymphocyte	  lineage,	   Prdm1	   acts	   as	   a	   transcriptional	   repressor	   to	   drive	   plasma	   cell	   differentiation	  (Turner	   et	   al.,	   1994),	   with	   multiple	   domains	   necessary	   for	   this	   repression	   (N-­‐terminal	  acidic	  domain,	  the	  proline	  rich	  region	  and	  the	  C-­‐terminal	  acidic	  domain)	  (Yu	  et	  al.,	  2000).	  In	   most	   cases,	   it	   acts	   in	   conjunction	   with	   co-­‐repressors	   such	   as	   histone	   deacetylases,	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histone	  methyltransferase	   enzymes	   and	   Groucho	   family	   proteins	   to	   repress	   target	   gene	  transcription	  (reviewed	  by	  John	  and	  Garrett-­‐Sinha,	  2009).	  This	  mode	  of	  activity	  seems	  to	  be	   conserved	   in	   zebrafish	   muscle,	   since	   forced	   expression	   of	   a	   Prdm1a-­‐EngR	   fusion	   is	  sufficient	   to	   rescue	   slow-­‐twitch	   fibre	   differentiation	   in	  ubo	   mutants	   (von	   Hofsten	   et	   al.,	  2008).	   Chromatin	   immunoprecipitation	   (ChIP)	   analysis	   revealed	   that	   regulatory	  sequences	   from	   fast-­‐specific	  muscle	   genes,	   fast	  myosin	   light	   chain	   2	   (mylz2),	   fast	  myosin	  
heavy	   chain	   (fmyhcx),	   troponin	   t	   3a	   (tnnt3a)	   and	   troponin	   i2	   (tnni2)	  were	   enriched	   in	  Prdm1-­‐precipitated	   chromatin	   verifying	   that	   Prdm1a	   promotes	   the	   slow	   twitch	  differentiation	  programme	  by	  direct	  repression	  of	  fast-­‐twitch	  lineage	  genes	  (von	  Hofsten	  et	   al.,	   2008)	   (Figure	   1.2).	   By	   contrast,	   slow-­‐specific	   genes,	   slow	   myosin	   heavy	   chain	   1	  
(smyhc1),	   slow	   troponin	   c	   1b	   (tnnc1b)	   and	   prox1a	   were	   not	   enriched,	   leading	   to	   the	  question	   of	   how	   the	   expression	   of	   slow-­‐twitch	   genes	   are	   activated	   in	   slow	   fibres,	   in	   a	  Prdm1a-­‐	  dependent	  manner.	  One	  possible	  explanation	  was	   that,	   if	  Prdm1a	   is	  acting	  as	  a	  repressor,	   it	   might	   be	   acting	   indirectly	   through	   one	   or	   more	   proteins	   to	   activate	   slow-­‐specific	   genes.	   Slow-­‐specific	   gene	   expression	   might	   be	   achieved	   by	   Prdm1a-­‐	   mediated	  repression	   of	   a	   repressor	   of	   slow	   muscle	   genes.	   	   Sox6	   was	   identified	   as	   a	   possible	  candidate	   for	   such	   a	   slow-­‐specific	   transcriptional	   repressor	   (von	   Hofsten	   et	   al.,	   2008)	  (Figure	  1.2).	  	  
	  
Figure	  1.2:	  Prdm1a	  acts	  as	  a	  switch	  that	  specifies	  slow-­‐twitch	  muscle	  differentiation	  in	  adaxial	  
cells	  by	  directly	  repressing	  the	  fast-­‐twitch	  muscle	  programme	  and	  repressing	  repressors	  of	  the	  
















	   22	  
1.5	  Prdm1	  in	  amniotes	  The	  prdm1	   gene	   is	  well	   conserved	  across	   the	  vertebrates	   and	   invertebrates.	  This	   strong	  conservation,	  combined	  with	  the	  fact	  that	  mouse	  Prdm1	  protein	  can	  rescue	  the	  phenotype	  of	  a	   zebrafish	  prdm1	  mutant	   suggests	  an	  evolutionarily	   conserved	   function	   for	   this	  gene	  (Liew	  et	  al.,	  2008).	  Prdm1	  is	  expressed	  dynamically	  throughout	  the	  mouse	  embryo	  during	  development,	  including	  the	  endoderm,	  ectoderm	  and	  mesoderm	  (Chang	  et	  al.,	  2002).	  As	  in	  zebrafish,	   the	   myotomal	   expression	   of	   mouse	   prdm1	   is	   dependent	   on	   Hh	   signalling	  (Vincent	   et	   al.,	   2012).	   However,	   in	   stark	   contrast	   to	   the	   zebrafish,	   tissue-­‐specific	  knockdown	   of	   prdm1	   has	   no	   detectable	   effect	   on	   the	   early	   formation	   of	   the	   mouse	  myotome,	   with	   normal	   onset	   of	   smyhc	   expression	   in	   mutant	   embryos	   (Vincent	   et	   al.,	  2012).	   Loss	   of	   prdm1	   in	   the	   muscle	   also	   had	   no	   effect	   on	   sox6	   expression,	   a	   known	  repressor	  of	  slow	  muscle	  in	  both	  mouse	  and	  zebrafish	  (Vincent	  et	  al.,	  2012).	  The	  exact	  role	  of	   Prdm1	   in	   mouse	   myogenesis	   remains	   obscure.	   Similarly,	   Prdm1	   expression	   is	   not	  restricted	  to	  fast	  or	  slow	  muscle	  cells	  in	  cultured	  avian	  somite-­‐derived	  cells	  (Beermann	  et	  al.,	   2010).	  Unlike	   in	   zebrafish	  where	   there	   is	  only	   transient	  expression	  of	  prdm1a	   in	   the	  myotome	  during	  development	   (Baxendale	  et	  al.,	   2004,	  Liew	  et	  al.,	   2008),	   chick	  prdm1	   is	  expressed	  both	  at	  early	  stages	  of	  myogenesis	  and	  in	  terminally	  differentiated	  muscle	  cells.	  Moreover,	  chick	  prdm1	   it	   is	  also	  required	  for	  the	  expression	  of	  both	  slow	  and	  fast	  MyHC	  isoforms	  (Beermann	  et	  al.,	  2010),	  in	  contrast	  to	  its	  role	  in	  zebrafish,	  where	  prdm1a	  is	  only	  required	  for	  the	  expression	  of	  slow	  muscle	  genes.	  It	  is	  notable	  that	  even	  in	  the	  zebrafish,	  Prdm1a	   activity	   is	   not	   absolutely	   required	   for	   all	   slow	   fibre	   specification.	   A	   small	  population	  of	  slow	  fibres,	  distinguished	  by	  their	  expression	  of	  the	  smyhc2	  gene,	  have	  been	  shown	  to	  differentiate	   in	   the	  absence	  of	  Prdm1a	  function	  (Elworthy	  et	  al.,	  2008).	  On	  the	  other	   hand,	   Prdm1a	   is	   required	   for	   secondary	   slow	   twitch	   fibres	   that	   are	   specified	  independently	   of	   Hh	   signalling	   (Barresi	   et	   al.,	   2000).	   These	   results	   suggest	   some	  evolutionary	  divergence	  of	  the	  roles	  of	  Prdm1,	  in	  fish,	  birds	  and	  mammals.	  
1.6	  Sox6	  Members	  of	  the	  Sox	  family	  of	  transcription	  factors	  are	  characterised	  by	  the	  presence	  of	  a	  high	  mobility	  group	  (HMG)	  box,	  which	  is	  an	  evolutionarily	  conserved	  DNA	  binding	  domain	  consisting	  of	  79	  amino	  acids	   (Schepers	  et	  al.,	  2002).	  Unlike	   the	  majority	  of	  DNA-­‐binding	  proteins	  that	  target	  the	  major	  groove	  of	  DNA,	  Sox	  proteins	  interact	  with	  the	  minor	  groove	  of	  the	  DNA	  helix	  and	  are	  able	  to	  induce	  a	  dramatic	  bend	  in	  the	  DNA	  molecule	  (Grosschedl	  et	  al.,	  1994,	  Wegner,	  1999).	  This	  characteristic	  has	  led	  to	  the	  hypothesis	  that	  Sox	  proteins	  can	   function	   as	   architectural	   proteins	   by	   assembling	   other	   DNA-­‐bound	   transcription	  factors	  and	  organising	  local	  chromatin	  structure	  (Werner	  and	  Burley,	  1997,	  Wolffe,	  1994).	  Indeed,	   although	   the	  HMG	  boxes	   of	   Sox	   genes	   bind	   to	   a	   similar	  AT-­‐rich	   sequence	  motif,	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they	   are	   able	   to	   modulate	   unique	   sets	   of	   target	   genes	   in	   specific	   cells	   types	   through	  recruitment	  of	  different	  interaction	  protein	  partners	  (Kamachi	  et	  al.,	  2000).	  Thus,	  each	  Sox	  gene	  can	  regulate	  its	  own	  distinct	  set	  of	  target	  genes	  during	  the	  differentiation	  of	  different	  cell	  types.	  Sox	  proteins	  are	  subgrouped	  based	  on	  similarities	  in	  their	  amino	  acid	  sequence	  (Schepers	   et	   al.,	   2002).	   Sox6	  belongs	   to	   group	  D,	   along	  with	   Sox5	   and	   Sox13,	  which	   are	  distinguished	  by	  the	  presence	  of	  a	  leucine	  zipper	  and	  glutamine-­‐rich	  domain	  located	  in	  the	  N-­‐terminal	  half	  of	  the	  protein	  (Kamachi	  et	  al.,	  2000,	  Wegner,	  1999).	  The	  leucine	  zipper	  of	  group	   D	   Sox	   proteins	   is	   followed	   by	   a	   glutamine-­‐rich	   region	   with	   which	   it	   forms	   a	  contiguous	   coiled-­‐coil	   domain	   (Wegner,	   1999).	   This	   coiled-­‐coil	   domain	   is	   one	   of	   the	  known	  functional	  domains	  of	  Sox	  D	  proteins	  along	  with	  the	  HMG	  box	  (Connor	  et	  al.,	  1995,	  Lefebvre	  et	  al.,	  1998).	  The	  leucine	  zipper	  allows	  homodimerization	  or	  heterodimerization	  between	   group	   D	   Sox	   proteins,	   greatly	   increasing	   the	   binding	   efficiency	   of	   the	   two	   Sox	  proteins	  to	  adjacent	  Sox	  sites,	  but	  also	  serves	  to	  mediate	  interactions	  with	  other	  proteins,	  examples	  of	  which	  are	  discussed	  below.	  	  Sox6	   is	   able	   to	   regulate	   many	   different	   processes	   in	   a	   variety	   of	   cell	   types	   (Hagiwara,	  2011).	   Like	  other	   Sox	  proteins,	   it	   achieves	   specificity	   as	  part	   of	  multiprotein	   complexes,	  additional	   components	  of	  which	  are	  unique	   to	  different	   cell	   types.	   Importantly	   the	   Sox6	  protein	   lacks	   a	   transcriptional	   regulatory	   domain	   (i.e.	   an	   activator	   or	   repressor),	  which	  enables	   it	   to	   pair	   with	   a	   number	   of	   different	   partner	   proteins,	   resulting	   in	   a	   range	   of	  distinct	  roles	  in	  transcriptional	  regulation,	  depending	  on	  the	  tissue-­‐type	  or	  developmental	  stage	   (Kamachi	  et	  al.,	  2000).	   In	  both	  mice	  and	  zebrafish	   the	  ability	  of	  Sox6	   to	   regulate	  a	  number	   of	   different	   processes,	   is	   reflected	   in	   the	   expression	   of	   the	   gene	   in	   a	   variety	   of	  distinct	  tissues.	  In	  zebrafish,	  expression	  of	  sox6	  has	  been	  reported	  in	  the	  somites,	  pectoral	  fin,	   otic	   vesicles,	   kidney,	   retina,	   optic	   tectum	   and	   in	   other	   specific	   regions	   of	   the	   brain	  (Wang	   et	   al.,	   2011).	   In	   some	   of	   these	   tissues,	   sox6	  plays	   an	   essential	   role,	   but	   in	   others	  tissues,	  sox6	  exhibits	   functional	   redundancy	  with	  other	  SoxD	   family	  members,	  especially	  
sox5.	  For	  example	  during	  mouse	  chondrogenesis	  Sox6,	  Sox5,	  and	  Sox9	  are	   important	   for	  the	  establishment	  and	  differentiation	  of	  chondrocytes	  (Hattori	  et	  al.,	  2008,	  Lefebvre	  et	  al.,	  1998).	  Sox5	  and	  Sox6	  dimerise	   through	   their	   coiled	  coil	  domains	   to	  greatly	   increase	   the	  binding	  efficiency	  of	  the	  two	  Sox	  proteins	  to	  DNA	  sequences	  that	  contain	  adjacent	  Sox	  sites	  to	   directly	   activate	   chondrocyte-­‐specific	   gene	  markers	   (Lefebvre	   et	   al.,	   1998).	   In	   sox5-­‐/-­‐	  and	   sox6-­‐/-­‐	   single	   null	   knockout	   mice,	   the	   mineralization	   of	   only	   a	   small	   subset	   of	  endochondral	   elements	   are	   affected.	   However,	   in	   double	   mutant	   sox5-­‐/-­‐;sox6-­‐/-­‐	   knockout	  mice,	  there	  is	  severe	  underdevelopment	  of	  the	  skeleton	  and	  cartilage	  (Smits	  et	  al.,	  2001).	  This	   indicates	   the	   existence	   of	   functional	   redundancy	   between	   these	   two	   transcription	  factors,	  although	  this	   is	  not	  complete,	  as	  there	  is	  a	  minor	  effect	  on	  cartilage	  formation	  in	  the	  sox5-­‐/-­‐	  and	  sox6-­‐/-­‐	  single	  mutants	  (Smits	  et	  al.,	  2001).	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During	   development	   of	   the	   chondrocyte	   lineage,	   Sox5	   and	   Sox6	   further	   cooperate	   with	  Sox9	  to	  suppress	   the	  entry	  of	  chondroblasts	   into	   the	  cell	  cycle	   (Han	  and	  Lefebvre,	  2008,	  Lefebvre	   et	   al.,	   1998).	   Moreover,	   chondrogenesis	   depends	   on	   interactions	   between	   Sox	  proteins	   and	   histone	   modifying	   enzymes.	   These	   enzymes	   are	   able	   to	   change	   the	  transcriptional	  status	  of	  a	  gene	  reversibly	  by	  modifying	  core	  histones,	  so	  called	  epigenetic	  changes,	  by	  acetylation	  or	  methylation	  of	  basic	  amino	  acids	   in	  their	  N-­‐terminal	  domains.	  Histone	   Acetyltransferases	   (HATs)	   add	   acetyl	   groups	   onto	   certain	   histone	   residues,	  whereas	  Histone	  Deacetylases	  (HDACs)	  are	  able	  to	  remove	  these	  acetylation	  marks.	  Sox9	  interacts	   with	   HAT	   Tip60	   through	   its	   C-­‐terminal	   transactivation	   domain	   in	   order	   to	  regulate	  the	  expression	  of	  cartilage-­‐specific	  genes	  (Hattori	  et	  al.,	  2008).	  The	  acetylation	  of	  histones	   by	   Tip60	   may	   be	   important	   for	   the	   ability	   of	   Sox9	   to	   enhance	   transcriptional	  activity	   of	   cartilage-­‐specific	   genes.	   Similarly,	   in	   the	   pancreas	   Sox6	   regulates	   glucose-­‐stimulated	   insulin	   secretion	   from	   β-­‐cells	   by	   repressing	   the	   Cyclin	   D1	   promoter	   through	  recruitment	   of	   the	   histone	   deacetylase	   HDAC1	   and	   interacting	  with	   promoter-­‐bound	   β-­‐catenin	  protein,	  rather	  than	  by	  binding	  directly	  to	  Cyclin	  D1	  (Iguchi	  et	  al.,	  2007).	  	  In	  recent	  years,	  there	  has	  been	  a	  vast	  increase	  in	  our	  understanding	  of	  the	  biological	  and	  molecular	   functions	   of	   SoxD	   proteins	   in	  mammals.	   The	   role	   of	   this	   group	   of	   proteins	   in	  zebrafish	  however,	  is	  less	  well	  characterised.	  
1.7	  Sox6	  in	  myogenesis	  Sox6	   was	   first	   implicated	   in	   muscle	   fibre	   differentiation	   through	   studies	   in	   mouse	  (Hagiwara	  et	  al.,	  2000,	  Hagiwara	  et	  al.,	  2005,	  Hagiwara	  et	  al.,	  2007).	  Microarray	  analyses	  performed	   on	   mice	   homozygous	   for	   a	   targeted	   mutation	   of	   the	   sox6	   gene	   showed	   a	  significant	   increase	   in	   the	   expression	   of	   slow-­‐specific	   genes	   as	   well	   as	   a	   significant	  decrease	   in	   the	   expression	   of	   fast-­‐specific	   genes	   compared	   to	   wild-­‐type	   littermates	  (Hagiwara	   et	   al.,	   2005).	   These	   results	   suggested	   that	   the	   loss	   of	   sox6	   expression	   could	  relieve	  the	  transcriptional	  repression	  of	  slow-­‐specific	  genes	  in	  foetal	  muscle.	  In	  zebrafish,	  transcription	   of	   sox6	   is	   activated	   specifically	   in	   fast	   twitch	   fibre	   progenitors	   at	   the	   10-­‐somite	  stage	  in	  response	  to	  MyoD	  and	  Myf5	  activity	  (Wang	  et	  al.,	  2011).	  Forced	  expression	  of	   sox6	   in	   adaxial	   cells	   in	   wild-­‐type	   embryos	   inhibited	   Prox1a	   expression,	   whereas	  morpholino	  mediated	  knockdown	  of	  Sox6	  resulted	  in	  a	  partial	  rescue	  of	  Prox1a,	  complete	  rescue	  of	  smyhc1	  expression	  in	  the	  adaxial	  cells	  of	  ubo	  mutants	  and	  caused	  robust	  ectopic	  expression	  of	  the	  slow	  twitch	  specific	  tnnc1b	  gene	  in	  fast	  muscle	  fibres	  of	  genetically	  wild-­‐type	   fish	   (von	   Hofsten	   et	   al.	   2008).	   These	   findings	   are	   consistent	   with	   Sox6	   acting	   to	  repress	   the	   slow	   twitch	   differentiation	   programme	   in	   fast	   twitch	  myoblasts.	   In	  ubo/nrd	  mutant	   embryos,	   sox6	   is	   ectopically	   expressed	   in	   adaxial	   cells	   (von	  Hofsten	  et	   al.	   2008),	  indicating	  that	   its	  repression	  by	  Prdm1a	  underlies	   the	  activation	  of	  slow-­‐lineage-­‐specific	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genes	   in	   these	   cells.	  However,	  whether	  or	  not	   sox6	   is	   a	  direct	   target	  of	  Prdm1a	   remains	  unclear;	  no	  enrichment	  of	  Sox6	  regulatory	  sequences	  by	  Prdm1a	  ChIP	  has	  been	  reported	  and	  mutation	  of	  potential	  Prdm1	  binding	  sites	  in	  the	  cis-­‐acting	  regulatory	  elements	  of	  sox6	  had	  no	  effect	  on	  reporter	  gene	  expression	  (Wang	  et	  al.	  2011).	  	  Although	  these	  data	  support	  a	  simple	  model	  whereby	  Prdm1a	  acts	  to	  repress	  fast-­‐specific	  genes	  and	  promote	  slow-­‐specific	  gene	  expression	  by	  repressing	  sox6,	   the	   inability	  of	   the	  Sox6	  morpholino	  to	  cause	  in	  ectopic	  expression	  of	  all	  slow	  muscle	  genes	  in	  the	  fast	  muscle	  implies	  that	  either	  the	  knockdown	  of	  Sox6	  was	  incomplete	  or	  other	  factors	  are	  involved	  in	  this	  regulatory	  network.	  	  
1.8	  Post-­‐transcriptional	  regulation	  of	  fibre-­‐type	  identity	  Another	  conundrum	  posed	  by	  the	  transient	  nature	  of	  prdm1a	  expression	  in	  adaxial	  cells,	  is	  how	  the	  repression	  of	  Sox6	  activity	  is	  maintained	  in	  slow-­‐twitch	  progenitors	  once	  prdm1a	  expression	   has	   been	   extinguished.	   One	   explanation,	   given	   its	   capacity	   to	   direct	   histone	  methylation	   (Ancelin	   et	   al.,	   2006),	   could	   be	   that	   Prdm1a	   is	   able	   to	   cause	   the	  transcriptional	  shutdown	  of	  sox6	  through	  chromatin	  modifications.	  It	  is	  however,	  unclear	  whether	  sox6	  is	  a	  direct	  target	  of	  Prdm1a;	  mutation	  of	  potential	  Prdm1	  binding	  sites	  in	  the	  
cis-­‐acting	  regulatory	  elements	  of	  sox6	  had	  no	  effect	  on	  reporter	  gene	  expression	  (Wang	  et	  al.,	   2011).	   In	   any	   case,	   the	   slow-­‐specific	   repression	   of	   sox6	   transcription	   is	   lost	   by	   early	  larval	   stages,	   arguing	   against	   this	   model	   (Wang	   et	   al.,	   2011).	   Notably	   however,	   the	  accumulation	  of	  Sox6	  protein	  remains	  restricted	   to	   the	   fast	   twitch	   fibres	  suggesting	   that	  repression	   is	   maintained	   at	   the	   post-­‐transcriptional	   level	   (Wang	   et	   al.	   2011).	   Recent	  studies	   have	   shown	   that	   the	   microRNA	   miR-­‐499	   can	   regulate	   sox6	   transcript	   levels	   in	  mammalian	  myofibres	   (McCarthy	   et	   al.	   2009;	   van	   Rooij	   et	   al	   2009).	   MicroRNAs	   inhibit	  translation	  by	  binding	  to	  the	  3’	  UTR	  of	  a	  gene.	   Indeed,	   in	  zebrafish,	   the	  endogenous	  sox6	  3’UTR,	  can	  restrict	  reporter	  gene	  expression	  to	  the	  fast	  fibres	  at	  6	  dpf	  (Wang	  et	  al.,	  2011).	  The	  zebrafish	  sox6	  3’UTR	  contains	  consensus	  recognition	  sites	   for	   the	  SEED	  sequence	  of	  miR-­‐499,	  which	  is	  encoded	  by	  the	  intron	  of	  the	  slow	  specific	  gene	  slow	  myosin	  heavy	  chain	  
b	   (Myh7b).	   When	   these	   sites	   are	   mutated	   in	   the	   sox6:eGFP	   construct	   containing	   the	  endogenous	  sox6	  3’UTR	  ectopic	  EGFP	  expression	  appears	  in	  slow	  specific	  fibres.	  Moreover	  misexpression	  of	  miR-­‐499	  in	  the	  fast	  muscle	  using	  the	  UAS;GAL4	  system	  results	  in	  a	  loss	  of	  
sox6	  in	  the	  fast-­‐twitch	  muscle,	  revealing	  miR-­‐499	  is	  sufficient	  to	  repress	  sox6	  (	  Wang	  et	  al.	  2011).	  	  Whether	   fast-­‐specific	   gene	   expression	   is	   also	   regulated	   by	   miR-­‐499	   remains	   to	   be	  answered;	   if	   sox6	   repression	   needs	   to	   be	   maintained	   by	   miR-­‐499	   in	   larvae	   after	   the	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expression	  of	  Prdm1a	  is	  extinguished	  at	  24	  hpf	  (Liew	  et	  al.,	  2008),	  this	  suggests	  that	  fast-­‐specific	  genes	  may	  also	  be	  repressed	  by	  miR-­‐499.	  	  	  Taken	   together,	   these	   studies	   suggest	   a	   Shh-­‐activated	   gene	   regulatory	   network	   through	  which	   the	   slow-­‐twitch	   lineage	   is	   established	   at	   least	   in	   part	   by	   Prdm1a-­‐mediated	  transcriptional	  repression	  of	  Sox6,	  a	  repressor	  of	  a	  sub-­‐set	  of	  slow-­‐twitch	  specific	  genes.	  This	   network	   is	   then	   maintained	   by	   post-­‐translational	   repression	   of	   sox6	   by	   miR-­‐499,	  expression	  of	  whose	  host	  gene,	  myh7b,	  is	  itself	  negatively	  regulated	  by	  Sox6,	  establishing	  a	  two-­‐way	  feedback	  loop	  (Figure	  1.3).	  The	  implication	  of	  the	  indirect	  repression	  of	  sox6	  by	  Prdm1a	  and	  the	  inability	  of	  the	  loss	  of	  sox6	  to	  cause	  ectopic	  expression	  of	  all	  slow	  twitch	  fibre	   specific	   genes	   indicates	   that	   other	   key	   components	   of	   this	   network	   remain	   to	   be	  discovered.	  	  
	  
Figure	   1.3:	   Shh	   signalling	   activates	   a	   gene	   regulatory	   network	   that	   specifies	   and	  
maintains	   the	   slow-­‐twitch	   fibre	   lineage	   through	   transcriptional	   and	   post-­‐
transcriptional	  feedback	  regulation.	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expression	  of	  the	  slow	  myosin	  heavy	  chain	   isoform	  is	  up-­‐regulated	  in	  sox6	  mutant	   foetal	  fibres	  in	  mice.	  	  A	  further	  similarity	  between	  mammals	  and	  fish	  is	  found	  in	  the	  regulation	  of	  Sox6	  by	  micro	  RNAs.	  As	  mentioned	  above,	  miR-­‐499,	  encoded	  by	  myh7b,	  regulates	  sox6	  transcript	   levels	  in	  both	  fish	  and	  mammalian	  myofibres.	  Contrastingly,	   the	  microRNA-­‐mediated	  inhibition	  of	  sox6	  in	  zebrafish	  leads	  to	  the	  inhibition	  of	  translation,	  whereas	  in	  mouse	  it	  appears	  miR-­‐499	   promotes	   the	   degradation	   of	   the	   transcript	   (McCarthy	   et	   al.,	   2009,	   van	   Rooij	   et	   al.,	  2009).	  	  In	  addition	  to	  its	  role	  in	  regulating	  the	  differentiation	  of	  fibre	  types	  in	  the	  mouse	  embryo,	  Sox6	  also	  plays	  an	  essential	  role	  in	  maintaining	  fibre	  -­‐type	  identity	  in	  adult	  mice	  (Quiat	  et	  al.,	  2011).	  The	  conditional	  knockout	  of	  sox6	  in	  adult	  mouse	  muscle	  results	  in	  a	  conversion	  of	  fast	  muscle	  fibres	  to	  a	  slow	  muscle	  phenotype.	  The	  mechanism	  for	  this	  switch	  appears	  to	   be	   independent	   of	   other	   known	   fibre-­‐type	   switching	   pathways	   such	   as	   Pgc-­‐1αm,	   a	  transcriptional	   coactivator	   sufficient	   to	   drive	   slow	   fibre	   formation,	   and	   phosphorylated	  AMPK,	  a	  regulator	  of	  muscle	  fibre-­‐type	  transition	  in	  response	  to	  endurance	  exercise	  (Quiat	  et	  al.,	  2011).	  In	  muscular	  atrophy	  studies	  in	  adult	  mice,	  miR-­‐499	  represses	  sox6	  such	  that	  when	  miR-­‐499	   expression	   is	   decreased	   in	   response	   to	   hindlimb	   suspension,	   this	   results	  leads	   to	   increased	   expression	   of	   sox6	   and	   a	   subsequent	   decrease	   in	   smyhc	   isoforms	  (McCarthy	   et	   al.,	   2009).	   This	   example	   provides	   rare	   evidence	   of	   a	   transcription	   factor	  acting	   in	   both	   the	   developmental	   and	   physiological	   programmes	   of	   fibre	   type	  differentiation.	   It	  would	  be	   interesting	   to	   explore	  whether	   this	   fibre	   type-­‐switching	   role	  for	  Sox6	   is	   conserved	  across	  other	   species,	   and	  whether	   sox6	   and	  miR-­‐499	   have	   roles	   in	  atrophy	  and	  fibre	  switching	  in	  adult	  fish.	  	  A	  perhaps	  notable	  difference	  between	  fish	  and	  mammals	  is	  the	  expression	  pattern	  of	  sox6.	  It	  is	  unclear	  from	  the	  literature	  whether,	  like	  zebrafish,	  sox6	  protein	  is	  excluded	  from	  the	  slow	  muscle	  in	  the	  mouse.	  However,	  reports	  suggest	  that	  in	  contrast	  to	  zebrafish,	  sox6	   is	  expressed	   in	   slow	   fibres	   of	   adult	   mice,	   albeit	   at	   a	   significantly	   lower	   level	   than	   its	  expression	   level	   in	   the	   fast	   muscle	   (Quiat	   et	   al.,	   2011),	   with	   its	   expression	   in	   mouse	  embryos	   remaining	   obscure.	   This	   raises	   the	   question	   of	   how	   repression	   of	   slow	   fibre	  genes	  is	  specific	  to	  the	  fast	  muscle	  and	  whether	  there	  is	  a	  role	  for	  sox6	  in	  the	  slow	  muscle.	  The	  importance	  of	  Sox6	  in	  both	  mouse	  and	  zebrafish	  muscle	  fibre	  type	  differentiation	  and	  maintenance	   implies	   a	   conserved	   function,	   yet	   key	   differences	   are	   apparent	   in	   its	  regulation.	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1.10	  Adaxial	  cell	  migration	  Shortly	   after	   adaxial	   cells	   commit	   to	   the	   slow-­‐twitch	   lineage,	   the	  majority	   of	   these	   cells	  begin	  to	  traverse	  the	  myotome	  before	  differentiating	  into	  the	  subcutaneous	  layer	  of	  slow-­‐twitch	  fibres	  (Devoto	  et	  al.,	  1996).	  Only	  the	  Muscle	  Pioneers	  (MPs)	  remain	  in	  their	  medial	  location	   and	   elongate	   to	   span	   the	   width	   of	   the	   myotome,	   so	   forming	   the	   horizontal	  myoseptum.	  Relatively	  little	  is	  known	  about	  the	  control	  of	  this	  migration	  and	  whether	  it	  is	  directed	  by	  a	  secreted	  signalling	  molecule,	  or	  if	  instead	  it	  is	  contact	  dependent.	  	  Cortes	   et	   al	   (2003)	   highlighted	   the	   dynamic	   and	   complementary	   expression	   patterns	   of	  the	   calcium-­‐dependent	   cell	   adhesion	   proteins,	   M-­‐Cadherin	   and	   N-­‐Cadherin,	   implicating	  them	   as	   key	   mediators	   of	   adaxial	   cell	   migration.	   Waves	   of	   expression	   of	   the	   genes	  encoding	  both	  proteins	  pass	  through	  the	  myotome	  as	  the	  adaxial	  cells	  migrate,	  with	  high-­‐level	  expression	  of	  both	  genes	  uniquely	  defining	  the	  migrating	  cells.	  According	  to	  Cortes	  et	  al,	  it	  is	  the	  homophilic	  interaction	  between	  neighbouring	  cells	  promoted	  by	  both	  proteins	  that	  drives	  adaxial	   cell	  migration.	  Consistent	  with	   this	  view,	  expression	  of	  M-­‐cadherin	   is	  down-­‐regulated	   specifically	   in	   the	   non-­‐migratory	   MPs,	   while	   loss	   of	   either	   cadherin	   or	  overexpression	  of	  N-­‐cadherin	  disrupts	  adaxial	  cell	  migration	  (Cortes	  et	  al.,	  2003).	  Notably,	   however,	   most	   adaxial	   cells	   fail	   to	   complete	   their	   migration	   in	   the	   absence	   of	  Prdm1a	  function	  (Baxendale	  et	  al.,	  2004,	  Roy	  et	  al.,	  2001,	  von	  Hofsten	  et	  al.,	  2008).	  Wild-­‐type	   slow	   muscle	   progenitor	   transplants	   are	   able	   to	   differentiate	   into	   mononucleated	  fibres	  and	  migrate	  accordingly	   in	  prdm1a	  mutants,	   indicating	   that	  Prdm1a	   is	  acting	  cell-­‐autonomously	   (Roy	   et	   al.	   2001).	   This	   finding	   implicates	  prdm1a	   as	   a	   key	   factor	   in	   slow	  fibre	  migration.	  Although	  Cortes	  et	  al	  noted	   increased	  repression	  of	  M-­‐Cadherin	  close	   to	  the	  midline	  in	  prdm1a	  mutants,	  its	  expression	  in	  the	  majority	  of	  the	  adaxial	  cell	  population	  appears	   unaffected	   by	   this	   mutation,	   therefore	   the	   spatially	   regulated	   expression	   of	  cadherins	  alone	  is	  not	  sufficient	  to	  drive	  migration.	  The	  differential	  expression	  other	  genes	  in	  SSF	  and	  MPs,	  such	  as	  engrailed	  could	  be	  accountable	  for	  this	  migratory	  behaviour,	  but	  this	   possibility	   remains	   to	   be	   investigated.	   These	   observations	   also	   raise	   the	   issue	   of	  whether	   MPs	   are	   specified	   as	   such	   because	   they	   don’t	   migrate	   or	   rather,	   they	   don’t	  migrate	   because	   they	   are	   specified.	   Overall,	   the	   migration	   of	   slow	   muscle	   precursor	  through	   the	   zebrafish	  myotome	   is	   a	   process	   that	   remains	   poorly	   understood,	   and	  more	  research	  is	  needed	  to	  identify	  the	  protein	  components	  of	  the	  mechanisms	  involved	  in	  this	  process.	  	  	  
1.11	  Fast	  muscle	  specification	  The	  majority	  of	  the	  zebrafish	  myotome	  is	  composed	  of	  multinucleated	  fast-­‐twitch	  muscle	  fibres.	   Myoblasts	   become	   committed	   to	   the	   fast	   twitch	   lineage	   after	   their	   slow-­‐twitch	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counterparts,	   and	   the	   differentiation	   of	   fast-­‐twitch	   myoblasts	   begins	   only	   after	   adaxial	  cells	  have	  migrated	  past	  them.	  	  The	  delayed	  commitment	  of	  cells	  to	  the	  fast	  lineage	  is	  reflected	  in	  the	  later	  onset	  of	  MyoD	  expression	   in	   the	   characteristic	   “wings”	   in	   each	   somite,	   from	   which	   the	   fast	   fibres	   are	  derived.	  MyoD	  expression	   is	  reduced	   in	   the	   fgf8	  mutant	  acerebellar	   (Reifers	  et	  al.,	  1998)	  suggesting	  a	  possible	  role	  for	  FGFs	  in	  activating	  the	  Shh-­‐independent	  expression	  of	  myoD.	  In	   fgf8	  morphants,	  myoD	   is	   lost	   in	  the	   lateral	   fast	  muscle	  precursors,	  concomitant	  with	  a	  loss	  of	  fast	  myosin	  heavy	  chain	  expression	  (Groves	  et	  al.,	  2005),	  suggesting	  a	  requirement	  for	   FGFs	   in	   fast	   muscle	   differentiation.	   Evidence	   suggests	   that	   Retinoic	   Acid	   (RA)	   is	  responsible	   for	   activating	   fgf8	   expression,	   with	   inhibition	   of	   RA	   resulting	   in	   the	  downregulation	   fgf8	   and	   its	   target	   genes	   (Hamade	   et	   al.,	   2006).	   Interestingly	   the	   more	  medial	  fast	  muscle	  precursors	  express	  myoD	  independently	  of	  FGF8	  and	  Hh	  signalling.	  The	  distinction	   between	   these	   FGF8-­‐	   and	   Hh-­‐	   independent	   fast-­‐twitch	   fibres	   and	   the	   eng-­‐positive	  Medial	  Fast	  Fibres	  (MFFs)	  is	  unclear	  as	  eng	  expression	  was	  not	  assessed	  in	  these	  residual	   fibres.	   However,	   these	   FGF8-­‐	   and	   Hh-­‐	   independent	   fibres	   can	   be	   ablated	   by	  mutations	   that	   abolish	   midline	   patterning,	   suggesting	   dependence	   on	   another	   midline	  signal	   (Groves	   et	   al.	   2005).	   Although	   Hh	   signalling	   is	   not	   required	   for	   the	   early	  specification	   of	   fast	   muscle	   fibres,	   there	   is	   a	   later	   role	   for	   Hh	   in	   regulating	   the	  differentiation	  of	  the	  dermomyotome	  into	  fast	  muscle	  fibres	  (Feng	  et	  al.,	  2006).	  The	  homeodomain	  transcription	  factor	  Six1	  has	  been	  implicated	  in	  the	  specification	  of	  fast	  muscle	  fibres	  in	  both	  mice	  and	  fish	  (Bessarab	  et	  al.,	  2008,	  Grifone	  et	  al.,	  2004,	  Niro	  et	  al.,	  2010).	  Expression	  of	   the	  MRF,	  myogenin	   (myog),	   follows	   the	  expression	  of	  myod	   in	  both	  fast	   and	   slow	  muscle	   precursors	   (Weinberg	   et	   al.,	   1996).	   In	   zebrafish	   six1a	  morphants,	  early	  myog	  expression	  is	  lost	  exclusively	  from	  fast	  muscle	  precursors	  with	  a	  concomitant	  reduction	   in	   expression	  of	   fast	  muscle	   genes;	  however	   the	   expression	  of	  both	  myog	  and	  fast	  muscle	   genes	   is	   restored	   at	   later	   stages	   (Bessarab	   et	   al.,	   2008).	   This	   indicates	   that	  although	   six1a	   is	   important	   in	   controlling	   the	   onset	   of	   fast	  muscle	   differentiation,	   other	  factors	   are	   also	   needed	   for	   the	   regulation	   of	  myog	   in	   fast	   precursors,	   and	   also	   that	   the	  expression	  of	  myog	  is	  differentially	  regulated	  in	  fast	  and	  slow	  muscle	  precursors.	  A	  second	  six	  gene,	  six4a	  (six4.2)	  is	  also	  expressed	  in	  the	  somites,	  although	  unlike	  six1a	  its	  expression	  is	  not	  excluded	  from	  the	  adaxial	  cells	  (Kobayashi	  et	  al.,	  2000).	  The	  role	  of	  six4a	  in	  zebafish	  myogenesis	  remains	  unknown	  but	  the	  protein	  could	  be	  responsible	   for	  two	  things:	  (a)	   it	  could	   be	   responsible	   for	   the	   later	   activation	   of	   myog	   and	   fast	   specific	   genes	   in	   six1a	  morphants,	   and	   (b)	   it	   could	   also	   be	   necessary	   for	   the	   initial	   activation	   of	   myog	   in	   the	  adaxial	  cells,	  a	  process	  in	  which	  six1a	  does	  not	  play	  a	  part.	  	  
Similarly,	   the	  Six	  proteins	  appear	   to	  play	  a	   role	   in	  activating	   the	   fast-­‐specific	  network	  of	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genes	   in	  mice.	  The	  knockdown	  of	  both	  six1	  and	  six4	  results	   in	  a	  downregulation	  of	  myog	  and	   fast-­‐specific	   genes	   in	   the	   primary	   myotome,	   with	   ChIP	   analysis	   revealing	   a	   direct	  interaction	   between	   fast	   genes	   and	   Six	   homeoproteins	   (Niro	   et	   al.,	   2010).	   Curiously	   it	  appears	   that	   the	   slow-­‐specific	   gene	   tnnc1	   is	   also	  directly	  downregulated	   in	   six	  mutants;	  unlike	  in	  adult	  mice,	  fast-­‐specific	  and	  slow-­‐specific	  genes	  are	  co-­‐expressed	  in	  the	  myocytes	  present	  in	  the	  primary	  myotome	  (Niro	  et	  al.,	  2010).	  	  
In	   adult	   mice,	   overexpression	   of	   six1	   reveals	   its	   ability	   to	   transform	   a	   slow/oxidative	  phenotype	  to	  a	  fast/glycolytic	  phenotype	  (Grifone	  et	  al.,	  2004).	  Like	  Sox6,	  it	  appears	  that	  Six1	  stands	  out	  as	  one	  of	  the	  few	  transcription	  factors	  involved	  in	  both	  embryonic	  muscle	  fibre-­‐type	   specification	   and	   fibre-­‐type	   switching	   in	   adults.	   The	   conserved	   roles	   of	   Six	  proteins	   in	   activating	   fast	  muscle	   genes	  during	   embryogenesis,	   suggests	   that	   as	   in	  mice,	  Six	  proteins	  may	  also	  have	  a	  role	  in	  adult	  fish.	  	  
A	  second	  set	  of	  homeodomain	  proteins,	  the	  Pbx	  proteins,	  have	  also	  been	  associated	  with	  the	  activation	  of	  fast-­‐specific	  muscle	  genes	  (Maves	  et	  al.,	  2007).	  Pbx	  appears	  to	  modulate	  the	  broad	  range	  of	  MyoD	  targets,	  directing	  cells	  to	  a	  fast	  twitch	  fate.	  Although	  Pbx	  proteins	  are	   expressed	   in	   both	   the	   presumptive	   slow	   and	   fast	   muscle,	   knockdown	   of	   Pbx	   only	  results	   in	   downregulation	   of	   fast	   specific	   genes,	   leaving	   slow-­‐twitch	   genes	   unaffected.	  More	   specifically,	   it	   is	   only	   the	   lateral	   fast	   fibres	   that	   are	   affected,	  with	   the	  eng	  positive	  fibres	  appearing	  normal	  (Maves	  et	  al.,	  2007).	  How	  Pbx	  proteins	  facilitate	  the	  activation	  of	  a	  specific	  subset	  of	  genes	  by	  MyoD	  remains	  unknown;	  one	  possibility	  is	  that	  they	  interact	  with	  Six	  proteins	  to	  regulate	  this	  network	  of	  genes.	  	  	  
1.12	  Myoblast	  fusion	  Fast-­‐twitch	   muscle	   precursors	   fuse	   with	   each	   other	   to	   form	   a	   multinucleated	   array	   of	  syncytial	   fibres,	   in	  contrast	  to	  slow	  twitch	  precursors,	  which	  are	  fusion	  incompetent	  and	  mature	   into	  mononucleated	   fibres	   (Devoto	   et	   al.,	   1996,	   Roy	   et	   al.,	   2001).	   In	  Drosophila,	  
Dumbfounded,	   an	   Ig-­‐domain	   transmembrane	   protein,	   is	   essential	   for	   fusion	   of	   muscle	  founder	   cells	   to	   other	   myoblasts	   and	  morpholino	  mediated	   knockdown	   of	   its	   zebrafish	  orthologue,	   kirrel3l,	   indicates	   this	   function	   is	   conserved	   across	   species	   (Srinivas	   et	   al.	  2007).	  Notably,	  kirrel3l	  is	  expressed	  exclusively	  in	  fast-­‐twitch	  progenitors,	  suggesting	  that	  its	   repression	   in	   adaxial	   cells	   could	   underlie	   the	   failure	   of	   slow-­‐twitch	   myoblasts	   to	  undergo	   fusion.	   Surprisingly,	   however,	  kirrel3l	   remains	   repressed	   in	   adaxial	   cells	   in	  ubo	  mutants,	  indicating	  that	  its	  function	  is	  not	  required	  for	  their	  aberrant	  fusion	  and	  implying	  that	   that	  other	  genes	  repressed	  by	  Prdm1a	  must	  be	  sufficient	   to	  promote	   fusion.	  A	  good	  candidate	  for	  such	  a	  gene	  is	  that	  encoding	  the	  junctional	  adhesion	  molecule	  JamC.	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Recently,	   a	   novel,	   vertebrate-­‐specific	   cell	   surface	   receptor	   pair	   essential	   for	   myocyte	  fusion	  has	  been	   identified	   in	   the	  zebrafish	  using	  an	  assay	  developed	   for	   identifying	  brief	  and	  weak	  interactions	  between	  extracellular	  surface	  proteins	  (Powell	  and	  Wright,	  2011).	  
jamb	  and	  jamc	  are	  expressed	  highly	  in	  fast	  muscle	  precursors	  and	  mutations	  in	  either	  gene	  result	   in	   a	   near	   complete	   loss	   of	   fast	  muscle	   fusion.	   Although	   Jamb	   and	   Jamc	   can	   form	  homodimers,	   the	   heterophilic	   interaction	   between	   them	   is	   significantly	   stronger,	   and	  transplant	   experiments	   revealed	   the	   requirement	   of	   this	   heterophilic	   interaction	   for	  muscle	   fusion.	   	   Notably,	   in	  prdm1a	  mutants,	   jamc	   is	   ectopically	   expressed,	  whereas	   the	  expression	  of	   jamb,	   similar	   to	  kirrel3l,	   remains	  unchanged.	  The	  misexpression	  of	   jamc	   in	  the	  slow	  muscle	  does	  not	  however	  trigger	  fusion	  of	  these	  fibres,	  implying	  that	  prdm1a	  may	  repress	   expression	   of	   other	   factors	   required	   for	   myoblast	   fusion	   (Powell	   and	   Wright,	  2011).	  	  Transducers	  of	  the	  intracellular	  signalling	  pathways	  associated	  with	  myoblast	  fusion	  also	  appear	  to	  be	  conserved	  between	  flies	  and	  fish.	  The	  gene	  myoblast	  city	  in	  Drosophila	  and	  its	  homolog	   in	   zebrafish,	   dedicator	   of	   cytokinesis	   1	   (DOCK1),	   are	   key	   components	   of	   the	  intracellular	  fusion	  pathway	  (Erickson	  et	  al.,	  1997,	  Moore	  et	  al.,	  2007).	  Loss	  of	  function	  of	  DOCK1	  and	  a	  closely	  related	  protein,	  DOCK5,	  results	   in	  elongated,	  mononucleated,	   fibres	  that	  are	  still	  capable	  of	  expressing	  fast	  muscle	  specific	  genes.	  Conversely,	  in	  mice,	  only	  loss	  of	  DOCK1	  results	  in	  a	  myoblast	  fusion	  defect,	  with	  loss	  of	  DOCK5	  having	  no	  effect	  on	  fusion	  (Laurin	  et	  al.,	  2008)	  .	  Similarly,	  knockdown	  of	  the	  adaptor	  proteins	  Crk	  and	  Crk-­‐like	  (Crkl),	  which	  are	  known	  to	  interact	  physically	  with	  DOCK	  proteins,	  also	  blocks	  myoblast	  fusion	  in	  the	   zebrafish	   (Moore	   et	   al.	   2007).	   Interestingly,	   overexpression	  of	   the	  crk	   or	  crkl	  mRNA	  results	   in	   an	   enhancement	   in	   fusion,	   not	   seen	   when	   either	   DOCK1	   or	   DOCK5	   are	  overexpressed	   (Moore	   et	   al.,	   2007).	   A	   constitutively	   active	   form	  of	   the	  GTPase,	   Rac,	   the	  most	   downstream	   component	   of	   the	   fusion	   signal,	   also	   results	   in	   the	   formation	   of	   giant	  syncytia	   (Srinivas	   et	   al.,	   2007).	   This	   hyperfusion	   is	   dependent	   on	   the	   fusion	   receptor	  Kirrel3l,	  as	  constitutively	  active	  Rac	  in	  kirrel3l	  morphants	  is	  unable	  to	  cause	  an	  increase	  in	  fusion.	  The	  dependence	  of	  Crk	  and	  Crkl	  on	  upstream	  fusion	  receptors	  to	  cause	  hyperfusion	  has	  not	  been	  analysed.	  Very	  recently,	  Casein	  kinase	  2	   interacting	  protein-­‐1	   (CKIP-­‐1)	  has	  been	   implicated	   in	   zebrafish	   myoblast	   fusion	   (Baas	   et	   al.,	   2012).	   In	   vitro	   studies	   have	  suggested	  that	  the	  role	  of	  CKIP-­‐1	  may	  be	  conserved	  in	  mice,	  and	  knockdown	  of	  CKIP-­‐1	  in	  both	  zebrafish	  and	  mouse	  cultured	  myoblasts	  blocks	  myoblast	  fusion	  (Baas	  et	  al.,	  2012).	  The	  question	  still	  remains	  as	  to	  how	  all	   the	   identified	  components	  of	  zebrafish	  myoblast	  fusion	   integrate	   to	   form	   an	   organised	   syncytial	   array	   of	   exclusively	   fast	  myoblasts	   that	  fuses	   a	   finite	   number	   of	   times	   at	   a	   specific	   developmental	   timepoint.	   How	   is	   the	  downregulation	   of	   these	   components	   regulated	   in	   order	   to	   terminate	   the	  muscle	   fusion	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programme?	   The	   association	   and	   integration	   of	   all	   of	   these	   proteins	   is	   crucial	   to	  understanding	   the	  mechanisms	   of	   zebrafish	  myoblast	   fusion	   and	   could	   provide	   insights	  into	  other	  cell	  fusion	  events,	  both	  in	  teleosts	  and	  mammals.	  	  
1.13	  Diversity	  within	  lineages	  Within	  both	  the	  slow	  and	  fast	  lineage,	  distinct	  sub-­‐types	  of	  fibre	  can	  be	  distinguished	  both	  on	  the	  basis	  of	  their	  medial	  location	  as	  well	  as	  by	  their	  expression	  of	  the	  Engrailed	  (Eng)	  family	   of	   homeodomain	   transcription	   factors	   (Roy	   et	   al.,	   2001).	  Muscle	   Pioneers	   (MPs)	  constitute	  a	   sub-­‐set	  of	   the	   slow-­‐twitch	   fibres	   that	  derive	   from	   the	  adaxial	   cells,	  but	   they	  are	  distinguished	  from	  the	  SSFs	  by	  their	  location	  as	  well	  as	  by	  expression	  of	  eng	  (Hatta	  et	  al.,	   1991).	   During	   somite	  maturation,	   the	   MPs	   elongate	   to	   span	   the	   entire	   width	   of	   the	  somite,	   separating	   the	   dorsal	   and	   ventral	   domains	   of	   the	   myotome	   by	   forming	   the	  horizontal	  myoseptum	  (Figure	  1.4).	  The	  MPs	  also	  provide	   instructive	   cues	   for	  migrating	  motor	  neurons	  (Melancon	  et	  al.,	  1997)	  and	  thus	  play	  a	  critical	  role	  in	  the	  patterning	  of	  the	  locomotor	   system.	   Consistent	   with	   their	   adaxial	   origin,	   MPs,	   like	   SSFs,	   are	   completely	  absent	   from	  embryos	   that	   lack	  Hh	  pathway	  activity	   (Lewis	  et	  al.,	  1999,	  van	  Eeden	  et	  al.,	  1996);	  however,	  mutant	  embryos	  that	  have	  reduced	  Hh	  pathway	  activity,	  lack	  MPs	  whilst	  retaining	  SSFs	  (Lewis	  et	  al.,	  1999).	  This	  observation	  implies	  that	  the	  level	  of	  Hh	  activity	  to	  which	   an	   adaxial	   cell	   is	   exposed	   determines	   whether	   it	   will	   follow	   the	   SSF	   or	   MP	  differentiation	   pathway.	   Consistent	   with	   this,	   high	   level	   ectopic	   activation	   of	   the	   Hh	  pathway	  drives	  differentiation	  of	  myoblasts	   into	  MPs	  at	   the	  expense	  of	  SSFs	   (Currie	  and	  Ingham,	  1996,	  Wolff	  et	  al.,	  2003).	  This	   finding	  poses	  the	  question	  as	  to	  how	  adaxial	  cells	  come	   to	   be	   exposed	   to	   differing	   levels	   of	   Hh	   activity.	   Transient	   inhibition	   of	   the	   Hh	  pathway	  using	  cyclopamine	  showed	  that	  MP	   induction	  requires	  a	   longer	  exposure	   to	  Hh	  activity	   than	   is	   sufficient	   for	   SSF	   induction	   (Hirsinger	   et	   al.,	   2004),	   while	   cell-­‐labelling	  experiments	  show	  that	  MPs	  arise	  from	  the	  most	  medially	  located	  adaxial	  cells	  (Nguyen-­‐Chi	  et	  al.,	  2012),	  which	  might	  be	  expected	  to	  receive	  the	  highest	  levels	  of	  midline-­‐derived	  Hh	  activity.	  The	  response	  of	  myoblasts	  to	  Hh	  signalling	  can	  be	  attenuated	  by	  the	  experimental	  manipulation	  of	  BMP	  activity	  (Du	  et	  al.,	  1997,	  Kawakami	  et	  al.,	  2005,	  Maurya	  et	  al.,	  2011),	  suggesting	  that	  these	  two	  signals	  may	  act	  in	  concert	  to	  specify	  different	  cell	  types.	  In	  line	  with	  this,	  high	  levels	  of	  phosphorylated	  Smad	  (pSmads)	  accumulate	  in	  the	  nuclei	  of	  most	  adaxial	   cells	   but	   are	   excluded	   from	   the	   nuclei	   of	   MPs,	   which	   is	   consistent	   with	   the	  possibility	   that	   BMP	   signalling	   plays	   an	   inhibitory	   role	   in	  MP	   specification	   (Dolez	   et	   al.,	  2011,	  Maurya	  et	  al.,	  2011).	  ChIP	  analysis	  suggests	  that	  both	  Gli	  proteins	  and	  pSmads	  can	  directly	   bind	   to	   the	   eng2a	   promoter	   (Maurya	   et	   al.	   2012),	   although	   no	   consensus	   Gli	  binding	  site	  has	  been	   found	   in	   this	  genomic	  region.	  High	  BMP	  signalling	   from	  the	  dorsal	  and	  ventral	  edges	  of	  embryos	  causes	  accumulation	  of	  pSmads	  in	  the	  nucleus	  (Kawakami	  et	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al.,	   2005,	  Nguyen-­‐Chi	   et	   al.,	   2012),	  which	  might	   allow	   the	   direct	   inhibition	   of	   the	   eng2a	  promoter.	  Further	  to	  this,	  laminins	  appear	  to	  also	  play	  a	  key	  role	  in	  establishing	  the	  eng-­‐positive	  central	  domain	  by	  sequestering	  BMPs	   (Dolez	  et	  al.	  2011).	  eng	   expression	   in	   the	  lamininC1	   (LamC1)	   mutant	   sly,	   is	   severely	   reduced	   or	   absent	   in	   the	   MPs,	   with	   the	  knockdown	   of	   BMP	   signalling	   able	   to	   rescue	   it	   (Dolez	   et	   al.,	   2011).	   This	   interaction	  between	   BMPs	   and	   lamC1	   appears	   to	   be	   mediated	   via	   heparin	   sulphate	   proteoglycans	  (HSPG)	   as	   their	   inhibition	   in	   wild	   type	   embryos	   leads	   to	   the	   ectopic	   activation	   of	   BMP	  target	   genes	   and	   therefore	   an	   inhibition	   of	   eng	   expression	   (Dolez	   et	   al.,	   2011).	   The	  crosstalk	  between	  these	  two	  pathways	  seems	  to	  be	  regulated	  at	  multiple	  levels:	  a	  physical	  sequestering	  of	  BMPs	  by	  HSPGs,	  as	  well	  as	  a	  regulated	  balance	  between	  the	  relative	  levels	  of	   the	  effectors	  of	   the	   two	  pathways.	  Remarkably,	   the	  nuclear	  accumulation	  of	  pSmad	   is	  dependent	  not	  only	  upon	  BMP	  activity	  but	  also	  on	  Hh	  signalling;	  in	  embryos	  in	  which	  the	  Hh	  pathway	  is	  constitutively	  activated,	  the	  nuclear	  accumulation	  of	  pSmad	  is	  significantly	  attenuated.	   Various	   lines	   of	   evidence	   suggest	   that	   this	   regulation	   occurs	   downstream	  of	  the	  BMP	  receptor	  (Maurya	  et	  al.,	  2011),	  though	  exactly	  how	  it	  is	  meditated	  remains	  to	  be	  determined.	  	  
	  
Figure	   1.4:	   Sub-­‐populations	   within	   both	   the	   fast	   and	   slow-­‐twitch	   lineages	   express	  
Engrailed	  family	  homeodomain	  proteins.	  Eng	  positive	  cells	  (red)	  can	  be	  identified	  in	  both	  
the	   slow	  muscle,	   identifiable	  by	   the	  expression	  of	   smyhc1:GFP	   (green);	   the	  muscle	  pioneers	  
(MPs)	   and	   in	   the	   fast	   muscle;	   the	   medial	   fast	   fibres	   (MFFs)	   (A	   and	   B).	   	   The	   adaxial	   cells	  
(green)	   lying	   closest	   to	   the	  notochord	  activate	   expression	   of	  Eng	  proteins	   (red)	   (C	  and	  D).	  
These	  eng	  expressing	  adaxial	  cells	  do	  not	  migrate,	  but	   instead	  form	  muscle	  pioneers,	  which	  
elongate	  to	  form	  the	  horizontal	  myoseptum.	  Following	  the	  migration	  of	  the	  adaxial	  cells,	  the	  
most	  medial	   fast-­‐twitch	  myoblasts	   are	   displaced	   and	   become	   juxtaposed	   to	   the	   notochord	  
and	  also	  express	  eng.	  These	  eng-­‐expressing	  cells	  will	  differentiate	  into	  multinucleated	  medial	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However,	  this	  still	  does	  not	  answer	  the	  question	  as	  to	  how	  the	  adaxial	  cells	  give	  rise	  to	  two	  different	  types	  of	  slow	  muscle	  cells	  along	  the	  anterior	  posterior	  boundary,	  where	  they	  are	  exposed	   to	   similar	   levels	   of	   BMP	   and	   Hh	   signalling.	   Cell	   tracing	   experiments	   have	  indicated	  that	  only	  the	  most	  anterior	  member	  of	  the	  medial	  row	  of	  adaxial	  cells	  is	  destined	  to	  differentiate	  into	  an	  MP	  (Nguyen-­‐Chi	  et	  al.,	  2012),	  implying	  that	  an	  additional	  signal	  is	  required	  to	  single	  out	  this	  cell.	  A	  recent	  explanation	  for	  this	  implicates	  the	  involvement	  of	  FGFs	   in	   this	   process.	   FGF	   signalling	   appears	   to	   be	   restricted	   to	   the	   posterior	   half	   of	   the	  somites	   by	   the	   FGF	   inhibitor	   sprouty4	   (Nguyen-­‐Chi	   et	   al.,	   2012).	   Overexpression	   of	  
sprouty4	   doubled	   the	   number	   of	   MPs	   within	   the	   embryo	   whereas	   a	   dominant	   negative	  form	  of	  sprouty4	  resulted	  in	  a	  loss	  of	  MPs	  (Nguyen-­‐Chi	  et	  al.,	  2012).	  Contradictory	  to	  this,	  another	  study	  has	  suggested	  that	  the	  numbers	  of	  MPs	  is	  decreased	  in	  the	  absence	  of	  FGF	  signalling,	   based	  on	   absence	  of	  eng2	   expression	   in	   the	   acerebellar	  mutant	   (Reifers	   et	   al.	  1998).	  	  Interestingly,	  inhibition	  of	  FGF	  signalling	  by	  overexpression	  of	  sprouty4,	  induced	  a	  unique	  population	  of	  eng	  expressing	  cells	  that	  are	  able	  to	  migrate,	  a	  behaviour	  never	  seen	  in	  wild-­‐type	   embryos	   (Nguyen-­‐Chi	   et	   al.,	   2012).	   These	   observations	   suggest	   that	   FGF	   signalling	  may	  play	  a	  role	   in	  regulating	  the	  migration	  of	  myogenic	  precursors;	   further	  experiments	  are	  required	  to	  establish	  this	  definitively.	  	  Another	  eng	  positive	  population	  exist,	  but	   in	  contrast	  do	  not	  express	  slow	  specific	  genes	  such	   as	   smyhc1.	   Instead	   these	   cells	   form	   fast-­‐twitch	   fibres,	   expressing	   fast	   myosin	  isoforms	   and	   displaying	   multinucleated	   fused	   fibres.	   These	   fibres,	   named	   Medial	   Fast	  Fibres	  (MFF),	  lie	  lateral	  to	  the	  MPs	  and	  are	  specified	  at	  a	  later	  stage	  after	  slow	  muscle	  cell	  migration	  (Figure	  1.4).	  Surprisingly,	  despite	  their	  fast-­‐twitch	  identity,	  these	  cells	  are	  also	  Hh	   responsive,	  with	  Hh	  acting	   in	   a	   concentration	  dependent	  manner	   to	   induce	  different	  cell	  identities	  (Wolff	  et	  al.,	  2003).	  Conditional	  inhibition	  of	  Shh	  signalling	  in	  zebrafish	  can	  be	  achieved	  by	  administration	  of	  cyclopamine,	  which	  revealed	  that	  MPs	  require	  a	  higher	  level	   of	   Hh	   signalling	   than	   that	   of	   MFFs,	   which	   in	   turn	   require	   higher	   levels	   than	   SSFs	  (Wolff	   et	   al.,	   2003).	   As	   described	   previously,	   the	   onset	   of	   slow-­‐twitch	   differentiation	  precedes	   that	   of	   the	   fast-­‐twitch	   lineage	   programme,	   therefore	   the	  migration	   of	   the	   SSF	  displaces	   the	   fast-­‐twitch	  precursors	   leaving	   them	  closer	   to	   the	  Shh-­‐	   secreting	  notochord	  (Cortes	  et	  al.,	  2003),	  which	  exposes	  these	  cells	  to	  a	  higher	  concentration	  of	  Shh,	  to	  which	  they	  respond	  by	  up-­‐regulation	  of	   the	  Hh	   target	  gene	  ptch2	  (Concordet	  et	  al.,	  1996).	  Like	  the	   adaxial	   cells	   before	   them,	   the	   majority	   of	   these	   fast–twitch	   progenitors	   respond	   to	  BMP	  signalling	  by	  accumulating	  high	   levels	  of	  pSmad	   in	   their	  nuclei.	  However,	   the	  most	  medially	  located	  fast-­‐twitch	  progenitors	  lack	  such	  pSmad	  accumulation	  and	  it	  is	  these	  cells	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that	  activate	  Eng	  transcription	  (Maurya	  et	  al.,	  2011).	  Thus,	  as	  for	  the	  MPs,	  the	  activation	  of	  Eng	  in	  MFFs	  depends	  upon	  the	  antagonistic	  effect	  of	  Hh	  on	  BMP	  activity.	  	  One	  question	   is	   that	  why	  MFFs	  don’t	  differentiate	   into	  slow	  fibres?	  Although	  ectopic	  Hh	  can	  induce	  supernumerary	  slow	  fibres,	  this	  competence	  becomes	  lost	  at	  later	  stages	  (Wolff	  et	  al.,	  2003),	  and	   it	   is	  unable	   to	   induce	  prdm1a	   expression.	  Secondary	   to	   that,	  heatshock	  induced	   Prdm1a	   is	   unable	   to	   increase	   the	   slow	   muscle	   fibres	   after	   18	   hpf	   (Liew	   et	   al.	  2008).	  This	  indicates	  that	  myoblasts	  lose	  their	  competence	  to	  respond	  to	  the	  slow	  twitch	  lineage	  programme	  and	  express	  Prdm1a,	  and	  instead	  go	  on	  to	  give	  rise	  to	  the	  MFFs.	  	  The	   restricted	   expression	   of	   eng	   and	   its	   precise	   regulation	   in	   the	   myotome	   raises	   the	  question	   of	   its	   function.	   It	   could	   have	   a	   role	   in	   myogenesis,	   perhaps	   by	   regulating	   the	  expression	   of	   genes	   involved	   in	   slow	  muscle	  migration,	   although	   this	   would	   be	   a	   time-­‐dependent	  role,	  as	  MFF	  do	  not	  migrate.	  Alternatively,	  as	  MPs	  act	  as	  signalling	  centres	  for	  controlling	  axon	  guidance	  (Melancon	  et	  al.,	  1997)	  and	  neural	  crest	  migration	  (Honjo	  and	  Eisen,	   2005),	   eng	   could	   have	   a	   role	   in	   regulating	   genes	   involved	   in	   these	   processes.	  Furthermore,	  it	  remains	  an	  open	  question	  as	  to	  whether	  Eng	  has	  the	  same	  role	  in	  both	  the	  MFF	   and	   MPs.	   These	   two	   cells	   types	   have	   different	   gene	   expression	   profiles	   and	  morphology	  (mononucleated	  vs.	  multinucleated),	  perhaps	  indicating	  distinct	  roles	  for	  this	  transcription	  factor	  in	  the	  two	  populations,	  or	  instead	  it	  is	  possible	  that	  eng	  fulfils	  a	  role	  in	  these	  cells	  that	  is	  unrelated	  to	  myogenesis.	  	  
1.14	  Engrailed	  positive	  domain	  in	  amniote	  muscle	  Hh	   and	   BMP	   also	   act	   to	   regulate	   the	   expression	   of	   eng	   in	   amniotes,	   and	   this	   gene	  expression	   domain	   demarcates	   the	   epaxial	   and	   hypaxial	   boundary,	   a	   structure	   possibly	  homologous	   to	   the	   fish	   myoseptum	   (Cheng	   et	   al.,	   2004).	   Shh-­‐soaked	   beads	   are	   able	   to	  rescue	  eng	  expression	  in	  chicks	  with	  ablated	  notochords,	  whereas	  BMP4-­‐soaked	  beads	  are	  able	   to	  extinguish	  eng	   expression	   (Cheng	  et	  al.,	  2004).	  Differences	  are	  apparent	   in	   these	  populations	  of	  cells	  between	  species,	  namely	  the	  timing	  of	  signalling	  events	  and	  the	  exact	  location	  of	  signal	  sources	  as	  well	  as	  responsive	  tissue.	  The	  Engrailed-­‐expressing	  cells	  are	  formed	  at	  a	  relatively	  late	  timepoint	  in	  amniotes,	  with	  the	  expression	  domain	  significantly	  larger,	  extending	  to	  the	  dermomyotome,	  myotome	  and	  dermatome	  (Cheng	  et	  al.,	  2004),	  in	  contrast	  to	  the	  situation	  in	  zebrafish,	  where	  this	  domain	  is	  restricted	  to	  a	  thin	  layer	  of	  cells	  in	  the	  midline	  (Roy	  et	  al.,	  2001).	  Nevertheless,	  an	  eng-­‐	  expressing	  population	  exists	  in	  both	  zebrafish	  and	  amniotes	  that	  originates	  close	  to	  the	  midline,	  is	  dependent	  on	  Hh	  signalling	  and	  is	  antagonised	  by	  BMPs,	  highlighting	  the	  striking	  similarities	  between	  the	  species,	  and	  perhaps	  identifying	  a	  homologous	  population	  of	  cells.	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1.15	  Troponins	  The	   basic	   contractile	   unit	   of	   striated	   muscle	   is	   the	   sarcomere,	   which	   is	   composed	   of	  myosin	   thick	   filaments,	   intercalated	  with	  actin	   thin	   filament,	   each	  of	  which	   is	  associated	  with	   a	   tropomyosin	   and	   a	   troponin	   regulatory	   complex.	  This	   complex	   acts	   in	   a	   calcium-­‐responsive	   manner	   to	   regulate	   contractions	   in	   striated	   muscle	   and	   consist	   of	   three	  subunits:	   troponin	   c,	   the	   calcium-­‐binding	   subunit,	   troponin	   T,	   the	   tropomyosin-­‐binding	  subunit,	   and	   troponin	   I,	  which	   inhibits	   the	   ATP-­‐ase	   activity	   of	   actomyosin	   (Greaser	   and	  Gergely,	   1973).	   Muscle	   cell	   contraction	   is	   generated	   from	   the	   cyclic	   interactions	   of	   the	  myosin	   heads	   and	   the	   actin	   subunits	   of	   the	   thin	   filaments	   forming	   a	   cross-­‐bridge	  formation.	   In	   the	   absence	   of	   calcium,	   troponin	   and	   tropomyosin	   interact	   and	   inhibit	  interactions	  between	  actin	  and	  myosin.	  Upon	  depolarization	  of	  the	  muscle	  cell,	  the	  calcium	  released	  into	  the	  cytoplasm	  binds	  to	  Troponin	  C,	  causing	  a	  conformational	  change	  in	  the	  tropomyosin-­‐troponin	   regulatory	   complex,	   leading	   to	   the	   derepression	   of	   the	   actin-­‐myosin	  interactions	  and	  subsequent	  muscle	  contraction	  (Lehman	  et	  al.,	  1994).	  	  Muscle	   fibres	   can	   be	   identified	   through	   their	   distinct	   gene	   expression	   profiles.	   Each	  troponin	   is	   composed	   of	   multiple	   isoforms	   that	   are	   encoded	   by	   distinct	   genes.	   These	  isoforms	  are	  expressed	  in	  a	  tissue	  specific	  manner,	  be	  it	  slow-­‐twitch,	  fast-­‐twitch	  or	  cardiac	  muscle,	   and	   at	   a	   specific	   developmental	   stage.	   In	  mammals,	   there	   is	   one	   fast	   troponin	   c	  gene	  that	  is	  expressed	  specifically	  in	  the	  fast	  muscle,	  and	  one	  slow	  troponin	  c	  (Tnnc1)	  gene	  that	   is	   expressed	   in	   both	   the	   slow-­‐twitch	   skeletal	   muscle	   and	   the	   cardiac	   muscle	  (Parmacek	  and	  Leiden,	  1991).	  Precise	  molecular	  mechanisms	   regulate	   the	   expression	  of	  
Tnnc1,	   with	   respect	   to	   its	   tissue	   specificity.	   Studies	   have	   shown	   that	   a	   skeletal	  muscle-­‐specific,	   developmentally	   regulated	   transcriptional	   enhancer	   is	   located	   within	   the	   first	  intron	   of	   the	   mouse	   Tnnc1	   gene	   (Parmacek	   et	   al.,	   1994).	   Conversely,	   a	   distinct	   and	  independent	   enhancer	   located	   in	   the	   immediate	   5’	   flanking	   region	   of	   the	   gene	   drives	  
Tnnc1	  expression	  in	  cardiac	  myocytes	  (Parmacek	  et	  al.,	  1992).	  In	  contrast,	  zebrafish	  have	  two	   paralogous	   genes,	   tnnc1a	   and	   tnnc1b,	   which	   are	   expressed	   specifically	   in	   the	   heart	  and	  slow-­‐twitch	  skeletal	  muscle,	  respectively	  (Sogah	  et	  al.,	  2010).	  Nothing	  is	  known	  about	  the	  regulation	  of	  these	  two	  different	  genes	  in	  zebrafish.	  	  Tnnc1	  is	  an	  important	  gene	  clinically	  as	  mutations	  in	  this	  gene	  have	  been	  linked	  to	  certain	  forms	   of	   familial	   cardiomyopathy	   (Hoffmann	   et	   al.,	   2001,	   Mogensen	   et	   al.,	   2004).	   A	  mutation	   in	   the	   heart-­‐specific	   troponin	   c	   in	   zebrafish,	   tnnc1a,	   results	   in	   defective	  ventricular	   contractility,	   with	   the	   ventricle	   failing	   to	   express	   ventricular	   myosin	   heavy	  chain	  (Sogah	  et	  al.,	  2010).	  	  The	  loss	  of	  ventricular	  myosin	  heavy	  chain	  expression	  suggests	  that	  contractile	  function	  of	  the	  ventricle	  may	  be	  required	  for	  the	  sustained	  expression	  of	  this	   gene.	   The	   high	   conservation	   of	   this	   gene	   between	   zebrafish	   and	   humans	   (91.3%)	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2.1 Fish	  stocks	  and	  maintenance	  
2.1.1	  Fish	  maintenance	  Adult	  fish	  were	  maintained	  on	  a	  14h	  light/	  10h	  dark	  cycle	  at	  28°C	  in	  the	  AVA	  (Singapore)	  certificated	   IMCB	   zebrafish	   facility.	   All	   experiments	   were	   subject	   to	   A*STAR	   IACUC	  approval.	  Zebrafish	  were	  maintained	  and	  staged	  following	  standard	  methods	  (Kimmel	  et	  al.,	  1995).	  	  	  
2.1.2	  Mutants	  Mutant	   strains	   of	   zebrafish	  were	  maintained	   as	   heterozygote	   and	   homozygote	   embryos	  were	   obtained	   by	   incrossing	   the	   heterozygote	   adults.	   Zebrafish	   mutant	   lines	   ubotp39,	  
nrdm805	   and	   smub641	   have	   been	   described	   previously	   (Barresi	   et	   al.,	   2000,	   Hernandez-­‐Lagunas	  et	  al.,	  2005,	  van	  Eeden	  et	  al.,	  1996,	  Varga	  et	  al.,	  2001).	  Homozygous	  mutants	  were	  identified	  by	  their	  U-­‐shaped	  somites.	  sox6	  and	  sox5	  mutant	   lines	  were	  generated	  for	  this	  thesis	  (described	  later).	  	  
2.1.3	  Transgenic	  lines	  Transgenic	   lines	   Tg(smyhc1:eGFP)i108,	   Tg(ubo:GFP)i106,	   Tg(smyhc1:lyn-­‐tdTomato)i261,	  
mylz2:GFP,	  fmyhcx:GFP,	  sox6:eGFPsox63’UTR	  have	  been	  previously	  described	  (Elworthy	  et	  al.,	   2008,	   von	   Hofsten	   et	   al.,	   2008,	   Wang	   et	   al.,	   2011).	   Tg(tnnc1b:eGFP)	   and	  
Tg(tnnc1a:eGFP)	  were	  generated	  for	  this	  thesis	  (described	  later).	  	  The	  UAS:sox6-­‐GFP;actin:GAL4	  line	  was	  generated	  by	  the	  crossing	  the	  previously-­‐described	  Tg(actin1β:GAL4)i269	   line	   (Scheer	   and	   Campos-­‐Ortega,	   1999)	   to	   the	   UAS:sox6-­‐GFP	   line	  generated	  by	  Wang	  Xingang	  in	  the	  Ingham	  laboratory.	  	  
	  
2.2 Molecular	  Biology	  General	  procedures	  
	  
2.2.1	  PCR	  (General)	  10ng	  of	  plasmid	  DNA	  was	  added	  to	  a	  20µl	  reaction	  containing	  10µl	  2x	  GoTaq	  (Promega)	  and	   10pmol/µl	   of	   each	   primer.	   The	   cycling	   reaction	  was	   carried	   out	   as	   follows:	   95oC	   2	  minutes	  30	  seconds,	  then	  30x	  cycles	  of	  (95oC	  45	  seconds,	  53-­‐58oC	  for	  30	  seconds,	  72oC	  for	  1	  minutes	  per	  kb	  of	  product)	  and	  finally	  72oC	  for	  10	  minutes.	  Annealing	  temperature	  was	  5oC	  lower	  than	  the	  lowest	  primer	  melting	  temperature.	  	  
	  
2.2.2	  PCR	  (Cloning)	  100ng	  of	  plasmid	  DNA	  or1µl	  of	   a	   cDNA	  synthesis	   reaction	  was	  added	   to	  a	  50µl	   reaction	  volume	  containing	  1µl	  iproof	  DNA	  polymerase	  (BioRad),	  high	  fidelity	  buffer,	  0.2mM	  dNTP,	  10pmol/µl	  of	  each	  primer.	  The	  cycling	  reaction	  was	  carried	  out	  as	  follows:	  98oC	  2	  minutes	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30	   seconds	   then	   30x	   cycles	   of	   (98oC	   for	   45	   seconds,	   58-­‐63oC	   for	   1	  minute,	   72oC	   for	   30	  seconds	  plus	  15	  seconds/kb),	  and	  finally	  72oC	  for	  10	  minutes.	  Annealing	  temperature	  was	  3oC	  higher	  than	  the	  lowest	  primer	  melting	  temperature.	  	  	  
2.2.3	  Restriction	  endonuclease	  digestion	  All	   restriction	   endonuclease	   digestions	   were	   performed	   in	   20-­‐100µl	   reaction	   volumes	  containing	  1	  unit	  of	  restriction	  enzyme	  per	  µg	  DNA	  and	  reaction	  buffer	  diluted	  in	  milli-­‐Q	  water.	   Reactions	  were	   performed	   at	   appropriate	   temperature	   for	   the	   particular	   enzyme	  for	  2-­‐4	  hours.	  	  
2.2.4	  Phenol:	  chloroform	  extraction	  and	  ethanol	  precipitation	  of	  DNA	  DNA	  was	   diluted	   to	   a	   total	   volume	   of	   400µl	   using	   milli-­‐Q	   water	   to	   which	   400µl	   of	   1:1	  phenol:	  chloroform	  pH7	  was	  added.	  The	  mixture	  was	  emulsified	  and	  then	  centrifuged	  at	  13000rpm	   for	  5	  minutes	   at	   room	   temperature.	  40µl	  3M	  NaAc	   (pH	  5.2)	   and	  1ml	   ethanol	  was	   then	  added	   to	   the	  extraction	  aqueous	  phase	  of	   the	   solution	  and	   then	   centrifuged	  at	  13000rpm	   for	  30minutes	  at	  4oC.	  The	  DNA	  pellet	  was	  washed	  with	  200µl	  70%n	  ethanol,	  centrifuged	  for	  a	  further	  15	  minutes	  at	  13000rpm	  at	  4oC,	  air-­‐dried,	  and	  resuspended	  in	  the	  appropriate	  volume	  of	  nuclease-­‐free	  water.	  
	  
2.2.5	  Gel	  extraction	  DNA	   fragments	   were	   extracted	   from	   0.8%-­‐1%	   agarose	   gel	   and	   the	   DNA	   was	   extracted	  using	  the	  Axygen	  “AxyPrep	  DNA	  gel	  extraction	  kit”	  according	  to	  manufacturer’s	  protocol.	  	  	  
2.2.6	  Standard	  cloning	  Primers	  were	  designed	  containing	  restriction	  sites	  at	  the	  end.	  After	  PCR	  amplification	  the	  product	  was	  gel	  extracted	  and	  digested,	  using	  the	  appropriate	  enzyme,	  and	  then	  purified.	  50ng	  of	  vector	  was	  also	  digested	  using	  the	  appropriate	  enzyme,	  followed	  by	  the	  removal	  of	   the	   phosphate	   groups	   from	   the	   5’	   end	   of	   cut	   plasmid	   using	   calf	   intestinal	   alkaline	  phosphatase	   to	   prevent	   recircularization	   of	   the	   linearized	   vector.	   The	   ligation	   reaction	  was	   set	   up	   in	   a	   total	   volume	   of	   10µl	   containing	   the	   insert	   and	   the	   vector	   in	   an	  approximately	  3:1	  molar	  ratio.	  The	  reaction	  was	  incubated	  for	  12	  hours	  at	  16oC	  then	  2µl	  was	   transformed.	   Colonies	   where	   then	   prepped,	   digested	   and	   sequenced	   to	   select	   for	  positive	  inserts.	  	  	  	  
2.2.7	  Transformation	  of	  chemically	  competent	  cells	  50µl	  of	  chemically	  competent	  Top10	  (Invitrogen)	  cells	  were	  used	  for	  each	  transformation.	  Approximately	  10ng	  of	  plasmid	  was	  incubated	  with	  the	  cells	  on	  ice	  for	  5-­‐20	  minutes.	  Cells	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were	  then	  heat-­‐shocked	  at	  42oC	  for	  30	  seconds	  then	  place	  immediately	  on	  ice	  for	  1	  minute.	  250µl	  of	  LB	  was	  added	  to	  the	  cells,	  which	  were	  then	  placed	  in	  a	  37oC-­‐shaking	  incubator	  for	  1	  hour.	  50µl-­‐200µl	  of	  culture	  was	  spread	  onto	  LB	  agar	  plates	  containing	  the	  appropriate	  antibody.	  Plates	  were	  incubated	  overnight	  at	  37oC.	  	  
	  
2.2.8	  mRNA	  synthesis	  for	  microinjection	  Capped	   mRNA	   was	   prepared	   from	   cDNA	   clones	   inserted	   into	   plasmids	   amenable	   to	   in	  vitro	  transcription,	  using	  the	  appropriate	  restriction	  enzyme	  and	  RNA	  polymerase	  mRNA	  Message	  Machine	  Kit	  (Ambion),	  following	  the	  manufacturer’s	  instructions.	  	  	  
2.2.9	  RNA	  extraction	  10	   embryos	   were	   dechorionated.	   500µl	   of	   Trizol	   was	   added	   and	   the	   embryos	   were	  homogenized	   using	   a	   homogeniser.	   A	   further	   500µl	   of	   Trizol	   was	   added,	   and	   after	   5	  minutes	  of	   incubation	  at	  room	  temperature,	  200µl	  of	  chloroform	  was	  added	   followed	  by	  vigorous	   shaking.	   After	   three	   minutes,	   the	   tube	   was	   centrifuged	   at	   12,000xg	   for	   15	  minutes	   at	   4oC.	   The	   aqueous	   phase	   was	   transferred	   to	   a	   new	   tube	   and	   the	   DNA	   was	  precipitated	  by	  the	  addition	  of	  isopropanol,	  and	  then	  washed	  with	  75%	  ethanol.	  The	  RNA	  pellet	  was	  resuspended	  in	  50µl	  of	  RNase	  free	  water.	  	  	  
2.2.10	  First-­‐strand	  cDNA	  synthesis	  1µg	  of	  RNA	  was	   added	   to	   a	  13µl	   reaction	   containing	  0.05ng	  oligo(dT)	   and	  10ng	  of	   each	  dNTP.	  The	  reaction	  was	  incubated	  at	  65oC	  for	  5	  minutes	  then	  transferred	  to	  ice	  for	  at	  least	  one	  minute.	  First-­‐strand	  buffer,	  0.1µg	  DTT,	  40units	  of	  RNase	  OUT	  and	  200	  units	  of	  reverse	  transcriptase	  (Superscript	  III)	  was	  added	  to	  the	  reaction.	  The	  reaction	  was	  then	  incubated	  for	  1	  hour	  at	  50oC	  and	  inactivated	  for	  15	  minutes	  at	  70oC.	  	  
	  
2.2.11	  Digoxigenin-­‐labelled	  RNA	  probe	  synthesis	  Antisense	   RNA	   probes	   were	   synthesised	   by	   in	   vitro	   transcription,	   in	   a	   20µl	   reaction	  containing	  1µg	  of	  linearised	  DNA,	  10x	  transcription	  buffer,	  10x	  DIG	  RNA	  labelling	  mix,	  2µl	  RNA	   polymerase,	   1µl	   ribonuclease	   inhibitor	   (RNasin)	   and	   nuclease-­‐free	   water.	   The	  reaction	   was	   incubated	   for	   2	   hours	   at	   37oC	   followed	   by	   the	   addition	   of	   DNase	   I	   for	   a	  further	  15	  minutes	  at	  37oC.	  The	  RNA	  products	  were	  precipitated	  by	  the	  addition	  of	  130µl	  nuclease	   free	   water,	   15µl	   3M	   sodium	   acetate	   (pH5.2)	   and	   375µl	   100%	   ethanol	   and	  centrifuged	   at	   13000rpm	   for	   30	  min	   at	   4oC.	   The	   pellet	  was	  washed	   in	   70%	   ethanol,	   air	  dried	  and	  resuspended	  in	  50µl	  nuclease	  free	  water	  and	  50µl	  formamide.	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2.3 Microinjection	  Zebrafish	   embryos	   were	   injected	   with	   1nl	   of	   mRNA/BAC/DNA/Morpholino	  (concentrations	  below)	  into	  either	  the	  yolk	  or	  the	  cell	  within	  the	  first	  20	  minutes	  of	  them	  being	  laid.	  	  	  
	  
2.3.1	  Capped	  mRNA	  
In	   vitro-­‐synthesised	   capped	   mRNA	   encoding	   the	   Tol2	   transposase	   was	   injected	   at	   a	  concentration	  of	  30ng/µl.	  	  
2.3.2	  BACs	  BACs	  were	  injected	  at	  a	  concentration	  between	  50-­‐150ng/µl.	  	  	  
2.3.3	  Plasmid	  DNA	  Plasmid	  DNA	  was	  injected	  at	  a	  concentration	  between	  25-­‐50ng/µl	  
	  
2.3.4	  Morpholinos	  Morpholinos	  (MO)	  were	  designed	  and	  manufactured	  by	  Gene	  Tools,	  LLC	  (Philomath,	  OR,	  USA)	  
	  
Name	   Sequence	   Injection	  
Concentration	  
prdm1a-­‐MO	   TGGTGTCATACCTCTTTGGAGTCTG	   0.5mM	  
six1a-­‐MO	   TCTCCTCTGGATGCTACGAAGGAAG	   0.8mg/ml	  
six4a-­‐MO	   CCGCCTCGTTTCTGCCCAAGCTGAT	   0.8mg/ml	  
pbx2-­‐MO2	   CCGTTGCCTGTGATGGGCTGCTGCG	   0.25mg/ml	  
pbx2-­‐MO3	   GCTGCAACATCCTGAGCACTACATT	   0.5mg/ml	  
pbx4-­‐MO1	   AATACTTTTGAGCCGAATCTCTCCG	   0.5mg/ml	  
pbx4-­‐MO2	   CGCCGCAAACCAATGAAAGCGTGTT	   0.5mg/ml	  
	  
2.4 In	  situ	  hybridisation	  
2.4.1	  Standard	  in	  situ	  hybridisation	  protocol	  Embryos	  were	   fixed	  with	   4%	  PFA	  overnight	   at	   4oC	   and	   stored	   in	   100%	  MeOH	  at	   -­‐20oC.	  Fixed	   embryos	   were	   rehydrated	   in	   50%	   MeOH	   in	   PBS,	   follow	   by	   4	   washes	   in	   PBST.	  Embryos	   were	   permeabilized	   in	   0.01mg/ml	   Proteinase	   K	   (time	   dependent	   on	  developmental	  stage)	  then	  fixed	  for	  20	  minutes	  in	  4%	  PFA,	  followed	  by	  5	  washes	  in	  PBST.	  Embryos	  were	  pre-­‐hybridised	  for	  3	  hours	  in	  hybridisation	  buffer	  at	  70oC	  then	  hybridised	  overnight	  at	  70oC	  in	  appropriate	  concentration	  of	  DIG-­‐labelled	  RNA	  probe.	  The	  following	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day,	   the	   embryos	   were	   washed	   at	   65oC	   in	   50:50	   hybridisation	   solution:2xSSC	   for	   10	  minutes,	  2xSSC	  for	  10	  minutes,	  0.2xSSC	  2x	  30	  minutes	  and	  finally	  50:50	  PBT:0.2xSSC	  for	  10	  minutes	  at	  room	  temperature.	  Embryos	  were	  then	  blocked	  in	  PBT	  for	  3	  hours	  at	  room	  temperature	  before	  being	  incubated	  with	  anti-­‐DIG	  alkaline	  phosphatase	  (Roche,	  1/3000)	  in	  PBT	  at	  4oC	  overnight.	  The	  embryos	  were	  then	  washed	  6x	   for	  20	  minutes	   in	  PBST	  and	  then	   equilibrated	   in	   Staining	   Buffer	   (lacking	  NBT	   and	  BCIP)	   by	  washing	   4x	   10	  minutes,	  then	   stained	   in	   staining	   solution	   in	   the	   dark	   until	   a	   desirable	   level	   of	   staining	   had	  been	  achieved.	   Embryos	   were	   then	   washed	   in	   PBST	   and	   fixed	   in	   4%	   PFA	   overnight	   at	   4oC	  followed	  by	  storage	  in	  75%	  glycerol.	  For	  embryos	  that	  needed	  to	  be	  separated	  prior	  to	  the	  
in	   situ	   hybridisation	   procedure	   and	   then	   compared	   afterward	   (i.e.	   Sox6-­‐/-­‐	   mutants	   and	  siblings	  separated	  on	  the	  basis	  of	  their	  tnnc1:GFP	  expression	  or	  UAS:sox6-­‐GFP;actin:GAL4	  embryos	  based	  on	  their	  GFP	  expression)	  the	  two	  sets	  of	  embryos	  (i.e.	  mutant	  vs.	  siblings)	  were	  treated	  exactly	  the	  same	  and	  stained	  for	  exactly	  the	  same	  length	  of	  time	  in	  NBT	  and	  BCIP.	  All	  images	  displayed	  in	  this	  thesis	  are	  a	  representative	  phenotype	  of	  all	  the	  embryos	  examined.	  	  	  
2.4.2	  in	  situ	  hybridisation	  on	  sections	  Sections	  were	  defrosted	  at	   room	  temperature	   for	  one	  hour	  and	  circled	  using	  a	  PAP	  pen.	  The	  pre-­‐heated	  probe	  at	   the	  appropriate	  concentration	  was	  added	  to	  the	  sections.	  Slides	  were	   covered	  with	   a	   coverslip	   and	  hybridised	   at	   70oC	   overnight.	   Slides	  were	  washed	   in	  pre-­‐warmed	  wash	  solution	  for	  4x	  30	  minutes	  allowing	  the	  coverslip	  to	  fall	  off	  in	  the	  first	  wash.	  Slides	  were	  transferred	  to	  MABT	  and	  washed	  3x	  30	  minutes	  in	  this	  solution	  at	  room	  temperature.	  Sections	  were	  blocked	  in	  blocking	  solution	  for	  3	  hours	  at	  room	  temperature	  before	  being	  incubated	  with	  1:5000	  anti-­‐DIG	  overnight	  at	  room	  temperature.	  Slides	  were	  washed	  5x	  20	  minutes	  in	  MABT	  at	  room	  temperature	  then	  2x	  10	  minutes	  in	  staining	  buffer	  lacking	  NBT/BCIP.	  Sections	  were	  stained	  in	  staining	  buffer	  overnight	  at	  37oC.	  Staining	  was	  stopped	  by	  washing	  with	  PBS	  two	  times.	  Glycerol	  and	  a	  cover	  slip	  were	  added	  to	  each	  slide	  ready	  for	  imaging.	  	  	  
2.4.3 Fluorescent	  in	  situ	  hybridisation	  Fluorescent	   in	   situ	   hybridisation	   was	   done	   using	   the	   ‘TSATM	   Plus	   Cyanine	   5	   and	  Fluorescein’	  and	  ‘TSATM	  DNP	  (HRP)	  System’	  from	  PerkinElmer.	  Day	  one	  is	  same	  at	  normal	  
in	  situ	  hybridisation.	  On	  day	  two,	  after	  final	  0.2xSSC	  wash,	  embryos	  were	  washed	  in	  50:50	  0.2xSSC:PBST,	   followed	   by	   a	   wash	   in	   PBST	   alone	   for	   10	   minutes.	   The	   endogenous	  peroxidase	   was	   quenched	   in	   2%	   hydrogen	   peroxidase	   (H2O2)	   for	   one	   hour	   at	   room	  temperature.	  Embryos	  were	  washed	  4x	  5	  minutes	  in	  TNT	  buffer	  then	  blocked	  in	  TNT	  block	  for	  3	  hours.	  Anti-­‐DIG-­‐POD	  (1:500)	  and	  anti-­‐GFP	  (1:500)	  were	  added	  and	  incubated	  at	  4oC	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overnight.	   Embryos	   were	   washed	   3x	   25	   minute	   TNT	   buffer	   the	   next	   day	   and	   DNP-­‐tyramide	   1:50	   in	   amplification	   buffer	   was	   added	   for	   one	   hour.	   A	   further	   3x	   25	  minute	  washes	  in	  TNT	  buffer	  were	  then	  performed,	  followed	  by	  blocking	  in	  TNT	  block	  for	  3	  hours.	  The	  secondary	  antibody	  against	  the	  DNP	  substrate,	  anti-­‐DNP	  POD	  (1:500)	  and	  secondary	  antibody	   against	   GFP	   were	   added	   and	   incubated	   at	   4oC	   overnight.	   The	   following	   day	  embryos	  were	  washed	  3x	  25	  minutes	  in	  TNT	  buffer	  then	  incubated	  in	  cy5-­‐tyramide	  (1:50)	  for	  one	  hour	  at	  room	  temperature.	  Embryos	  were	  subsequently	  washed	  3x	  25	  minutes	  in	  TNT	  buffer	  then	  put	  through	  a	  glycerol	  series	  up	  to	  75%	  glycerol	  and	  imaged.	  	  	  
2.4.4	  Table	  of	  In	  situ	  hybridisation	  probes	  
Gene	  name	   Enzyme	   and	  
promoter	  used	  
Reference	  
sox6	   BamHI/T7	   (von	  Hofsten	  et	  al.,	  2008)	  
sox5	   NcoI/SP6	   (Wang	  et	  al.,	  2011)	  
tnnc1b	   EcoRI/T7	   (von	  Hofsten	  et	  al.,	  2008)	  
smyhc1	   Not1/SP6	   (Elworthy	  et	  al.,	  2008)	  
prox1a	   EcoRI/T7	   (Glasgow	   and	   Tomarev,	  1998)	  
tpm2	   SpeI/T7	   This	  thesis	  
mylz10	   SpeI/T7	   This	  thesis	  
ryr1a	   NcoI/SP6	   (Hirata	  et	  al.,	  2007)	  
fmyhcx	   HindIII/T7	   (von	  Hofsten	  et	  al.,	  2008)	  
mylz2	   BamHI/T7	   (von	  Hofsten	  et	  al.,	  2008)	  
myh7b	   NcoI/SP6	   (Wang	  et	  al.,	  2011)	  
tnni1a	   NcoI/SP6	   This	  thesis	  
tnnt1	   NcoI/SP6	   This	  thesis	  
tnnc1a	   NcoI/SP6	   This	  thesis	  
tnni1b	   SphI/SP6	   This	  thesis	  
tnnt2	   NcoI/SP6	   This	  thesis	  
	  
2.5	  Immunohistochemistry	  
2.5.1 Whole	  mount	  immunohistochemistry	  Embryos	  were	  fixed	  overnight	  in	  4%	  PFA	  at	  4oC*,	  washed	  twice	  for	  5	  min	  in	  PBS,	  the	  twice	  for	  5	  minutes	  in	  50%	  MeOH	  and	  PBS	  and	  finally	  stored	  in	  100%	  MeOH	  at	  -­‐20oC	  for	  at	  least	  2	   hours.	   For	   staining,	   embryos	   were	   rehydrated	   in	   50%	   MeOH/PBTX,	   then	   washes	   2x	  
	   45	  
5min	   in	   PBTX.	   For	   embryos	   over	   2	   dpf,	   embryos	   were	   permeabilized	   in	   acetone	   and	  trypsin	  (see	  below),	  then	  washed	  2x	  5min	  in	  PBTX.	  Embryos	  were	  then	  blocked	  in	  PBDT	  3x	  30min.	  The	  primary	  antibody	  was	  added	  to	  PBDT	  at	  the	  appropriate	  concentration	  and	  incubated	  overnight	  at	  4oC.	  The	   following	  day	  embryos	  were	  washed	  3x	  30min	   in	  PBDT	  and	   the	   secondary	   antibody	  was	   added	   at	   the	   appropriate	   concentration	   for	   3	   hours	   at	  room	  temperature.	  Embryos	  where	  then	  washed	  3x	  30min	  in	  PBDT,	  followed	  by	  2x	  5min	  in	  PBTX,	  and	  put	  through	  a	  glycerol	  series	  up	  until	  75%	  glycerol	  and	  imaged.	  *When	   staining	   using	   the	   S58	   antibody	   embryos	   were	   fixed	   in	   Carnoy’s	   solution	   (60%	  ethyl	   alcohol,	   30%	   chloroform,	   10%	   glacial	   acetic	   acid)	   overnight	   at	   room	   temperature,	  and	  then	  washed	  as	  above.	  
2.5.2	  Acetone	  and	  trypsin	  permeabilization	  
	  After	  PBTX	  washes,	  embryos	  were	  washed	  for	  5	  minutes	  in	  water.	  -­‐20oC	  acetone	  was	  then	  added	   to	   the	   embryos,	   which	   were	   subsequently	   incubated	   in	   at	   -­‐20oC	   for	   7	   minutes.	  Embryos	  were	   then	  washed	  2x	  5	  minutes	   then	  2x	  5	  minutes	  with	  PBTX.	  Fish	  were	   then	  either	   blocked	   in	   PBDT	   as	   above	   or	   a	   trypsin	   digest	   was	   performed	   (depended	   on	   the	  antibody	  that	  was	  going	  to	  be	  used	  and	  age	  of	  embryo).	  For	   the	   trypsin	  digest,	   embryos	  were	   incubated	   in	  0.1%	   trypsin	   for	  30	  minutes	  at	   room	  temperature.	  Embryos	  were	  then	  washed	  2x	  5	  minutes	  in	  PBTX	  then	  blocked	  in	  PBDT	  as	  above.	  	  
2.5.3	  Immunohistochemistry	  on	  sections	  Slides	  were	  thawed	  for	  1	  hour	  on	  bench	  then	  fixed	  in	  acetone	  for	  5	  minutes	  at	  -­‐20oC	  and	  allowed	  to	  dry.	  Sections	  were	  washed	  in	  PBTX	  2x	  5	  minutes	  then	  blocked	  in	  PBDT	  for	  one	  hour	   at	   room	   temperature.	   The	   primary	   antibody	   was	   pipetted	   on	   to	   slide	   at	   the	  appropriate	  concentration	   the	   incubated	  at	  4oC	  overnight.	  The	   following	  day	  slides	  were	  washed	   2x	   30	   minutes	   in	   PBDT	   then	   incubate	   in	   the	   appropriate	   concentration	   of	   the	  secondary	  antibody	  for	  1	  hour	  at	  room	  temperature.	  Sections	  were	  washed	  in	  PBDT	  for	  2x	  30	  minutes,	  then	  washed	  in	  PBTX	  for	  15	  minutes	  before	  the	  addition	  of	  Vectorshield	  and	  a	  coverslip.	  	  
2.5.4	  Table	  of	  primary	  antibodies	  used	  
Epitope/antibody	  
name	  
Animal	   developed	  
in	  
Dilution	   used	   for	  
staining	  
Provider	  
F59	   (slow	   myosin	  heavy	  chain)	   Mouse	   1/50	   DSHB	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F310	   (fast	   myosin	  light	  chain)	   Mouse	  	   1/50	   DSHB	  S58	   (slow	   myosin	  heavy	  chain)	   Mouse	   1/50	   DSHB	  GFP	   Rabbit	   1/500	  	   Torrey	  Pines	  mCherry	   Mouse	   1/500	   Living	   Colours,	  Clontech	  Prox1a	   Rabbit	   1/50	   (of	  preabsorbed	  stock)	   Stone	  Elworthy,	  	  Custom	  made	  Tnnc1b	   Rabbit	  	   1/250	   Genetex	  	  	  
2.5.5	  Table	  of	  secondary	  antibodies	  used	  
Epitope/antibody	  name	   Dilution	  
used	   for	  
staining	  
Provider	  
Goat	  anti-­‐mouse	  IgG-­‐488	   1	  in	  1000	   Molecular	  Probes,	  Invitrogen	  
Goat	  anti-­‐mouse	  IgG-­‐546	   1	  in	  1000	   Molecular	  Probes,	  Invitrogen	  Goat	  anti-­‐rabbit	  IgG-­‐488	   1	  in	  1000	   Molecular	  Probes,	  Invitrogen	  Goat	  anti-­‐rabbit	  IgG-­‐568	   1	  in	  1000	   Molecular	  Probes,	  Invitrogen	  Goat	  anti-­‐mouse	  IgG-­‐HRP	   1	  in	  1000	   Molecular	  Probes,	  Invitrogen	  Goat	  anti-­‐rabbit	  IgG-­‐HRP	   1	  in	  1000	   Molecular	  Probes,	  Invitrogen	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2.7	  Cyclopamine	  treatment	  Treatment	  was	   done	   before	   50%	   epiboly	   using	   40µM	   cyclopamine.	   Embryos	  were	   then	  fixed	  as	  normal	  in	  4%	  PFA	  at	  desired	  timepoint.	  	  	  
2.8	  Alcian	  Blue	  and	  Alizarin	  Red	  staining	  
2.8.1	  Adult	  zebrafish	  Alcian	  Blue	  and	  Alizarin	  Red	  staining	  Fish	  were	  fixed	  in	  4%	  PFA	  overnight	  at	  room	  temperature.	  After	  the	  skin	  and	  muscle	  was	  removed	  from	  the	  fish,	  a	  small	  incision	  was	  made	  in	  the	  abdominal	  cavity	  and	  the	  gut	  was	  removed.	   Fish	   were	   then	   digested	   in	   150mg/ml	   of	   trypsin	   made	   up	   in	   5%	   Borax,	   and	  incubated	  overnight	  at	  37oC.	  Fish	  were	  washed	  twice	  with	  water	  to	  remove	  trypsin,	  then	  acetone	  was	  added	  for	  approximately	  8	  hours	  until	  the	  fish	  were	  no	  longer	  shiny.	  If	  doing	  a	  double	  stain	  fish	  were	  then	  washed	  with	  50%	  EtOH	  then	  the	  alcian	  blue	  staining	  solution	  was	  added.	  Fish	  were	  stained	  overnight	  at	  room	  temperature	  in	  a	  glass	   jar,	  washed	  with	  Borax	   the	   following	   morning,	   then	   stained	   with	   Alizarin	   Red	   for	   one	   hour	   (20µl/ml	   of	  0.5%	   alizarin	   red,	   1%	   potassium	   hydroxide,	   50%	   ethanol).	   Pigment	   was	   then	   removed	  through	  bleaching	  of	  the	  embryo	  in	  1.5%	  hydrogen	  peroxide	  and	  1%	  potassium	  hydroxide	  for	  approximately	  20	  minutes.	  Fish	  were	  then	  washed	  4x	  10	  minutes	  in	  water	  and	  cleared	  through	  a	  glycerol	  series	  (25%,	  50%	  and	  75%)	  all	  with	  0.25%	  KOH.	  	  	  
2.8.2	  Alizarin	  Red	  staining	  alone	  on	  adults	  After	  washes	  in	  acetone,	  fish	  were	  washed	  in	  5%	  Borax	  then	  stained	  with	  alizarin	  red	  for	  1-­‐4	  hours	  at	  room	  temperature.	  Fish	  were	  then	  bleached	  as	  above,	  washed	   in	  water	  and	  cleared	  through	  a	  glycerol	  series.	  	  	  
2.8.3	  Alcian	  Blue	  and	  Alizarin	  Red	  staining	  of	  embryos	  and	  juvenile	  zebrafish	  (3	  dpf-­‐	  
30	  dpf)	  Larvae	  were	  fixed	  in	  4%	  PFA	  at	  4oC	  overnight.	  Fish	  were	  washed	  in	  water	  and	  dehydrated	  in	   50%	  EtOH	   for	   10	  minutes	   at	   room	   temperature.	   	   1ml	   of	   staining	   solution	  was	   added	  (either	   double	   staining	   solution	   or	  Alizarin	  Red	   staining	   solution)	   and	   left	   over	   night	   at	  room	   temperature	   for	   less	   than	  16	  hours.	  The	   larvae	  were	  washed	  with	  water	  and	   then	  bleached	   in	   bleaching	   solution	   for	   20	  minutes	   at	   room	   temperature.	   After	   three	  washes	  with	   water	   embryos	   were	   incubated	   in	   clearing	   solution	   1	   for	   30	   minutes	   at	   room	  temperature,	   clearing	   solution	   2	   for	   2	   hours	   at	   room	   temperature	   and	   finally	   stored	   in	  storage	  solution	  at	  4oC.	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2.9	  BAC	  recombineering	  
2.9.1	  Identification	  and	  preparation	  of	  the	  BAC	  Using	   the	   Ensemble	   Genome	   Browser	   (zv9),	   three	   BACs	   were	   identified	   which	  encompassed	   the	   tnnc1b	   locus.	   These	   BACs	   were	   streaked	   out	   onto	   Chloramphenicol	  plates	   (12.5µg/ml)	   and	   prepared	   using	   the	   Nucleobond	   PC100	  Midi	   kit.	   300ng	   purified	  BAC	   DNA	   was	   electroporated	   at	   1.8kV	   into	   EL250	   E.	   coli	   cells	   containing	   the	   red	  recombineering	  system.	  	  
2.9.2	  Ultramer	  design	  for	  eGFP	  cassette	  and	  targeting	  of	  cassette	  	  The	  heat-­‐shock	  inducible	  red	  recombineering	  system	  was	  used	  to	  insert	  an	  eGFP	  cassette	  with	  an	  SV40	  polyadenylation	  site	  into	  the	  tnnc1b	  ATG	  start	  site	  (Lee	  et	  al.,	  2001).	  A	  DNA	  cassette	   containing	   eGFP-­‐SV40pA-­‐FRT-­‐Kan-­‐FRT	   (gift	   from	   Dr	   Stone	   Elworthy)	   was	  modified	  by	  the	  addition	  of	  80	  nucleotide	  homology	  arms	  for	  the	  tnnc1b	   locus,	  using	  two	  long	   oligonucleotides	   named	   ultramers	   (Tnnc1b	   ultramer	   L	   and	   Tnnc1b	   ultramer	   R	   in	  primer	  list)	  that	  had	  a	  20	  nucleotide	  overlap	  with	  the	  reporter	  cassette	  (Figure	  2.1A	  and	  B,	  and	  Appendix	  A1).	  Following	  PCR	   amplification	   of	   this	   cassette,	  Dpn1	  was	   added	   to	   the	  reaction	   to	   digest	   the	   plasmid	   template,	   and	   the	   DNA	   was	   then	   purified	   by	   gel	  electrophoresis	  and	  extraction.	  300ng	  of	  the	  purified	  product	  was	  then	  electroporated	  at	  1.8kV	  into	  the	  EL250	  cells	  containing	  the	  BAC.	  Successful	  integration	  for	  the	  construct	  was	  screened	   for	   using	   Kanamycin	   resistance,	   the	   gene	   for	  which	  was	   then	   removed	   by	   Flp	  recombinase-­‐mediated	   removal	   using	   the	   flanking	   FRT	   sites	   (Lee	   et	   al.,	   2001).	   Primer	  pairs	  Tnnc1b	  left	  and	  Tnnc1b	  right,	  and	  Tnnc1b	  left	  and	  GFP	  right	  were	  used	  to	  confirm	  correct	  insertion	  into	  the	  BAC.	  	  
2.9.3	  iTol2	  modification	  of	  the	  BAC	  A	   further	  modification	  to	   the	  BAC	  was	  made	  by	   the	  replacement	  of	   the	  Chloramphenicol	  resistance	   gene	   with	   an	   iTol2-­‐Amp-­‐iTol2	   targeting	   cassette	   (Figure	   2.1C)	   (Suster	   et	   al.,	  2011).	  This	  targeting	  cassette	  was	  then	  modified	  by	  the	  addition	  of	  homology	  arms	  (itol2	  HA1	  and	   itol2	  HA2	   in	  primer	   list)	   and	   electroporated	   into	   the	   cells	   containing	   the	   eGFP	  modified	   BAC.	   Successful	   integration	   of	   the	   cassette	   was	   screened	   for	   using	   Ampicillin	  resistance.	   Primer	   pairs	   itol2	   outside	   left	   and	   inside	   itol2	  were	   used	   to	   confirm	   correct	  insertion	  into	  the	  BAC.	  The	  modified	  BAC	  was	  then	  injected	  into	  zebrafish	  embryos	  along	  with	  capped	  Tol2	  transposase	  mRNA	  to	  allow	  transposition	  of	  the	  BAC	  into	  the	  zebrafish	  genome.	  Embryos	  were	  grown	  to	  sexual	  maturity	  then	  screened	  for	  successful	  integration	  of	  the	  reporter	  by	  incrossing.	  	  
	   49	  
	  
Figure	   2.1:	   Schematic	   illustration	   of	   the	  BAC	   recombineering	   strategy.	   An	   eGFP-­‐FRT-­‐
KAN-­‐FRT	  reporter	  cassette	  was	  inserted	  into	  a	  BAC	  containing	  the	  tnnc1b	  locus	  (A).	  The	  start	  
site	  of	  the	  GFP	  cassette	  replaced	  the	  start	  site	  of	  the	  tnnc1b	  gene	  (B).	  iTol2	  sites	  were	  added	  
to	   the	   eGFP	   modified	   BAC	   using	   the	   same	   strategy,	   with	   ampicillin	   (Amp)	   replacing	   the	  
chloramphenicol	  (Cm)	  gene	  (C).	  Red	  arrows	  in	  A	  represent	  FRT	  sites.	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pairs	  were	  then	  used	  to	  confirm	  the	  correct	  insertion	  of	  the	  iTol2	  and	  the	  deletion	  of	  the	  downstream	  sequence.	  	  	  	  This	   BAC	  was	   further	  modified	   by	   the	   deletion	   of	   upstream	   sequence.	   A	   construct	   was	  designed	   that	  contained	  a	  Kanamycin	  resistance	  gene	  with	   two	   flanking	  homology	  arms.	  This	   construct	   was	   targeted	   to	   the	   upstream	   sequence	   of	   tnnc1b,	   leaving	   intact	   the	   F	  replicon	   (Figure	   2.2B,	   Reverse	   ultramer	   4	   in	   primer	   list).	   The	   homology	   arms	   were	  designed	   so	   they	   would	   remove	   differing	   amounts	   of	   upstream	   sequence	   (Forward	  ultramer	   4,	   +7kb	   tnnc1b	   HA	   forward,	   +4kb	   tnnc1b	   HA	   forward	   and	   +2.5kb	   tnnc1b	   HA	  forward	   primers	   were	   used	   leaving	   10kb,	   7kb,	   4kb	   and	   2.5kb	   of	   upstream	   sequence	  respectively).	  Successful	   integration	  was	  selected	  for	  based	  on	  kanamycin	  resistance	  and	  PCR	   was	   used	   to	   confirm	   the	   correct	   insertion	   of	   the	   construct	   and	   the	   deletion	   of	  upstream	  sequence.	  	  	  
	  
Figure	  2.2:	  Schematic	  to	  illustrate	  strategy	  for	  generating	  deletion	  derivative	  of	  BAC.	  
The	   iTol2	   cassette	   was	  modified	   so	   that	   one	   of	   the	   homology	   arms	   would	   recombine	   1kb	  
downstream	  of	  the	  tnnc1b	  stop	  site	  (A).	  The	  upstream	  sequence	  was	  deleted	  by	  targeting	  a	  
Kanamycin	  resistance	  cassette	  flanked	  by	  homology	  arms	  that	  would	  target	  different	  regions	  
in	  the	  upstream	  sequence	  (B).	  HA	  (homology	  arm).	  	  	  
2.9.5	  Making	  smaller	  constructs	  of	  tnnc1b:eGFP	  Smaller	   constructs	   containing	   the	  GFP	   reporter	   sequence	  were	  PCR	  amplified	  out	  of	   the	  BAC	  and	   cloned	   into	   the	  pDB739	  vector	   (from	  Steve	  Ekker	   lab;	   (Balciunas	   et	   al.,	   2006))	  that	  contains	  iTol2	  sites	  (see	  2.2.6.	  standard	  cloning).	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cloned	   into	   the	   same	   site	   of	   pDB739	   (Balciunas	   et	   a.,	   2006).	   	   Potential	   enhancers	  were	  then	  cloning	  into	  this	  vector	  as	  detailed	  in	  “2.2.6.	  Standard	  cloning”	  	  
2.9.7	  Mutating	  potential	  sox6	  binding	  sites	  in	  the	  tnnc1b:eGFP	  promoter	  The	  plasmid	  containing	  2.5kb	  upstream	  of	  the	  start	  site	  of	  tnnc1b	  as	  well	  as	  the	  first	  intron	  was	   analysed	   manually	   to	   identify	   possible	   Sox6	   binding	   sites.	   Once	   these	   sites	   were	  identified	   they	  were	  mutated	   sequentially	   and	   the	  mutant	   constructs	  were	   injected	   into	  zebrafish	   embryos	   so	   establish	   stable	   transgenic	   lines.	   Sites	  were	  mutated	   by	   designing	  forward	  and	  reverse	  primers	  that	  had	  approximately	  10bp	  homology	  to	  the	  sequence	  5’	  of	  the	  potential	  Sox6	  binding	  site	  and	  30bp	  homology	  to	  the	  sequence	  3’	  of	  the	  Sox6	  site,	  with	  a	   4	   base	  pair	  mismatch	   in	   the	   seed	   sequence	   of	   the	   sox6	  binding	   site	   (see	  Figure	  3.7	   in	  Chapter	  3).	  After	  PCR	  using	  these	  primer	  pairs,	  1µl	  of	  Dpn1	  restriction	  enzyme	  was	  added	  to	  the	  reaction	  to	  digest	  the	  methylated	  plasmid	  template.	  After	  a	  two-­‐hour	  incubation	  at	  37oC,	   the	  sample	  was	  PCR	  purified	  (AxyPrep	  PCR	  clean-­‐up	  kit	  Axygen),	   transformed	  and	  plated	  onto	  Ampicillin	  agar	  plates.	  Six	  colonies	  were	  prepped	  and	  sequenced.	  Sequences	  were	   analysed	   using	   Lasergene	   SeqMan	   (DNA	   STAR)	   and	   the	   mini-­‐preps	   that	   were	  positive	  for	  the	  mutation	  were	  then	  used	  in	  the	  next	  reaction	  to	  mutate	  the	  next	  binding	  site.	   	  Mutated	  plasmids	  were	   injected	   into	  zebrafish	  embryos	  and	  stable	   transgenic	   lines	  were	  created	  for	  each	  construct.	  	  	  
2.10	  Generation	  of	  zinc-­‐finger	  nuclease	  Sox6	  mutant	  A	  zinc-­‐finger	  nuclease	  designed	   to	   target	   the	   sox6	   locus	  was	  purchased	   from	  Sigma	  and	  injected	   into	   zebrafish	   embryos	   (see	   Figure	  2.3	   for	   design	   strategy).	   	   The	   sox6	   gene	  has	  two	   transcripts,	   so	   the	  DNA-­‐binding	   domain	   of	   the	   zinc-­‐finger	   nuclease	  was	   targeted	   so	  that	   a	   mutation	   would	   be	   generated	   up	   stream	   of	   the	   HMG	   box	   in	   both	   of	   the	   sox6	  transcripts	  (Figure	  2.4A	  and	  B).	  The	  zinc-­‐finger	  nuclease	  was	  injected	  into	  AB	  embryos	  by	  Dr	   Wang	   Xingang.	   Once	   the	   injected	   fish	   had	   reached	   maturity	   they	   were	   screened	   by	  incrossing.	  48	  embryos	  from	  each	  pair	  were	  placed	  in	  separate	  wells	  of	  a	  96-­‐well	  plate	  and	  digested	   in	   DNA	   extraction	   buffer	   (10mM	   Tris	   pH	   8,	   2mM	   EDTA,	   0.2%	   Triton	   X-­‐100,	  200μg/ml	  Proteinase	  K)	  overnight	  at	  55oC.	  Sox6	  ZF	  F	  and	  Sox6	  ZF	  R	  primers	  were	  used	  to	  amplify	   the	   region	   of	   interest	   and	   Sox6	   ZF	   seq	   primer	   was	   used	   for	   sequencing.	   2	  heterozygous	  mutant	   fish	  were	   identified	   in	   the	   40	   fish	   screened.	   The	   fish	   carrying	   the	  first	  allele	  identified,	  allele	  A1,	  produced	  15	  out	  of	  48	  heterozygous	  mutant	  embryos.	  The	  fish	   carrying	   the	   second	   allele	   identified,	   allele	   E2,	   gave	   rise	   to	   11	   out	   48	   heterozygous	  mutant	   embryos.	   The	   remaining	   embryos	   from	   the	   lay	   of	   the	   positively	   identified	  heterozygous	   mutants	   were	   grown	   up	   to	   adulthood.	   Progeny	   from	   allele	   A1	   were	   fin	  clipped	  and	  genotyped	  and	  8	  out	  of	  39	   fish	  were	   identified	  which	  carried	  the	  A1	  mutant	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allele.	  Progeny	  from	  allele	  E2	  were	  genotyped	  and	  6	  out	  of	  38	  fish	  were	  identified	  which	  carried	  the	  E2	  mutant	  allele.	  Both	  mutant	  alleles	  introduced	  a	  premature	  stop	  codon	  into	  the	  sequence	  (Figure	  2.4C).	  Heterozygous	  mutants	  were	  crossed	  to	  generate	  homozygous	  sox6	  mutants.	  
	  
Figure	  2.3:	   Zinc-­‐finger	  nucleases.	   A	   pair	   of	   zinc-­‐finger	  DNA-­‐binding	   domains,	   fused	   to	   a	  
DNA-­‐cleavage	  domain	  were	  targeted	  to	  a	  specific	  region	  of	  DNA,	  creating	  a	  double-­‐stranded	  
break	  in	  the	  DNA.	  This	  stimulates	  the	  cell’s	  endogenous	  DNA-­‐repair	  machinery	  and	  the	  DNA	  
is	  then	  repaired	  through	  non-­‐homologous	  end	  joining	  (NHEJ),	  which	  sometimes	  results	   in	  a	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Figure	   2.4:	   Sox6	   zinc-­‐finger	   nuclease.	   The	   zinc-­‐finger	   nuclease	   was	   designed	   so	   that	   it	  
targeted	  sequences	  that	  are	  present	  in	  both	  isoforms	  of	  Sox6,	  upstream	  of	  the	  HMG	  box	  at	  the	  
position	  of	  approximately	  amino	  acid	  249	  and	  amino	  acid	  230	  (A).	  Schematic	  representation	  
of	   the	  nucleotide	   sequence	   in	  exon	  8	  of	   the	  zebrafish	   sox6	  gene	   targeted	  by	   the	  zinc-­‐finger	  
nuclease	   (B).	   Two	   mutant	   alleles	   were	   identified,	   E2	   and	   A1,	   each	   of	   which	   introduced	   a	  
premature	  stop	  codon	  in	  the	  sequence	  (C).	  	  
	  
	  
2.11	  Western	  Blotting	  








   R   Q   Q   Q   E   Q   V   R   M 
CGC CAA CAG CAA GAG CAG GTG AGA ATG 
 
Allele 1 (E2) 
 R   Q   G   E   N   V  STOP    
CGC CAA GGT GAG AAT GTG TAA   
 
Allele 2 (A1) 
 R   Q   E   P   K  STOP 
CGC CAA GAG CCA AGG TGA  
CTGGCACGCCAAcagcaAGAGCAGGTGAGAATGTG!
GACCGTGCGGTTgtcgtTCTCGTCCACTCTTACAC!
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added	  to	  the	  sample	  and	  the	  tube	  was	  heated	  at	  95oC	  for	  10	  minutes.	  The	  sample	  was	  run	  on	   an	   SDS-­‐polyacrylamide	   gel	   then	   transferred	   to	   a	   nitrocellulose	  membrane	   overnight.	  The	  following	  day	  the	  membrane	  was	  blocked	  in	  Blocking	  Solution	  for	  1	  hour,	   incubated	  with	  the	  primary	  antibody	  for	  1	  hour	  and	  washed	  3x	  10	  minutes	  in	  PBST.	  The	  membrane	  was	  then	  incubated	  with	  a	  horseradish	  peroxidase-­‐conjugated	  secondary	  antibody	  for	  30	  minutes	   then	   washed	   4x	   10	   minutes	   with	   PBST.	   The	   immunoreactive	   proteins	   were	  detected	   on	   the	   nitrocellulose	   membranes	   using	   the	   Clarity	   Western	   ECL	   substrate	  detection	  kit	  (BioRad)	  and	  exposure	  to	  X-­‐ray	  medical	  film.	  	  	  
2.11.2	  Table	  of	  primary	  antibodies	  for	  western	  







β-­‐actin	   Rabbit	   N/A	   1/2000	   Cell	  Signalling	  GFP	   Mouse	   N/A	   1/2000	   Living	  Colours,	  Clontech	  Sox6	  ab66316	   Rabbit	   1/500	  1/2000	   1/5000	   Abcam	  Sox6	  GTX116236	   Rabbit	   1/250	  1/500	   1/2500	   Gentex	  Sox6	  A	  	   Rabbit	   1/1000	   1/2500	   Custom	  made-­‐	  Sdix	  Sox6	  2	  	   Rabbit	   1/1000	   1/2500	   Custom	  made-­‐	  Sdix	  Sox6	  M1	  	   Rabbit	   1/3000	   1/10000	   Custom	  made-­‐	  Absea	  	  
2.11.3	  Table	  of	  secondary	  antibodies	  for	  western	  
Name	   Concentration	  	   Provider	  Anti-­‐Rabbit	  HRP	   1/5000	   Molecular	  probes	  Anti-­‐Mouse	  HRP	   1/5000	   Molecular	  probes	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2.12	  Chromatin	  Immunoprecipitation	  (ChIP)	  
2.12.1	  Chromatin	  extraction	  and	  sonication	  1000	   UAS:sox6-­‐GFP;actin:GAL4	   positive	   embryos	   (experiment)	   or	   1000	   AB	   embryos	  (control)	   were	   dechorionated	   in	   1mg/ml	   Pronase,	   then	   washed	   with	   cold	   PBS.	   Deyolk	  Buffer	  was	   added	   and	   embryos	  were	   pipetted	   vigorously	   to	   dissolve	   the	   yolk.	   The	   cells	  were	  pelleted	  by	  centrifugation	  at	  600g	  for	  3	  minutes	  at	  4oC	  and	  washed	  twice	  in	  cold	  PBS.	  Cells	  were	  then	  fixed	  in	  2mM	  of	  the	  protein	  crosslinker	  DSG	  (Disuccinimidyl	  glutarte)	  (as	  described	  in	  An	  et	  al.,	  2011)	  for	  45	  minutes,	  followed	  by	  10	  minutes	  in	  1%	  formaldehyde	  at	  room	  temperature.	  1/20th	  volume	  of	  2.5M	  glycine	  was	  added	  for	  5	  minutes	   to	  quench	  the	  reaction.	  Cells	  were	  then	  spun	  down	  at	  1200g	  for	  1	  minute	  at	  4oC	  then	  washed	  3	  times	  in	  PBS.	  1ml	  of	  Cell	  Lysis	  Buffer	  was	  then	  added	  to	  the	  cells	  and	  the	  mixture	  was	  pipetted	  vigorously	   to	   homogenise	   cells.	   The	   tube	   was	   incubated	   on	   ice	   for	   15	  minutes	   and	   the	  mixture	  was	   regularly	   pipetted	   to	   ensure	   cells	   were	   completely	   lysed.	   The	   homogenate	  was	  then	  spun	  down	  for	  at	  1200g	  for	  5	  minutes	  at	  4oC	  and	  the	  pellet	  was	  resuspended	  in	  400µl	  of	  Nuclear	  Lysis	  Buffer.	  Cells	  were	  pipetted	  up	  and	  down	  to	  disrupt	  the	  nuclei	  and	  put	  on	  ice	  for	  10	  minutes	  with	  regular	  pipetting.	  The	  nuclear	  lysate	  was	  then	  transferred	  to	  a	  15ml	  tube	  and	  800µl	  of	  cold	  IP	  Buffer	  was	  added.	  The	  lysate	  was	  sonicated	  on	  ice	  (10	  seconds	  on,	  20	  seconds	  off,	  3.00	  minutes)	  and	  the	  final	  volume	  was	  made	  up	  to	  4ml	  and	  split	   into	   two	  2ml	   tubes.	  Tubes	  were	   either	   snap	   frozen	  or	  used	   straight	   away	   for	  ChIP.	  Sonication	  efficiency	  was	  tested	  by	  adding	  1μl	  of	  20mg/ml	  Proteinase	  K	  to	  a	  300μl	  sample	  of	   the	   Chromatin	   extract,	   and	   incubating	   the	   sample	   for	   2	   hours	   at	   42oC	   to	   reverse	   the	  protein-­‐DNA	   crosslinks.	   The	   sample	   was	   then	   Phenol-­‐Chloroform	   extracted	   and	  resuspended	   in	   20μl	   of	   distilled	   water	   and	   run	   out	   onto	   a	   1%	   agarose	   gel.	   If	   the	  fragmentation	  was	  satisfactory	  (i.e.	  most	  of	  the	  DNA	  fragment	  are	  in	  the	  size	  range	  of	  300-­‐700bp),	  the	  Chromatin	  Immunoprecipitation	  protocol	  was	  performed.	  	  	  	  	  
2.12.2	  ChIP	  using	  GFP-­‐Trap	  (ChromoTek)	  	  Protocol	  was	  adapted	  from	  Dubin	  et	  al.,	  2010.	  The	  chromatin	  was	  pre-­‐cleared	  with	  20µl	  of	  Sepharose-­‐4B	   beads	   (ChromoTek)	   for	   2	   hours,	   on	   a	   rotating	   platform	   in	   the	   cold	   room.	  The	   beads	   were	   then	   spun	   down	   at	   2500xg	   for	   3	   minutes	   and	   the	   supernatant	   was	  removed	  and	  put	   in	  a	  new	   tube.	  100µl	  was	   removed	  and	  set	  aside	  as	   the	   input	   fraction.	  20µl	  of	  GFP-­‐Trap	  beads	  (ChromoTek)	  were	  washed	  3	  times	  in	  wash	  buffer,	  then	  added	  to	  the	  chromatin	  and	  incubated	  on	  a	  roller	  overnight	  at	  4oC.	  The	  beads	  were	  spun	  down	  for	  2	  minutes	   at	   2500xg	   at	   4oC	   (if	   doing	   IP	  with	  western,	   100µl	  was	   removed	   as	   supernatant	  sample).	  Beads	  were	  then	  washed	  twice	  with	  Low	  Salt	  Buffer,	  once	  with	  High	  Salt	  Buffer,	  twice	  with	  LiCl	  Buffer	  and	   finally	   twice	  with	  TE	  Buffer.	  250µl	  of	  Elution	  Buffer	  was	   then	  added	   to	   the	  beads	   and	   the	   samples	  were	   incubated	   at	   65oC	   for	  15	  minutes	  with	   gentle	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agitation.	  The	  supernatant	  was	  then	  transferred	  to	  a	  new	  tube	  and	  250µl	  of	  fresh	  Elution	  Buffer	  was	   added	   and	   this	   previous	   stage	   repeated.	  To	   reverse	   the	   crosslinking	   the	   two	  elutes	  were	  pooled	  and	  15µl	  of	  5MNaCl	  was	  added	  and	  incubated	  overnight	  at	  65oC.	  400µl	  of	  Elution	  Buffer	  was	  also	  added	  to	  the	  IP	  with	  15µl	  5MNaCl	  and	  samples	  were	  incubated	  overnight	   at	   65oC.	   The	   following	   day,	   DNA	  was	   precipitated	   from	  both	   the	   input	   and	   IP	  samples	  by	  the	  addition	  of	  EDTA	  and	  Tris-­‐HCl	  pH	  6.8	  to	  a	  final	  concentration	  of	  40mM	  and	  10mM	  respectively.	  Proteinase	  K	  was	  added,	  and	  samples	  were	   incubated	   for	  2	  hours	  at	  55oC.	  The	  DNA	  was	  then	  phenol:	  chloroform	  extracted	  and	  resuspended	  in	  100µl	  of	  water.	  	  	  
2.12.3	  ChIP	  Western	  blotting	  using	  GFP-­‐Trap	  The	  chromatin	  was	  pre-­‐cleared	  as	  above,	  with	  100μl	   set	  aside	  as	   the	   input	   fraction.	  The	  GFP-­‐Trap	   was	   washed	   and	   incubated	   with	   the	   chromatin	   as	   above,	   followed	   by	   the	  removal	  of	  a	  supernatant	  fraction.	  The	  beads	  were	  washed	  as	  above	  and	  then	  resuspended	  in	  100μl	  of	  2x	  SDS	  loading	  buffer.	  The	  sample	  was	  then	  boiled	  for	  10	  minutes	  at	  95oC	  and	  run	  on	  a	  10%	  SDS	  polyacrylamide	  gel	  along	  with	  the	  input	  and	  the	  supernatant	  fractions.	  The	  western	  blot	  protocol	  above	  was	  then	  followed.	  	  	  
2.13	  Quantitative	  PCR	  (qPCR)	  Quantitative	   PCR	   was	   performed	   using	   an	   iCycler	   iQ	   Real-­‐Time	   PCR	   detection	   system	  (BioRad	   Laboratories	   Ltd)	   and	   iQ	   SYBR	   Green	   Supermix	   (BioRad	   Laboratories	   Ltd).	   All	  primers	  were	  optimized	  to	  determine	  that	  amplification	  of	  the	  product	  was	  linear.	  Single	  products	  were	  confirmed	  by	  dissociation	  curve	  analysis.	  All	  qPCR	  reactions	  were	  carried	  out	   at	   95oC	   for	   1	  min,	   followed	  by	  50	   cycles	   (95oC	   for	   10	   seconds,	   56oC	   for	   20	   seconds,	  72oC	  20	  seconds).	  The	  quantitative	  data	  was	  analysed	  with	  the	  iCycler	  iQ	  software	  package	  (BioRad	  Laboratories	  Ltd).	  	  The	  ChIP	  experiment	  using	  the	  GFP-­‐Trap	  was	  repeated	  three	  times	  using	  both	  UAS:Sox6-­‐
GFP;actin:GAL4	   embryos	  and	  wild-­‐type	  AB	  embryos.	  Quantification	  of	  PCR	  products	  was	  performed	  by	  comparing	  the	  threshold	  cycles	  (Ct)	  of	  all	  samples	  run	  in	  triplicates.	  All	  Cts	  were	  normalised	  against	  the	  β-­‐actin	  housekeeping	  gene	  Ct	  values,	  using	  the	  2(delta	  delta	  Ct)	   method	   (Livak	   and	   Schmittgen,	   2001)	   to	   give	   an	   expression	   value	   relative	   to	   the	  internal	  control	  of	  β-­‐actin	  expression.	  The	  fold	  changes	  relative	  to	  the	  β-­‐actin	  gene	  were	  averaged	   for	   each	   ChIP	   experiment	   and	   then	   the	   average	   fold	   change	   for	   the	  UAS:sox6-­‐
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2.14	  Imaging	  	  Light	  microscopy	  images	  were	  captured	  using	  the	  Carl	  Zeiss	  AXIO	  Zeiss	  Imager	  M2	  and	  the	  AXIO	  Vision	   4.7.2	   software.	   Confocal	   images	  were	   captured	   using	   the	  Olympus	   FV-­‐1000	  confocal	  microscope	  and	  the	  Olympus	  FluoView	  FV-­‐1000	  ASW	  1.6	  confocal	  software.	  	  	  
2.15	  Solutions	  and	  Buffers	  
2.15.1	  General	  
Solution	  or	  buffer	   Composition	  PBST	   PBS	  with	  0.1%	  Tween	  20	  DNA	  Extraction	  Buffer	   10mM	  Tris	  pH	  8,	  2mM	  EDTA,	  0.2%	  Triton	  X-­‐100,	  200μg/ml	  Proteinase	  K	  
	  
2.15.2	  Solutions	  and	  Buffers	  for	  in	  situ	  hybridisation	  Hybridisation	  Solution	   50%	  Formamide,	  5xSSC,	  0.1%	  Tween	  20,	  50µg/ml	  Heparin,	  500µg/ml	  tRNA,	  pH	  6.0	  with	  Citric	  Acid	  Staining	  Buffer	   100mM	  Tris-­‐HCl	  pH9.5,	  50mM	  MgCl2,	  100mM	  NaCl,	  0.1%	  Tween20,	  4.5µg/ml	  NBT,	  3.5µg/ml	  BCIP	  PBT	   PBS	  with	  0.1%	  Tween	  20,	  2%	  Sheep	  Serum,	  0.2%	  BSA	  	  
2.15.3	  Solutions	  and	  buffers	  for	  in	  situ	  hybridisation	  on	  sections	  MABT	   150mM	  Maleic	  acid,	  100mM	  NaCl,	  0.1%	  Tween	  20,	  pH7.5	  	  Blocking	  Solution	   2%	  Boehringer	  Blocking	  Reagent,	  20%	  Sheep	  Serum	  in	  MABT	  	  
2.15.4	  Solutions	  and	  buffers	  for	  fluorescent	  in	  situ	  hybridisation	  TNT	  Buffer	   0.1M	  Tris-­‐HCl	  pH	  7.5,	  0.15M	  NaCl,	  0.5%	  Tween20	  TNT	  Block	   TNT	  with	  0.5%	  Perkin-­‐Elmer	  blocking	  powder	  
	  
2.15.5	  Solutions	  and	  buffers	  Immunohistochemistry	  PBTX	   PBS	  	  with	  0.1%	  TritonX-­‐100	  PBDT	   PBS	  with	  1%	  BSA,	  1%	  DMSO	  and	  0.5%	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TritonX-­‐100	  	  
2.15.6	  Solutions	  and	  buffers	  for	  Alizarin	  red	  and	  Alcian	  blue	  staining	  on	  larvae	  (3	  dpf-­‐	  
30	  dpf)	  Alcian	  Blue	  Stock	   0.4%	  in	  70%	  EtOH	  (dissolve	  in	  50%	  then	  adjusted	  to	  70%)	  Alizarin	  Red	  stock	   0.5%	  in	  water	  Alcian	  Blue	  working	  solution	   50µl	  Alcian	  Blue	  Stock	  in	  70%	  EtOH	  with	  60mM	  MgCl2	  Double	  staining	  solution	   10µl	  Alizarin	  Red	  Stock	  per	  1ml	  Alcian	  Blue	  working	  solution	  	  Alizarin	  red	  staining	  solution	   10µl	  Alizarin	  Red	  Stock	  in	  70%	  EtOH	  Bleaching	  solution	   1.5%	  H2O2,	  1%	  KOH	  Clearing	  solution	  1	   20%	  Glycerol,	  0.25%	  KOH	  Clearing	  solution	  2	   50%	  Glycerol,	  0.25%	  KOH	  Storage	  solution	   50%	  Glycerol,	  0.1%	  KOH	  
	  
2.15.7	  Solutions	  and	  buffers	  for	  Alizarin	  red	  and	  Alcian	  blue	  staining	  on	  adult	  fish	  Alcian	  Blue	  staining	  solution	   40mg	  Alcian	  Blue	  in	  30%	  Acetic	  Acid,	  70%	  absolute	  EtOH	  (dissolve	  in	  50%	  Ethanol	  and	  then	  adjust	  to	  70%)	  Alizarin	  Red	  stock	  solution	   0.5%	  Alizarin	  Red	  in	  water	  Alizarin	  Red	  staining	  solution	   20µl	  per	  1ml	  of	  1%	  KOH	  and	  50%	  EtOH	  Bleaching	  solution	   1.5%	  H2O2	  and	  1%	  KOH	  
	  
2.15.8	  Solutions	  and	  buffers	  for	  western	  blotting	  Protease	  inhibitor	  cocktail	  tablets	  was	  purchased	  from	  Roche	  and	  dissolved	  in	  water	  to	  make	  a	  50x	  stock	  solution.	  	  Deyolk	  Buffer	   PBS	  +	  2x	  Protease	  Inhibitor	  Cocktail	  	  	  Cell	  Lysis	  Buffer	  (western)	   10mM	  HEPES	  pH	  7.9,	  1.5mM	  MgCl,	  10mM	  KCl,	  300mM	  Sucrose,	  0.5%	  NP-­‐40	  +	  1x	  Protease	  Inhibitor	  Cocktail	  	  RIPA	  buffer	   50mM	  Tris	  HCl	  pH8,	  150mM	  NaCl,	  1%	  NP-­‐40,	  0.5%	  Sodium	  Deoxycholate,	  0.1%	  SDS	  +	  1x	  Protease	  Inhibitor	  Cocktail	  	  Blocking	  Solution	  (western)	   5%	  Milk	  Powder,	  0.1%	  Tween-­‐20	  in	  PBS	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2.15.9	  Solutions	  and	  buffers	  for	  chromatin	  extraction	  	  Deyolk	  Buffer	   PBS	  and	  2x	  Protease	  Inhibitor	  Cocktail	  	  Cell	  Lysis	  Buffer	  	   10mM	  Tris-­‐HCl	  pH	  7.5,	  10mM	  NaCl,	  0.5%	  NP-­‐40,	  2x	  Protease	  Inhibitor	  Cocktail	  	  Nuclear	  Lysis	  Buffer	   50mM	  Tris-­‐HCl	  pH7.5,	  10mM	  EDTA,	  1%SDS,	  2x	  Protease	  Inhibitor	  Cocktail	  IP	  Buffer	   16.7mM	  Tris-­‐HCl	  pH	  7.5,	  167mM	  NaCl,	  1.2mM	  EDTA,	  0.01%	  SDS,	  2x	  Protease	  Inhibitor	  Cocktail	  (Nuclear	  Lysis	  buffer	  was	  used	  instead	  of	  RIPA	  buffer,	  as	  previous	  optimisation	  for	  the	  zebrafish	  ChIP	  protocol	  in	  the	  lab	  had	  been	  performed	  with	  Nuclear	  Lysis	  Buffer.)	  
2.15.10	  Solutions	  and	  buffers	  for	  ChIP	  with	  GFP-­‐Trap	  Wash	  Buffer	  	   10mM	  Tris-­‐HCl	  pH	  7.5,	  150mM	  NaCl,	  0.5mM	  EDTA	  Low-­‐Salt	  Wash	  Buffer	   150mM	  NaCl,	  0.1%	  SDS,	  1%	  Triton	  X-­‐100,	  2mM	  EDTA,	  20mM	  Tris-­‐HCl	  pH	  8	  High-­‐Salt	  Wash	  Buffer	   500mM	  NaCl,	  0.1%	  SDS,	  1%	  Triton	  X-­‐100,	  2mM	  EDTA,	  20mM	  Tris-­‐HCl	  pH	  8	  LiCl	  Wash	  Buffer	   250mM	  LiCl,	  	  1%	  NP-­‐40,	  1%	  Na-­‐Deoxycholate,	  1mM	  EDTA,	  10mM	  Tris-­‐HCl	  pH	  8	  TE	  Buffer	   10mM	  Tris-­‐HCl	  pH	  8,	  1mM	  EDTA	  pH	  8	  Elution	  Buffer	   1%	  SDS,	  100mM	  NaHCO3	  	  
2.16	  Primers	  Primers	  were	  designed	  using	  Primer3	  v0.4.0	  (Rozen	  and	  Skaletsky,	  2000)	  with	  an	  optimum	  melting	  temperature	  of	  60oC.	  	  
	  
2.16.1	  Primers	  for	  tnnc1b:eGFP	  BAC	  transgenesis	  	  
Tnnc1b ultramer L GTCTGCCGTGAAGAGAGGAGCGCTGGATTACCTGTGA
GGAGTTTACTGACCATTTCAAAAAAGGAAAATCTAAA
CCCGTCGCCACCATGGTGAGCAA 




Tnnc1b ultramer L end GTCTGCCGTGAAGAGAGGAG 
Tnnc1b ultramer R end CTGTTAAACATCACATGGGA 
Tnnc1b Left primer 5’ GTCTGCCGTGAAGAGAGGAG 
Tnnc1b Right primer 3’ AGATGTCGAACGCAGCAC 
eGFP R GTTTACGTCGCCGTCCAG 
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Tnnc1b insert 5' CCCATAACTTACCGCTGCTT 
Tnnc1b insert 3' TTTTCTAAGCCATCCATTCCA 
	  
2.16.2	  Primers	  for	  iTol2	  BAC	  transgenesis	  
itol2 HA1	   AAGAGGTTCCAACTTTCACCATAATGAAATAAGATCACTA
CCGGGCGTATTTTTTGAGTTATCGAGATTCCCTGCTCGAG
CCGGGCCC 
itol2 HA2	   GCCATTCATCCGCTTATTATCACTTATTCAGGCGTAGCAA
CCAGGCGTTTAAGGGCACCAATAACTATTATGATCCTCTA
GATCAGATCT 
itol2 HA1 end AAGAGGTTCCAACTTTCACCA 
itol2 HA2 end GCCATTCATCCGCTTATTATC 
itol2 outside left AAATCCTGGTGTCCCTGTTG 
itol2 outside right CATCGAATTTCTGCCATTCA 
inside itol2R  TTTTGGGGATTTTTACTTTACTTGA 
	  
2.16.3	  Primers	  for	  tnnc1b:eGFP	  BAC	  deletions	  






itol2 ultramer 3 end CAACAGTGAGGGCATCTCAG 
itol2 outside primer 3 GGCAGATTAGATGGGCAGTT 
forward test primer itol2 AGCCCTCCCGTATCGTAGTT 
Forward ultramer 4 
(to delete upstream 









Forward ultramer 4 end TCTTCTGTGTCACATGATCCAA 
Reverse ultramer 4 end GGAGCCACTATCGACTACGC 
Outside forward ultramer 4 TCATGCACTGTATAGGCAAAATG 
Outside reverse ultramer 4 TCCGCTCATGAGACAATAACC 
Test primer R before Kan TTTGATGGTCCGTTTGTTGA 
Test primer R in Kan  CTCGTCCTGCAGTTCATTCA 
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+7kb tnnc1b HA end TCCTCCCCCACAGTCAATTA 
F test +7kb tnnc1b CACAGTTGTTGCCCATTTTG 
+4kb tnnc1b HA forward  CAGCCGCATTTTGGACTAATTGCAATCTATTCA
GGGCATTTTGACTAATACCCACAGGTAGCTTGC
AGTGGGCTT 
+4kb tnnc1b HA end CAGCCGCATTTTGGACTAAT 
F test +4kb tnnc1b AGTCTGATCCCCACTTGCAC 





+2.5kb tnnc1b HA end TCGCCCAATTACCCTAACCT 
F test +2.5kb tnnc1b CAGAGCAAGGGAATTTTCACA 
	  
2.16.4	  Primers	  to	  clone	  tnnc1b:eGFP	  fragments	  into	  pDB739	  
XbaI F tnnc1b -40bp 
(just after GFP) 
CTGCGCTCTAGACCCATAACTTACCGCTGCTT 
	  
XbaI R +2.5kb	   CTGCGCTCTAGAGGTTAATTAGGTTAACTAGGCAGGTT 
XbaI R +1kb	   CTGCGCTCTAGAGACAAGCATGTGACATTTTATGC 
HindIII F intron 1	   GGGCCCAAGCTTCCAGCGATATGACAGATTTCAA 
HindIII R +2.5kb GGGCCCAAGCTTGGTTAATTAGGTTAACTAGGCAGGTT 
HindIII R +1kb GGGCCCAAGCTTGACAAGCATGTGACATTTTATGC 
HindIIItnnc1b+240(2) GGGCCCAAGCTTCAGGTGACCGGTGGATAAGT 
HindIII tnnc1b +570  GGGCCCAAGCTTCACCTATCCAGGCACAGCTT 
HindIII tnnc1b +760	   GGGCCCAAGCTTAAGCATGCATCCAACGTACA 
	  
2.16.5	  Primers	  for	  cloning	  zebrafish	  tnnc1b	  intron1	  into	  βglobin-­‐GFP	  minimal	  
promoter	  vector	  
F intron1 tnnc1b XbaI 2 CTGCGCTCTAGAGCGGTAAGTTATGGGCACAG 
R intron1 tnnc1b XbaI 2 CTGCGCTCTAGACCATTCTTCTGCTCCTCTGTC 
	  
2.16.6	  Primers	  for	  cloning	  human	  tnnc1	  intron1	  into	  βglobin-­‐GFP	  minimal	  promoter	  
vector	  
F intron1 tnnc XbaI GCTCTAGAATCTACAAGGCTGCGGTGAG 
R intron1 tnnc XbaI GCTCTAGAGTGACCACTCAATGCCCTTT 
	  
2.16.7	  Primers	  for	  Sox6	  site	  mutations	  
F Sox6 1 ATAATGATGTGGGTTTCTATAGACTTTCAGGAAAAAAAAATATAG 
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R Sox6 1 GTCTATAGAAACCCACATCATTATACAATAACTCGCCC 
F Sox6 2 TCATGTCTGTAAAGGGATAATAGTCAGTAAACTGCAGAAACG 
R Sox6 2 TGACTATTATCCCTTTACAGACATGAATTTCATTCTTCTG 
F Sox6 3 GGCAATCCAAAAAGGGTTATAAATGGGAGTGAAGCGACG 
R Sox6 3 CCATTTATAACCCTTTTTGGATTGCCTTATGGGATAGT 
F Sox6 4 TATCCATTCAAAAGGGTGCTGTAACTATAGATTATTAAAAATCACA 
R Sox6 4 AGTTACAGCACCCTTTTGAATGGATAAATGCTGTGAAGTG 
F Sox6 5 TGAAGCATTTAAAGGGGAGGGTGTCTGGTGTCTGAA 
R Sox6 5 AGACACCCTCCCCTTTAAATGCTTCAACCTCAGTGTCT 
F Sox6 8 CTGATATGGGGGGTTTGCTTAGGCGGCCAGAAAGAC 
R Sox6 8 CCGCCTAAGCAAACCCCCCATATCAGGTTCTAAACTTATCCA 	  
2.16.8	  Primers	  for	  sequencing	  Sox6	  site	  mutations	  
F tnnc1b +1.1kb seq. GCATGTGACATTTTATGCCATT 
R tnnc1b +0.3kb seq. CATTTGCCAATCATTTGCTG 
	  











F ultramer end tnnc1a:eGFP GGCGGTCTCTCTATAAAGCTCA 
R ultramer end tnnc1a:eGFP TGTTTAAAACTCAAAGCACGAAA 
F promoter tnnc1a TGCTCAGTGATCCTGTCTGC 
R intron 1 tnnc1a AACATCCTGCCACTTACCAA 
F tnnc1a +9kb GCCCACAACCCTAAAGTGAA 
R tnnc1a +9kb TGTCATTTGCCTCTCACACC 
	  
2.16.10	  Primers	  for	  tnnc1a:eGFP	  cloning	  	  
Tnnc1a F 2.2kb HindIII GGGCCCAAGCTTGTGTTCCCCAGCGGTCAG 
Tnnc1a R 2.2kb HindIII GGGCCCAAGCTTTCACCGCTGCTTTGTAGATG 
Tnnc1a F 124bp XbaI CTGCGCTCTAGATTTTTACAGATTACGTTTTGTTTGA 
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2.16.11	  Primers	  for	  Sox6	  zinc-­‐finger	  mutant	  genotyping	  
Sox6 ZF F GGGTGCAGGGTTGTGAAGTG 
Sox6 ZF R ATACATGCACATTACTGCAGGTG 
Sox6 ZF seq CTTCCTTCTTCCATTTTGTTC 	  After	  PCR	  using	  Sox6	  ZF	  F	  and	  Sox6	  ZF	  R,	  product	  is	  sequenced	  using	  Sox6	  ZF	  seq	  
2.16.12	  Primers	  for	  Sox5	  zinc-­‐finger	  mutant	  genotyping	  
Lsmallsox5 GATAGCACATCTCGGGAGGA 
Rsmallsox5 ATTTGCTGGCGTTGTTTTTC After	  PCR,	  product	  is	  sequenced	  using	  Lsmallsox5	  	  
2.16.13	  Primers	  for	  cDNA	  to	  make	  probes	  
Tnnc1a F GAACCCTACCCCTGAAGAGC 
Tnnc1a R GCTCCTTCACGAGACTCCAC 
Tnnt1 F CAGAGTTCGAGGAGGAGGTG 
Tnnt1 R CAACCTTGGTTCCCTTTTGA 
Tnnt2 F CTGAGCTGGTTTTCCTCTGC 
Tnnt2 R TCAGCACAGCATTCACTTCC 
Tnni1a F TCACATGAATCATTTAGCAGCA 
Tnni1a R TCACTGCCTTGAGGGTCTTT 
Tnni1b F GAGGCATTGTTCTAGAGCATCA 
Tnni1b R  TTTGCAGATTACACAATTTATTGACA 
Tpm2 F CAGCCGCCTCTCAGCTACGC 
Tpm2 R GCTTCGCCACAGACCTCTCAGC 
Mylz10 F GTGTCCCTCAGGCTTTTTGAGACCA 
Mylz10 R AGGAACGCAACACACTGGAACACA 
	  
2.16.14	  Primers	  for	  ChIP-­‐qPCR	  
Tnnc1b qPCR F1   CAAAGAATGCGTCCTTTTCCT 
Tnnc1b qPCR R1 AAAAAGCCCATATTTGAATTTTACA 
Tnnc1b qPCR F2 TCCTTTCCTTGCTCCTTTTTAAC 
Tnnc1b qPCR R2 GTTCTATCAGCGTTTCTGCAGTT 
Tnnc1b qPCR F3 TGCTCAATATGCAAGAAGTACCC 
Tnnc1b qPCR R3 CCATGTTCTCATTATCACATGACC 
Tnnc1b qPCR F4 AATATAGCACCTATCCAGGCACA 
Tnnc1b qPCR R4 AATCAGTGCTTGGTTGAAGGTAA 
Tnnc1b qPCR F5 GACCGGTGGATAAGTTTAGAACC 
Tnnc1b qPCR R5 GAGGGATGAGTGAAAAAGGAAAG 
Tnnc1b qPCR F6 CAGGAAACACTGTCAAAATGGAT 
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Tnnc1b qPCR R6 GTAACGGTCTTCAGACACCAGAC 
Smyhc1 qPCR F1 CGGTGACTGTAAAGAAGCTGAGA 
Smyhc1 qPCR R1 TATAGATGAAGGCGATGGACAAC 
Smyhc1 qPCR F2 TAAATTGCATATGCTGGCTCTTT 
Smyhc1 qPCR R2 AGCAGTCTATTTTGGATCCCTTC 
Smyhc1 qPCR F3 CCATCCTCCTTTAAGCCTATTGT 
Smyhc1 qPCR R3 CTCCAGAGCTGGTTCTACCTTTT 
Smyhc1 qPCR F4  ACCAGCTCTGCAGTTACAAGGTA 
Smyhc1 qPCR R4 CTCTGAGAAAAGGAACAGCACAG 
Myh7b qPCR F1.2 CTGGCGTTTACAACAAAGGATT 
Myh7b qPCR R1.2 CGGCTCTTTAACATCTCCTCAAT 
Myh7b qPCR F2 ATTGCTGCATTCCTGTTATTGTT 





Prox1a qPCR F1.3 AACAGATTTTGTTGCCATTTTGT 
Prox1a qPCR R1.3 AAATTCTGAGACATGCACCTTGT 
Prox1a qPCR F2 GTTTCTTTGGCAAATGGTACATC 
Prox1a qPCR R2 CTGCATGCCAAAAGTCTAATTCT 
Prox1a qPCR F3  TAATTTCGGAAGACTGGTTCTCA 
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3.1	  Introduction	  It	  is	  well	  established	  that	  Sox	  proteins	  are	  able	  to	  regulate	  the	  transcription	  of	  their	  target	  genes	   in	   various	   ways,	   through	   both	   direct	   and	   indirect	   mechanisms	   (Kamachi	   et	   al.,	  2000).	   Based	   on	   previous	   research,	   whereby	   sox6	   is	   able	   to	   directly	   repress	   MyHCβ	  expression	   in	   the	   mouse	   (Hagiwara	   et	   al.,	   2007),	   it	   is	   hypothesised	   that	   Sox6	   directly	  represses	   zebrafish	   slow	  muscle	   genes.	   In	  order	   to	   characterise	   the	   interaction	  between	  Sox6	  and	  slow	  muscle	  genes,	  a	  transgenic	  line	  of	  the	  slow	  muscle	  gene,	  tnnc1b,	  was	  made	  using	  BAC	  recombineering	  to	  enable	  us	  to	  identify	  the	  promoter	  and	  cis-­‐regulatory	  regions	  of	  the	  gene	  that	  are	  required	  to	  confer	  slow-­‐twitch	  specific	  expression.	  	  	  
	  
Figure	  3.1:	  Three	  BACs	  encompassing	  the	  tnnc1b	  gene	  were	  modified	  by	  the	  addition	  
of	   a	   GFP	   reporter.	   The	   three	   BACs	   had	   differing	   amounts	   of	   upstream	   and	   downstream	  
sequence	  from	  the	  tnnc1b	  gene.	  
	  
3.2	  Results	  
3.2.1	  Generation	  of	  tnnc1b:eGFP	  reporter	  line	  Three	  BACs	  were	  identified	  that	  contained	  tnnc1b,	  with	  differing	  amounts	  of	  upstream	  and	  downstream	   sequence	   flanking	   the	   tnnc1b	  exon	   sequences.	  The	  BACs	  were	  modified	   by	  the	  insertion	  of	  an	  eGFP	  reporter	  gene	  downstream	  of	  the	  tnnc1b	  promoter	  (Figure	  3.1).	  The	   GFP	  was	   inserted	   so	   that	   the	   ATG	   start	   codon	   of	   the	   GFP	   replaced	   the	   ATG	   of	   the	  
tnnc1b	  gene,	   enabling	   the	  GFP	   to	   act	   as	   a	   reporter	   gene	   for	   tnnc1b	  expression.	  All	   three	  modified	  BACs	  gave	  mosaic	  eGFP	  expression	  specifically	  in	  the	  slow	  muscle	  when	  injected	  into	   zebrafish	   embryos,	   and	   one	   of	   these	   BACs,	   zc137P17,	  was	   used	   (after	  modification	  with	   the	   eGFP	   cassette)	   to	   make	   a	   stable	   transgenic	   line.	   The	   transgenic	   line	  
tg(tnnc1b:eGFP)	   recapitulated	   expression	   of	   the	   endogenous	   tnnc1b	   gene	   as	   GFP	  
!
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fluorescence	   	   was	   only	   seen	   in	   slow	  muscle	   cells	   (Figure	   3.2A-­‐B).	   This	   was	   verified	   by	  fluorescent	   in	  situ	  hybridisation	  combined	  with	  a	  GFP	  antibody	  stain	  to	  show	  the	  precise	  overlap	  between	  the	  expression	  domains	  of	  the	  endogenous	  gene	  and	  the	  GFP	  transgene	  (Figure	  3.2D-­‐F).	  GFP	  expression	  was	  also	  observed	  in	  the	  head	  muscles	  of	  transgenic	  fish	  from	   approximately	   2dpf	   onwards	   (Figure	   3.2C).	   Most	   head	   muscles	   at	   this	   embryonic	  stage	   of	   development	   are	   a	  mix	   of	   slow	   and	   fast-­‐twitch	   fibres	   (Hernandez	   et	   al.,	   2005)	  making	  it	  difficult	  to	  discern,	  without	  the	  use	  of	  another	  slow-­‐twitch	  marker	  such	  as	  F59,	  whether	  the	  tnnc1b:GFP	  transgenic	  line	  has	  slow-­‐specific	  GFP	  expression	  in	  the	  head.	  GFP	  expression	  in	  the	  transgenic	  line	  was	  also	  visible	  in	  neurons	  of	  the	  embryo,	  most	  likely	  the	  trigeminal	   ganglion	   (Figure	   3.3A).	   As	   another	   control	   for	   the	   slow-­‐twitch	   muscle	  specificity,	  the	  tnnc1b:eGFP	  reporter	  line	  was	  crossed	  to	  the	  Tg(smyhc1:lyntdtom)	  reporter	  line,	  which	  recapitulates	  the	  expression	  of	  smyhc1.	  Both	  reporter	   lines	  overlapped	  in	  the	  slow-­‐twitch	  muscle	  of	  the	  embryo	  (Figure	  3.3).	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Figure	   3.2:	   A	   tnnc1b:eGFP	   reporter	   line	   was	   generated	   using	   BAC	   recombineering.	  
Expression	  was	  seen	  specifically	   in	  the	  slow-­‐twitch	  muscle	  (A-­‐B),	  and	  from	  2	  dpf	  expression	  
could	   be	   seen	   in	   jaw	   muscles	   of	   the	   embryo,	   specifically	   the	   adductor	   mandibulae	  
intermandibularis	   anterior,	   intermandibularis	   posterior	   and	   the	   sternohyal.	   (C).	   The	  
tnnc1b:eGFP	   transgenic	   reporter	   line	   (Green)	   replicates	   the	   endogenous	   expression	   of	   the	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Figure:	   3.3	   tnnc1b:eGFP	   and	   smyhc1;lyn-­‐tdtom	   are	   slow-­‐twitch	   muscle	   specific	  
reporter	   lines	   (A-­‐D).	  Expression	  of	   tnnc1b:eGFP	   is	  also	   seen	   in	  a	   cluster	  of	  neurons	   in	   the	  
head	  of	  the	  fish	  whereas	  smyhc1;lyn-­‐tdtom	  is	  not	  seen	  in	  these	  cells	  (A).These	  neurons	  most	  
likely	  represent	  sensory	  neurons	  of	  the	  trigeminal	  ganglion.	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Figure	   3.4:	   The	   tnnc1b:eGFP	   reporter	   construct	   is	   Hedgehog-­‐responsive.	   The	  
tnnc1b:eGFP	   BAC	   construct	   (zc137P17)	   with	   tol2	   transposase	   was	   injected	   into	   embryos	  
from	   a	   smo+/-­‐	   incross.	   The	   neuron-­‐specific	   GFP	   expression	   served	   as	   a	   positive	   control	   for	  
successful	   injection	   of	   the	   construct	   as	   it	  was	   not	  Hedgehog-­‐responsive	   (C	   and	  D).	   28%	   of	  
siblings	  and	  38%	  of	  mutants	  had	  GFP	  expression	   in	  one	  or	  more	  of	   these	  neurons	   (siblings	  
n=122,	  mutants	  n=43,	  total	  n=165)	  (E).	  Of	  the	  embryos	  that	  expressed	  GFP	  in	  these	  neurons,	  
100%	  of	  the	  siblings	  expressed	  GFP	  in	  the	  muscle	  (3	  or	  more	  fibres)	  (A	  and	  F)	  and	  no	  mutants	  
expressed	  GFP	  in	  the	  muscle	  (3	  or	  more	  fibres,	  with	  38/43	  fish	  displaying	  no	  muscle	  specific	  
expression	  at	  all)	  (B	  and	  F).	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All	   transgenic	   lines	   generated	   from	   the	   deletion	   derivatives	   of	   the	   BAC	   retained	   slow-­‐specific	  GFP	  expression	  (summarised	  in	  Table	  3.1).	  
	  
Figure	   3.5:	   A	   series	   of	   deletions	   were	   made	   to	   the	   original	   BAC	   construct	   and	   all	  
transgenic	   lines	   generated	   from	   these	   constructs	   retained	   slow	   specific	   expression.	  
Summary	  of	  deletion	  derivative	  made	  (A).	  A	  construct	  containing	  2.5kb	  of	  upstream	  sequence	  
from	  the	  translation	  initiation	  codon	  and	  1kb	  of	  downstream	  sequence	  from	  the	  translation	  
stop	  codon,	  exhibited	  slow-­‐specific	  GFP	  expression	  (B-­‐D)	  Green	  box	  represents	  GFP.	  
	  
Line	   Founder	   Expression	  Pattern	  
tnnc1b:eGFP	   1	   Slow-­‐twitch	  muscle	  and	  neurons	  
tnnc1b:eGFP	  +25kb-­‐1kb	  	   1	  2	   Slow-­‐twitch	  muscle	  and	  neurons	  Slow-­‐twitch	  muscle	  and	  neurons	  
tnnc1b:eGFP	  +10kb-­‐1kb	  	   1	  2	   Slow-­‐twitch	  muscle	  and	  neurons	  Slow-­‐twitch	  muscle	  and	  neurons	  
tnnc1b:eGFP	  +7kb-­‐1kb	  	   1	  2	   Slow-­‐twitch	  muscle	  and	  heart	  Slow-­‐twitch	  muscle	  and	  neurons	  
tnnc1b:eGFP	  +4kb-­‐1kb	  	   1	  2	   Slow-­‐twitch	  muscle	  and	  neurons	  Slow-­‐twitch	  muscle	  
tnnc1b:eGFP	  +2.5kb-­‐1kb	   1	  2	   Slow-­‐twitch	  muscle	  and	  neurons	  Slow-­‐twitch	  muscle	  and	  neurons	  
	  Table	   3.1:	   A	   summary	   of	   the	   expression	   characteristics	   of	   stable	   transgenic	   lines	  
generated	  from	  the	  modified	  BAC	  zc137P17	  construct.	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constructs	  were	  made	  this	  way	  and	  stable	  transgenic	  lines	  were	  generated	  with	  all	  of	  them	  (summarised	   in	   Table	   3.2).	   All	   embryos	   that	  were	   GFP	   positive	   after	   injection	  with	   the	  constructs	   were	   grown	   to	   adulthood	   and	   screened,	   whether	   the	   GFP	   expression	   was	  observed	  in	  the	  fast-­‐	  or	  slow-­‐twitch	  domain	  or	  both	  domains.	  It	  appears	  that	  that	  the	  first	  intron	  of	   tnnc1b	   is	   vital	   for	  GFP	  expression.	  When	   constructs	  where	  made	  which	   lacked	  this	  first	  intron,	  no	  GFP	  expression	  was	  observed,	  indicating	  the	  presence	  of	  an	  enhancer.	  A	  construct	  comprising	  560bp	  upstream	  of	  the	  tnnc1b	  start	  site	  plus	  the	  first	  intron,	  gave	  rise	   to	   GFP	   expression	   in	   the	   fast	   muscle	   in	   the	   progeny	   of	   one	   founder.	   However,	   in	  contrast,	  the	  progeny	  of	  two	  other	  founders,	  generated	  with	  the	  same	  construct,	  exhibited	  slow-­‐specific	  GFP	  expression.	  The	  offspring	  of	  other	   founders	  also	  exhibited	  ectopic	  GFP	  expression	   in	   the	   heart,	   although	   no	   clear	   trend	   emerged,	   making	   the	   elucidation	   of	   a	  heart-­‐specific	   repressor	   element	   difficult.	   A	   summary	   of	   the	   transgenic	   lines	   generated	  and	  the	  expression	  patterns	  of	  their	  transgenes	  are	  shown	  in	  Table	  3.2.	  	  
Line	   Founder	   Expression	  Patter	  
tnnc1b:eGFP	  +	  2.5kb	  +	  intron1	   1	  2	   Slow-­‐twitch	  muscle	  and	  neurons	  Slow-­‐twitch	  muscle	  and	  neurons	  
tnnc1b:eGFP	  +	  2.5kb	   N/A	   No	  GFP	  expression	  seen	  in	  any	  embryos	  injected	  so	  no	  fish	  were	  grown	  up	  
tnnc1b:eGFP	  +1kb	  +inton1	   1	  2	  3	   Slow-­‐twitch	  muscle,	  nose	  and	  neurons	  Slow-­‐twitch	  muscle	  and	  neurons	  Slow-­‐twitch	  muscle	  and	  neurons	  
tnnc1b:eGFP	  +	  760	  +	  inton1	  	   1	  2	  3	   Slow-­‐twitch	  muscle	  and	  heart	  Slow-­‐twitch	  muscle	  Slow-­‐twitch	  muscle	  and	  neurons	  
tnnc1b:eGFP	  +	  560	  +intron1	   1	  	  2	  3	  
Slow-­‐twitch	  muscle	  and	  fast-­‐twitch	  muscle	  (weak)	  Slow-­‐twitch	  muscle,	  heart	  and	  neurons	  Slow-­‐twitch	  muscle	  and	  heart	  
tnnc1b:eGFP	  +270	  +intron1	   1	  2	   Slow-­‐twitch	  muscle	  and	  heart	  Slow-­‐twitch	  muscle	  and	  heart	  
Table	  3.2:	  List	  of	  tnnc1b:eGFP	  pDB739	  lines	  generated	  including	  number	  of	  founders	  
and	  expression	  pattern	  
	  
3.2.3	  Cloning	  of	  tnnc1b	  first	  intron	  into	  a	  beta-­‐globin	  minimal	  promoter	  vector	  As	  the	  loss	  of	  the	  first	  intron	  of	  tnnc1b	  resulted	  in	  a	  complete	  loss	  of	  GFP	  expression,	  this	  region	  was	   cloned	   into	   a	  β-­‐globin	  minimal	   promoter	   vector	   to	   see	   if	   it	  was	   acting	   as	   an	  enhancer	  (Figure	  3.6D).	  This	  vector	  was	  made	  by	  inserting	  a	  β-­‐globin-­‐eGFP-­‐polyA	  cassette	  into	   the	   pDB739	   plasmid,	   which	   enabled	   the	   testing	   of	   the	   regulatory	   potential	   of	  suspected	  enhancer	  elements.	  The	  GFP	  expression	  seen	  in	  the	  progeny	  of	  two	  founder	  fish	  for	  the	  β-­‐globin-­‐GFP:intron1-­‐tnnc1b	  reporter,	  was	  seen	  not	  only	  in	  the	  slow-­‐twitch	  muscle	  but	  also	   throughout	   the	   fast	  muscle	   (Figure	  3.6A	  and	  B).	   Interestingly	  a	  skeletal	  muscle-­‐
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specific	   enhancer	   has	   been	   shown	   to	   reside	   in	   the	   first	   intron	   of	   the	  mouse	   tnnc1	   gene,	  indicating	   the	  possible	  presence	  of	  a	  conserved	  non-­‐coding	  element	   (CNE)	  (Parmacek	  et	  al.,	   1994).	   Since	   the	   mouse	   and	   human	   first	   intron	   of	   tnnc1	   have	   high	   sequence	  conservation	  (Parmacek	  et	  al.,	  1994),	  the	  first	  intron	  of	  human	  tnnc1	  gene	  was	  cloned	  into	  the	   β-­‐globin	   minimal	   promoter	   vector	   and	   this	   construct	   was	   injected	   into	   zebrafish	  embryos	   (Figure	   3.6D).	   Two	   founders	   were	   identified	   which	   had	   the	   same	   expression	  pattern	   as	   the	   zebrafish	   intron1	   construct	   (β-­‐globin-­‐GFP:intron1-­‐tnnc1b),	   i.e.	   in	   which	  expression	  was	  seen	  in	  both	  the	  slow	  and	  fast	  twitch	  muscle	  (Figure	  3.6C).	  This	  suggests	  the	  presence	  of	  a	  conserved	  skeletal	  muscle	  enhancer	  in	  the	  first	  intron	  of	  tnnc1.	  
	  
	  
Figure	  3.6:	  Zebrafish	  slow	  troponin	  c	  contains	  a	  conserved	  enhancer	  in	  intron1.	  The	  
zebrafish	  (A	  and	  B)	  and	  the	  human	  (C)	  first	  intron	  of	  slow	  troponin	  c	  can	  driver	  transgene	  
expression	  in	  both	  the	  fast-­‐twitch	  and	  slow-­‐twitch	  muscle.	  Schematic	  of	  constructs	  generated	  
(D).	  (Skin	  staining	  in	  panel	  C	  is	  a	  staining	  artefact	  and	  was	  not	  visible	  in	  embryos	  before	  
immunohistochemistry	  staining).	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constructs	   was	   used	   to	   make	   a	   stable	   transgenic	   line	   (Figure	   3.8).	   No	   ectopic	   GFP	  expression	  was	  seen	  in	  the	  fast-­‐twitch	  muscle	  of	  any	  of	  the	  lines	  (Table	  3.3).	  	  
	  
Figure	  3.7:	  Sox6	  sites	  were	  mutated	  in	  the	  construct	  containing	  2.5kb	  upstream	  of	  the	  
tnnc1b	   start	   site	   and	   the	   first	   intron.	   Six	   sox6	   sites	   were	   identified	   and	   mutated	  
(highlighted	   in	   yellow)	   Red	   box	   below	   represents	   the	   nucleotide	   mutations	   that	   were	  
introduced	   into	   the	   construct	   by	   PCR.	   GFP	   is	   highlighted	   in	   green.	   Exon1	   is	   highlighted	   in	  
dark	  red.	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Figure	   3.8:	   Mutation	   of	   potential	   Sox6	   binding	   sites	   in	   the	   tnnc1:eGFP	   reporter	  
construct	  had	  no	  effect	  on	  GFP	  expression.	  GFP	  expression	  remained	  restricted	  to	  the	  slow	  






Expression	  Pattern	  1	   1	  2	  3	   Slow	  muscle	  Slow	  muscle	  (strong)	  Slow	  muscle,	  Heart	  1,2	   1	  2	  3	   Slow	  muscle	  Slow	  muscle	  (weaker	  than	  3)	  Slow	  muscle,	  heart	  (very	  weak)	  1,2,3	   1	  2	   Slow	  muscle	  Slow	  muscle,	  heart,	  neuron	  1,2,3,4	   1	  2	   Slow	  muscle	  (strong),	  neuron,	  heart	  Slow	  muscle	  weak	  1,2,3,4,5	   1	  2	  3	  4	  
Slow	  muscle	  (weak),	  neuron	  Slow	  muscle	  (very	  weak)	  Slow	  muscle,	  neuron	  Slow	  muscle,	  neuron	  1,2,3,4,5,6	   1	  2	  3	   Slow	  muscle,	  neuron,	  heart	  Slow	  muscle,	  neuron	  Slow	  muscle,	  neuron	  
Table	  3.3:	  Summary	  table	  of	   the	   tnnc1b:eGFP	  Sox6	  site	  mutant	   lines	  generated,	  with	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3.2.5	  Generation	  of	  tnnc1a:eGFP	  transgenic	  line	  As	  was	  mentioned	  in	  Chapter	  1,	  in	  contrast	  to	  mammals,	  which	  have	  a	  single	  slow	  troponin	  
c	  (Tnnc1)	  gene	  that	  is	  expressed	  in	  both	  slow-­‐skeletal	  and	  cardiac	  muscle,	  zebrafish	  have	  two	   paralogous	   genes,	   tnnc1a	   and	   tnnc1b,	   which	   are	   expressed	   specifically	   in	   the	   heart	  and	   slow-­‐twitch	   skeletal	   muscle,	   respectively	   (Sogah	   et	   al.,	   2010).	   Since	   the	   results	  described	  above	  suggest	  that	  the	  skeletal	  muscle	  enhancer	  is	  conserved	  between	  zebrafish	  and	   humans,	   it	  was	   investigated	  whether	   this	  was	   also	   the	   case	   for	   the	   heart	   enhancer.	  Previous	   studies	   have	   localised	   the	   mammalian	   Tnnc1	   heart	   muscle	   enhancer	   to	  sequences	  encompassing	   the	   transcription	  start	  site	  of	   the	  Tnnc1	  gene	  (bp	   -­‐123	   to	  +32).	  The	   BAC	   zc117LI9	   which	   encompasses	   the	   tnnc1a	   gene	   along	   with	   125kb	   of	   upstream	  sequence	   and	   35kb	   of	   downstream	   sequence	   was	   modified	   by	   the	   addition	   of	   a	   GFP	  reporter	  construct	  so	  that	  the	  start	  site	  of	   the	  GFP	  reporter	  replaced	  the	  start	  site	  of	   the	  
tnnc1a	   gene	   (same	   strategy	   that	   was	   used	   for	   the	   generation	   of	   the	   tnnc1b	   transgenic	  reporter	  line).	  iTol2	  sites	  were	  then	  inserted	  into	  the	  BAC	  by	  recombination	  and	  a	  stable	  transgenic	   line	  was	  then	  generated	  which	  expressed	  GFP	  specifically	   in	  the	  heart	  muscle	  (Figure	  3.9).	  Expression	  could	  be	  seen	  clearly	  throughout	  the	  heart	  from	  approximately	  48	  hpf	  with	  GFP	  fluorescence	  appearing	  slight	  stronger	  in	  the	  ventricle.	  	  	  
	  
Figure	  3.9	  tnnc1a:eGFP	  is	  expressed	  exclusively	  in	  the	  heart	  muscle	  and	  excluded	  from	  
the	   skeletal	  muscle.	   Two	   founders	  were	   identified	  which	   carried	   the	   transgene	   and	   both	  
had	  the	  same	  expression	  pattern.	  In	  order	  to	  try	  and	  identify	  the	  enhancer	  I	  cloned	  approximately	  2.2kb	  upstream	  of	  the	  start	  site	  and	  the	  GFP	  into	  the	  pDB739	  vector	  and	  also	  cloned	  a	  240bp	  immediate	  upstream	  fragment	  into	  the	  βglobin	  minimal	  promoter	  vector.	  However,	  when	  both	  of	  these	  constructs	  were	  injected	  into	  zebrafish	  embryos	  there	  was	  no	  GFP	  expression.	  More	  analysis	  is	  needed	  to	  determine	  the	  cis-­‐regulatory	  regions	  of	  this	  gene.	  	  	  	  
Tg(tnnc1a:GFP)& 72hpf& Tg(tnnc1a:GFP)&& 72hpf&
B&A&
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3.3	  Discussion	  	  
3.3.1	  	  tnnc1b	  promoter	  analysis	  The	  identification	  and	  characterization	  of	  the	  cis-­‐regulatory	  regions	  of	  genes	  is	  crucial	  for	  understanding	   how	   the	   transcriptional	   programmes	   and	   signalling	   pathways	   that	  orchestrate	   development	   are	   functionally	   integrated	   (Li	   and	   Davidson,	   2009).	   The	   key	  components	  of	  the	  transcriptional	  mechanisms	  that	  regulate	  expression	  of	  zebrafish	  slow-­‐twitch	   muscle-­‐specific	   genes	   are	   largely	   unknown.	   Previous	   experiments	   in	   mice	   and	  zebrafish	   have	   implicated	   the	   transcription	   factor	   Sox6	   as	   a	   negative	   regulator	   of	   these	  genes	   (An	  et	  al.,	  2011,	  Hagiwara	  et	  al.,	  2007,	  von	  Hofsten	  et	  al.,	  2008).	  Although	  Sox6	   is	  known	   to	   be	   able	   to	   directly	   inhibit	   slow-­‐specific	   genes	   in	   mice	   (An	   et	   al.,	   2011),	   it	   is	  unknown	   whether	   this	   is	   the	   case	   in	   zebrafish.	   Previous	   unpublished	   work	   in	   our	  laboratory	  has	  suggested	  that	   there	   is	  a	  direct	   interaction	  between	  Sox6	  and	  the	  smyhc1	  promoter,	   because	  mutating	   the	   potential	   Sox6	   binding	   sites	   in	   a	   smyhc1:GFP	   construct,	  which	   lie	   upstream	  of	   the	   smyhc1	  proximal	   promoter	   sequences,	   resulted	   in	   the	   ectopic	  expression	  of	  GFP	  in	  several	  fast-­‐twitch	  fibres.	  Moreover,	  a	  recent	  study	  has	  indicated	  that	  the	  mutation	  of	  Sox6	  binding	  sites	   in	  a	   fugu	  slow	  MYH:eGFP	  reporter	   cassette	   results	   in	  ectopic	   GFP	   expression	   in	   the	   fast-­‐twitch	  muscle	   when	   injected	   into	   zebrafish	   embryos	  (Asaduzzaman	  et	  al.,	  2013).	   	   In	  order	  to	  determine	  whether	  another	  slow-­‐twitch-­‐specific	  muscle	  gene	  exhibited	  ectopic	  expression	  in	  fast	  muscle	  when	  its	  regulation	  by	  Sox6	  was	  compromised,	   a	   transgenic	   reporter	   line	  was	   generated	   in	  which	   the	   expression	   of	   GFP	  was	  placed	  under	  the	  control	  of	  the	  tnnc1b	  promoter.	  This	  construct	  enabled	  us	  to	  identify	  the	  minimal	  promoter	  and	  enhancer	  regions	  for	  the	  tnnc1b	  gene	  required	  for	  slow-­‐twitch	  specific	  transcription,	  and	  to	  then	  identify	  and	  mutate	  any	  potential	  Sox6	  binding	  sites	  in	  this	  region	   in	  order	  to	  establish	  whether	  there	   is	  a	  direct	   functional	   interaction	  between	  the	  regulatory	  elements	  of	  this	  gene	  and	  the	  Sox6	  transcription	  factor.	  	  	  	  The	   tnnc1b:GFP	   transgenic	   reporter	   line	   faithfully	   recapitulated	   the	   endogenous	   tnnc1b	  expression	   pattern	   in	   zebrafish	   embryos,	   being	   restricted	   to	   slow-­‐twitch	   muscle	   fibres.	  The	  transgenic	   line	  thus	  provides	  us	  not	  only	  with	  a	  useful	  readout	  of	  tnnc1b	  expression	  but	  also	  a	  new	  slow-­‐twitch	  muscle-­‐specific	  fluorescent	  reporter	  with	  which	  the	  behaviour	  of	  slow-­‐twitch	  muscle	  fibres	  can	  be	  studied	  during	  embryonic	  and	  larval	  development.	  The	  
tnnc1b:GFP	   transgenic	   reporter	  was	   hedgehog-­‐responsive,	   confirming	   previous	   reports	  that	   describe	   the	   dependency	   of	   genes	   involved	   in	   slow-­‐twitch	  muscle	   development	   on	  hedgehog	  signalling	  (Barresi	  et	  al.,	  2000,	  Baxendale	  et	  al.,	  2004,	  Blagden	  et	  al.,	  1997,	  Du	  et	  al.,	  1997,	  Hirsinger	  et	  al.,	  2004,	  Lewis	  et	  al.,	  1999,	  Roy	  et	  al.,	  2001).	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A	  common	  strategy	  to	   identify	  enhancers	  of	  genes	   is	   to	  search	  for	  conserved	  non-­‐coding	  elements	   (CNEs)	   bioinformatically,	   using	   software	   tools	   such	   as	   VISTA	   (Frazer	   et	   al.,	  2004).	   This	   type	   of	   approach	   can	   identify	   genomic	   regions	  within	   a	   specified	   locus	   that	  have	   high	   nucleotide	   similarity	   with	   putative	   orthologous	   regions	   in	   other	   species.	   An	  mVISTA	   analysis	   (Frazer	   et	   al.,	   2004)	  was	   performed	   that	   compared	   the	   tnnc1b	  gene	   of	  zebrafish	  to	  its	  orthologous	  genes	  in	  medaka,	  stickleback,	  tetraodon	  and	  fugu	  (all	  of	  which	  have	  two	  tnnc1	  genes),	  as	  well	  as	  to	  mouse	  and	  human	  tnnc1	  orthologues	  (Appendix	  A2).	  Although	   the	  protein	   coding	   region	  of	   this	  gene	   is	  highly	   conserved	   (represented	  by	   the	  three	  pink	  peaks)	  the	  upstream	  region	  of	  the	  gene	  and	  the	  introns	  are	  not	  conserved	  (with	  a	   threshold	  of	   50%	   identity).	   Since	  no	  CNEs	  were	   recognised	  bioinformatically,	   deletion	  analysis	  of	  the	  initial	  reporter	  construct	  was	  then	  performed.	  The	  deletion	  analysis	  of	  the	  
tnnc1b	   promoter	   led	   to	   the	  discovery	   that	   the	  minimal	   regulatory	  elements	  determining	  the	   slow-­‐specific	   transcription	   of	   tnnc1b	   lay	   within	   a	   region	   encompassing	   240bp	  immediately	  upstream	  of	  the	  transcription	  start	  site,	  and	  the	  first	  intron	  of	  the	  gene.	  The	  loss	  of	  the	  first	  intron	  of	  tnnc1b	  resulted	  in	  a	  complete	  loss	  of	  GFP	  expression,	  identifying	  a	  possible	  enhancer	  in	  this	  region.	  This	  intron	  was	  therefore	  cloned	  into	  a	  β-­‐globin	  minimal	  promoter	  vector	  containing	  a	  GFP	  reporter	  and	  the	  resulting	  construct	  tested	  for	  its	  ability	  to	  drive	  muscle	   fibre-­‐type-­‐specific	  gene	  expression.	  The	  results	   revealed	   that	   this	   intron	  could	  drive	  GFP	  expression	  in	  both	  the	  fast-­‐	  and	  the	  slow-­‐twitch	  muscle,	  when	  linked	  to	  a	  
β-­‐globin	  minimal	  promoter.	  This	  result	  suggested	  that	  a	  muscle-­‐specific	  enhancer	  may	  lie	  in	  the	  first	  intron	  of	  tnnc1b	  and	  further	  indicated	  that	  a	  repressor	  element	  may	  lie	  within	  the	   240bp	   of	   DNA	   sequence	   immediately	   upstream	   of	   the	   transcription	   start	   site.	   Since	  previous	  studies	  by	  other	  researches	  had	  shown	  that	  a	  skeletal	  specific	  enhancer	  is	  located	  in	   the	   first	   intron	   of	   the	  mouse	  Tnnc1	   gene,	  which	   is	   highly	   conserved	  with	   the	   human	  
Tnnc1	   gene	   (Parmacek	   et	   al.,	   1994),	   a	   DNA	   fragment	   containing	   the	   first	   intron	   of	   the	  human	   Tnnc1	   gene	   was	   also	   cloned	   into	   the	   β-­‐globin	   minimal	   promoter	   vector,	   and	   its	  ability	   to	   drive	   fibre-­‐type-­‐specific	   gene	   expression	   was	   tested	   by	   microinjection	   into	  zebrafish	   embryos.	   This	   construct	   exhibited	   GFP	   expression	   in	   both	   the	   slow-­‐	   and	   fast-­‐twitch	  muscle,	  mirroring	  what	  is	  seen	  with	  the	  zebrafish	  intron1	  tnnc1b	  construct.	  These	  results	  suggested	  the	  presence	  of	  an	  evolutionarily	  conserved	  enhancer	  in	  the	  first	  intron	  of	  the	  zebrafish	  and	  human	  tnnc1	  genes.	  Minimal	   promoter	   vectors	   are	   a	   commonly	   used	   tool	   for	   assessing	   enhancer	   activity	   in	  zebrafish	  (Bessa	  et	  al.,	  2009,	  Fisher	  et	  al.,	  2006b).	  The	  minimal	  promoter	  vector	  employed	  in	  this	  study	  (human	  β-­‐globin),	  does	  not	  drive	  any	  pattern	  of	  expression	  on	  its	  own	  when	  injected	   into	   zebrafish	   embryos	   ((MacDonald	   et	   al.,	   2010),	  my	   data),	   and	   only	   responds	  specifically	  to	  the	  activity	  of	  the	  enhancer	  that	  is	  cloned	  into	  the	  vector.	  However,	  care	  is	  needed	   when	   interpreting	   the	   results	   of	   this	   type	   of	   analysis,	   as	   problems	   with	   this	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technique	   can	   result	   from	   the	   random	   integration	  of	   this	   vector	   into	   the	   genome,	  which	  can	  often	  lead	  to	  the	  reporter	  gene	  becoming	  exposed	  to	  enhancer	  activities	  present	  in	  the	  surrounding	  genomic	  regions.	  Such	  “Position	  Effects”	  (Chung	  et	  al.,	  1993)	  could	  result	   in	  reporter	  gene	  expression	  patterns	   that	  do	  not	   result	   from	  enhancer	  activities	  within	   the	  transgene	   construct	   itself.	   This	   phenomenon	  was	   corrected	   for,	   as	   at	   least	   two	   or	  more	  stable	   lines	   for	   each	   construct	   were	   generated,	   which	   were	   derived	   from	   independent	  insertions	   into	  the	  genome	  that	  had	  a	  reproducible	  GFP	  expression	  pattern.	  To	  minimise	  the	  possibility	  of	  an	  effect	  of	  the	  genomic	  position	  at	  which	  the	  transgene	  was	  inserted,	  on	  the	  reporter	  gene	  expression	  pattern,	  one	  could	  insert	  insulator	  sequences	  into	  the	  vector,	  which	   would	   increase	   the	   specificity	   of	   the	   transgene	   by	   protecting	   it	   from	   the	  transcriptional	  silencing	  effects	  of	  adjacent	  heterochromation	  (Bessa	  et	  al.,	  2009,	  Chung	  et	  al.,	  1993).	  Another	  way	  to	  optimize	  the	  analysis	  would	  have	  been	  to	  introduce	  a	  positive	  control	  for	  transgenesis	  into	  the	  construct,	  such	  as	  a	  fluorescent	  reporter	  gene	  under	  the	  control	  of	  the	  eye	  lens-­‐specific	  crystalline	  promoter	  (Kwan	  et	  al.,	  2007).	  This	  would	  mean	  that	   constructs	  which	  exhibited	  no	  GFP	  expression,	   e.g.	   the	   tnnc1b	  construct	   that	   lacked	  the	   first	   intron,	   could	   still	   be	   injected	   into	   zebrafish	   embryos	   and	   a	   stable	   line	   could	  be	  created	  based	  on	  expression	  of	  the	  linked	  reporter	  in	  the	  eye.	  The	  lack	  of	  GFP	  expression	  in	  the	  muscle	  of	  these	  fish	  would	  then	  confirm	  that	  the	  first	  intron	  is	  absolutely	  required	  for	  the	  expression	  of	  the	  gene.	  	  Regardless	  of	  the	  suggested	  improvements	  to	  the	  transgenic	  strategy,	  based	  on	  the	  results	  of	   the	   experiments	   performed,	   it	   is	   tempting	   to	   speculate	   that	   the	   first	   intron	   of	   tnnc1b	  contains	  a	  cis-­‐regulatory	  conserved	  non-­‐coding	  element	  (CNE)	  that	  is	  needed	  to	  drive	  the	  expression	   of	   tnnc1b	   in	   the	   slow-­‐twitch	   myotome.	   The	   conservation	   of	   the	   enhancer	  activity	  in	  the	  mammalian	  Tnnc1	  first	  intron	  and	  the	  zebrafish	  tnnc1b	  first	  intron,	  despite	  the	  absence	  of	  any	  clear-­‐cut	  DNA	  sequence	  conservation,	  adds	  to	  an	  accumulating	  body	  of	  evidence	   which	   indicates	   that	   conservation	   of	   CNE	   sequence	   is	   not	   necessary	   for	   the	  conservation	   of	   CNE	   regulatory	   activity	   (Fisher	   et	   al.,	   2006a,	   Friedli	   et	   al.,	   2010,	  McGaughey	   et	   al.,	   2008,	   Visel	   et	   al.,	   2008,	  Weirauch	   and	  Hughes,	   2010).	   Although	   there	  appears	  to	  be	  little	  DNA	  sequence	  conservation	  between	  the	  first	  introns	  of	  slow	  troponin	  c	  in	  zebrafish	  and	  either	  mouse	  or	  human,	  the	  ability	  of	  the	  human	  and	  zebrafish	  introns	  to	  drive	   the	   same	   GFP	   expression	   pattern	   in	   zebrafish	   suggests	   that	   there	   is	   a	   functional	  conservation	   of	   regulatory	   activity.	   	   It	   was	   previously	   thought	   that	   DNA	   sequence	  divergence	   represents	   a	   mechanism	   for	   the	   divergence	   of	   function,	   yet	   studies	   such	   as	  ours	   indicate	   that	   this	   relationship	   does	   not	   always	   hold.	   For	   example,	   when	   the	   cis-­‐regulatory	   regions	   of	   the	   human	   and	   zebrafish	   receptor	   tyrosine	   kinase	   gene,	   ret,	  orthologues	   were	   compared,	   it	   was	   found	   that	   despite	   a	   lack	   of	   DNA	   sequence	  conservation	  in	  the	  vicinity	  of	  the	  gene	  in	  each	  of	  these	  species,	  the	  transgene	  expression	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pattern	   conferred	   by	   the	   human	   cis-­‐regulatory	   sequences	   closely	   mimicked	   that	   of	   the	  zebrafish	  orthologue	  (Fisher	  et	  al.,	  2006a).	  	  There	   are	   thought	   to	   be	   two	   types	   of	  mechanism	   that	   govern	  how	  a	   cis-­‐regulatory	  DNA	  sequence	  can	  be	  altered	  without	  any	  change	  in	  the	  transcriptional	  regulation	  of	  the	  gene	  under	   its	   control.	   Firstly,	   a	   transcription	   factor	   regulating	   the	   expression	   of	   a	   gene	  may	  also	  be	  changed	  along	  with	  the	  change	  in	  cis-­‐regulatory	  DNA	  sequence,	  to	  compensate	  for	  the	  change	  in	  DNA	  sequence	  (Weirauch	  and	  Hughes,	  2010).	  Secondly,	  it	  is	  possible	  that	  the	  
cis-­‐regulatory	  sequences	  may	  be	  rearranged	  and	  dispersed	  into	  distinct	  locations	  and	  yet	  retain	   their	  collective	   functionality,	  due	   to	   the	  ability	  of	  enhancers	   to	  act	   independent	  of	  position	  and	  orientation,	  relative	  to	  the	  promoter	  (Weirauch	  and	  Hughes,	  2010).	  Further	  experimental	   and	   bioinformatical	   analysis	   would	   be	   needed	   to	   confirm	   which	   of	   these	  mechanisms	  is	  correct.	  	  
	  3.3.2	  Mutation	  of	  sox6	  binding	  sites	  Sox6	   is	   able	   to	   directly	   inhibit	   Tnnc1	   transcription	   in	   mice	   (An	   et	   al.,	   2011).	   Previous	  studies	   in	   our	   laboratory	   have	   suggested	   that	   Sox6	   inhibits	   the	   expression	   of	   tnnc1b	   in	  zebrafish	  (von	  Hofsten	  et	  al.,	  2008),	  but	  it	  remain	  unclear	  as	  to	  whether	  this	  inhibition	  is	  a	  consequences	   of	   a	   direct	   interaction	   between	   Sox6	   protein	   and	   tnnc1b	   cis-­‐regulatory	  sequences,	   or	  not.	  To	  address	   this	  question,	  potential	   Sox6	  binding	   sites	  were	   identified	  bioinformatically	   and	   then	   mutated	   in	   the	   2.5kb	   +	   intron1	   transgene	   construct,	   which	  drives	   slow-­‐specific	  expression	  of	  GFP.	  Unexpectedly,	  mutation	  of	   these	  sites	   resulted	   in	  no	   ectopic	   GFP	   expression	   in	   the	   fast-­‐twitch	   muscle.	   This	   result	   suggested	   that	   Sox6	  inhibits	   the	   expression	   of	   tnnc1b	   through	   a	   mechanism	   that	   is	   independent	   of	   the	  conserved	   putative	   Sox6	   binding	   sites	   in	   intron	   1,	   and	   potentially	   indirectly,	   in	   direct	  contradiction	  to	  what	  was	  previously	  reported	  in	  mice	  (An	  et	  al.,	  2011).	  	  Another	   possibility	   that	   could	   help	   to	   explain	   my	   results	   is	   that	   Sox6	   might	   exert	   its	  repressive	   effects	   on	   tnnc1b	   through	  multiple	   sites,	   including	   one	   or	  more	   cryptic	   Sox6	  binding	  sites.	  The	  binding	  of	  Sox	  proteins	  to	  A/T	  rich	  sequences	  is	  well	  documented,	  the	  preferred	   consensus	   sequence	   being	   AACAAT	   (Connor	   et	   al.,	   1995,	   Harley	   et	   al.,	   1994).	  However,	   Sox	   proteins	   can	   bind	   to	   variants	   of	   this	   DNA	   sequence,	   albeit	   with	   a	   lower	  affinity	   (Harley	   et	   al.,	   1994).	   As	   described	   above,	   the	   deletion	   analysis	   of	   the	   tnnc1b	  reporter	  construct	  revealed	  that	  the	  first	  intron	  of	  the	  gene	  is	  able	  to	  drive	  GFP	  expression	  in	  both	  the	  fast-­‐twitch	  and	  slow-­‐twitch	  muscle	  fibres.	  This	  observation	  suggests	  that	  there	  is	   a	   repressor	  element	  present	   in	  DNA	  sequences	   lying	  outside	  of	   the	   first	   intron	   that	   is	  needed	   for	   the	   repression	   of	   tnnc1b	   in	   the	   fast-­‐twitch	   muscle.	   Further	   deletion	   of	   the	  upstream	   DNA	   sequence	   revealed	   that	   240bp	   of	   DNA	   sequence	   lying	   immediately	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upstream	  of	   the	   transcription	  start	   site	  plus	   the	   first	   intron	   is	   sufficient	   for	   slow-­‐twitch-­‐specific	  GFP	  expression.	   It	  may	  be	  that	  cryptic	  binding	  sites	   for	  Sox6	  exist	   in	  this	  region,	  which	   allows	   Sox6	   to	   directly	   repress	   gene	   expression	   in	   the	   fast-­‐twitch	   muscle.	  Interestingly,	   one	   out	   of	   three	   of	   the	   founder	   fish	   that	   I	   identified	   carrying	   the	  +560bp+intron1	  construct	  exhibited	  relatively	  weak	  GFP	  expression	  throughout	  the	  slow-­‐twitch	  and	  fast-­‐twitch	  muscle.	  It	  may	  be	  that	  this	  weak	  expression	  is	  caused	  by	  a	  position	  effect,	   as	   only	   one	   founder	   was	   identified	   with	   this	   weak	   expression	   pattern.	   Another	  possibility	   is	   that	  there	  may	  have	  been	  a	  cryptic	  Sox6	  binding	  site	   in	  the	  genomic	  region	  immediately	  upstream	  of	  the	  DNA	  sequences	  contained	  within	  the	  construct	  that	  was	  lost,	  leaving	  fewer,	  low-­‐affinity,	  cryptic,	  Sox6	  binding	  sites	  in	  the	  remaining	  region,	  and	  making	  it	  more	   likely	   that	  Sox6	   is	  unable	  to	   inhibit	   the	  expression	  of	   the	  transgene.	  However,	   in	  order	  to	  confirm	  whether	  there	  is	  a	  direct	  or	  indirect	  inhibition	  of	  the	  tnnc1b	  promoter	  by	  Sox6,	   extensive	   chromatin	   immunoprecipitation	   analysis	   of	   the	   genomic	   region	  encompassing	   tnnc1b	   would	   need	   to	   be	   performed,	   to	   examine	   whether	   there	   is	   an	  enrichment	  of	  tnnc1b-­‐associated	  sequences	  in	  the	  Sox6-­‐precipitated	  chromatin.	  	  
3.3.3	  tnnc1a	  promoter	  analysis	  The	  zebrafish	  has	  a	  second	  slow	  troponin	  c	  gene,	  tnnc1a,	  and	  a	  preliminary	  bioinformatics	  analysis	  was	  performed	  to	  explore	  its	  DNA	  sequence	  similarity	  with	  zebrafish	  tnnc1b	  and	  other	   vertebrate	   orthologues.	   Perhaps	   unsurprisingly,	   VISTA	   analysis	   indicated	   that	   the	  non-­‐coding	   regions	   between	   the	   zebrafish	   tnnc1a	   and	   tnnc1b	   genes	   are	   not	   conserved	  (Appendix	   A3).	   These	   differences	   could	   be	   due	   to	   the	   divergence	   in	   the	   expression	  patterns	  of	   these	   two	  genes,	  and	   in	  order	   for	  each	  gene	   to	  be	  expressed	  exclusively	   in	  a	  specific	  tissue,	  distinct	  sets	  of	  cis-­‐regulatory	  DNA	  sequences	  might	  be	  required.	  Similarly,	  the	  heart-­‐specific	  and	  the	  skeletal-­‐specific	  enhancers	  in	  the	  mammalian	  Tnnc1	  gene	  share	  little	   sequence	   similarity	   (Parmacek	   et	   al.,	   1994),	   which	   presumably	   facilitates	   the	  differential	  tissue-­‐specific	  expression	  of	  this	  gene	  in	  these	  two	  types	  of	  muscle.	  	  To	  facilitate	  the	  analysis	  of	  cis-­‐regulatory	  elements	  that	  regulate	  transcription	  of	  tnnc1a,	  a	  transgenic	   line	  was	  generated	  using	  BAC	  recombineering,	   in	  which	   the	   tnnc1a	  promoter	  specifically	   drove	   GFP	   expression	   in	   the	   heart	   muscle	   of	   zebrafish	   embryos.	   Further	  analysis	  is	  now	  needed	  to	  determine	  whether	  this	  pattern	  of	  GFP	  expression	  corresponds	  precisely	   to	   the	   expression	   pattern	   of	   the	   endogenous	   tnnc1a	   gene,	   but	   in	   situ	  hybridization	   using	   a	   tnnc1a	   specific	   probe	   revealed	   that,	   like	   the	   tnnc1a:eGFP	   reporter	  line,	  expression	  of	  the	  gene	  is	  confined	  exclusively	  to	  the	  heart.	  Likewise,	  previous	  analysis	  of	   the	   zebrafish	   tnnc1a	   expression	   pattern	   has	   revealed	   that	   by	   1	   dpf,	   transcripts	   are	  found	   throughout	   the	   heart	  muscle,	   and	  by	   2	   dpf,	   expression	   is	  mostly	   restricted	   to	   the	  ventricular	  chamber	  (Sogah	  et	  al.,	  2010).	  The	  tnnc1a:eGFP	  expression	  seen	  in	  the	  reporter	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line	  appears	  to	  be	  stronger	  in	  the	  ventricle	  at	  3	  dpf,	  yet	  some	  expression	  does	  also	  persists	  in	  the	  atrium,	  although	  this	  could	  be	  due	  to	  the	  perdurance	  of	  residual	  GFP	  protein.	  Taken	  together,	  it	  seems	  fair	  to	  conclude	  that	  the	  tnnc1a:eGFP	  transgenic	  reporter	  line	  faithfully	  recapitulates	  endogenous	  tnnc1a	  expression.	  	  A	   previous	   report	   had	   localised	   the	   Tnnc1	   heart-­‐specific	   enhancer	   in	   the	   immediate	   5’	  region	   of	   the	   mouse	   Tnnc1	   promoter	   (Parmacek	   et	   al.,	   1992).	   To	   test	   whether	   the	  equivalent	   zebrafish	   genomic	   region	   contained	   a	   similar	   heart-­‐specific	   enhancer,	   2.2kb	  upstream	  of	  the	  tnnc1a	  transcription	  start	  site	  was	  cloned	  into	  the	  pDB739	  vector,	  which	  contains	   itol2	  arms	   for	   stable	   integration	  of	   the	   transgene	   into	   the	   zebrafish	  genome.	   In	  addition,	   a	   smaller	   DNA	   fragment	   encompassing	   240bp	   immediately	   upstream	   of	   the	  transcription	   start	   site	   was	   cloned	   into	   the	   β-­‐globin	   minimal	   promoter	   vector.	   Upon	  microinjection	   into	   embryos,	   neither	   construct	   drove	   GFP	   expression	   in	   any	   embryonic	  tissue,	   including	   the	  heart.	  There	   are	   several	  possible	   reasons	   for	   this.	   Firstly,	   the	  2.2kb	  and	  240bp	  fragments	  did	  not	  contain	  the	  32bp	  DNA	  sequence	  located	  downstream	  of	  the	  transcription	  start	  site	  that	  had	  previously	  been	  reported	  to	  be	  part	  of	   the	  heart-­‐specific	  enhancer	   in	   the	   initial	   report	   (Parmacek	   et	   al.,	   1992).	   Consequently,	   essential	   elements	  needed	  for	  the	  heart-­‐specific	  transcription	  of	  the	  gene	  may	  have	  been	  omitted.	  Secondly,	  with	  regards	   to	   the	  240bp	  DNA	   fragment	  combined	  with	   the	  β-­‐globin	  minimal	  promoter	  vector	   not	   driving	   any	   GFP	   expression,	   the	   previous	   report	   that	   had	   identified	   the	  enhancer	   located	   in	   this	   region,	   discovered	   that	   it	   only	   functioned	   in	   concert	   with	   the	  endogenous	  Tnnc1	  promoter	  (Parmacek	  et	  al.,	  1992).	  This	  observation	  contrasts	  with	  the	  skeletal	  muscle	  enhancer	   for	   the	  mouse	  Tnnc1	  gene	  skeletal-­‐specific	  enhancer	   located	   in	  intron	   1,	  which	   was	   able	   to	   function	   with	   a	   minimal	   SV40	   promoter	   (Parmacek	   et	   al.,	  1994).	  Although	  this	  could	  also	  be	  the	  case	  in	  zebrafish,	  it	  is	  important	  to	  note	  that	  these	  experiments	   were	   carried	   out	   in	   vitro	   using	   cultured	   cells,	   and	   therefore	   care	   must	   be	  taken	  when	   analysing	   these	   results.	   In	   vitro	   studies	   using	   cultured	   cells	   can	   sometimes	  give	  a	  misleading	  impression.	  For	  example,	  enhancers	  previously	  identified	  in	  the	  mouse	  
beta	   myosin	   heavy	   chain	   promoter	   in	   vitro	   and	   implicated	   as	   being	   dispensable	   for	   the	  muscle-­‐specific	  expression	  of	  this	  gene,	  were	  found	  to	  be	  essential	  when	  analysed	  in	  vivo	  (Knotts	  et	  al.,	  1994).	  	  The	  experiments	  described	  in	  this	  section	  could	  be	  extended,	  firstly	  by	  taking	  into	  account	  the	  various	  issues	  discussed	  above,	  and	  secondly	  by	  analysing	  further	  the	  conservation	  of	  
tnnc1a	  enhancer	  function	  by	  cloning	  the	  human	  Tnnc1	  heart-­‐specific	  enhancer	  into	  the	  β-­‐
globin	  minimal	  promoter	  vector	  and	  testing	  whether	  it	  can	  drive	  heart-­‐specific	  expression	  of	  the	  GFP	  reporter	  cassette.	  Increased	  understanding	  of	  the	  regulation	  of	  tnnc1a	  may	  be	  clinically	  relevant	  as	  a	  mutation	  in	  the	  zebrafish	  tnnc1a	  leads	  to	  aberrant	  blood	  flow	  due	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4.1	  Introduction	  
Sox6	  expression	  appears	  in	  the	  somites	  at	  approximately	  the	  10-­‐somite	  stage	  (Wang	  et	  al	  2011).	   The	   expression	   of	   sox6	   is	   excluded	   from	   the	   adaxial	   cells	   and	   is	   absent	   from	   the	  slow	  muscle	  throughout	  myogenesis,	  remaining	  restricted	  to	  the	  fast	  muscle	  domain	  only.	  Evidence	   has	   suggested	   that	   Sox6	   protein	   is	   able	   to	   repress	   slow-­‐twitch	   muscle	   genes,	  since	   heatshock-­‐induced	   expression	   of	   sox6	   inhibited	   prox1a	   expression	   in	   the	   adaxial	  cells	  (von	  Hofsten	  et	  al.,	  2008).	  In	  order	  to	  examine	  whether	  Sox6	  is	  capable	  of	  inhibiting	  the	   expression	   of	   slow	   muscle	   genes,	   the	   UAS:GAL4	   system	   was	   utilised	   in	   order	   to	  misexpress	  Sox6	  protein	  in	  the	  slow-­‐twitch	  muscle.	  	  
4.2	  Results	  
4.2.1	  UAS:sox6-­‐GFP:smyhc1:GAL4	  A	  UAS:sox6-­‐GFP	   line	   (made	   by	  Wang	   Xingang)	   and	   a	   smyhc1:GAL4	   line	   (made	   by	  Wang	  Xingang)	  were	  crossed	  to	  generate	  a	  UAS:sox6-­‐GFP;smyhc1:GAL4	  line,	  whereby	  sox6	  would	  be	  expressed	   in	  the	  slow-­‐twitch	  muscle	   fibres	  under	  the	  control	  of	   the	  smyhc1	  promoter	  (Figure	  4.1A-­‐C).	  In	  order	  to	  determine	  whether	  misexpression	  of	  Sox6	  in	  the	  slow-­‐twitch	  fibre	   domain	   was	   sufficient	   to	   repress	   slow-­‐specific	   gene	   expression,	   the	   expression	   of	  
smyhc1,	   tnnc1b	   and	   prox1a	   was	   assessed	   in	   UAS:sox6-­‐GFP;smyhc1:GAL4	   fish.	   For	  immunohistochemistry	   analysis	   embryos	   were	   collected	   from	   a	   UAS:sox6-­‐
GFP;smyhc1:GAL4	   incross	   and	   stained	   in	   the	   same	   tube	   with	   either	   	   a	   Tnnc1b,	   F59	   or	  Prox1a	   antibody	   together	   with	   an	   anti-­‐GFP	   antibody.	   Therefore	   control	   embryos,	   as	  assessed	   for	   by	   their	   lack	   of	   GFP	   expression	   consisted	   of	   UAS:sox6-­‐GFP	   embryos,	  
smyhc1:GAL4	   embryos,	   and	   embryos	   containing	   neither	   transgene.	   UAS:sox6-­‐
GFP;smyhc1:GAL4	  embryos	  were	  identified	  on	  the	  basis	  of	  their	  Sox6-­‐GFP	  expression.	  For	  
in	   situ	  hybridisation	  analysis,	  embryos	  were	  collected	   from	  a	  UAS:sox6-­‐GFP;smyhc1:GAL4	  
incross	   and	   separated	   based	   on	   their	   Sox6-­‐GFP	   expression;	   embryos	   expressing	   strong	  Sox6-­‐GFP	   were	   collected	   into	   one	   tube	   and	   embryos	   expressing	   no	   Sox6-­‐GFP	   were	  separated	   into	   another	   tube.	   Embryos	   with	   little	   or	   weak	   Sox6-­‐GFP	   expression	   were	  discarded.	  Therefore	  the	  in	  situ	  hybridisation	  reactions	  were	  carried	  out	  in	  separate	  tubes,	  with	  the	  same	  number	  of	  embryos	  in	  each	  and	  were	  stained	  for	  exactly	  the	  same	  length	  of	  time.	  
tnnc1b	   expression	   is	   clearly	   downregulated	   in	   slow-­‐muscle	   fibres	   expressing	   Sox6-­‐GFP,	  which	  also	  exhibit	   reduced	   levels	  of	  Tnnc1b	  protein	   levels	   (Figure	  4.2A-­‐D).	   Similarly,	  by	  comparing	   slow-­‐twitch	   fibres	   that	   are	   expressing	   Sox6-­‐GFP	   with	   those	   that	   aren’t,	   it	   is	  apparent	  that	  there	  is	  a	  strong	  decrease	  in	  Prox1a	  expression	  in	  the	  Sox-­‐GFP	  positive	  cells	  (Figure	   4.2I-­‐K).	   The	   extent	   of	   the	   downregulation	   of	   smyhc1	   in	   response	   to	   the	   ectopic	  Sox6	  expression	  seems	  somewhat	  variable	  and	  unclear.	  When	  looking	  at	  Smyhc1	  protein	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levels	   using	   the	   F59	   antibody,	   it	   seems	   that	   there	   may	   be	   a	   slight	   reduction	   in	   its	  expression	   with	   some	   effect	   on	   the	   fibre	   morphology,	   but	   the	   transcript	   levels	   appear	  barely	  affected	  if	  at	  all	  (Figure	  4.2E-­‐H).	  This	  data	  suggests	  that	  Sox6	  is	  able	  to	  repress	  the	  expression	  of	  at	   least	  some	  slow	  muscle	  genes,	  and	  with	  a	  particularly	  strong	  repressive	  affect	  on	  particular	  slow-­‐twitch	  genes,	  such	  as	  tnnc1b.	  	  	  
	  
Figure	   4.1:	   The	   alpha-­‐actin	   and	   smyhc1	   promoters	   drive	   the	   expression	   of	   GAL4,	  
which	  then	  binds	  to	  the	  UAS	  promoter	  to	  drive	  the	  expression	  of	  sox6-­‐GFP	  (A).	  sox6-­‐GFP	  
was	   expressed	   under	   the	   control	   of	   either	   the	   smyhc1	   or	   the	   actin	   promoter	   in	   order	   to	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Figure	  4.2:	  Protein	  and	  transcript	  levels	  of	  tnnc1b	  are	  strongly	  repressed	  in	  response	  
to	  ectopic	  expression	  of	  Sox6-­‐GFP	  under	  the	  control	  of	  the	  smyhc1	  promoter	  (A-­‐D).	  By	  
contrast,	   ectopic	   expression	   of	   Sox6	   in	   the	   slow	   muscle	   lineage	   causes	   only	   a	   subtle	  
downregulation	   in	   both	   protein	   and	   transcript	   levels	   of	   smyhc1	   (E-­‐H).	   Prox1a	   protein	  
expression	   is	   inhibited	   by	   UAS:sox6-­‐GFP;smyhc1:GAL4.	   In	   nuclei	   expressing	   Sox6-­‐GFP	   the	  
expression	  of	  Prox1a	  is	  either	  completely	  lost	  or	  strongly	  downregulated	  (I-­‐K).	  Each	  asterisk	  
in	   J	  and	  K	   indicates	  a	   slow	  muscle	  cells	  nucleus	   that	   strongly	  expresses	  Sox6-­‐GFP	  (green	   in	  
panels	  I	  and	  J).	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4.2.2	  UAS:sox6-­‐GFP;actin:GAL4	  Since	  Sox6-­‐GFP	  expression	  was	  placed	  under	   the	   control	   of	   the	   smyhc1	   promoter,	   Sox6-­‐GFP	  will	  only	  be	  expressed	  when	  smyhc1	   transcription	  begins,	  which	  would	  obscure	   the	  ability	   to	   assess	  whether	   Sox6	   can	   inhibit	   smyhc1	  expression.	  To	   address	   this	   issue,	   the	  expression	  of	  the	  Sox6-­‐GFP	  was	  placed	  under	  the	  control	  of	  regulatory	  elements	  from	  the	  alpha-­‐actin	  gene,	  which	  is	  expressed	  prior	  to	  smyhc1,	  by	  crossing	  the	  UAS:sox6-­‐GFP	  line	  to	  a	  line	  carrying	  the	  previously	  described	  actin:GAL4	  transgene	  (Scheer	  and	  Campos-­‐Ortega,	  1999).	  Embryos	  were	  collected	  from	  a	  UAS:sox6-­‐GFP;actin:GAL4	   incross	  and	  sorted	  for	   in	  
situ	   hybridisation	   and	   immunohistochemistry	   as	   described	   above	   for	   the	   UAS:sox6-­‐
GFP;actin:GAL4	   embryos.	   Fluorescent	   in	   situ	   hybridisation	   confirmed	   that	   tnnc1b	  expression	  is	  downregulated	  in	  response	  to	  Sox6,	  but	  also	  indicated	  that	  both	  smyhc1	  and	  
myh7b	   levels	   are	   decreased	   in	   the	   slow	  muscle	   fibres	   expressing	   Sox6-­‐GFP	   (Figure	  4.3).	  The	   expression	   of	   other	   slow-­‐specific	   muscle	   genes	   was	   then	   examined	   by	   in	   situ	  hybridisation,	  which	  revealed	  that	  troponin	  t1	   (tnnt1),	   troponin	   i1a	  (tnni1a),	  myosin	   light	  
chain	   10	   (mylz10),	   tropomyosin	   2	   (tpm2)	  and	   the	   ryanodine	   receptor	  1a	   (ryr1a)	  were	   all	  downregulated	   in	   Sox6-­‐GFP	   positive	   fish	   (Figure	   4.4).	   Whole-­‐mount	  immunohistochemistry	   using	   the	   F59	   and	   S58	   antibodies,	   which	   both	   recognise	   slow	  myosin	  heavy	   chain	  protein,	   further	   confirmed	   that	   the	  misexpressed	  Sox6	   could	  down-­‐regulate	  the	  protein	  expression	  of	  Smyhc1	  (Figure	  4.5A-­‐B	  and	  D-­‐E).	  	  
	  
Figure	   4.3:	   smyhc1,	   tnnc1b	   and	   myh7b	   expression	   is	   downregulated	   in	   UAS:sox6-­‐
GFP;actin:GAL4	  embryos.	  The	  expression	  of	  three	  slow-­‐specific	  genes,	  smyhc1,	   tnnc1b	  and	  
myh7b	   in	   control	   embryos	   at	   30	   hpf	   (A-­‐C).	  When	   Sox6	   is	  misexpressed	   in	   the	   slow	   twitch	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Figure	  4.4:	  The	  expression	  of	  slow-­‐specific	  genes	  is	  downregulated	  in	  UAS:sox6-­‐
GFP;actin:GAL4	  embryos.	  The	  expression	  tnnt1	  (A	  and	  B),	  tnni1a	  (C	  and	  D),	  mylz10	  (E	  and	  
F),	  tpm2	  (G	  and	  H)	  and	  ryr1a	  (I	  and	  J)	  is	  specifically	  seen	  in	  slow-­‐twitch	  fibres	  of	  control	  
embryos.	  The	  expression	  of	  these	  genes	  is	  downregulated	  in	  slow	  muscle	  fibres	  ectopically	  
expressing	  Sox6-­‐GFP.	  	  Additionally	  to	  this	  the	  tnnc1b:eGFP	  line	  was	  crossed	  to	  the	  UAS:sox6-­‐GFP;actin:GAL4	  line.	  The	   Sox6-­‐GFP	   expression	   repressed	   the	   tnnc1b:eGFP	   expression	   in	   the	   slow	   muscle	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(Figure	  4.5C	  and	  F),	  confirming	  the	  ability	  of	  Sox6	  to	  repress	  this	  gene	  and	  also	  providing	  another	  confirmation	  of	  the	  validity	  of	  the	  tnnc1b:eGFP	  line.	  	  Taken	  together	  these	  results	  demonstrated	  that	  Sox6	  is	  able	  to	  repress	  the	  expression	  of	  slow-­‐twitch	  muscle	  genes	  in	  zebrafish	  embryonic	  trunk	  muscle.	  	  
	  
Figure	   4.5:	   The	   protein	   levels	   of	   slow-­‐specific	   genes	   are	   decreased	   in	   UAS:sox6-­‐
GFP;actin:GAL4	   embryos.	   In	   control	   embryos	   S58	   and	   F59	   label	   Smyhc	   in	   slow-­‐twitch	  
fibres,	  nicely	   identifying	  the	  fibre	  striations	  (A	  and	  B).	  Ectopic	  expression	  of	  Sox6	  under	  the	  
control	   of	   the	   actin	   promoter	   causes	   a	   decrease	   in	   Smyhc	   protein	   expression,	   which	   also	  
disrupts	   the	  slow-­‐fibre	  striations	  (D	  and	  E).	   	   tnnc1b:eGFP	  expression	   is	  also	  downregulated	  
when	  crossed	  to	  the	  UAS:sox6-­‐GFP;actin:GAL4	  line	  (C	  and	  F)	  (Bright	  green	  nuclei	  in	  panel	  F	  
indicates	  localised	  Sox6-­‐GFP).	  	  	  
4.2.3	  Analysis	  of	  head	  muscles	  In	  order	  to	  determine	  whether	  Sox6	  could	  also	  repress	  expression	  of	  slow-­‐twitch	  muscle	  genes	  in	  the	  head,	  UAS:sox6-­‐GFP;actin:GAL4	  positive	  	  and	  negative	  fish	  were	  fixed	  at	  4	  dpf.	  At	  this	  stage	  Sox6-­‐GFP	  was	  expressed	  strongly	  in	  the	  head	  muscle	  under	  the	  control	  of	  the	  actin	   promoter.	   Similar	   to	   the	   above	   experiments,	   embryos	   with	   strong	   Sox6-­‐GFP	  expression	  in	  the	  head	  muscles	  were	  sorted	  from	  Sox6-­‐GFP	  negative	  embryos	  and	  in	  situ	  hybridisation	   was	   carried	   out	   in	   two	   separate	   tubes	   containing	   the	   same	   number	   of	  embryos.	   In	   situ	   hybridisation	   to	   detect	   tnnc1b	   transcripts	   indicated	   that	   there	   was	   no	  significant	  difference	  in	  the	  expression	  of	  the	  gene	  between	  the	  Sox6-­‐GFP	  -­‐positive	  and	  -­‐negative	   embryos	   (Figure	   4.6),	   suggesting	   that	   although	   Sox6	   is	   able	   to	   inhibit	   the	  expression	   of	   this	   tnnc1b	   in	   the	   trunk	  muscle	   it	   does	   not	   have	   any	   repressive	   effect	   on	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Figure	  4.6:	  Misexpression	  of	   sox6	   in	  head	  muscles	  has	  no	  effect	  on	   the	  expression	  of	  
tnnc1b	  in	  the	  head.	  Panels	  A-­‐C	  represent	  control	  tnnc1b	  expression	  in	  the	  head	  muscles	  of	  3	  
dpf	  embryos.	  Panels	  D-­‐F	  represent	  three	  examples	  of	  tnnc1b	  expression	  in	  embryos	  that	  also	  
strongly	   expressed	  Sox6-­‐GFP	   in	   the	  head	  muscles.	  There	  appears	   to	  be	  no	  difference	   in	   the	  
expression	  of	  tnnc1b	  between	  control	  and	  UAS:sox6-­‐GFP;actin:GAL4	  fish.	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Recent	   studies	   have	   shown	   that	   the	   microRNA,	   miR-­‐499,	   encoded	   by	  Myh7b,	   regulates	  Sox6	  expression	  in	  both	  fish	  and	  mouse	  myofibres	  (McCarthy	  et	  al.,	  2009,	  van	  Rooij	  et	  al.,	  2009,	  Wang	  et	  al.,	  2011).	  Moreover,	  myh7b/miR-­‐499	  expression	  can	  also	  be	  repressed	  by	  Sox6	   (An	  et	  al.,	  2011,	  Hagiwara	  et	  al.,	  2007).	  This	   reciprocal	   regulatory	  relationship	  had	  not	  been	  confirmed	  in	  zebrafish,	  although	  the	   loss	  of	  myh7b	   from	  the	  adaxial	  cells	   in	  the	  
prdm1a	  mutants	  was	  predicted	  to	  be	  due	  to	  the	  inhibitory	  effect	  of	  the	  ectopic	  Sox6	  in	  the	  adaxial	  cells	  (Wang	  et	  al.,	  2011).	  The	  results	  presented	  in	  this	  chapter	  indeed	  confirm	  that	  
myh7b	  (and	   likely	  miR-­‐499)	  can	  be	  repressed	  by	  Sox6	   in	  vivo,	  providing	  evidence	  for	  the	  existence	  of	  a	  regulatory	  loop	  of	  negative	  feedback	  between	  sox6	  and	  myh7b/miR-­‐499.	  	  In	   sox6	   mutant	   mice,	   expression	   of	   fast-­‐specific	   muscle	   genes	   is	   downregulated	   in	  response	   to	   the	   increased	   in	   expression	   of	   slow-­‐twitch	   muscle	   genes	   (Hagiwara	   et	   al.,	  2005,	   Quiat	   et	   al.,	   2011).	   Therefore	   it	   is	   possible	   that	   an	   increase	   in	   fast-­‐twitch-­‐specific	  gene	  expression	  could	  compensate	   for	   the	   loss	  of	  slow-­‐twitch	  muscle	  gene	  expression	   in	  the	  UAS:sox6-­‐GFP;actin:GAL4	   line.	  Had	   time	  permitted,	   it	  would	  have	  been	   interesting	   to	  look	  at	   the	  expression	  of	   fast-­‐twitch-­‐specific	  genes	   in	  this	   line	  to	  see	   if	   indeed	  this	   is	   the	  case.	  However,	  in	  light	  of	  existing	  knowledge	  about	  the	  transcriptional	  regulation	  of	  fast-­‐twitch	   muscle	   genes	   in	   development,	   the	   regulatory	   mechanisms	   are	   likely	   to	   be	  complicated.	   For	   example,	   in	   zebrafish,	   activation	   of	   fast-­‐twitch	   muscle	   differentiation	  relies	  on	  the	  expression	  of	  genes	  such	  as	  fgf8	  and	  six1a,	  which	  are	  not	  found	  in	  the	  slow-­‐twitch	  muscle	  (Bessarab	  et	  al.,	  2008,	  Reifers	  et	  al.,	  1998).	  	  Another	   area	   of	   research	   that	   would	   be	   worthy	   of	   further	   investigation	   is	   the	   topic	   of	  whether	   Sox6	   represses	   expression	   of	   slow-­‐specific	   genes	   that	   are	   expressed	   in	   the	  secondary	  slow	  fibres,	  such	  as	  smyhc2	  and	  smyhc3	  (Elworthy	  et	  al.,	  2008).	  Sox6	  is	  one	  of	  only	   a	   few	   transcription	   factors	   that	   are	   implicated	   in	   both	   developmental	   fibre-­‐type	  specification	   and	   adult	   muscle	   plasticity	   (Hagiwara	   et	   al.,	   2005,	   Hagiwara	   et	   al.,	   2007,	  McCarthy	  et	  al.,	  2009,	  Quiat	  et	  al.,	  2011,	  von	  Hofsten	  et	  al.,	  2008).	  For	  this	  reason,	  it	  seems	  reasonable	  to	  hypothesise	  that	  Sox6	  is	  associated	  with	  fibre-­‐type	  switching	  in	  juvenile	  and	  adult	  zebrafish.	  	  
Sox6	   in	   situ	   hybridisation	   (Chapter	   5,	   figure	   5.1)	   suggests	   that	   sox6	   is	   not	   normally	  expressed	  in	  the	  head	  muscle	  of	  zebrafish	  embryos,	  however	  a	  more	  detailed	  analysis	  of	  
sox6	  expression	   in	   the	  head	   is	  needed.	  Nevertheless,	   the	   forced	  expression	  of	  Sox6	   in	  all	  head	   muscles	   using	   the	   UAS:sox6-­‐GFP;actin:GAL4	   line	   resulted	   in	   no	   change	   in	   the	  expression	   pattern	   of	   tnnc1b.	   This	   result	   raises	   the	   question	   as	   to	   why	   Sox6	   is	   able	   to	  repress	  the	  expression	  of	  tnnc1b	  in	  trunk	  muscle	  but	  has	  no	  effect	  on	  the	  same	  gene	  in	  the	  head	   muscles.	   During	   development,	   the	   head	   mesoderm	   and	   the	   somites	   express	   both	  overlapping	   and	   distinct	   combinations	   of	   transcription	   factor	   genes,	   and	   interestingly,	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5.1	  Introduction	  Expression	  of	  sox6	  can	  first	  be	  detected	  in	  the	  somites	  at	  the	  10-­‐somite	  stage	  (Wang	  et	  al.,	  2011),	  where	  it	  is	  restricted	  to	  the	  fast-­‐twitch	  domain	  and	  excluded	  from	  adaxial	  cells.	  In	  addition,	   sox6	   is	   expressed	   in	   other	   locations	   during	   development	   including	   the	   otic	  vesicles	   and	   the	   brain	   (Figure	  5.1).	   In	   order	   to	   investigate	   the	   function	   of	   Sox6	   in	   these	  tissues	   more	   thoroughly,	   I	   sought	   to	   create	   mutant	   alleles	   of	   sox6	   using	   zinc-­‐finger	  nuclease	  (ZFN)	  technology	  (Meng	  et	  al.,	  2008).	  	  
5.2	  Results	  
5.2.1	  Generation	  of	  sox6	  zinc-­‐finger	  nuclease	  mutant	  The	   ZFN	  was	   designed	   so	   that	   both	   sox6	   transcripts	  would	   be	  mutated	   upstream	  of	   the	  HMG	  box	  at	  the	  position	  of	  approximately	  amino	  acid	  249	  and	  amino	  acid	  230	  (Figure	  2.4A	  and	   B).	   Two	   alleles,	   each	   of	   which	   introduces	   a	   premature	   stop	   codon	   into	   the	   open	  reading	  frame	  that	  are	  predicted	  to	  encode	  truncated	  forms	  of	  the	  protein,	  were	  isolated	  (Figure	   2.4C).	  Homozygous	  mutants	  were	   found	   to	   lack	   full-­‐length	   Sox6	   protein	   in	   both	  fast-­‐twitch	   fibres	   and	   in	   the	   forebrain,	   as	   assessed	   by	   whole-­‐mount	  immunohistochemistry	   using	   a	   Sox6-­‐specific	   antibody	   (Figure	   5.2;	   see	   Chapter	   6	   for	  further	   details	   about	   the	   antibody).	   	   40	   embryos	   were	   collected	   from	   a	   sox6-­‐/+	  heterozygous	  incross	  and	  incubated	  with	  the	  Sox6-­‐specific	  antibody.	  Of	  those	  40	  embryos	  32	   embryos	   had	   specific	   staining	   in	   the	   nuclei	   of	   the	   fast-­‐twitch	   fibres	   and	   the	   optic	  tectum,	  whereas	  8	  embryos	  had	  no	  specific	  staining.	  These	  embryos	  were	  then	  genotyped	  to	   confirm	   that	   those	   embryos	   that	   showed	   no	   specific	   staining	   were	   sox6-­‐/-­‐	   mutant	  embryos.	  	  Indeed,	  all	  8	  embryos	  with	  no	  staining	  were	  sox6-­‐/-­‐	  mutants	  and	  no	  homozygous	  mutant	  sox6	  embryos	  where	  identified	  which	  displayed	  specific	  staining.	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Figure	  5.1:	   In	  situ	  hybridisation	  to	  detect	  sox6	  transcripts,	  reveals	  expression	  of	   this	  
gene	   throughout	   zebrafish	   embryonic	   development.	   Sox6	   is	   not	   maternally	   expressed	  
(A).	   The	   expression	   of	   sox6	   in	   the	   somites	   is	   restricted	   to	   the	   fast	   domain	   throughout	  
myogenesis	  (B-­‐E).	  Sox6	  is	  also	  expressed	  in	  the	  otic	  vesicles	  and	  brain	  regions	  including	  the	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Figure	  5.2:	  No	   Sox6	  protein	   is	   generated	   in	   the	   sox6-­‐/-­‐	  mutant.	   Immunohistochemistry	  
analysis	  of	  Sox6	  protein	  expression	  using	  a	  Sox6-­‐specific	  antibody	  reveals	  that	  Sox6	  protein	  is	  
detectable	  in	  the	  nuclei	  of	  fast	  muscle	  fibres	  (arrows)	  and	  the	  optic	  tectum	  (arrows)	  of	  wild-­‐
type	  embryos	  (A-­‐D).	   In	  sox6	  zinc-­‐finger	  mutants	  (E2	  allele,	   sox6-­‐/-­‐),	   the	  antibody	  detects	  no	  
Sox6	  protein	  in	  either	  the	  muscle	  or	  the	  optic	  tectum	  indicating	  the	  successful	  generation	  of	  a	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5.2.2	  tnnc1b	  is	  ectopically	  expressed	  in	  sox6	  homozygous	  mutants	  As	  discussed	  in	  Chapter	  4,	  ectopic	  expression	  of	  Sox6	  protein	  in	  the	  slow-­‐twitch	  muscle	  of	  wild-­‐type	   embryos	   inhibits	   the	   expression	   of	   slow-­‐specific	   genes.	   It	   was	   therefore	  predicted	  that	  loss	  of	  sox6	  might	  cause	  the	  derepression	  of	  these	  slow-­‐specific	  genes	  in	  the	  fast	  myotome.	  The	  sox6	  homozygous	  mutant	  embryos	  show	  no	  morphological	  phenotype;	  however,	   in	   situ	   hybridisation	   revealed	   robust	   ectopic	   expression	   of	   the	   slow-­‐specific	  
tnnc1b	  gene	  in	  the	  fast-­‐twitch	  muscle	  in	  about	  a	  quarter	  (12	  out	  of	  60	  embryos,	  confirmed	  by	   genotyping)	   of	   embryos	   at	   30hpf	   generated	   by	   a	   sox6	   heterozygous	   incross	   (Figure	  5.3B	  and	  F).	  sox6-­‐/+	  heterozygous	  mutants	  were	  crossed	   to	   the	  UAS:sox6-­‐GFP;actin:GAL4	  line,	   enabling	   the	   generation	   of	   sox6-­‐/-­‐	   homozygous	   mutants	   that	   expressed	   Sox6-­‐GFP	  throughout	  the	  myotome.	  The	  rescue	  of	  Sox6-­‐GFP	  throughout	  the	  fast-­‐twitch	  myotome	  of	  
sox6-­‐/-­‐	  mutants	  was	   able	   to	   inhibit	   the	   ectopic	   expression	   of	   tnnc1b	   in	   the	   fast-­‐muscle	  (Figure	  5.4	  A	  and	  B).	  The	  ectopic	  tnnc1b	  expression	  was	  detectable	  from	  approximately	  22	  hpf	  onwards	  and	  thus	  provides	  a	  means	  of	  identifying	  sox6	  homozygous	  mutants	  (Figure	  5.3A	   and	   E).	   To	   take	   advantage	   of	   this	   in	   subsequent	   experiments,	   I	   crossed	   the	  
tnnc1b:eGFP	   transgene	   described	   in	   Chapter	   3	   into	   the	   sox6	   mutant	   background.	  Incrossing	  of	  the	  resultant	  sox6-­‐/+;tnnc1b:GFP	  fish	  produced	  progeny,	  one	  quarter	  (53	  out	  of	  230	  embryos,	  confirmed	  by	  genotyping)	  of	  which	  exhibited	  ectopic	  GFP	  expression	   in	  the	   fast-­‐twitch	  muscle	   (Figure	  5.3D,	  H,	   I	   and	  L).	   The	   ectopic	  GFP	  expression	   seen	   in	   the	  
sox6-­‐/-­‐;tnnc1b:GFP	   line	   allowed	   sorting	   of	   sox6	   homozygous	   mutants	   in	   subsequent	  experiments.	  Embryos	  could	  be	  sorted	  by	  this	  method	  from	  approximately	  24hpf	  (Figure	  5.3	   D	   and	   H).	   Whilst	   still	   in	   there	   chorions	   the	   embryos	   could	   be	   manipulated	   with	   a	  needle	  so	  that	  the	  dorsal	  side	  of	  the	  embryos	  was	  visible	  under	  the	  dissection	  microscope.	  Sibling	  embryos	  displayed	  the	  normal	  pattern	  of	  tnnc1b:GFP	  with	  a	  one-­‐fibre-­‐thick	  layer	  of	  slow	   muscle	   fibres	   expressing	   GFP	   along	   the	   out	   most	   edges	   of	   the	   myotome.	   Sox6-­‐/-­‐	  homozygous	   mutants	   however,	   could	   be	   easily	   identified	   as	   the	   GFP	   expression	   had	  expanded	  medially	   and	   a	   think	   line	   of	   GFP	   expression	  was	   visible	   on	   either	   side	   of	   the	  notochord.	  This	  method	  proved	  reliable	  as	  embryos	  that	  were	  identified	  as	  sox6-­‐/-­‐	  mutants	  based	  on	   their	   expression	  of	   tnnc1b:GFP	  were	  positively	   identified	   as	   sox6-­‐/-­‐	  mutants	   by	  genotyping,	  with	   a	   100%	  correlation.	   Likewise,	   embryos	   that	   displayed	  no	   expansion	   in	  their	  tnnc1b:GFP	  expression	  domain	  were	  always	   identified	  as	  either	  wild-­‐type	  or	  sox6-­‐/+	  heterozygous	  embryos	  when	  genotyped.	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Figure	  5.3:	  tnnc1b	  is	  ectopically	  expressed	  in	  fast-­‐twitch	  fibres	  of	  homozygous	  sox6	  
mutants.	  Tnnc1b	  expression	  is	  usually	  restricted	  to	  the	  slow-­‐twitch	  fibres	  (A).	  In	  situ	  
hybridisation	  analysis	  revealed	  that	  mutant	  fast-­‐twitch	  fibres	  begin	  to	  ectopically	  express	  
tnnc1b	  at	  22	  hpf	  (E).	  By	  30hpf	  there	  is	  robust	  expression	  of	  tnnc1b	  throughout	  the	  myotome	  
of	  sox6-­‐/-­‐	  mutants	  (F)	  as	  compared	  to	  siblings	  (B).	  tnnc1b:eGFP;sox6-­‐/-­‐	  mutant	  embryos	  
faithfully	  recapitulate	  the	  ectopic	  expression	  of	  tnnc1b	  observed	  in	  sox6-­‐/-­‐	  mutant	  embryos	  
(C,	  D,	  G,	  H,	  I	  and	  L).	  tnnc1b:GFP;sox6	  embryos	  can	  be	  sorted	  for	  genotyping	  from	  24hpf	  
onwards	  where	  ectopic	  GFP	  expression	  can	  be	  clearly	  visualised	  in	  the	  fast-­‐twitch	  domain	  (D	  
and	  H).	  Expression	  of	  fast-­‐myosin	  light	  chain	  appears	  unaffected	  in	  tnnc1b:eGFP;sox6-­‐/-­‐	  
mutant	  embryos	  (J	  and	  M)	  with	  both	  fast-­‐myosin	  light	  chain	  and	  tnnc1b:eGFP	  co-­‐expressed	  
in	  the	  same	  fibres	  in	  sox6-­‐/-­‐	  mutants	  compared	  to	  their	  segregated	  expression	  pattern	  in	  wild-­‐
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Figure	  5.4	  Expression	  of	  Sox6-­‐GFP	  can	  inhibit	  the	  ectopic	  expression	  of	  tnnc1b	  in	  sox6-­‐
/-­‐	   mutants.	   The	   actin:GAL4	   line	   was	   crossed	   to	   the	   UAS:sox6-­‐GFP	   line	   in	   order	   to	   drive	  
expression	  of	  Sox6-­‐GFP	  throughout	  the	  myotome.	  In	  sibling	  embryos	  the	  expression	  of	  Sox6-­‐
GFP	   could	   inhibit	   the	   expression	   of	   tnnc1b	   in	   the	   slow-­‐twitch	  muscle	   (A	   and	   A’).	   In	   sox6-­‐/-­‐	  
mutants,	  where	  tnnc1b	  is	  expressed	  throughout	  the	  myotome,	  the	  expression	  of	  Sox6-­‐GFP	  can	  
inhibit	  the	  expression	  of	  tnnc1b	  in	  both	  slow-­‐	  and	  fast-­‐twitch	  muscle	  fibres	  (B	  and	  B’).	  	  
	  
5.2.3	  Expression	  of	  fast-­‐twitch	  muscle	  genes	  are	  unaffected	  in	  sox6-­‐/-­‐	  mutant	  fish	  Utilising	   the	   tnnc1bGFP;sox6	  mutant	   line	   to	   identify	  sox6-­‐/-­‐	  homozygous	  mutant	  embryos,	  the	   effect	   of	   loss	   of	   sox6	   function	   on	   the	   expression	   of	   fast-­‐specific	   genes	   was	   next	  examined.	  The	  loss	  of	  sox6	  function	  could	  result	  in	  a	  decrease	  in	  fast-­‐specific	  genes,	  similar	  to	   what	   is	   seen	   in	   mice	   (Hagiwara	   et	   al.,	   2005;	   Hagiwara	   et	   al.,	   2007).	   Interestingly,	   it	  appeared	  that	  expression	  of	  fast-­‐twitch	  genes	  was	  unaffected	  in	  the	  sox6-­‐/-­‐	  mutants.	  In	  situ	  hybridizations	  analysis	   to	  detect	  expression	  of	   fast	  myosin	  heavy	  chain	   (fmyhcx)	  and	   fast	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antibody	  to	  detect	  fast	  myosin	  light	  chain	  protein	  levels,	  which	  were	  also	  unaffected	  in	  the	  
sox6-­‐/-­‐	  mutants	  (Figure	  5.3J	  and	  M).	  These	  experiments	  suggest	  that	  the	  expression	  of	  fast	  muscle-­‐specific	  genes	  is	  independent	  of	  sox6	  function.	  	  	  
	  
Figure	  5.5:	  Expression	  of	  the	  fast-­‐specific	  muscle	  genes	  fmyhcx	  (A	  and	  B)	  and	  mylz2	  (C	  
and	  D)	  is	  unaffected	  in	  sox6-­‐/-­‐	  mutant	  embryos	  compared	  to	  their	  siblings.	  	  
	  
5.2.4	  Only	  a	  subset	  of	  slow-­‐twitch	  muscle	  genes	  are	  ectopically	  expressed	  in	  sox6-­‐/-­‐	  
mutant	  embryos	  at	  30	  hpf	  The	  expression	  patterns	  of	  other	  slow-­‐twitch	  muscle	  genes	  were	  next	  examined	  using	  the	  
tnnc1b:eGFP;sox6	  mutant	  line.	  Surprisingly,	  while	  troponin	  t1	  (tnnt1)	  and	  the	  slow-­‐specific	  
ryanodine	   receptor	   1a	   (ryr1a)	   were	   ectopically	   expressed	   throughout	   the	   fast-­‐twitch	  muscle	  of	  30hpf	  sox6-­‐/-­‐	  mutant	  embryos,	  the	  expression	  patterns	  of	  troponin	  i1a	  (tnni1a),	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Figure	  5.6:	  Both	  tnnt1	  (A	  and	  F)	  and	  ryr1a	  (B	  and	  G)	  are	  ectopically	  expressed	  in	  the	  
fast	   domain	   of	   sox6	   homozygous	  mutant	   embryos	   at	   30	   hpf.	   Conversely	   expression	   of	  
tnni1a	   (C	   and	   H),	   mylz10	   (D	   and	   I)	   and	   tpm2	   (E	   and	   J)	   is	   unaffected	   at	   30	   hpf	   in	   these	  
mutants.	  	  The	   expression	   of	   prox1a	  was	   also	   analysed	   by	   whole-­‐mount	   in	   situ	   hybridisation,	   but	  these	  transcripts	  were	  difficult	  to	  detect	  at	  30	  hpf.	  However,	  at	  22	  hpf	  prox1a	  transcripts	  were	  detectable	  in	  the	  slow	  muscle	  domain	  of	  wild-­‐type	  and	  sox6-­‐/-­‐	  mutants,	  but	  there	  was	  no	  expression	  of	  this	  gene	  in	  the	  fast	  domain	  of	  sox6-­‐/-­‐	  mutants	  (Figure	  5.7A	  and	  E).	  These	  observations	   were	   further	   supported	   by	   immunostaining	   embryos	   using	   the	   Prox1a	  antibody,	  which	   verified	   that	   no	   Prox1a	   protein	   is	   expressed	   in	   the	   fast	  muscle	   of	   sox6	  homozygous	  mutant	  embryos	  (Figure	  5.7B	  and	  F).	  	  
tnni1a&tnnt1& 30hpf& ryr1a& 30hpf& 30hpf& mylz10& 30hpf& tpm2& 30hpf&














	   103	  
	  
Figure	   5.7:	   Expression	   of	   prox1a	   and	   smyhc1	   in	   sox6-­‐/-­‐	  mutants.	  prox1a	   expression	   is	  
unaffected	   sox6	  mutant	  embryos.	   In	   situ	  hybridisation	  and	   immunohistochemistry	   revealed	  
no	   ectopic	   fibres	   in	   the	   fast	   domain	   at	   22	   hpf	   (A	   and	   E)	   and	   30	   hpf	   (B	   and	   F).	   smyhc1	   is	  
expressed	  in	  a	  few	  fast	  fibres	  at	  30	  hpf	  as	  shown	  by	  in	  situ	  hybridisation	  (C	  and	  G).	  By	  48	  hpf	  
the	  smyhc1:GFP	  reporter	  line	  reveals	  more	  fast	  fibres	  expressing	  GFP	  in	  the	  mutant,	  yet	  it	  is	  
still	   not	   throughout	   the	   whole	   domain	   (D	   and	   H)	   Arrows	   represent	   fast-­‐twitch	   fibres	  
ectopically	  expressing	  smyhc1.	  	  	  Comparative	  analysis	  with	  a	  probe	  to	  detect	  expression	  of	  the	  slow-­‐specific	  smyhc1	  gene	  revealed	   that	  smyhc1	  exhibited	  a	  small	  amount	  of	  ectopic	  expression	   in	  a	   few	   fast	   fibres	  per	   fish	   at	   30	   hpf	   (Figure	   5.7C	   and	   G).	   This	   result	   was	   confirmed	   by	   crossing	   the	   sox6	  mutant	   to	   the	   smyhc1:GFP	   line	   to	   generate	   sox6	   mutants	   that	   carried	   the	   smyhc1:GFP	  reporter.	   One	   quarter	   of	   the	   embryos	   from	   a	   heterozygous	   incross	   displayed	   GFP	  expression	  in	  a	  small	  number	  (2-­‐10)	  of	  fast	  fibres,	  confirming	  the	  results	  from	  the	   in	  situ	  hybridisation	  analysis	  (Figure	  5.7D	  and	  H).	  No	  sibling	  embryos	  ever	  displayed	  any	  smyhc1	  positive	   fast-­‐twitch	   fibres	   either	   by	   in	   situ	   hybridisation	   or	   reporter	   gene	   expression.	  Previous	   studies	   in	   the	   lab	   had	   identified	   a	   series	   of	   potential	   Sox6	   binding	   sites	   in	   the	  
smyhc1	  promoter	  and	  these	  were	  mutated	  in	  a	  smyhc1:GFP	  reporter	  transgene.	  Transgenic	  lines	  were	  then	  generated	  with	  this	  mutated	  reporter	  construct.	  The	  resulting	  founder	  fish	  displayed	   a	   small	   number	   of	   GFP-­‐	   expressing	   fast	   fibres	   (Stone	  Elworthy	   and	   Jonas	   von	  Hofsten,	   unpublished;	   Figure	   5.8),	   an	   effect	   similar	   to	   the	   ectopic	   expression	   of	   smyhc1	  observed	   in	   sox6-­‐/-­‐	  mutant	   embryos.	   This	   result	   confirms	   that	   the	   ectopic	   expression	   of	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Figure	   5.8:	   Sox6	   restricts	   expression	   of	   a	   smyhc1:GFP	   transgene	   to	   the	   slow-­‐muscle	  
fibres	  of	  wild-­‐type	  embryos	   (A	  and	  B).	  When	  potential	  Sox6	  binding	  sites	  are	  mutated	   in	  
the	  promoter	  of	  a	  smyhc1:GFP	  transgene,	  ectopic	  GFP	  expression	  can	  be	  readily	  detected	  in	  
some	   fast-­‐twitch	  muscle	   fibres	  as	  well	   as	   in	   the	   spinal	   cord	   (C	  and	  D)	   (Dr	   Stone	  Elworthy;	  
unpublished).	  	  
	  
5.2.5	  The	  loss	  of	  sox6	  can	  rescue	  the	  expression	  of	  slow-­‐specific	  genes	  in	  prdm1a-­‐/-­‐	  
mutants	  As	   previously	   described	   in	   Chapter	   1	   the	   prdm1a	   mutant	   alleles	   ubo	   and	   nrd,	   show	   a	  severe	  decrease	   in	  or	   complete	  absence	  of	   the	  expression	  of	   slow	  muscle-­‐specific	  genes,	  reflecting	   the	   transformation	   of	   the	   slow-­‐twitch	   lineage	   to	   fast-­‐twitch	   fibres.	   A	   previous	  study	  from	  this	  laboratory	  had	  demonstrated	  that	  injection	  of	  a	  sox6-­‐specific	  morpholino	  into	   ubo	  mutant	   embryos	   restored	   the	   expression	   of	   smyhc1	   and	   partially	   rescued	   the	  expression	   of	  prox1a	   in	   the	   slow	  muscle	   domain	   (von	  Hofsten	   et	   al.,	   2008).	   In	   order	   to	  confirm	   and	   extend	   these	   observations,	   a	   prdm1a-­‐specifc	  morpholino	   was	   injected	   into	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in	   the	   slow	   domain	   of	   smyhc1	  gene	   expression	   raised	   the	   possibility	   that	   the	   individual	  cells	  labelled	  in	  the	  fast	  domain	  may	  actually	  be	  slow-­‐twitch	  myoblasts	  that	  have	  failed	  to	  migrate	   to	   the	   surface	   of	   the	   myotome.	   By	   contrast	   to	   smyhc1,	   tnnc1b	   was	   robustly	  expressed	  throughout	  the	  myotome	  of	  prdm1aMO;sox6-­‐/-­‐	  mutant	  embryos,	  indicating	  that	  expression	   of	   this	   gene	   was	   both	   completely	   rescued	   in	   the	   slow-­‐twitch	   domain	   and	  ectopically	  expressed	  in	  all	  of	  the	  fast-­‐twitch	  fibres	  (Figure	  5.9B	  and	  D).	  This	  is	  consistent	  with	   the	   notion	   that	   Prdm1a	   activates	   slow-­‐twitch	   gene	   expression	   indirectly	   through	  repression	  of	  sox6	  transcription.	  
	  
Figure	  5.9:	  Expression	  of	   smyhc1	  and	   tnnc1b	   is	   rescued	   in	  Prdm1a	  morphant;sox6-­‐/-­‐	  
mutant	  embryos.	  Prdm1a	  morphant	  embryos	  exhibit	  a	  loss	  of	  smyhc1	  and	  tnnc1b	  (A	  and	  B).	  
The	   loss	  of	   sox6	   in	  prdm1a	  morphants	   rescues	   the	  expression	  of	   smyhc1	  and	   tnnc1b	   in	   the	  
slow-­‐twitch	  domain	  and	  also	  causes	  robust	  expression	  of	  tnncb1	  throughout	  the	  myotome	  (C	  
and	  D).	  	  	  As	   mopholino	   knockdown	   of	   a	   gene	   often	   does	   not	   result	   in	   the	   complete	   loss	   of	  expression	   of	   the	   targeted	   gene,	   the	   nrd	   mutant,	   which	   harbours	   a	   null	   mutation	   in	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rescue	   of	   tpm2	   expression	   occurs	   in	   a	   different	   population	   of	   cells	   than	   the	   rescue	   of	  
smyhc1	  and	  mylz10,	  although	   lineage	   tracing	  and	  double	   in	   situ	  hybridisation	  analysis	   is	  required	  to	  confirm	  this.	  These	  results	  indicate	  that	  a	  loss	  of	  sox6	  in	  prdm1a	  mutants	  can	  partially	  rescue	  the	  loss	  of	  slow-­‐twitch	  muscle	  gene	  expression.	  	  Prdm1a	  has	  been	  identified	  as	  a	  key	  factor	  in	  regulating	  slow-­‐twitch	  myoblast	  migration.	  Most	  adaxial	  cells	  fail	  to	  complete	  their	  migration	  in	  the	  absence	  of	  Prdm1a	  (Baxendale	  et	  al.,	  2004;	  Roy	  et	  al.,	  2001;	  von	  Hofsten	  et	  al.,	  2008),	  whereas	  transplanted	  wild-­‐type	  slow	  myoblasts	  are	  able	  to	  differentiate	   into	  mononucleated	  fibres	  and	  migrate	  accordingly	   in	  
prdm1a	  mutants	  (Roy	  et	  al.,	  2001).	  Notably,	  the	  expression	  pattern	  of	  smyhc1	   in	  prdm1aMO;sox6-­‐/-­‐	  mutant	  embryos	  suggests	  that	   the	   loss	   of	   sox6	   in	   prdm1a	   morphants	   rescues	   the	   migration	   of	   many	   slow-­‐twitch	  myoblasts,	   as	   smyhc1	  expression	   is	  observed	  mainly	   in	   the	  outer	   fibres	  of	   the	  myotome.	  However,	   in	   contrast	   to	   prdm1aMO;sox6-­‐/-­‐	   mutant	   embryos,	   the	   rescue	   of	   slow-­‐specific	  gene	  expression	   in	  nrd-­‐/-­‐;sox6-­‐/-­‐	  double	  mutant	  embryos,	  was	  restricted	   largely	   to	  medial	  fibres,	  indicating	  the	  failure	  of	  these	  slow-­‐fibres	  to	  migrate.	  	  To	  verify	  whether	   the	   loss	  of	   sox6	   in	  prdm1a	  mutants	   is	   able	   to	   rescue	   the	  migration	  of	  slow-­‐twitch	  fibres,	  the	  sox6-­‐/-­‐;nrd-­‐/-­‐	  double	  mutant	  was	  crossed	  to	  the	  ubo:GFP	  transgenic	  reporter	   line.	   This	   transgene	   allowed	   the	   migratory	   behaviour	   of	   prdm1a-­‐expressing	  presumptive	  slow-­‐twitch	  myoblasts	  to	  be	  compared	  in	  double	  sox6-­‐/-­‐;nrd-­‐/-­‐	  mutant,	  single	  mutant	  and	  wild-­‐type	  embryos.	  In	  wild-­‐type	  embryos,	  GFP	  positive	  fibres	  were	  observed	  only	   in	   the	   fully	   migrated	   superficial	   slow	   fibres	   and	   in	   the	   medially	   located	   muscle	  pioneers	  at	  30	  hpf	  (Figure	  5.11A	  and	  E).	  By	  contrast	  in	  nrd-­‐/-­‐	  mutants	  ubo:GFP	  expression	  was	   seen	   throughout	   the	  myotome	   of	   the	   embryo,	   indicating	   a	   failure	   of	   slow	  myoblast	  migration	   (Figure	   5.11C	   and	   G).	   In	   sox6-­‐/-­‐;ubo:GFP	  mutant	   embryos,	   the	   pattern	   of	   GFP	  expression	   is	   essentially	   the	   same	   as	   in	   sox6-­‐/+;ubo:GFP	   sibling	   embryos,	   with	   only	   the	  superficial	   slow	   fibres	   and	   muscle	   pioneers	   expressing	   GFP	   (Figure	   5.11B	   and	   F).	   In	  double	   sox6-­‐/-­‐;nrd-­‐/-­‐	   mutant	   embryos,	   GFP-­‐positive	   cells	   were	   observed	   throughout	   the	  myotome,	   similar	   to	   nrd-­‐/-­‐;ubo:GFP	   mutant	   embryos	   (Figure	   5.11D	   and	   H).	   This	  observation	   indicates	   that	   the	   loss	   of	   sox6	   in	   prdm1a	   mutants	   does	   not	   rescue	   slow	  myoblast	   migration.	   Thus,	   although	   the	   loss	   of	   sox6	   can	   rescue	   the	   expression	   of	   some	  slow	  muscle	  genes	  in	  prdm1a	  mutants,	  rescue	  of	  slow	  muscle	  fate	  is	  incomplete,	  as	  adaxial	  cells	  fail	  to	  complete	  their	  radial	  migration.	  	  In	  nrd-­‐/-­‐	  embryos,	  fast	  muscle	  genes	  are	  expressed	  ectopically	  in	  adaxial	  cells	  (Hernandez-­‐Lagunas	  et	  al.,	  2005;	  Roy	  et	  al.,	  2001).	  They	  also	   lack	  muscle	  pioneers,	  and	  consequently	  no	   horizontal	   myoseptum	   is	   formed,	   which	   causes	   fast-­‐twitch	   gene	   expression	   to	   be	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continuous	  throughout	  the	  dorsal-­‐ventral	  midline.	  These	  effects	  were	  not	  rescued	  by	  loss	  of	  sox6	  activity	  in	  sox6-­‐/-­‐;nrd-­‐/-­‐	  double	  mutant	  embryos	  (Figure	  5.12).	  	  	  
	  
Figure	  5.10:	  Slow-­‐specific	  gene	  expression	   is	  rescued	   in	  nrd-­‐/-­‐;sox6-­‐/-­‐	  double	  mutants.	  
tnnc1b,	   smyhc1,	   tpm2	   and	   myz10	   are	   slow	   specific	   genes	   which	   are	   expressed	   in	   the	  
superficial	  slow-­‐twitch	  fibres	  in	  wildtype	  embryos	  at	  30hpf	  (A-­‐D).	  In	  sox6-­‐/-­‐	  mutant	  embryos	  
the	   expression	   of	   tnnc1b	   is	   throughout	   the	  myotome,	   smyhc1	   is	   ectopically	   expressed	   in	   a	  
small	   subset	  of	   fast-­‐twitch	   fibres	  and	  expression	  of	   tpm2	  and	  myz10	   is	  unaffected	  (E-­‐H).	   In	  
nrd-­‐/-­‐	  mutants,	   the	   expression	   of	   slow	  muscle	   genes	   is	   almost	   completely	   lost	   (I-­‐L).	   tnnc1b	  
expression	   is	   rescued	   throughout	   the	   myotome	   of	   double	   nrd-­‐/-­‐;sox6-­‐/-­‐	   mutants,	   whereas	  
expression	  of	  smyhc1,	   tpm2	  and	  myz10	  is	  rescued	   in	  a	  small	  subset	  of	   fibres	  (N-­‐P).	  Notably	  
the	  expression	  of	  tpm2	  appears	  to	  be	  in	  a	  different	  population	  of	  cells,	  when	  compared	  to	  the	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Figure	   5.11:	   Loss	   of	   sox6	   in	   nrd-­‐/-­‐	  mutants	   does	   not	   rescue	   slow-­‐twitch	  muscle	   fibre	  
migration.	  ubo:GFP	  expression	  is	  restricted	  to	  the	  slow-­‐twitch	  fibres	  by	  30	  hpf	  in	  wild-­‐type	  
embryos	  and	  sox6	  mutants	  (E	  and	  F).	   In	  nrd-­‐/-­‐	  mutants	  the	  expression	  of	  ubo:GFP	  indicates	  
that	   the	   cells	   expressing	   the	   reporter	   gene	   have	   not	   migrated	   to	   the	   outer	   surface	   of	   the	  
myotome	  (G).	  The	  loss	  of	  sox6	  in	  nrd	  mutants	  does	  not	  rescue	  the	  migration	  of	  these	  cells	  to	  
the	   superficial	  myotome	   (H),	   implying	  Prdm1a-­‐dependent	  myoblast	  migration	   is	   regulated	  
independently	  of	  sox6.	  	  
	  
	  
Figure	   5.12:	   Expression	   of	   fast-­‐specific	   genes	   is	   unaffected	   in	   sox6-­‐/-­‐;nrd-­‐/-­‐	   double	  
mutants	  compared	  to	  nrd-­‐/-­‐	  single	  mutants.	  In	  nrd-­‐/-­‐	  mutant	  embryos,	  fmyhcx	  is	  expressed	  
throughout	   the	  myotome,	  and	  neither	  differentiated	  slow,	  nor	  muscle	  pioneers,	  are	   formed.	  
In	  double	  mutant	   embryos,	   there	   is	  no	   rescue	  of	   the	  muscle	  pioneers	  at	   the	  midline,	   so	   the	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5.2.6	  Fast-­‐twitch	  gene	  expression	  in	  Cyclopamine	  treated	  sox6-­‐/-­‐	  mutants	  Inhibition	   of	   Hedgehog	   signalling	   by	   Cyclopamine	   treatment	   causes	   a	   failure	   of	   slow	  muscle	   differentiation	   in	   zebrafish	   embryos	   and	   somites	   appear	   U-­‐shaped	   (Wolff	   et	   al.,	  2003).	   In	   the	  proposed	  model	   for	  slow-­‐twitch	  muscle	  development,	  sox6	   transcription	   is	  repressed	  by	  the	  Hh-­‐dependent	  expression	  of	  the	  transcription	  factor	  Prdm1a.	  As	  prdm1a	  is	   not	   expressed	   in	   Cyclopamine	   treated	   embryos,	   their	   muscle	   phenotype	   should	  resemble	  that	  of	  nrd-­‐/-­‐	  mutants,	  with	  sox6	  being	  expressed	  in	  both	  the	  slow	  and	  fast-­‐	  twitch	  muscle,	   inhibiting	   the	   slow-­‐specific	   genes	   throughout	   the	   myotome	   (von	   Hofsten	   et	   al.,	  2008	   and	   my	   data).	   I	   therefore	   investigated	   whether	   loss	   of	   sox6	   could	   rescue	   the	  expression	   of	   slow	   muscle	   in	   Cyclopamine-­‐treated	   embryos.	   In	   confirmation	   of	   this	  hypothesis,	  sox6-­‐/-­‐	  mutants	  treated	  with	  Cyclopamine	  exhibited	  a	  rescue	  in	  the	  expression	  of	   tnnc1b	   expression	   throughout	   the	   myotome,	   similar	   to	   what	   is	   seen	   in	   sox6-­‐/-­‐;nrd-­‐/-­‐	  double	  mutant	  embryos	  (Figure	  5.13).	  	  
	  
Figure	  5.13:	  Loss	  of	  sox6	  in	  Cyclopamine-­‐treated	  embryos	  rescues	  tnnc1b	  expression.	  
In	  Cyclopamine-­‐treated	  embryos	  very	  little	  tnnc1b	  is	  expressed	  (E	  and	  F)	  when	  compared	  to	  
control	   untreated	   embryos	   (A	  and	  B).	   The	   loss	   of	   sox6	   in	   control	   and	  Cyclopamine-­‐treated	  
embryos	  rescues	   the	  expression	  of	   tnnc1b	  (C,	  D,	  G	  and	  H).	  Rescue	  of	   tnnc1b	  expression	  was	  
seen	  in	  12	  out	  of	  41	  embryos	  treated	  from	  a	  sox6+/-­‐	  incross.	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six1a	  gene	  is	  expressed	  at	  the	  same	  time	  and	  in	  the	  same	  population	  of	  myoblasts	  as	  the	  HMG	   domain	   transcription	   factor	   Sox6,	   I	   sought	   to	   investigate	   whether	   these	   proteins	  functionally	   interact	   during	   muscle	   development.	   Since	   sox6-­‐/-­‐	   mutants	   exhibit	  unperturbed,	  slow-­‐specific	  expression	  of	  smyhc1	  (in	  contrast	  to	  the	  ectopic	  expression	  of	  the	   slow-­‐specific	   gene	   tnnc1b),	   I	   hypothesized	   that	   six1a	   or	   another	   fast-­‐specific	  transcription	  factor	  under	  the	  control	  of	  six1a,	  might	  inhibit	  smyhc1:GFP	  expression	  in	  fast	  muscle.	   In	   this	   view,	   injecting	   a	   six1a	   morpholino	   (Bessarab	   et	   al.,	   2008)	   into	   sox6-­‐/-­‐	  mutants	   would	   be	   predicted	   to	   cause	   ectopic	   smyhc1:GFP	   expression	   throughout	   the	  whole	   of	   the	   fast-­‐twitch	   domain	   from	   24	   hpf	   onwards.	   However,	   injection	   of	   the	   six1a	  morpholino	   into	   sox6	   homozygous	   mutant	   and	   sibling	   embryos	   had	   no	   effect	   on	   the	  expression	  of	  smyhc1:GFP,	  when	  compared	  to	  the	  non-­‐injected	  sox6-­‐/-­‐	  mutants	  and	  siblings	  (Figure	   5.14A-­‐B	   and	  D-­‐E).	   This	   result	   indicates	   that	   the	   loss	   of	   six1a	   is	   not	   sufficient	   to	  derepress	   the	   expression	   of	   smyhc1:GFP	   in	   fast-­‐twitch	   muscles	   of	   wild-­‐type	   or	   sox6-­‐/-­‐	  mutant	  embryos.	  A	  second	  six	  gene,	  six4a,	  is	  expressed	  in	  the	  adaxial	  cells	  as	  well	  as	  in	  the	  fast-­‐twitch	   myoblasts	   of	   the	   zebrafish	   myotome,	   suggesting	   the	   possibility	   that	   the	  function	  of	  this	  gene	  might	  compensate	  for	  the	  loss	  of	  six1a	  expression	  in	  six1a	  morphants.	  However,	  when	  morpholinos	  specific	  for	  both	  six1a	  and	  six4a	  were	  injected,	  there	  was	  still	  no	  increase	  in	  ectopic	  GFP	  expression	  in	  smyhc1:GFP;sox6-­‐/-­‐	  embryos	  (Figure	  5.14C	  and	  F).	  
	  
Figure	   5.14:	   Knockdown	   of	   six1a	   and	   six4a	   has	   no	   effect	   on	   the	   expression	   of	  
smyhc1:GFP	   expression	   in	   sox6	   sibling	   or	  mutant	   embryos.	   smyhc1:GFP	   expression	   is	  
restricted	   to	   the	   slow	   fibres	   in	   uninjected	   sox6	   siblings	   (A),	   six1a	   morphants	   (B)	   and	  
six1a/six4a	  morphants	  (C).	  No	   increase	   is	  observed	   in	  the	  number	  of	  ectopic	   fibres	   in	  six1a	  
MO	  injected	  and	  six1a/six4a	  MO	  injected	  sox6-­‐/-­‐	  mutants	  (E	  and	  F)	  compared	  to	  uninjected	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5.2.8	  Knockdown	  of	  pbx	  gene	  expression	  in	  sox6-­‐/-­‐	  mutant	  embryos	  Pbx	  proteins	  are	  another	  subtype	  of	  homeodomain	  transcription	  factor	  that	  are	  involved	  in	   transcriptional	   activation	   of	   fast-­‐specific	   genes	   (Maves	   et	   al.,	   2007).	   As	   with	   Six1a,	   I	  hypothesised	   that,	   as	   this	   protein	   is	   needed	   for	   the	   activation	   of	   fast-­‐twitch	   genes,	   its	  expression,	  or	  the	  expression	  of	  one	  of	  its	  downstream	  effectors,	  could	  be	  repressing	  slow-­‐twitch	  gene	  expression	   in	   fast-­‐twitch	  cells.	  Morpholinos	   specific	   for	  pbx2	   and	  pbx4	  were	  injected	   together	   into	   embryos	   produced	   by	   intercrossing	   sox6	   heterozygous	   adults.	  Efficient	   knockdown	   of	  pbx	  was	   confirmed	   by	   the	   loss	   of	   the	   otic	   vesicles	   (Maves	   et	   al.,	  2007).	   However,	   there	   was	   no	   effect	   of	   either	   the	   pbx2	   or	   the	   pbx4	   morpholino	   on	  
smych1:GFP	  expression,	   in	  microinjected	  sox6-­‐/-­‐	  mutant	  or	  sibling	  embryos,	  as	  compared	  to	  the	  uninjected	  embryos	  (Figure	  5.15).	  Thus,	  simultaneous	  loss	  of	  Sox6	  and	  Pbx	  function	  is	  not	  sufficient	  to	  cause	  derepression	  of	  smyhc1:GFP.	  	  
	  
Figure	   5.15:	   Knockdown	   of	   pbx2	   and	   pbx4	   has	   no	   effect	   on	   the	   expression	   of	  
smyhc1:GFP	  expression	  in	  sox6	  sibling	  and	  mutant	  embryos.	  Smyhc1:GFP	  is	  restricted	  to	  
the	   slow	   twitch	   fibres	   in	   sibling	   uninjected	   (A)	   and	   Pbx2;Pbx4	   morphants	   (B)	   In	   sox6-­‐/-­‐
;Pbx2;Pbx4	   morphants	   (D)	   the	   expression	   of	   smyhc1:GFP	   remains	   restricted	   to	   the	   slow	  
domain	  with	   just	  a	   few	  GFP	  positive	   fast	   fibres,	   similar	  to	  what	   is	  seen	   in	  uninjected	  sox6-­‐/-­‐	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5.2.9	  Fast-­‐twitch	  myoblast	  fusion	  in	  sox6-­‐/-­‐	  mutants	  As	  sox6	  is	  specifically	  expressed	  in	  the	  fast-­‐twitch	  muscle,	   it	  may	  have	  a	  role	  in	  myoblast	  fusion,	  since	  formation	  of	  syncytial,	  multinucleate	  fibres	  is	  a	  specific	  feature	  of	  this	  muscle	  subtype	  (Devoto	  et	  al.,	  1996,	  Roy	  et	  al.,	  2001).	  Myoblast	  fusion	  was	  assessed	  by	  counting	  the	   number	   of	   nuclei	   in	   fast-­‐twitch	   fibres	   (demarcated	   by	   β-­‐catenin	   staining)	   (Figure	  5.16A	   and	   B).	   The	   average	   number	   of	   nuclei	   in	   each	   fast	   fibre	   was	   not	   significantly	  different	  between	  the	  sox6	  homozygous	  mutants	  and	  their	  sibling	  embryos	  (Figure	  5.16C).	  This	  result	  implies	  that	  Sox6	  is	  not	  required	  for	  fast-­‐twitch	  myoblast	  fusion.	  	  	  
	  
Figure	  5.16:	  Fast	  muscles	  fibres	  fuse	  normally	  in	  sox6	  homozygous	  mutants	  (A	  and	  B).	  
There	  is	  no	  significant	  difference	  between	  the	  average	  number	  of	  nuclei	  per	  fast	  muscle	  fibre	  
in	  sox6-­‐/-­‐	  mutant	  and	  sibling	  embryos.	  Student’s	  two-­‐tailed,	  unpaired	  t-­‐test	  P=0.7,	  error	  bars	  
represent	  standard	  deviation,	  sibling	  n=23,	  mutant	  n=23	  (C).	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/-­‐	  mutant	  larvae	  was	  not	  detected	  throughout	  the	  whole	  of	  the	  fast-­‐twitch	  domain,	  rather	  this	  expression	  was	  only	  observed	  in	  a	  few	  fast	  fibres.	  Expression	  of	  smyhc1:GFP	  was	  also	  compared	   in	   sox6-­‐/-­‐	  mutant	   and	   sibling	   larvae	   at	   5	   dpf.	   At	   this	   stage,	   a	   number	   of	   fast-­‐twitch	   fibres	   were	   GFP-­‐positive	   most	   of	   which	   are	   located	   on	   the	   ventral	   side	   of	   the	  embryo	   (Figure	   5.18),	   comparable	   to	   what	   is	   seen	   by	   in	   situ	   hybridisation	   for	   smyhc1,	  
tpm2	   and	  mylz10.	   Moreover,	   it	   is	   noticeable	   that	   expression	   of	   fast	   myosin	   light	   chain,	  detected	  with	  the	  F310	  antibody,	   is	  not	   lost	   in	  the	  fibres	  expressing	  smyhc1:GFP;	   instead	  these	   two	  proteins	   are	   co-­‐expressed	   in	   the	   same	   fibres	   (Figure	   5.18B	   and	  E).	   Therefore	  ectopic	  expression	  of	  slow-­‐twitch	  muscle	  genes	  observed	  in	  sox6-­‐/-­‐	  mutant	  larvae	  does	  not	  occur	  at	  the	  expense	  of	  fast-­‐twitch	  specific	  gene	  expression.	  	  	  	  	  
	  
Figure	  5.17:	  Ectopic	  expression	  of	  slow-­‐twitch	  genes	  in	  the	  fast-­‐twitch	  domain	  of	  3	  dpf	  
sox6-­‐/-­‐	  mutant	  larvae.	  smych1,	  tpm2	  and	  mylz10	  are	  restricted	  to	  the	  slow-­‐twitch	  fibres	  in	  
wild-­‐type	   embryos	   (A-­‐C).	   In	   sox6-­‐/-­‐	   mutants,	   by	   3	   dpf	   some	   ectopic	   expression	   of	   all	   three	  
genes	  is	  detectable	  in	  the	  fast	  fibres	  of	  the	  myotome	  (D-­‐F).	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Figure	  5.18:	  Slow-­‐twitch	  and	  fast-­‐twitch	  specific	  genes	  are	  co-­‐expressed	  in	  a	  subset	  of	  
muscle	   fibres	   located	   in	   the	   fast-­‐twitch	   domain	   of	   sox6-­‐/-­‐	   mutant	   larvae	   at	   5	   dpf.	  
smyhc1:GFP	  expression	  is	  restricted	  to	  the	  slow	  fibres	  at	  5	  dpf	  in	  sibling	  larvae	  (A).	  Analysis	  
of	   smyhc1:GFP;sox6-­‐/-­‐	   mutant	   larvae	   reveals	   that	   at	   5	   dpf	   a	   subset	   of	   fast-­‐twitch	   fibres	  
ectopically	   express	   GFP	   (D).	   Expression	   of	   the	   fast-­‐twitch	  marker	   F310	   in	   the	   fast	   domain	  
remains	  unaffected	  (B	  and	  E),	  with	  the	  same	  muscle	  fibres	  expressing	  both	  smyhc1	  and	  fast	  
myosin	  heavy	  chain	  isoforms	  (C	  and	  F).	  	  
	  
5.2.11	  Bone	  and	  cartilage	  differentiation	  in	  sox6-­‐/-­‐	  mutants	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assess	   this	  scoliosis	  phenotype	  more	  closely,	   the	  development	  of	  cartilage	  and	  bone	  was	  examined.	   As	   described	   in	   Chapter	   1,	   Sox6	   and	   Sox5	   co-­‐operate	   with	   Sox9	   to	   regulate	  chondrogenesis	  in	  mice	  (Lefebvre	  et	  al.,	  1998).	  Alcian	  Blue	  staining	  was	  therefore	  used	  to	  stain	   the	   cartilage	   in	   sox6-­‐/-­‐	   mutant	   and	   sibling	   fish.	   There	   were	   no	   consistent	  morphological	  differences	  in	  cartilage	  development	  between	  the	  sibling	  and	  mutant	  fish	  at	  6	  dpf	  and	  13	  dpf	  (Figure	  5.19),	  although	  2	  out	  of	  the	  5	  mutants	  examined	  at	  13	  dpf	  were	  already	   noticeably	   smaller	   than	   their	   siblings	   and	   showed	   a	   slight	   delay	   in	   cartilage	  development.	  	  When	   bone	   formation	   was	   analysed	   using	   Alizarin	   Red	   staining,	   scoliosis	   was	   readily	  apparent	  in	  all	  sox6-­‐/-­‐	  mutant	  fish	  examined,	  with	  a	  slight	  curve	  in	  the	  spine	  noticeable	  as	  early	   as	   17	   dpf	   in	   some	   fish	   (Figure	   5.20A	   and	   C).	   The	   scoliosis	   was	   a	   very	   variable	  phenotype,	  with	   some	   fish	   exhibiting	   only	   a	   slight	   kink	   in	   the	   spine,	  whereas	   other	   fish	  displayed	  a	  massive	  crumpling	  of	  the	  spine.	  At	  17	  dpf	  the	  majority	  of	  the	  mutant	  fish	  (4/5)	  showed	  a	  delay	  in	  the	  formation	  of	  the	  bone	  (Figure	  5.20A	  and	  C).	  By	  27	  dpf,	  sox6-­‐/-­‐	  mutant	  fish	  were	   significantly	   smaller	  when	  compared	   to	   siblings,	  but	   the	   structure	  of	   the	  bone	  appeared	  mostly	  normal	  apart	  from	  the	  scoliosis	  (Figure	  5.20B,	  D	  and	  F).	  The	  scoliosis	  was	  apparent	  not	  only	   along	   the	  antero-­‐	  posterior	   axis	  of	   the	   fish,	   but	   also	   along	   the	  medio-­‐lateral	  axis	  (Figure	  5.20	  E).	  By	  80	  dpf,	  surviving	  sox6-­‐/-­‐	  mutant	  fish	  all	  displayed	  scoliosis	  to	  some	   extent	   (Figure	   5.20	   G-­‐J).	   sox6-­‐/-­‐	   mutants	   also	   displayed	   abnormalities	   in	   the	  formation	   of	   the	   spinal	   processes,	   particularly	   towards	   their	   caudal	   end.	   Some	   spinal	  processes	  were	  abnormal	   in	   shape,	  and	  a	   subset	  of	   these	  processes	  displayed	  branching	  not	  seen	  in	  sibling	  fish.	  As	  the	  sample	  size	  at	  this	  stage	  was	  very	  small	  (mutants,	  n=2),	  it	  is	  difficult	   to	   infer	  whether	   these	   variations	   represent	   natural	   phenotypic	   variance	  within	  the	  spinal	  processes	  or	  whether	  they	  are	  caused	  by	  loss	  of	  sox6.	  Nevertheless,	  the	  scoliosis	  phenotype	   is	   clearly	   linked	   to	   the	   sox6-­‐/-­‐	  mutation,	   and	   could	   be	   either	   a	   primary	   effect	  resulting	  from	  the	  loss	  of	  sox6	   function	  in	  bone,	  or	  an	  indirect	  secondary	  consequence	  of	  abnormal	  myogenesis.	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Figure	  5.19:	  Alcian	  Blue	  staining	  of	  sox6-­‐/-­‐	  mutant	  and	  sibling	  fish	  revealed	  that	  there	  
is	  no	  apparent	  defect	  in	  cartilage	  formation	  at	  6	  dpf	  (A	  and	  B)	  and	  13	  dpf	  (C	  and	  D)	  in	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Figure	   5.20:	   Alizarin	   Red	   staining	   of	   sox6-­‐/-­‐mutant	   and	   sibling	   fish	   indicated	   that	  
scoliosis	   begins	   in	   sox6-­‐/-­‐	  mutants	   at	   approximately	   17-­‐27	   days	   of	   age	   (A-­‐D).	   At	   one	  
month	  of	  age,	  sox6-­‐/-­‐	  mutants	  are	  significantly	  smaller	  than	  siblings	  (indicated	  by	  asterisk).	  
Student’s	  two-­‐tailed,	  unpaired	  t-­‐test	  P<0.05,	  error	  bars	  represent	  standard	  deviation,	  sibling	  
n=17,	  mutant	  n=17	  (F).	  The	  scoliosis	  of	  the	  spine	  in	  sox6-­‐/-­‐	  mutants	  is	  evident	  along	  both	  the	  
anterior-­‐posterior	  axis	  as	  well	  as	  the	  medial-­‐lateral	  axis	  (E).	  By	  80	  dpf	  there	  is	  clear	  scoliosis	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5.2.12	  Analysis	  of	  adult	  sox6-­‐/-­‐	  mutant	  myotome	  	  To	  address	  whether	  the	  scoliosis	  phenotype	  results	  from	  the	  direct	  loss	  of	  sox6	  function	  or	  is	  a	  secondary	  consequence	  of	  myotomal	  abnormalities,	  muscle	  fibres	  were	  examined	  by	  visualizing	  the	  expression	  of	  fast-­‐twitch	  and	  slow-­‐twitch	  markers	  in	  sections	  through	  the	  trunk	   regions	   of	   adult	   sox6-­‐/-­‐	   mutants	   and	   siblings	   carrying	   the	   tnnc1b:eGFP	   reporter.	  These	  revealed	  that	  tnnc1b	  expression	  is	  robustly	  overexpressed	  throughout	  the	  myotome	  of	   adult	   sox6-­‐/-­‐	   mutants,	   as	   well	   as	   during	   development	   (Figure	   5.21).	   However,	   the	  expression	  of	  tnnc1b:eGFP	  in	  the	  slow	  domain	  is	  clearly	  stronger	  than	  in	  the	  fast	  domain	  of	  
sox6-­‐/-­‐	  mutant	  fish.	  The	  overall	  morphology	  of	  the	  mutant	  myotome	  is	  very	  different	  to	  that	  of	   sibling	   fish.	   In	   cross-­‐section,	   the	   sox6-­‐/-­‐	  mutant	  myotome	   appears	  much	   smaller	   than	  that	   of	   sibling	   fish	   and	   its	   shape	   varies	   between	   individuals,	   unlike	   the	   highly	   regular	  cross-­‐sections	   of	   wild-­‐type	   or	   heterozyogous	   siblings	   (Figure	   5.21).	   The	   sharp	   border	  between	  slow-­‐	  and	   fast-­‐twitch	   fibres	   typical	  of	  wild-­‐type	   fish	   is	   replaced	  by	  an	   irregular	  border	   in	   sox6-­‐/-­‐	   mutants,	   and	   the	   muscle	   fibres	   are	   significantly	   smaller	   than	   those	  observed	  in	  sibling	  fish,	  in	  some	  cases	  by	  as	  much	  as	  10	  times	  smaller.	  	  The	   differential	   expression	   of	   smyhc1:GFP	   between	   siblings	   and	   sox6-­‐/-­‐	   mutants	   also	  appears	  to	  be	  maintained	  into	  zebrafish	  adulthood.	  As	  was	  seen	  in	  sox6-­‐/-­‐	  mutant	  embryos,	  the	  ectopic	  expression	  of	  smyhc1	  observed	  in	  the	  adult	   is	  subtle	  (Figure	  5.22).	  There	  is	  a	  slight	  medial	  expansion	  of	  the	  GFP-­‐positive	  domain,	  with	  some	  cells	  in	  the	  most	  medially	  located	  muscle	  fibres	  faintly	  expressing	  GFP,	  as	  well	  as	  a	  dorsal	  and	  ventral	  expansion	  in	  the	  expression	  domain	  (Figure	  5.22B	  and	  F).	  In	  the	  fast-­‐twitch	  domain	  of	  sox6	  siblings,	  no	  GFP-­‐positive	   fibres	  can	  be	   identified,	  whereas	   in	   the	  mutants	   there	  are	  a	   few	   fast-­‐twitch	  fibres	  faintly	  expressing	  GFP	  (Figure	  5.22D	  and	  H).	  These	  results	  show	  that	  in	  sox6-­‐/-­‐	  mutants	  the	  aberrant	  expression	  patterns	  of	  tnnc1b:GFP	  and	   smyhc1:GFP	   are	   maintained	   into	   zebrafish	   adulthood,	   with	   tnnc1b:GFP	   being	  expressed	  throughout	  the	  whole	  myotome	  and	  smyhc1:GFP	  	  being	  ectopically	  expressed	  in	  a	  subset	  of	  fast-­‐twitch	  fibres.	  In	  situ	  hybridisation	  analysis	  is	  needed	  to	  confirm	  this	  result	  in	  order	  to	  indicate	  whether	  the	  tnnc1b:GFP	  and	  smyhc1:GFP	  transgenes	  are	  recapitulating	  the	  endogenous	  gene	  expression.	  	  	  An	   in	   situ	   hybridisation	   using	   the	   smyhc	   probe	   was	   also	   carried	   out	   on	   these	   adult	  sections.	  The	  smyhc	  probe	  identifies	  three	  isoforms	  of	  slow	  myosin	  heavy	  chain	  (Elworthy	  et	  al.,	  2008).	  Before	  48	  hpf	  only	  smyhc1	  is	  expressed	  in	  the	  slow	  myoblasts,	  therefore	  the	  
smyhc	  probe	  will	  only	  identify	  this	  isoform	  (Elworthy	  et	  al.,	  2008).	  smych2	  and	  smyhc3	  are	  expressed	  from	  48	  hpf	  and	  96	  hpf	  respectively,	  so	  potentially	  all	  three	  isoforms	  could	  be	  expressed	  in	  adulthood	  (Elworthy	  et	  al.,	  2008).	  The	  in	  situ	  hybridisation	  on	  adult	  siblings	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using	  the	  smyhc	  probe	  identified	  an	  expression	  domain	  larger	  than	  the	  domain	  identified	  by	  the	  smyhc1:GFP	  transgene,	   implying	  that	  smyhc2	  and/or	  smyhc3	  are	  expressed	   in	  at	  a	  least	  some	  distinct	  muscle	  cells	  to	  smyhc1	  (Figure	  5.23).	  The	  expression	  domain	  identified	  with	   the	   smyhc	  probe	  overlapped	  with	   the	   tnnc1b:eGFP	   adult	   expression.	   In	  adult	   sox6-­‐/-­‐	  mutant	  sections	  the	  expression	  of	  the	  smyhc	  genes	  appears	  to	  be	  extended	  more	  medially	  (Figure	   5.23),	   similar	   to	  what	   is	   seen	   in	   tnnc1b:eGFP;sox6-­‐/-­‐	   mutants	   (Figure	   5.21).	   This	  implies	  that	  other	  smyhc	  isoforms,	  besides	  smyhc1,	  are	  derepressed	  in	  the	  absence	  of	  Sox6.	  	  
	  
Figure	   5.21:	   tnnc1b	   expression	   persists	   throughout	   the	   myotome	   of	   sox6-­‐/-­‐	   mutant	  
adult	   fish.	   In	   wild-­‐type	   zebrafish	   adults,	   tnnc1b:eGFP	   expression	   is	   found	   in	   a	   wedge	   of	  
myotome,	  which	   corresponds	   to	   the	  adult	   slow-­‐twitch	   fibre	  domain	   (A).	   In	   sox6-­‐/-­‐	  mutants,	  
tnnc1b:eGFP	  expression	  is	  seen	  in	  both	  the	  fast	  and	  slow-­‐twitch	  fibres	  and	  the	  wedge	  shape	  
appears	   to	   encroach	   further	   towards	   the	   midline	   of	   the	   fish	   (B).	   The	   overall	   size	   of	   the	  
myotome	  is	  significantly	  smaller	  in	  sox6-­‐/-­‐	  mutant	  fish	  (panels	  A	  and	  C,	  and	  B	  and	  D	  are	  at	  the	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Figure	  5.22:	  The	  smyhc1	  expression	  domain	  is	  slightly	  expanded	  in	  sox6-­‐/-­‐	  mutant	  
adults	  in	  comparison	  to	  the	  situation	  in	  sibling	  fish.	  The	  expression	  of	  smyhc1:GFP	  is	  
spread	  further	  dorsally	  and	  ventrally	  in	  the	  sox6-­‐/-­‐	  mutants	  (A	  ,	  B,	  E	  and	  F).	  There	  appears	  to	  
be	  more	  fibres	  expressing	  GFP	  in	  the	  slow	  domain	  of	  sox6-­‐/-­‐	  mutants	  (C	  and	  G).	  In	  the	  fast	  
domain	  of	  sibling	  fish	  there	  are	  no	  GFP-­‐	  positive	  fibres	  (D).	  Conversely,	  in	  sox6-­‐/-­‐	  mutant	  fish,	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Figure	   5.23:	   in	   situ	   hybridisation	   to	   detect	   smyhc	   isoforms	   in	   sox6-­‐/-­‐	   mutant	   and	  
sibling	  fish.	  In	  the	  sibling	  fish	  the	  expression	  of	  smyhc	  isoforms	  are	  restricted	  to	  the	  wedge	  
shaped	   muscle	   on	   either	   side	   of	   the	   myotome	   named	   lateralis	   superficialis	   (Devoto	   et	   al.	  
1996;	  Elworthy	  et	  al.	  2008)	  (A).	  In	  sox6-­‐/-­‐	  mutants	  this	  expression	  domain	  has	  spread	  further	  
medially	  (B),	  with	  more	  smyhc-­‐positive	  fibres	  than	  there	  are	  observed	  in	  smyhc1:GFP;sox6-­‐/-­‐	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Figure	  5.24:	  Both	  slow-­‐	  (B	  and	  D)	  and	  fast-­‐twitch	  (A	  and	  C)	  muscle	  fibres	  are	  smaller	  
in	  sox6	  homozygous	  mutants	  in	  comparison	  to	  the	  muscle	  fibres	  of	  sibling	  fish.	  F310	  staining	   is	   non-­‐specific	   signal,	   as	   the	   staining	   appears	   in	   the	   sarcolemma	   instead	   of	   the	  myofibres.	  However,	  the	  staining	  is	  useful	  in	  this	  image	  to	  outline	  individual	  fibres.	  	  
5.2.13	  Sox6	  expression	  in	  the	  bone	  In	  order	  to	  determine	  whether	  the	  scoliosis	  phenotype	  results	  from	  a	  primary	  effect	  due	  to	  the	   loss	   of	   sox6	   expression	   in	   the	   bone,	   or	   a	   secondary	   effect	   due	   to	   the	   loss	   of	   sox6	  expression	   in	   the	  muscle,	  we	  must	   first	  establish	  whether	  sox6	   is	  expressed	   in	  zebrafish	  bone.	   The	   opercle,	   which	   makes	   up	   part	   of	   the	   operculum,	   is	   one	   of	   the	   first	   bones	   to	  develop	  in	  zebrafish	  embryos	  at	  approximately	  4	  dpf	  (Figure	  5.25A)	  (Wada	  et	  al.,	  2010).	  In	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Figure	  5.25:	  sox6	  expression	  is	  not	  expressed	  in	  the	  opercula	  in	  wild-­‐type	  embryos	  at	  4	  
dpf.	  The	  opercle	  bone	  is	  situated	  posterior	  to	  the	  eye,	  outlined	  in	  panel	  A.	  Op-­‐	  opercle	  (Panel	  
A	   taken	   from	  Wada	   et	   al.,	   2010).	   In	   situ	   hybridisation	   revealed	   no	   sox6	   expression	   can	   be	  
detected	  in	  the	  opercle	  at	  4	  dpf,	  implying	  that	  sox6	  is	  probably	  not	  expressed	  in	  the	  bone	  (B-­‐D	  
are	  of	  the	  same	  embryo	  taken	  on	  a	  different	  focal	  plane).	  	  	  







	   124	  
	  
Figure	   5.26:	   The	   expression	   of	   sox5	   during	   zebrafish	   development.	   sox5	   is	   first	  
specifically	   expressed	   in	   the	   embryonic	   tailbud	   and	   head	   regions,	   most	   prominently	   the	  
forebrain,	  at	  the	  15-­‐somite	  stage,	  with	  expression	  persisting	  in	  these	  regions	  until	  at	  least	  24	  
hpf.	  From	  the	  approximately	  18-­‐somite	   stage,	   sox5	   is	  weakly	  expressed	   in	   the	   somites	  with	  
this	  expression	  persisting	  until	  at	  least	  24	  hpf.	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Figure	   5.27:	   Morphological	   comparison	   of	   sox5-­‐/-­‐;sox6-­‐/-­‐	   mutant	   and	   sibling	   larval	  
phenotypes	  at	  6	  dpf.	  sox5-­‐/-­‐;sox6-­‐/-­‐	  double	  mutant	  larvae	  have	  a	  smaller	  head	  and	  oedema	  
around	   the	  otic	  vesicles,	  and	   their	  pectoral	   fins	  protrude	  at	  an	  abnormal	  angle.	  The	  sox5-­‐/-­‐
;sox6-­‐/-­‐	  double	  mutant	  larvae	  also	  appear	  to	  lack	  a	  lower	  jaw.	  (The	  curvature	  of	  the	  body	  axis	  
seen	  in	  panel	  D	  is	  not	  representative	  of	  the	  double	  mutants).	  
	  
	  
Figure	  5.28:	  The	  expression	  of	  the	  slow-­‐twitch	  specific	  muscle	  genes	  tnnc1b,	  smyhc1,	  
mylz10,	   tnni1a,	   tpm2	  and	  myh7b	   is	  unchanged	   in	  sox5-­‐/-­‐	  mutants	   (G-­‐L)	  compared	   to	  











tpm2& 30hpf&tnnc1b& 30hpf& mylz10& 30hpf&smyhc1& 30hpf&
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In	  order	  to	  investigate	  whether	  sox6	  and	  sox5	  might	  execute	  partially	  redundant	  functions	  in	   the	   myotome,	   the	   expression	   pattern	   of	   slow	   muscle	   genes	   was	   examined	   in	   sox5-­‐/-­‐	  single	  mutant,	  sox6-­‐/-­‐	  single	  mutant,	  sox5-­‐/-­‐;sox6-­‐/-­‐	  double	  mutant	  and	  sibling	  embryos	  at	  30	  hpf.	   For	   the	   three	  markers	   examined,	   the	   phenotype	   of	   the	   sox5-­‐/-­‐;sox6-­‐/-­‐	  double	  mutant	  embryos	   was	   indistinguishable	   from	   that	   of	   sox6-­‐/-­‐	   single	   mutant	   embryos,	   and	   the	  phenotype	  of	  the	  sox5-­‐/-­‐	  single	  mutant	  embryos	  was	  indistinguishable	  from	  that	  of	  sibling	  embryos	  (Figure	  5.29).	  Moreover,	  there	  was	  also	  no	  significant	  difference	  in	  the	  number	  of	  fast	   fibres	   expressing	   smyhc1	   between	   the	   sox6-­‐/-­‐	   embryos	   and	   the	   sox5-­‐/-­‐;sox6-­‐/-­‐	   double	  mutants	  at	  3	  dpf	  (double	  mutants	  could	  be	  separated	  by	  phenotype,	  single	  mutants	  were	  genotyped)	  (Figure	  5.30).	  Taken	  together,	  these	  results	  implied	  that	  sox5	  does	  not	  have	  a	  function	  in	  muscle	  fibre-­‐type	  specification	  that	  is	  redundant	  with	  that	  of	  sox6.	  	  
	  
Figure	   5.29:	   The	   expression	   patterns	   of	   slow-­‐twitch	   muscle-­‐specific	   genes	   are	   the	  
same	   in	   sox6-­‐/-­‐	   single	   mutant	   and	   sox5-­‐/-­‐;sox6-­‐/-­‐	   double	   mutant	   embryos	   at	   30	   hpf.	  
tnnc1b	   is	   misexpressed	   throughout	   the	   whole	   myotome	   in	   sox5-­‐/-­‐;sox6-­‐/-­‐	   double	   mutant	  
embryos	  (D),	  just	  as	  is	  observed	  in	  single	  sox6-­‐/-­‐	  mutants	  (C).	  myh7b	  expression	  is	  restricted	  
to	   the	  slow	   fibres	   in	  siblings	  (E),	   single	  sox5-­‐/-­‐mutant	  (F),	   sox6-­‐/-­‐	  mutant	  (G)	  and	  the	  sox5-­‐/-­‐
;sox6-­‐/-­‐	  double	  mutant	  (H)	  embryos.	  The	  expression	  pattern	  of	  smyhc1	  in	  sox5-­‐/-­‐;sox6-­‐/-­‐	  double	  
mutant	   embryos	   (L)	   is	   the	   same	   as	   that	   of	   single	   sox6-­‐/-­‐	  mutants	   (K),	   with	   just	   a	   few	   fast	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Figure	  5.30:	  Loss	  of	  sox5	  function	  does	  not	  change	  the	  expression	  pattern	  of	  the	  slow-­‐
twitch	   muscle-­‐specific	   marker	   smyhc1	   in	   3	   dpf	   larvae.	   In	   sox5-­‐/-­‐	   mutants,	   smyhc1	  
expression	  remains	  restricted	  to	  the	  slow	  fibres	  at	  3	  dpf	  (A	  and	  B),	  as	  observed	  in	  wild-­‐type	  
sibling	  larvae.	  In	  	  	  sox6-­‐/-­‐	  mutants	  the	  domain	  of	  smyhc1	  expression	  is	  expanded	  to	  include	  the	  
ventral-­‐most	   fast-­‐twitch	   fibres	   at	   3	   dpf.	   There	   is	   no	   difference	   in	   the	   expression	  pattern	   of	  
this	  gene	  in	  sox6-­‐/-­‐	  single	  mutant	  and	  sox5-­‐/-­‐;sox6-­‐/-­‐	  double	  mutant	  larvae.	  	  	  
5.3	  Discussion	  The	  generation	  of	  a	  sox6	  null	  zebrafish	  mutant	  has	  allowed	  me	  to	  analyse	  more	  fully	  the	  role	   of	   sox6	   in	   zebrafish	  myogenesis.	   Additionally,	   it	   has	   uncovered	   an	   interesting	   adult	  phenotype	  associated	  with	  the	  loss	  of	  Sox6	  function,	  which	  needs	  further	  elucidation.	  The	  results	  described	  in	  the	  previous	  chapter	  (Chapter	  4)	  have	  demonstrated	  that	  Sox6	  is	  able	  to	  repress	  the	  expression	  of	  slow-­‐twitch	  muscle	  genes,	  a	  function	  that	  is	  conserved	  in	  mice	  (An	  et	  al.,	  2011;	  Hagiwara	  et	  al.,	  2005;	  Hagiwara	  et	  al.,	  2007;	  Quiat	  et	  al.,	  2011).	   In	  
sox6-­‐/-­‐	  mutant	   mice,	   the	   expression	   of	   slow-­‐twitch	   muscle	   genes	   is	   upregulated	   at	   the	  expense	   of	   fast-­‐specific	   muscle	   genes,	   resulting	   in	   a	   slow-­‐to-­‐fast	   fibre	   type	   conversion	  (Hagiwara	  et	  al.,	  2005;	  Hagiwara	  et	  al.,	  2007).	  Although	  this	   is	  at	   least	  partly	   the	  case	   in	  zebrafish,	  there	  are	  some	  clear	  and	  important	  differences.	  The	  sox6-­‐/-­‐	  zebrafish	  mutant	  has	  enabled	  me	  to	  elucidate	  some	  of	  these	  differences,	  as	  described	  in	  this	  chapter.	  	  
5.3.1	  Fast-­‐specific	  gene	  expression	  in	  sox6-­‐/-­‐	  mutant	  zebrafish	  One	   of	   the	   starkest	   differences	   between	   the	   zebrafish	   and	  mouse	   sox6-­‐/-­‐	   mutants	   is	   the	  distinct	   responses	   of	   the	   fast-­‐specific	   genes	   to	   the	   loss	   of	   sox6	   in	   these	   two	   species.	   In	  mice,	  the	  loss	  of	  sox6	  results	  in	  a	  decrease	  in	  the	  expression	  of	  several	  fast-­‐specific	  genes	  (Hagiwara	   et	   al.,	   2005).	   In	   contrast,	   the	   levels	   of	   fast-­‐twitch	   gene	   expression	   appear	   to	  remain	  unchanged	  in	  zebrafish	  sox6-­‐/-­‐	  mutant	  embryos,	  although	  as	  in	  mice,	  slow-­‐specific	  genes	   are	   upregulated	   in	   the	   zebrafish	   sox6-­‐/-­‐	  mutant.	   Consequently,	   the	   phenotype	   of	  zebrafish	   sox6-­‐/-­‐	  mutants	   is	   not	   a	   fast-­‐twitch	   to	   slow-­‐twitch	   fibre	   conversion,	   as	   seen	   in	  mouse.	   Rather,	   in	   zebrafish,	   both	   fast-­‐twitch	   and	   slow-­‐twitch	   genes	   are	   co-­‐expressed	   in	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the	  same	  fibres.	  The	  decreased	  expression	  of	  fast-­‐specific	  genes	  observed	  in	  mouse	  sox6-­‐/-­‐	  mutants	  could	  result	  from	  two	  possible	  mechanisms.	  Firstly,	  sox6	  may	  be	  necessary	  for	  the	  activation	  of	   fast-­‐muscle	  genes.	  However,	  as	  no	  peaks	  of	  Sox6	  binding	  were	   found	   in	  the	  promoters	   of	   fast-­‐specific	   genes	   in	  mouse	   ChIP	   seq	   analyses	   (An	   et	   al.,	   2011),	   it	   seems	  likely	   that	   this	   might	   be	   achieved	   indirectly,	   via	   indirect	   activation	   of	   the	   fast-­‐twitch	  programme.	  Secondly,	  the	  decrease	  in	  fast-­‐twitch	  genes	  in	  sox6-­‐/-­‐	  mouse	  mutants	  could	  be	  a	  secondary	  effect	  due	  to	  the	  increased	  expression	  of	  slow-­‐specific	  genes,	  as	  the	  activation	  of	  these	  genes	  may	  directly	  or	  indirectly	  repress	  the	  transcription	  of	  fast-­‐twitch	  genes.	  In	  the	  zebrafish	  sox6-­‐/-­‐	  mutant	  embryos,	  my	  results	   indicate	  that	   there	   is	  no	  repression	   fast	  myosin	   isoforms,	   which	   indicates	   that	   sox6	   is	   not	   necessary	   for	   the	   activation	   of	   these	  genes.	   qPCR	   would	   be	   needed	   to	   confirm	   this	   result	   and	   the	   expression	   of	   other	   fast-­‐specific	   genes	   needs	   to	   be	   examined.	   The	   reason	   why	   fast-­‐myosin	   isoforms	   are	  downregulated	   in	   mouse	   sox6-­‐/-­‐	  mutants,	   but	   not	   in	   fish	   sox6-­‐/-­‐	  mutants,	   may	   be	   that	   a	  slow-­‐specific	  gene	  that	   is	  upregulated	  in	  mouse,	  but	  not	   in	  fish,	   leads	  to	  the	  inhibition	  of	  fast-­‐twitch-­‐specific	   genes	   transcription.	   In	   zebrafish,	   fast-­‐specific	   genes	  are	  known	   to	  be	  directly	   inhibited	  by	  Prdm1a	  in	  slow-­‐twitch	  muscle	  (Liew	  et	  al.,	  2008;	  von	  Hofsten	  et	  al.,	  2008).	  Since	  Prdm1a	   is	  an	  essential	  gene	   for	  slow-­‐twitch	  muscle	  specification,	   it	  may	  be	  that	  ectopic	  expression	  of	  Prdm1a	  is	  needed	  in	  the	  fast-­‐twitch	  myotome	  of	  zebrafish	  sox6-­‐/-­‐	  mutants	   to	   fully	   convert	   the	   fast-­‐twitch	   domain	   into	   a	   slow-­‐twitch	   domain.	   In	   situ	  hybridization	   for	  prdm1a	   in	   zebrafish	   sox6-­‐/-­‐	  mutant	   and	   sibling	   embryos	  would	   help	   to	  determine	  whether	  prdm1a	  is	  ectopically	  expressed	  in	  the	  fast-­‐twitch	  muscle	  of	  zebrafish	  
sox6-­‐/-­‐	  mutants,	  although	  since	  Prdm1a	  normally	  directly	  represses	  fast-­‐twitch	  genes,	  the	  expression	  of	  fast	  myosin	  genes	  in	  the	  fast-­‐domain	  of	  sox6-­‐/-­‐	  mutants	  implies	  that	  there	  is	  no	  ectopic	  expression	  of	  prdm1a.	  
5.3.2	  Slow-­‐twitch	  muscle	  differentiation	  in	  nrd-­‐/-­‐;sox6-­‐/-­‐	  double	  mutant	  embryos	  Prdm1a	   mutants	   do	   not	   develop	   slow-­‐twitch	   muscle,	   and	   instead	   the	   whole	   myotome	  differentiates	   into	   multinucleated,	   fast-­‐twitch	   fibres	   (Roy	   et	   al.,	   2001).	   By	   contrast,	   I	  observed	  an	  expansion	  of	  the	  expression	  domain	  for	  a	  subset	  of	  slow-­‐twitch	  specific	  genes,	  in	   sox6-­‐/-­‐	  mutant	   embryos.	   Previous	   reports	   have	   demonstrated	   that	   sox6	  morpholino	  knockdown	  of	  sox6	  in	  prdm1a-­‐/-­‐	  mutants	  can	  rescue	  the	  expression	  of	  slow-­‐twitch	  muscle	  genes	  (von	  Hofsten	  et	  al.,	  2008).	  I	  sought	  to	  confirm	  these	  results,	  and	  to	  then	  extend	  them	  by	  determining	  whether	  a	  complete	  loss	  of	  sox6	  gene	  function	  in	  prdm1a-­‐/-­‐	  mutants	  could	  completely	   rescue	   slow-­‐twitch	   muscle	   differentiation.	   Interestingly,	   tnnc1b	   expression	  was	   both	   rescued	   in	   the	   slow	   domain	   of	   sox6-­‐/-­‐;nrd-­‐/-­‐	   double	   mutant	   embryos,	   and	  ectopically	   expressed	   in	   the	   fast	   domain	   (Figure	   5.10).	   smyhc1,	   tpm2	   and	   mylz10	  expression	  was	  also	  rescued	  in	  sox6-­‐/-­‐;nrd-­‐/-­‐	  double	  mutant	  embryos,	  although	  the	  ectopic	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expression	  of	  these	  genes	  was	  limited	  to	  a	  few	  fibres,	  mainly	  in	  the	  fast	  domain,	  and	  does	  not	   extend	   to	   all	   fibres	   of	   the	   myotome	   (Figure	   5.10).	   However,	   the	   slow-­‐twitch	  differentiation	  programme	  is	  not	  completely	  rescued,	  as	  slow-­‐twitch	  muscle	  fibres	  fail	  to	  migrate	  in	  sox6-­‐/-­‐;nrd-­‐/-­‐;ubo:GFP	  embryos	  (Figure	  5.11).	  This	  does	  not	  seem	  to	  be	  the	  case	  in	   sox6-­‐/-­‐;prdm1a	   morphant	   embryos,	   as	   the	   rescue	   in	   the	   expression	   of	   smyhc1	   was	  observed	   in	   the	   outer	   fibres	   of	   the	   myotome	   (Figure	   5.9),	   most	   likely	   due	   to	   the	  incomplete	  knockdown	  of	  prdm1a	  by	  the	  morpholino.	  	  
5.3.3	  Expression	  of	  slow-­‐twitch-­‐specific	  genes	  in	  the	  zebrafish	  sox6-­‐/-­‐	  mutant	  Previous	  studies	  using	  a	  sox6	  morpholino	  concluded	  that	  the	  knockdown	  of	  sox6	  results	  in	  no	  ectopic	  expression	  of	  smyhc1	  in	  fast-­‐twitch	  fibres	  (von	  Hofsten	  et	  al.,	  2008).	  However,	  the	   complete	   mutagenic	   inactivation	   of	   sox6	   through	   the	   use	   of	   zinc-­‐finger	   nucleases	  revealed	  that	  a	  small	  subset	  of	  fast	  fibres	  do	  express	  smyhc1	  in	  response	  to	  the	  loss	  of	  sox6.	  This	  observation	  corresponds	  with	  what	  is	  seen	  in	  the	  mouse,	  where	  there	  is	  an	  increased	  expression	  of	  smyhc	  transcripts	  in	  sox6-­‐/-­‐	  mutant	  foetal	  fibres.	  It	  seems	  to	  be	  that	  by	  3	  dpf	  there	   is	   a	   least	   some	   ectopic	   expression	   of	   all	   slow	  muscle	   genes	   examined	   in	   the	   fast-­‐twitch	  muscle.	  It	   is	  not	  known	  why	  there	  would	  be	  a	  delay	  in	  the	  ectopic	  expression	  of	  a	  subset	   of	   slow-­‐specific	   genes	   in	   sox6	   mutants.	   One	   possibility	   is	   that	   the	   presence	   of	  maternal	   transcripts	   of	   sox6	   present	   in	   the	   embryo	   at	   these	   early	   stages	  might	   repress	  slow-­‐twitch	  genes	  in	  sox6	  mutants.	  However,	  this	  hypothesis	  is	  likely	  to	  be	  incorrect,	  since	  
in	   situ	   hybridization	   analysis	   at	   the	   2-­‐cell	   stage	   revealed	   that	   sox6	   is	   not	   maternally	  expressed.	  Why	  there	  is	  this	  delay	  in	  the	  expression	  of	  a	  subset	  of	  slow-­‐twitch	  genes	  in	  the	  fast	  muscle	  of	  sox6-­‐/-­‐	  mutants	  remains	  an	  open	  question.	  	  Unlike	   tnnc1b,	   tnnt1	   and	   ryr1a,	   which	   are	   expressed	   throughout	   fast	   domain	   in	   sox6-­‐/-­‐	  mutants,	  other	  slow-­‐twitch	  genes	  such	  as	  smyhc1	  and	  tpm2	  are	  only	  ectopically	  expressed	  in	  a	  subset	  of	  fast	  twitch	  fibres	  in	  homozygous	  sox6	  mutants,	  raising	  the	  question	  of	  why	  some	   slow-­‐specific	   genes	   appear	   to	   be	   stringently	   repressed	   by	   sox6,	  whereas	   other	   do	  not.	  Notably	  the	  ectopic	  expression	  of	  smyhc1,	  tpm2	  and	  mylz10	  at	  3dpf	  and	  4dppf	  appears	  to	  be	  restricted	  to	  the	  dorsal	  and	  ventral	  edges	  of	  the	  myotome.	  Possible	  explanations	  for	  this	  could	  be	  the	  presence	  of	  an	  inhibitory	  signal	  emanating	  from	  the	  midline,	  restricting	  the	   ectopic	   expression	   of	   these	   genes	   to	   the	   outer	   edges.	   Another	   possible	   explanation	  could	  be	  that	  these	  cells	  are	  newly	  formed	  fibres	  and	  therefore	  could	  express	  slow-­‐specific	  genes	   when	   they	   first	   differentiate	   but	   this	   expression	   is	   lost	   when	   they	   mature.	   This	  would	  need	  to	  be	   investigated	   further,	  perhaps	  by	  observing	  areas	  where	  cell	  division	   is	  occurring,	  by	  using	  Edu	  staining.	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With	   the	   recent	   completion	   of	   the	   zebrafish	   genome,	   it	   has	   been	   suggested	   that	   one-­‐quarter	   of	   zebrafish	   genes	   have	   sister	   genes	  with	   high	   sequence	   similarity	   (Howe	   et	   al.	  2013),	   therefore	   it	   is	   possible	   that	   a	   gene	   that	   is	   similar	   in	   sequence	   to	   sox6	   could	  compensate	  for	  loss	  of	  sox6	  in	  sox6	  null	  mutant	  embryos,	  and	  maintain	  repression	  of	  slow	  muscle	  genes	  such	  as	  smyhc1	  and	  tpm2	  in	  the	  majority	  of	  fast-­‐twitch	  fibres.	  This	  possibility	  is	  discussed	  below.	  	  	  
5.3.4	  Six1a	  and	  Pbx	  transcription	  factors	  The	  possibility	  that	  transcription	  factors	  required	  for	  the	  activation	  of	  fast-­‐specific	  genes	  could	  also	  be	  repressing	  slow-­‐twitch	  gene	  expression	  in	  the	  fast	  muscle	  of	  sox6-­‐/-­‐mutants,	  was	  examined.	  	  As	  discussed	  in	  Chapter	  1,	  both	  Six1a	  and	  Pbx	  homeodomain	  transcription	  factors	  have	   previously	   been	   implicated	   in	   the	   transcriptional	   activation	   of	   fast-­‐specific	  genes	   in	   zebrafish	   (Maves	   et	   al.,	   2007).	   The	   examples	   of	   interactions	   between	  homeodomain	   transcription	   factors	   and	  HMG	  domain	   transcription	   factors	   in	   regulating	  transcription	   (Dailey	   and	   Basilico,	   2001)	   led	   to	   the	   hypothesis	   that	   Six	   proteins	   or	   Pbx	  proteins	  may	   be	   cooperating	  with	   Sox6	   during	  myogenesis	   to	   repress	   the	   expression	   of	  slow-­‐specific	   genes	   in	   the	   fast	  muscle.	   However,	   the	   knockdown	   of	   Six	   proteins	   or	   Pbx	  proteins	   in	  the	  fast-­‐twitch	  myoblasts	  of	  sox6-­‐/-­‐	  mutant	  embryos,	   led	  to	  no	   increase	   in	  the	  expression	   of	   the	   smyhc1:GFP	   transgene	   in	   the	   fast-­‐twitch	   fibres,	   as	   compared	   to	   the	  situation	  for	  sibling	  embryos.	  	  
5.3.5	  sox5-­‐/-­‐	  and	  sox6-­‐/-­‐	  zebrafish	  mutants	  Sox6	   is	   known	   to	   have	   partially	   redundant	   functions	   with	   Sox5	   in	   processes	   such	   as	  chondrogenesis,	   due	   to	   their	   high	   sequence	   similarity	   and	   co-­‐expression	   in	   cartilage	  precursors	  (Lefebvre	  et	  al.,	  1998,	  Smits	  et	  al.,	  2001).	  As	  sox5	   is	  also	  expressed	  weakly	   in	  the	  somites	  during	  development,	  it	  is	  plausible	  that	  it	  may	  be	  weakly	  repressing	  a	  subset	  of	  slow-­‐twitch	  muscle	  genes.	  The	  results	  described	  in	  Chapter	  3	  indicate	  that	  tnnc1b	  is	  not	  directly	   repressed	   by	   Sox6,	   therefore	   it	   could	   be	   that	   such	   genes	   which	   are	   indirectly	  repressed	   by	   Sox6,	   are	   expressed	   throughout	   the	   whole	   myotome	   in	   sox6-­‐/-­‐	   mutants,	  whereas	  genes	  that	  are	  directly	  repressed	  such	  as	  smyhc1,	  are	  expressed	  only	  in	  a	  subset	  of	  fibres	  as	  another	  repressor	  such	  as	  sox5,	  can	  weakly	  directly	  repress	  the	  expression	  of	  these	   genes.	   In	   order	   to	   test	   this	   hypothesis,	   a	   Zinc-­‐finger	   nuclease	  mutant	   for	   the	   sox5	  allele	  was	  generated.	  However,	  double	  sox5-­‐/-­‐;sox6-­‐/-­‐	  zebrafish	  mutant	  embryos	  displayed	  no	   increase	   in	   the	  number	  of	  smyhc1-­‐expressing	   fast-­‐twitch	   fibres,	   than	  the	  single	  sox6-­‐/-­‐	  mutant	   alone.	   This	   result	   indicates	   that	   sox5	   is	   not	   compensating	   for	   the	   loss	   of	   sox6	   in	  
sox6-­‐/-­‐	   mutants	   by	   repressing	   the	   expression	   of	   slow-­‐twitch	   genes	   in	   the	   fast-­‐twitch	  domain.	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5.3.6	  The	  possibility	  of	  a	  second	  sox6	  gene	  The	   sox6	   gene	   is	   duplicated	   in	  most	   teleost	   genomes	   that	   have	   been	   sequenced	   to	   date	  (Alfaqih	  et	  al.,	  2009,	  Cui	  et	  al.,	  2011,	  Koopman	  et	  al.,	  2004).	  The	  existence	  of	  two	  copies	  of	  
sox6	   in	   zebrafish	   could	   provide	   an	   explanation	   for	   the	   partial	   derepression	   of	   the	   slow-­‐twitch	   pathway	   that	   was	   observed	   in	   zebrafish	   sox6	   homozygous	   mutant	   embryos.	  Notably,	   however,	   the	   zebrafish	   genome	   seems	   to	   be	   exceptional	   in	   lacking	   a	   sox6	  duplicate	  (Zebrafish	  Zv9	  assembly	  http://www.ensembl.org/index.html).	  The	  presence	  of	  a	  second	  sox6	  gene	  has	  been	  searched	  for	  extensively	  using	  bioinformatic	  tools	  to	  analyse	  RNA-­‐seq	  data	  and	  no	  such	  duplicate	  has	  been	  identified.	  Double-­‐conserved	  synteny	  (DCS)	  blocks	  are	  runs	  of	  genes	  in	  the	  ancestral	  species	  lacking	  a	  whole	  genome	  duplication,	  that	  are	  found	  on	  two	  different	  chromosomes	  in	  the	  species	  where	  whole	  genome	  duplication	  did	  occur	  (Kellis	  et	  al.,	  2004).	  Interestingly,	  DCS	  blocks	  can	  be	  observed	  at	  the	  sox6	  locus	  in	  teleost	   species	   and	   humans,	   yet	   a	   duplicate	   sox6	   gene	   that	   is	   observed	   in	   other	   teleost	  species,	  appears	  to	  be	  missing	  at	  the	  predicted	  location	  in	  the	  zebrafish	  (Appendix	  A4).	  	  Since	   the	   recent	   publication	   of	   the	   complete	   zebrafish	   genome	   sequence	   (Howe	   et	   al.,	  2013,	  Kettleborough	  et	  al.,	  2013),	  a	  second	  sox6	  gene	  has	  still	  not	  been	  identified,	  leaving	  open	  the	  possibility	  that	  a	  distinct	  repressor	  is	  involved	  in	  restricting	  the	  expression	  of	  the	  
smych1	  and	  other	  slow-­‐specific	  genes	  to	  the	  adaxial	  cells	  during	  zebrafish	  myogenesis.	  	  
5.3.7	  Repression	  of	  muscle	  genes	  by	  microRNAs	  Myosins	  have	  been	   shown	   to	  not	   only	   encode	   the	  major	   contractile	  units	   of	  muscle,	   but	  they	   can	   also	   influence	  muscle	   gene	   expression	   by	   encoding	   intronic	  microRNAs,	  which	  inhibit	  the	  expression	  of	  other	  genes.	  For	  example,	  in	  zebrafish	  and	  mice,	  myh7b	  encodes	  miR-­‐499,	  which	   inhibits	   the	   expression	   of	   sox6,	  which	   in	   turn	   inhibits	   the	   expression	   of	  
myh7b,	   forming	   a	   negative	   feedback	   loop	   (McCarthy	   et	   al.,	   2009;	   van	   Rooij	   et	   al.,	   2009;	  Wang	   et	   al.,	   2011).	   Further	   to	   this,	   numerous	   mouse	   myosin	   genes	   encode	   related	  microRNAs	  within	   their	   introns,	  which	   regulate	  myosin	   expression	   in	   both	   skeletal	   and	  heart	  muscle,	   and	  which	   in	   turn	   can	   lead	   to	   changes	   in	   fibre-­‐type	   and	   therefore	  muscle	  performance	   (Rooij	   et	   al.,	   2009).	   A	   similar	   network	   of	   myosin	   gene-­‐associated	  miRNAs	  may	   also	   exist	   in	   zebrafish.	   Since	   the	   expression	   of	   fast-­‐specific	   myosins	   are	   not	  downregulated	   in	  sox6-­‐/-­‐	  mutants	   it	   is	  possible	  that	  a	  microRNA	  encoded	  by	  one	  of	   these	  fast-­‐specific	   myosins	   specifically	   inhibits	   the	   expression	   of	   smyhc1	   and	   possibly	   other	  slow-­‐specific	  muscle	  genes	  in	  sox6-­‐/-­‐	  mutants.	  Conversely,	  genes	  such	  as	  tnnc1b	  and	  ryr1a	  could	  be	  insensitive	  to	  such	  myosin-­‐encoded	  miRNAs.	  To	  test	  this	  hypothesis	  fast-­‐myosin	  heavy	  chain	  and	  light	  chain	  isoforms	  would	  need	  to	  be	  knocked	  out	   in	  the	  sox6-­‐/-­‐	  mutant	  background.	  Any	  miRNAs	  encoded	  in	  the	  introns	  of	  the	  fast	  myosins	  would	  therefore	  not	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be	  expressed,	  and	  if	  the	  hypothesis	  is	  correct,	  there	  would	  be	  no	  inhibitory	  effect	  on	  slow	  specific	   genes	   by	   these	  miRNAs,	   leading	   to	   ectopic	   expression	   of	   all	   slow-­‐specific	   genes	  throughout	  the	  myotome.	  
5.3.8	  Sox6-­‐independent	  regulators	  of	  slow-­‐twitch	  muscle	  fate	  The	  data	  therefore	  provides	  no	  explanation	  as	  to	  why	  a	  subset	  of	  slow-­‐muscle	  genes	  are	  ectopically	  expressed	   in	  only	  a	  subset	  of	   fast-­‐twitch	   fibres	   in	  sox6-­‐/-­‐	  mutants,	   rather	   than	  throughout	  the	  whole	  myotome	  as	  was	  observed	  for	  tnnc1b	  expression.	  This	  analysis	  has	  focused	  on	  the	  assumption	  that	  a	  second	  repressor	  of	  slow-­‐twitch	  muscle	  genes	  prevents	  the	  expression	  a	  subset	  of	  slow-­‐specific	  genes	  in	  the	  fast-­‐twitch	  muscle	  of	  sox6-­‐/-­‐	  mutants.	  It	   may	   be	   the	   case	   that	   another	   gene	   required	   for	   the	   transcriptional	   activation	   of	   this	  particular	   subset	   of	   slow-­‐specific	   genes	   is	   not	   expressed	   in	   the	   fast-­‐twitch	   domain.	  However,	   the	   rescue	   of	   smyhc1	   expression	   in	   nrd-­‐/-­‐;sox6-­‐/-­‐	   mutants	   suggests	   that	   this	  activator	  is	  probably	  not	  under	  the	  control	  of	  Prdm1.	  An	  interesting	  experiment	  would	  be	  to	   analyse	   the	   expression	   of	   smyhc1	   in	   Cyclopamine	   treated	   sox6-­‐/-­‐	  mutants.	   My	   results	  have	   revealed	   that	   tnnc1b	   expression	   can	   be	   rescued	   in	   Cyclopamine	   treated	   sox6-­‐/-­‐	  mutants,	  indicating	  that	  tnnc1b	  can	  be	  activated	  independently	  of	  Hh	  signalling.	  If	  smyhc1	  requires	  an	  Hh-­‐dependent	  activator	  for	  its	  expression,	  then	  it	  its	  expression	  would	  not	  be	  rescued	   in	   Cyclopamine	   treated	   sox6-­‐/-­‐	   mutants,	   indicating	   two	   different	   modes	   of	  activation	  for	  tnnc1b	  and	  smyhc1.	  As	  Prdm1a	  is	  thought	  to	  act	  as	  a	  switch	  that	  activates	  the	  slow-­‐twitch	   differentiation	   programme	   in	   zebrafish,	   it	   would	   be	   useful	   to	   look	   at	  differentially	  expressed	  genes	  in	  wild-­‐type	  and	  prdm1a-­‐/-­‐	  mutant	  embryos,	  to	  identify	  new	  candidate	  genes	  that	  may	  be	  involved	  in	  regulating	  slow-­‐twitch	  myoblast	  differentiation.	  	  
5.3.9	  The	  calcium	  link	  Intriguingly,	  the	  three	  slow-­‐specific	  genes	  that	  are	  strongly	  expressed	  throughout	  the	  fast	  domain	   in	   sox6-­‐/-­‐	  mutants	   at	   30	   hpf	   are	   all	   genes	   that	   regulate	   calcium	   signalling	   in	   the	  sarcomere	  to	  control	  muscle	  contraction.	  Both	  Tnnc1b,	  and	  Tnnt1	  are	  part	  of	  the	  troponin	  complex,	   which	   regulates	   actin	   and	   myosin	   interactions	   in	   response	   to	   changes	   in	  intracellular	   calcium	   levels	   (Lehman	   et	   al.,	   1994).	   Ryr1a,	   is	   a	   slow-­‐specific	   ryanodine	  receptor	   that	   acts	   as	   an	   intracellular	   calcium	   channel	   to	  mediate	   the	   release	   of	   calcium	  ions	   from	   the	   sarcoplasmic	   reticulum	   (Meissner,	   1994).	  The	   alternative	   combinations	  of	  both	  myosin	  heavy	  chain	   isoforms	  and	  troponin	  T,	   I	  and	  C	   isoforms	  regulate	  the	  force	  of	  contraction	   and	  myofibre	   calcium	  sensitivity,	   therefore	   changes	   in	   the	   isoforms	  of	   these	  genes	   that	   a	   particular	   myofibre	   expresses	   will	   change	   the	   contraction	   properties	  (Bottinelli	  et	  al.,	  1991,	  Geiger	  et	  al.,	  1999).	  Preliminary	  experiments	  in	  the	  lab	  have	  used	  a	  GCaMP	   calcium	   reporter	   gene	   under	   the	   control	   of	   the	  mylz2	   promoter	   to	   compare	   the	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calcium	  response	   in	   the	   fast-­‐twitch	   fibres	  of	   sox6-­‐/-­‐	  mutant	   fish	   compared	  with	   the	   fast-­‐twitch	   fibres	   of	   sibling	   fish	   (Yosuke	   Ono,	   unpublished	   data).	   The	   results	   of	   these	  experiments	  suggest	  that	  sox6-­‐/-­‐	  mutant	  fast-­‐twitch	  fibres	  are	  able	  to	  respond	  more	  quickly	  than	  sibling	  fast-­‐twitch	  fibres.	  We	  can	  speculate	  that	  this	  distinct	  responsiveness	  is	  due	  to	  an	   increase	   in	   the	   number	   of	   calcium	   responding	   subunits	   in	   sox6-­‐/-­‐	   mutant	   fast-­‐twitch	  fibres.	  For	  example,	   if	  a	  cell	  expresses	  both	  the	  fast-­‐	  and	  slow-­‐specific	  ryanodine	  calcium	  channel,	   as	   well	   as	   both	   the	   fast-­‐	   and	   slow-­‐	   specific	   troponin	   c	   isoforms,	   then	   upon	  depolarization	  of	  the	  muscle	  cell	  membrane,	  both	  ryanodine	  receptor	   isoforms	  would	  be	  able	   to	   release	   calcium	   from	   the	   sarcoplasmic	   reticulum,	   and	   both	   troponin	   c	   isoforms	  would	   be	   able	   to	   bind	   calcium	   to	   allow	   the	   necessary	   interactions	   between	   actin	   and	  myosin,	   which	   could	   result	   in	   a	   faster	   response	   time.	   In	   order	   to	   test	   this	   theory,	  morpholino	  knockdown	  of	  both	  ryr1b	  and	  tnnc1b	  in	  sox6-­‐/-­‐	  mutants	  could	  be	  performed	  to	  see	  if	  the	  response	  time	  of	  the	  fast-­‐twitch	  muscle	  returns	  to	  a	  wild-­‐type	  response	  time.	  	  Interestingly,	   Quiat	   et	   al.	   recently	   reported	   that	   Sox6	   mutant	   mice	   exhibit	   increased	  expression	   of	   a	   gene	   involved	   in	   regulating	   the	   calcium	   response,	   the	   calcium	   uptake	  channel	  ATP2a2	  (Quiat	  et	  al.,	  2011).	  This	  observation	  indicates	  that	  in	  both	  zebrafish	  and	  mice,	   Sox6	   regulates	   not	   only	   the	   expression	   of	   sarcomeric	   components	   of	   the	   muscle	  fibres,	  but	  also	  the	  calcium-­‐regulatory	  components.	  Further	  to	  this,	  mice	  with	  conditional	  loss	   of	   Sox6	   in	   their	  myofibres	   have	   higher	   endurance	   level	   and	   elevated	  mitochondrial	  activity	   in	   their	   muscles,	   as	   compared	   with	   sibling	   mice	   (Quiat	   et	   al.,	   2011).	   This	  abnormality	   is	   likely	   due	   to	   the	   increased	   expression	   of	   slow-­‐contractile	   and	   calcium-­‐regulatory	  genes	  in	  Sox6	  mutant	  muscles.	  It	  would	  be	  interesting	  to	  explore	  whether	  this	  is	  also	  the	  case	  in	  zebrafish.	  
5.3.10	  The	  phenotype	  of	  the	  sox6-­‐/-­‐	  mutant	  myotome	  in	  adult	  fish	  Sections	  taken	  from	  the	  trunk	  of	  sox6-­‐/-­‐	  mutant	  and	  sibling	  adults	  revealed	  that	  the	  ectopic	  expression	   of	   both	   tnnc1b:eGFP	   and	   smyhc1:GFP	   that	   was	   observed	   in	   the	   fast-­‐twitch	  muscle	   of	   mutant	   embryos	   also	   persists	   in	   mutant	   adult	   fish.	   Expression	   of	   the	  
tnnc1b:eGFP	   transgene	   is	   observed	   throughout	   the	   myotome	   of	   sox6-­‐/-­‐	   mutant	   adults,	  whereas	   there	   is	   only	   a	   small	   expansion	  of	   the	   smyhc1:GFP	  domain	   in	  mutant	   adults,	   as	  was	   also	   observed	   in	   sox6-­‐/-­‐	   mutant	   embryos,	   with	   only	   a	   small	   subset	   of	   fast	   fibres	  expressing	   the	   smhyc1:GFP	   transgene.	   It	   also	   appears	   that	   other	   smyhc	   isoforms	   are	  derepressed	   in	   a	   subset	   of	   fast-­‐fibres,	   as	   the	   smyhc	   in	   situ	   hybridization	   probe,	   which	  recognizes	   all	   isoforms	   of	   smyhc,	   labels	   an	   expression	   domain	   larger	   than	   that	   of	  
smyhc1:GFP	  in	  sox6-­‐/-­‐	  mutants.	  An	  intriguing	  observation	  common	  to	  both	  the	  tnnc1b:eGFP	  and	   the	   smyhc	   probe	   expression	   patterns,	   is	   that	   the	   wedge-­‐shaped	   tnnc1b	   and	   smyhc	  expression	  domain	  observed	  in	  wild-­‐type	  adults	  is	  still	  present	  in	  sox6-­‐/-­‐	  mutants	  but	  it	  has	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expanded	  more	  medially.	  Although	  the	  expression	  of	  tnnc1b	  is	  seen	  throughout	  the	  muscle	  of	   sox6-­‐/-­‐	  mutants,	   tnnc1b:eGFP	   expression	   is	  much	   stronger	   in	   the	   lateralis	   superficialis,	  which	  appears	   to	  have	  expanded,	  with	  a	   similar	   change	  also	  apparent	   for	   the	  domain	  of	  
smyhc	   expression.	   From	   looking	   at	   the	   differences	   in	   the	   size	   of	   the	  myotome	   between	  siblings	   and	   sox6-­‐/-­‐	   mutants	   it	   may	   be	   that	   this	   is	   not	   an	   expansion	   of	   the	   lateralis	  superficialis,	   but	   rather	   a	   lack	   of	   growth	   in	   the	   fast	   domain,	   resulting	   in	   the	   medial	  expression	  of	  smyhc1	  and	  tnnc1b.	  As	  the	  expression	  of	  tnnc1b	  was	  only	  examined	  using	  the	  
tnnc1b	   transgenic	   reporter	   line,	   in	   situ	  hybridisation	  would	  need	   to	   be	  performed	  using	  the	   tnnc1b	   probe	   to	   determine	   whether	   the	   reporter	   line	   is	   definitely	   mimicking	   the	  endogenous	  gene	  expression.	  The	   sustained	   ectopic	   expression	   of	   slow-­‐twitch	   muscle	   genes	   seen	   in	   zebrafish	   sox6-­‐/-­‐	  mutants	   is	   consistent	  with	  what	   is	   seen	   in	   adult	  mice,	   since	  mutant	  mice	   that	   lack	   sox6	  function	  in	  their	  muscles	  exhibit	  an	  increase	  in	  slow-­‐specific	  genes	  expression	  (Quiat	  et	  al.,	  2011).	  	  
5.3.11	  The	  sox6-­‐/-­‐	  mutant	  scoliosis	  adult	  phenotype	  An	  unexpected	  phenotype	  that	  occurs	  as	  a	  result	  of	  the	  loss	  of	  sox6	  function	  in	  zebrafish	  is	  scoliosis.	  This	  phenotype	  has	  not	  been	  reported	  in	  mouse,	  likely	  due	  to	  the	  fact	  that	  mouse	  
sox6	  mutants	   die	  within	   two	  weeks	   of	   birth	   (Hagiwara	   et	   al.,	   2001),	   by	  which	   time	   the	  mutant	  mice	  might	  still	  be	  too	  young	  for	  the	  scoliosis	  phenotype	  to	  be	  apparent.	  Scoliosis	  is	  a	  tree	  dimensional	  curvature	  of	  the	  spine	  and	  can	  be	  classified	  into	  three	  major	  types:	  congenital,	   syndromic,	   and	   idiopathic	   (Altaf	   et	   al.,	   2013).	   Congenital	   scoliosis	   refers	   to	  spinal	  deformities	   that	   are	  present	   at	  birth	   resulting	   from	  abnormally-­‐formed	  vertebrae	  (Hensinger,	   2009).	   Sox6	   and	   Sox5	   function	   together	   during	   chondrogensis,	   and	  knockdown	  of	  both	  genes	   leads	   to	  gross	   loss	  of	  cartilage,	  yet	  knockdown	  of	   sox6	  or	  sox5	  individually	  leads	  to	  minor	  cartilage	  defects	  (Lefebvre	  et	  al.,	  1998,	  Smits	  et	  al.,	  2001).	  The	  vertebral	   column	   is	   an	   endochondral	   bone	   i.e.	   bone	   formed	   is	   by	   the	   ossification	   of	  cartilage	   (Karsenty	   and	  Wagner,	   2002),	   therefore	   it	   is	   possible	   that	   a	   defect	   in	   cartilage	  formation	   causes	   abnormal	  morphogenesis	   of	   the	   vertebral	   column,	   leading	   to	   scoliosis.	  However,	  since	  the	  scoliosis	  observed	  in	  sox6-­‐/-­‐	  mutants	  is	  not	  apparent	  until	  at	  least	  one-­‐month	   postfertilisation,	   and	   the	   formation	   of	   the	   cartilage	   appears	   normal	   at	   a	   younger	  stages,	   I	  would	   suggest	   that	   this	   is	  not	   the	   form	  of	   scoliosis	   observed	   in	   sox6-­‐/-­‐	  mutants,	  although	  it	  cannot	  be	  ruled	  out.	  The	  majority	  of	  scoliosis	  observed	  in	  humans	  is	  idiopathic,	  meaning	  that	  there	  is	  no	  identifiable	  cause,	  with	  the	  majority	  of	  cases	  not	  developing	  until	  adolescence	  or	  adulthood	  (Lonstein,	  1994).	  The	   final	   form	  of	  scoliosis,	   syndromic,	  arises	  from	  a	  secondary	  effect	  on	  the	  skeleton	  that	  most	  commonly	  results	  from	  neuromuscular	  conditions,	  such	  as	  muscular	  dystrophy	  (Galasko	  et	  al.,	  1995).	  The	  muscle	  wasting	  which	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results	  from	  the	  progression	  of	  these	  diseases	  often	  leads	  to	  scoliosis	  because	  the	  muscles	  on	   either	   side	   of	   the	   spinal	   column	   are	   weak	   and	   therefore	   unable	   to	   maintain	   the	  straightness	  of	  the	  vertebral	  column.	  Both	  idiopathic	  and	  syndromic	  scoliosis	  tend	  to	  have	  a	   later	   onset	   than	   the	   congenital	   form,	   with	   curvature	   of	   the	   spine	   developing	   during	  adolescence	   or	   adulthood	   (Galasko	   et	   al.,	   1995;	   Lonstein	   et	   al.,	   1994).	   On	   this	   basis,	   I	  hypothesise	   that	   that	   the	   scoliosis	   observed	   in	   the	   sox6-­‐/-­‐	  mutant	   would	   most	   closely	  resemble	  these	  forms,	  and	  more	  phenotypic	  analysis	  is	  now	  needed	  to	  test	  this	  possibility.	  	  The	  scoliosis	  observed	  in	  zebrafish	  sox6	  mutant	  adults	  could	  arise	  from	  either	  a	  primary	  effect	  due	  to	  the	  loss	  of	  sox6	  function	  in	  the	  bone,	  or	  as	  an	  indirect,	  secondary	  consequence	  of	   loss	   of	   sox6	   function	   in	   the	   muscle.	   There	   are	   several	   ways	   in	   which	   these	   two	  possibilities	   could	   be	   investigated.	   First,	   it	   is	   important	   to	   determine	   whether	   sox6	   is	  expressed	   in	   the	   vertebral	   column.	   Preliminary	   data	   has	   suggested	   that	   sox6	   is	   not	  expressed	   in	   the	   bone,	   because	   no	   sox6	   transcripts	   could	   be	   identified	   in	   the	   zebrafish	  opercle	  at	  4	  dpf.	  However,	  sox6	  may	  be	  expressed	  later	  on	  during	  bone	  development,	  and	  this	  expression	  may	  also	  be	  specific	  to	  the	  vertebral	  column.	  This	  issue	  can	  be	  addressed	  by	  examining	  the	  sox6:eGFP	  line,	  to	  search	  for	  GFP	  expression	  in	  the	  vertebrae	  at	  various	  stages	  of	  development.	  	  If	  sox6	  is	  not	  expressed	  in	  the	  vertebral	  column,	  it	  seems	  likely	  that	  the	  scoliosis	  observed	  in	  sox6	  mutants	  could	  result	  from	  the	  loss	  of	  sox6	  in	  the	  myotome,	  and	  the	  altered	  muscle	  morphogenesis	  and	  contractility	  could	  be	  responsible	  for	  distorting	  the	  vertebral	  column.	  In	  order	  to	  test	  this	  hypothesis,	  conditional	  knockouts	  of	  sox6	  could	  be	  generated,	  which	  specifically	  knock	  out	  the	  expression	  of	  sox6	  in	  the	  bone	  or	  the	  muscle.	  Through	  the	  use	  of	  transcription	   activator-­‐like	   effector	   nucleases	   (TALENs)	   the	   sox6	   gene	   can	   be	   precisely	  modified	  by	  the	  addition	  of	  loxP	  sites,	  and	  a	  tissue	  specific	  promoter	  can	  be	  used	  to	  drive	  the	   expression	   of	   Cre	   recombinase	   in	   either	   the	   bone	   or	   the	   muscle	   generating	   a	  conditional	  knockout	  of	  the	  sox6	  gene	  (Bedell	  et	  al.,	  2012).	  If	  the	  scoliosis	  phenotype	  still	  developed	  in	  fish	  in	  which	  sox6	  expression	  is	  knocked	  out	  in	  bone,	  then	  the	  scoliosis	  could	  be	  due	  to	  the	  loss	  of	  sox6	  protein	  in	  the	  muscle,	  which	  would	  be	  confirmed	  if	  knockout	  of	  
sox6	  in	  the	  muscle	  prevented	  scoliosis.	  An	  alternative	  and	  perhaps	  simpler	  way	  to	  resolve	  this	   issue	  would	  be	   to	   rescue	   the	   expression	  of	   sox6,	   specifically	   in	   the	  muscle	   of	   sox6-­‐/-­‐	  mutants.	  This	  could	  be	  achieved	  by	  intercrossing	  sox6	  heterozygous	  mutants	  carrying	  the	  
UAS:sox6-­‐GFP;actin:GAL4	  transgene.	  This	  would	  drive	  the	  expression	  of	  sox6	  specifically	  in	  the	   muscle,	   rescuing	   its	   expression	   in	   the	   sox6	   null	   mutant.	   If	   no	   sox6-­‐/-­‐;UAS:sox6-­‐
GFP:actin:GAL4	  mutant	  fish	  developed	  scoliosis,	  this	  would	  verify	  that	  the	  scoliosis	  results	  from	  a	  loss	  of	  sox6	  specifically	  in	  the	  myotome.	  As	  there	  is	  no	  scoliosis	  phenotype	  reported	  in	  mice	  with	   a	   conditional	   knockout	   of	   sox6	   in	   the	  muscle	   (An	   et	   al.,	   2011;	   Quiat	   et	   al.,	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2011),	  this	  could	  lead	  us	  to	  believe	  that	  the	  scoliosis	  phenotype	  observed	  in	  fish	  is	  not	  due	  to	   the	   loss	  of	   sox6	   function	   in	   the	  muscle.	  However	   this	  would	  need	   to	  be	   confirmed	  by	  performing	  the	  experiments	  suggested	  about.	  If	  the	  scoliosis	  does	  result	  from	  a	  loss	  of	  sox6	  expression	  in	  the	  myotome,	  then	  what	  is	  the	  mechanism	  behind	   the	   scoliosis	  phenotype?	   I	   hypothesize	   that	   two	  distinct	  mechanisms	  may	   be	   involved,	   both	   based	   on	   the	   fact	   that	   sox6-­‐/-­‐	  mutant	   zebrafish	   are	   smaller	   than	  sibling	   fish.	  The	   cross-­‐sections	  of	   trunk	   tissue	   taken	   from	  adult	   sox6-­‐/-­‐	  mutant	   zebrafish,	  indicate	   that	   the	   sox6	   mutant	   fibres	   are	   significantly	   smaller	   than	   their	   sibling	  counterparts,	  likely	  resulting	  in	  the	  significant	  size	  difference	  that	  was	  observed	  between	  
sox6-­‐/-­‐	   mutant	   and	   sibling	   fish.	   Therefore,	   one	   hypothesis	   as	   to	   why	   a	   loss	   of	   sox6	  expression	  in	  the	  muscle	  results	  in	  scoliosis,	  would	  be	  that	  sox6	  mutant	  fibres	  fail	  to	  grow	  at	  a	  normal	  rate,	  or	  to	  a	  normal	  size,	  as	  compared	  to	  sibling	  fish.	  However,	   the	  vertebral	  column	  and	  other	  skeletal	  elements	  would	  grow	  at	  a	  normal	  speed	  and	  to	  a	  normal	  size,	  and	  with	   the	  muscle	   fibres	   being	   unable	   to	   keep	  up	  with	   this	   growth,	   there	  would	   be	   a	  crumpling	  of	  the	  spine.	  	  If	  further	  studies	  support	  this	  idea,	  then	  the	  mechanism	  of	  action	  of	  sox6	  in	  growth	  control	  would	  need	  to	  be	  elucidated.	  	  A	  second	  hypothesis	  regarding	  the	  mechanism	  underlying	  the	  scoliosis	  phenotype,	  which	  could	  result	  from	  the	  loss	  of	  sox6	  in	  zebrafish	  muscle,	  is	  again	  based	  on	  the	  smaller	  size	  of	  the	  sox6-­‐/-­‐	  mutant	  fibres.	  The	  loss	  sox6	  could,	  through	  mechanisms	  unknown,	  result	  in	  the	  degeneration	   of	   muscle	   fibres,	   resulting	   in	   the	   activation	   of	   satellite	   cells	   and	   the	  regeneration	   of	  muscle	   fibres.	   Satellite	   cells	   are	   normally	   quiescent	   in	   adult	  muscle,	   but	  are	   able	   to	   proliferate	   in	   response	   to	   degeneration,	   to	   give	   rise	   to	   regenerated	   muscle	  (Mauro,	   1961,	   Schultz	   et	   al.,	   1978,	   Seger	   et	   al.,	   2011).	   The	   constant	   degeneration	   and	  regeneration	  of	  muscle	  tissue	  in	  these	  mutants	  would	  mean	  that	  the	  myotome	  is	  not	  able	  to	  grow	  at	  the	  same	  rate	  as	  the	  spinal	  column	  and	  therefore	  the	  spine	  would	  crumple.	  One	  clue	   as	   to	  why	   this	  may	   be	   the	   case	   is	   the	   number	   of	   nuclei	   observed	   in	   sox6-­‐/-­‐	  mutant	  fibres.	  There	  appears	  to	  be	  many	  more	  nuclei,	   in	  both	  the	  slow-­‐	  and	  fast-­‐twitch	  fibres	  of	  
sox6-­‐/-­‐	   mutants,	   which	   might	   reflect	   increased	   proliferation	   driving	   regeneration.	  Alternatively,	  due	  to	  the	  much	  smaller	  size	  of	  the	  sox6-­‐/-­‐	  mutant	  myotome,	  it	  may	  be	  that	  there	  are	  the	  same	  number	  of	  nuclei	   in	  both	  the	  mutant	  and	  sibling	  myotome,	  but	  as	  the	  mutant	   myotome	   is	   much	   smaller,	   the	   nuclei	   are	   closer	   together	   and	   therefore	   appear	  more	   abundant.	   Nuclei	   counts	   would	   need	   to	   be	   done	   to	   confirm	   which	   of	   these	  hypotheses	  are	  correct.	  To	  address	  whether	  sox6-­‐/-­‐	  mutant	  fibres	  are	  degenerating,	  leading	  to	   an	   increase	   in	   regeneration,	   a	   number	   of	   experiments	   could	  be	  performed.	   Firstly,	   to	  look	  for	  evidence	  of	  degeneration,	  Evans	  blue	  dye	  could	  be	  injected	  into	  the	  heart	  of	  adult	  zebrafish.	   Evans	   blue	   dye	   penetrates	   degenerating	   or	   damaged	  muscle	   cells,	   and	   can	   be	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observed	   by	   red	   auto-­‐fluorescence	   by	   fluorescence	  microscopy	   (Hamer	   et	   al.,	   2002).	   In	  order	   to	  examine	  whether	   there	   is	  an	   increase	   in	  regeneration	   in	   the	  myotome	  of	  sox6-­‐/-­‐	  mutants	  compared	  to	  siblings,	  Edu	  staining	  could	  be	  utilized	  to	  assess	  the	  incorporation	  of	  these	  nucleotide	  analogues	  into	  the	  newly	  synthesized	  DNA	  of	  replicating	  cells	  (Salic	  and	  Mitchison,	  2008).	  Additionally,	   the	  expression	  of	  Pax7,	   a	  marker	  of	  muscle	   satellite	   cells	  (Seale	  et	  al.,	  2000,	  Seger	  et	  al.,	  2011),	  could	  be	  examined	  to	  determine	  whether	  there	  is	  an	  increase	   in	   regeneration.	  An	   increase	   in	   the	  number	  of	   satellite	   cells,	   as	   indicated	  by	   an	  increase	  in	  the	  number	  of	  Pax7-­‐expressing	  cells,	  would	  reveal	  an	  increase	  in	  regeneration.	  	  Another	   interesting	   possibility	   as	   to	   why	   knockdown	   of	   sox6	   in	   zebrafish	   results	   in	  scoliosis	  is	  related	  to	  the	  role	  of	  sox5	  and	  sox6	   in	  notochord	  formation.	  Knockout	  of	  both	  
sox5	  and	  sox6	  in	  mice	  results	  in	  a	  loss	  of	  cells	  in	  the	  notochord	  (Smits	  and	  Lefebvre,	  2003),	  with	   the	   consequence	  of	   this	  decline	   in	  notochord	  cell	  number	  often	   leading	   to	   scoliosis	  (Sivakamasundari	  and	  Lufkin,	  2012).	  Although	  there	  appears	  to	  be	  no	  effect	  on	  notochord	  formation	  in	  single	  sox5	  and	  sox6	  mutant	  mice	  in	  zebrafish	  it	  may	  be	  the	  case	  that	  the	  loss	  of	  sox6	  alone	  is	  enough	  to	  decrease	  the	  number	  of	  notochord	  cells,	  which	  could	  lead	  to	  the	  observed	  scoliosis	  phenotype.	  More	  analysis	   is	  needed	   to	  determine	   if	   this	  hypothesis	   is	  correct.	  Unexpectedly,	  the	  slow-­‐twitch	  muscle	  fibres	  as	  well	  as	  the	  fast-­‐twitch	  fibres	  were	  smaller	  in	  sox6-­‐/-­‐	  mutant	  adults	  than	  in	  siblings.	  Moreover,	  the	  slow-­‐twitch	  fibres	  were	  smaller	  in	  size	  to	  their	  sibling	  counterparts	  by	  a	  larger	  degree	  than	  were	  the	  fast-­‐twitch	  fibres.	  One	  explanation	   that	   could	   account	   for	   the	  more	   pronounced	   effect	   on	   the	   size	   of	   the	   slow-­‐twitch	  fibres	  in	  sox6-­‐/-­‐	  mutants	  is	  that	  sox6	  expression	  may	  no	  longer	  be	  restricted	  to	  the	  fast-­‐twitch	   domain	   in	   juvenile	   and	   adult	   fish.	   It	   may	   be	   that	   at	   some	   point	   after	  development	   and	   specification	   of	   the	  myotome,	   sox6	  has	   a	   distinct	   role	   in	   the	   zebrafish	  myotome	  in	  either	  growth	  or	  maintenance	  of	  both	  slow-­‐	  and	  fast-­‐twitch	  muscle	  fibres,	  so	  its	   expression	   would	   be	   required	   continuously	   throughout	   the	   myotome	   and	   into	  adulthood.	  This	  would	  need	  to	  be	  investigated	  by	  performing	  a	  sox6	  in	  situ	  hybridisation	  on	   adult	   fish.	   Alternatively,	   if	   the	   degeneration	   hypothesis	   is	   correct,	   the	   loss	   of	   sox6	  function	   in	   the	   fast-­‐fibres	  might	   cause	   them	   to	   degenerate	   and	   an	   excess	   of	   slow	   fibres	  might	  then	  regenerate	  in	  order	  to	  compensate	  for	  the	  loss	  of	  fast-­‐twitch	  fibres.	  	  The	   scoliosis	   and	   muscle	   phenotype	   observed	   in	   the	   sox6-­‐/-­‐	   mutant	   adults	   was	   always	  observed	   in	   the	   sox6	   homozygous	   mutants	   and	   never	   observed	   in	   the	   siblings.	  Nevertheless,	   it	   could	   be	   the	   case	   that	   the	   zinc-­‐finger	   nuclease	   caused	   an	   off-­‐target	  mutation	   in	   a	   gene	   other	   than	   sox6	   that	   is	   linked	   to	   the	   sox6	   locus	   therefore	   segregates	  with	  it.	  In	  order	  to	  confirm	  that	  the	  adult	  scoliosis	  and	  muscle	  phenotype	  results	  from	  the	  loss	  of	  Sox6	  protein	  it	  would	  be	  a	  good	  idea	  to	  cross	  the	  E2	  allele	  to	  the	  A1	  allele	  to	  make	  a	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double	   E2:A1	   heterozygous	   mutant.	   It	   would	   be	   highly	   unlikely	   that	   the	   zinc-­‐finger	  nuclease	  created	  the	  same	  off-­‐target	  mutation	   in	  both	  alleles	   therefore	  the	  presence	  of	  a	  scoliosis	  phenotype	  in	  these	  double	  heterozygous	  mutant	  fish	  would	  likely	  be	  the	  result	  of	  a	   loss	   of	   Sox6.	   Secondly,	   the	   UAS:Sox6-­‐GFP;actin:GAL4	   line	   can	   be	   used	   to	   rescue	   the	  expression	   of	   Sox6	   in	   the	  muscle	   and	   used	   to	   identify	   whether	   the	   adult	   sox6-­‐/-­‐	  muscle	  phenotype	  still	  develops.	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6.1	  Introduction	  The	  results	  described	  in	  Chapter	  4	  of	  this	  thesis	  demonstrated	  that	  Sox6	  is	  able	  to	  inhibit	  the	  expression	  of	  slow-­‐twitch	  muscle	  genes	  when	  Sox-­‐GFP	  is	  misexpressed	  in	  slow-­‐twitch	  fibres.	  This	   raised	   the	  question	  of	  whether	   this	   inhibition	   is	  direct,	   via	   interactions	  with	  
cis-­‐regulatory	   elements	   of	   these	   genes,	   or	   indirect,	   through	   interactions	   with	   cis-­‐regulatory	   elements	   of	   other	   genes.	   In	   mice,	   ChIP-­‐seq	   analysis	   has	   demonstrated	   that	  many	  slow-­‐specific	  muscle	  genes	  are	  direct	  targets	  of	  Sox6	  (An	  et	  al.,	  2001),	  but	  it	   is	  still	  not	   clear	   whether	   this	   is	   also	   the	   case	   in	   zebrafish.	   Previous	   studies	   in	   the	   laboratory	  revealed	  that	  mutation	  of	  the	  potential	  Sox6	  binding	  sites	  in	  the	  promoter	  of	  the	  zebrafish	  
smyhc1:GFP	  reporter	  gene	  resulted	   in	  ectopic	  GFP	  expression	   in	  a	  number	  of	   fast-­‐twitch	  muscle	   fibres	   (Chapter	   5,	   Figure	   5.8),	   implying	   Sox6	   normally	   acts	   to	   directly	   repress	  
smyhc1	  expression	  in	  the	  fast-­‐twitch	  muscle.	  In	  contrast	  to	  this,	  mutation	  of	  potential	  Sox6	  binding	  sites	   in	  the	  cis-­‐regulatory	  regions	  of	   the	  tnnc1b:eGFP	  transgene,	  had	  no	  effect	  on	  the	  expression	  of	   this	   transgene,	  with	  eGFP	  expression	  remaining	  restricted	  to	   the	  slow-­‐twitch	  fibres	  (Chapter	  3,	  Fig.3.8).	  These	  observations	  suggest	  that	  Sox6	  represses	  tnnc1b	  expression	  either	  indirectly	  or	  alternatively	  through	  direct	  inhibition	  by	  binding	  to	  an	  as-­‐yet	  unidentified,	  cryptic	  Sox6	  binding	  site.	  	  Chromatin	   immunoprecipitation	  (ChIP)	   is	  a	   technique	   that	  can	  be	  used	   to	   identify	   the	   in	  
vivo	  DNA	  sequence	  targets	  of	  a	  known	  transcription	  factor	  or	  other	  chromatin	  protein,	   if	  an	  antibody	  exists	  that	  is	  specific	  for	  the	  protein	  of	  interest	  and	  which	  interacts	  with	  that	  protein	   in	   its	   native	   conformation	   within	   chromatin.	   I	   therefore	   sought	   to	   use	   ChIP	   to	  determine	  whether	  cis-­‐regulatory	  sequences	  from	  slow-­‐specific	  genes	  are	  enriched	  in	  DNA	  fragments	  immunoprecipitated	  from	  chromatin	  using	  a	  Sox6-­‐specific	  antibody.	  	  
6.2	  Results	  
6.2.1	  Identification	  of	  a	  suitable	  sox6	  antibody	  In	  order	   to	  perform	  this	  experiment,	  a	  Sox6-­‐specific	  antibody	  that	  was	  able	   to	  recognise	  and	   pull-­‐down	   Sox6	   protein	   from	   chromatin	   extracts,	   needed	   to	   be	   identified.	   Two	  commercially	  available	  Sox6	  antibodies,	  ab66316	  (Abcam)	  and	  GTX116236	  (Gentex),	  were	  purchased	   and	   tested	   for	   their	   specificity	   by	   performing	   Western	   blotting	   and	   whole-­‐mount	   immunohistochemistry	   analysis	   of	   zebrafish	   embryos.	   The	   molecular	   weight	   of	  Sox6	  protein	  is	  expected	  to	  be	  approximately	  87kDa,	  but	  Western	  blot	  analysis	  using	  these	  antibodies	  was	  unable	  to	  identify	  a	  specific	  band	  of	  protein	  of	  the	  appropriate	  molecular	  weight	  (Figure	  6.1).	  Furthermore,	  whole-­‐mount	   immunohistochemistry	  using	  these	  Sox6	  antibodies	   revealed	   no	   specific	   staining	   in	   zebrafish	   embryos	   at	   30	   hpf,	   confirming	   that	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neither	   of	   these	   two	   commercially	   supplied	   antibodies	   was	   suitable	   for	   use	   in	   ChIP	  experiments.	  	  The	   ab6316	   and	   the	   GTX116236	   antibodies	   had	   been	   raised	   with	   immunogens	  corresponding	  to	  sequences	  present	  in	  the	  human	  and	  mouse	  Sox6	  proteins,	  therefore	  it	  is	  possible	   that	   the	   antibodies	   failed	   in	   my	   experiments	   because	   their	   epitopes	   were	   not	  present	   in	   the	   zebrafish	   Sox6	   protein.	   Therefore,	   a	   zebrafish-­‐specific	   Sox6	   protein	  expression	   vector	   was	   constructed	   and	   an	   antibody	   was	   raised	   by	   immunising	   rabbits	  with	  recombinant	  zebrafish	  Sox6	  protein.	  A	   fragment	  of	  zebrafish	  sox6	  cDNA	  was	  cloned	  into	  the	  His-­‐tag	  expression	  vector	  pET-­‐2lb	  (by	  Stone	  Elworthy),	  giving	  rise	  to	  the	  plasmid	  construct	  Sox6M.	  The	  sox6	   cDNA	   fragment	   incorporated	   into	   this	  plasmid	  coded	   for	  219	  amino	   acids	   of	   zebrafish	   Sox6	   protein	   immediately	   upstream	   of	   the	   HMG	   box	   motif	  (Appendix	   A5).	   Using	   the	   His-­‐tagged	   Sox6	   fusion	   construct,	   two	   antibody	   preparations	  were	   obtained	   from	   the	   company	   Sdix,	   Sdix-­‐SoxA	   and	   Sdix-­‐Sox6B.	   The	   two	   antibodies	  were	  generated	  from	  the	  same	  antigen	  but	   in	   two	  different	  rabbits.	  Neither	  of	   these	  two	  antibody	   preparations	   were	   able	   to	   detect	   Sox6	   protein,	   because	  Western	   blot	   analysis	  with	  each	  antibody	  failed	  to	  detect	  a	  specific	  protein	  band	  (Figure	  6.1),	  and	  whole-­‐mount	  immunohistochemistry	   staining	   with	   each	   antibody	   gave	   only	   diffuse	   and	   non-­‐specific	  staining.	  	  Finally,	   another	  Sox6	  antibody	  was	  generated	  using	   the	  Sox6M	  expression	  vector	  by	   the	  company	   Absea.	   This	   antibody,	   named	   Sox6M1,	   specifically	   labelled	   the	  myotome	   of	   30	  dpf	   embryos,	   as	   assessed	   by	   whole-­‐mount	   immunohistochemistry,	   with	   expression	  restricted	   to	   the	   fast-­‐muscle	   nuclei	   (Figure	   6.2A).	   Furthermore	   this	   specific	   signal	   was	  absent	  in	  the	  nuclei	  of	  both	  fast-­‐twitch	  muscle	  cells	  and	  in	  the	  optic	  tectum	  of	  homozygous	  
sox6	  mutants	  (Chapter	  5,	  Figure	  5.2).	  These	  results	  indicated	  that	  Sox6M1	  antibody	  might	  be	   potentially	   useful	   for	   ChIP	   experiments.	  However,	   a	  Western	   blot	   analysis	   of	   protein	  extracts	   from	   sox6-­‐/-­‐	   mutant	   and	   sox6	   sibling	   embryos	   revealed	   that	   the	   antibody	  recognises	  many	  non-­‐specific	  epitopes	  and	  although	  there	  is	  a	  protein	  band	  of	  the	  correct	  size	   (~87kD),	   this	   band	   was	   present	   in	   extracts	   from	   both	   sox6-­‐/-­‐	  mutant	   and	   sibling	  embryos	   (Figure	   6.2B).	   Taken	   together,	   these	   immunohistochemistry	   and	   Western	  blotting	  results	  indicate	  that	  the	  Sox6M1	  antibody	  preparation	  contains	  a	  component	  that	  recognises	   Sox6	   protein,	   but	   there	   are	   other	   components	   that	   recognise	   additional	  proteins,	   including	   some	   that	   are	   of	   comparable	   molecular	   weight	   to	   that	   of	   Sox6.	  Notwithstanding	   these	   limitations,	   immunoprecipitation	  was	   performed	  with	   the	   Absea	  Sox6M1	  antibody	  on	  chromatin	  samples	  prepared	  for	  ChIP	  analysis.	  A	  band	  at	  the	  correct	  size	   for	   Sox6	  protein	  was	   observed	   (Figure	   6.2C),	   but	   due	   to	   the	   previous	  Western	   blot	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analysis	   and	   the	   high	   level	   of	   non-­‐specific	   bands,	   an	   alternative	   approach	  immunoprecipitating	  Sox6	  protein	  was	  developed.	  	  
	  
Figure	  6.1:	  Western	  blot	   analysis	   reveals	   that	  neither	   of	   the	   commercially	  available	  
Sox6	   antibodies,	   ab66316	   and	   GTX116236,	   specifically	   recognised	   Sox6	   protein	   in	  
wild-­‐type	  embryos	  at	  30	  hpf.	  Moreover,	  two	  custom-­‐made	  antibodies,	  Sdix-­‐Sox6A	  and	  Sdix-­‐
SoxB,	  raised	  against	  a	  zebrafish	  Sox6	  epitope,	  did	  not	  exhibit	  specificity	  for	  Sox6	  protein	  in	  30	  
hpf	  wild-­‐type	  embryos.	  	  
	  
	  
Figure	   6.2:	   Analysis	   of	   the	   Absea	   Sox6M1	   antibody.	   The	   Sox6	   antibody,	   Sox6M1,	  
specifically	  labels	  fast-­‐twitch	  muscle	  nuclei	  (red),	  with	  no	  expression	  seen	  in	  the	  slow-­‐twitch	  
muscle	  at	  30	  hpf,	   identified	  by	  expression	  of	  smyhc1:GFP	  (green)	  (A).	  Western	  blot	  analysis	  
using	  the	  Sox6M1	  antibody	  (B)	  revealed	  a	  band	  at	  the	  approximate	  size	  of	  Sox6	  (87kDa)	  in	  
sox6	   sibling	  embryos	  at	  30	  hpf.	  Unfortunately	   this	  band	  was	  also	  present	   in	   sox6-­‐/-­‐	  mutant	  
embryos,	   indicating	   that	   the	   observed	   band	   is	   probably	   not	   Sox6.	   Crosslinked,	   sonicated	  
chromatin	  was	  prepared	  from	  30	  hpf	  wild-­‐type	  zebrafish	  embryos,	  and	  then	  incubated	  with	  
the	   Sox6M1	   antibody.	   Immune	   complexes	   were	   precipitated	   with	   Protein	   G-­‐beads	   and	  
immunoprecipitated	   proteins	   were	   analysed	   by	   SDS-­‐PAGE	   and	   Western	   blotting	   with	   the	  
anti-­‐Sox6	  antibody,	  with	  an	  equivalent	  sample	  of	  input	  chromatin	  run	  along	  side.	  The	  input	  
fraction	   revealed	   a	   band	   at	   the	   appropriate	   size	   for	   Sox6	   proteins,	   while	   40μl	   of	   eluate	  
revealed	  multiple	   bands	  with	   one	   band	   at	   the	   correct	   size	   for	   Sox6,	  whereas	   5μl	   of	   eluate	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6.2.2	  Pull-­‐down	  of	  Sox-­‐GFP	  using	  the	  GFP-­‐Trap	  The	  GFP-­‐Trap	  (ChromoTek)	  is	  a	  GFP-­‐binding	  protein	  coupled	  to	  agarose	  beads	  that	  can	  be	  used	   to	   pull-­‐down	   GFP	   fusion	   proteins	   (Rothbauer	   et	   al.,	   2008).	   The	   UAS:sox6-­‐
GFP;actin:GAL4	   line	  expresses	  Sox6	  fused	  to	  GFP,	  under	  the	  control	  of	  an	  actin	  promoter.	  The	  results	  described	  in	  Chapter	  4	  of	  this	  thesis	  demonstrated	  that	  this	  Sox6-­‐GFP	  protein	  is	   functional,	   as	   it	   is	   able	   to	   inhibit	   the	   expression	   of	   slow-­‐twitch	   muscle	   genes.	   The	  
actin:GAL4	   line	  was	   used	   instead	   of	   the	   smyhc1:GAL4	   line	   in	   order	   to	   express	   Sox6-­‐GFP	  throughout	   the	  myotome,	   including	   the	   fast-­‐twitch	  muscle,	   where	   the	   endogenous	   sox6	  gene	   is	  expressed.	  Proteins	  were	  extracted	   from	  UAS:sox6-­‐GFP;actin:GAL4	  embryos	  at	  30	  hpf	  and	  extracts	  were	  then	  probed	  with	  an	  anti-­‐GFP	  antibody	  in	  a	  Western	  blot	  analysis,	  which	  identified	  several	  weak	  bands	  of	  protein	  and	  one	  strong	  protein	  band	  (Figure	  6.3A).	  The	   strong	   band	   was	   thought	   to	   likely	   correspond	   to	   the	   Sox6-­‐GFP	   fusion	   protein,	  although	  it	  was	  slightly	  larger	  than	  the	  predicted	  size	  of	  117kDa	  (87kDa-­‐	  Sox6	  plus	  30kDa-­‐	  eGFP),	  which	  could	  be	  due	  to	  post-­‐translational	  modifications.	  The	  GFP-­‐Trap	  was	  used	  to	  selectively	   purify	   GFP	   fusion	   protein-­‐cross-­‐linked	   chromatin,	   from	   UAS:sox6-­‐
GFP;actin:GAL4	  embryos	  at	  30	  hpf.	  An	  extract	  was	  also	  made	  from	  wild-­‐type	  AB	  embryos	  and	  used	  as	  a	  negative	   control,	   as	   these	  embryos	  express	  no	  GFP	  protein,	   and	   therefore	  the	  GFP-­‐Trap	  was	  expected	  to	  pull	  down	  no	  proteins	  (or	  very	  few)	  from	  this	  sample.	  The	  resulting	   Western	   blot	   from	   this	   experiment	   identified	   two	   weak	   bands	   at	   37kDa	   and	  140kDa	   in	   the	   AB	   input	   control	   lane	   suggesting	   that	   the	   GFP-­‐trap	   does	   not	   specifically	  recognise	  GFP	  proteins	  under	  these	  conditions	  (Figure	  6.3B).	  The	  GFP-­‐Trap	  pull-­‐down	  on	  
UAS:sox6-­‐GFP;actin:GAL4	  embryos	  included	  a	  protein	  at	  the	  correct	  size	  that	  could	  be	  seen	  in	   the	  eluate	   fraction	  (indicated	  by	  Sox6-­‐GFP	   label	   in	  Figure	  6.3B),	  beneath	  which	  was	  a	  ladder	  of	  smaller	  protein	  bands,	  which	  could	  represent	  degradation	  products	  of	   the	   full-­‐length	  Sox6-­‐GFP	  fusion	  protein.	  As	  might	  be	  expected,	  no	  full-­‐length	  fusion	  protein	  band	  was	  apparent	  in	  the	  supernatant	  column,	  although	  a	  weaker	  band	  of	  the	  expected	  size	  was	  present	  in	  the	  input	  faction,	  indicating	  that	  the	  GFP-­‐Trap	  was	  able	  to	  selectively	  retain	  the	  Sox6-­‐GFP	   protein	   (Figure	   6.3B).	  With	   these	   results	   confirming	   that	   the	   GFP-­‐Trap	   could	  selectively	  purify	  the	  Sox6-­‐GFP	  fusion	  protein	  from	  chromatin,	  I	  proceeded	  to	  use	  the	  GFP-­‐Trap	  in	  ChIP	  experiments	  on	  UAS:sox6-­‐GFP;actin:GAL4	  embryos.	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Figure	  6.3:	  Immunoprecipitation	  of	  Sox6-­‐GFP	  using	  the	  GFP-­‐trap.	  Western	  blot	  analysis	  
carried	  out	  on	  UAS:sox6-­‐GFP;actin:GAL4	  embryos	  at	  30	  hpf	  using	  an	  anti-­‐GFP	  antibody	  (A).	  
Cross-­‐linked,	  sonicated	  chromatin	  was	  prepared	  from	  UAS:sox6-­‐GFP;actin:GAL4	  embryos	  and	  
AB	  embryos	  at	  30	  hpf	  and	  then	  incubated	  with	  a	  GFP-­‐Trap	  (B).	  Immunoprecipitated	  proteins	  
and	  unbound	  proteins	  were	  analysed	  by	   SDS-­‐PAGE	  and	  Western	  blotting	  with	  an	  anti-­‐GFP	  
antibody,	   and	   an	   equivalent	   sample	   of	   input	   chromatin	   was	   run	   alongside.	   No	   sox6-­‐GFP	  
protein	  was	   immunoprecipitated	   from	   the	  AB	   control	   embryos.	  However,	  multiple	   proteins	  
were	   precipitated	   from	   UAS:sox6-­‐GFP;actin:GAL4	   embryos,	   with	   the	   largest	   protein	   band	  
corresponding	   to	   the	   approximate	   size	   of	   Sox-­‐GFP,	   which	   was	   also	   present	   in	   the	   input	  
sample.	  	  
	  
6.2.3	  Chromatin	  Immunoprecipitation	  (ChIP)	  using	  the	  GFP-­‐Trap	  To	   investigate	  whether	  Sox6	  directly	  binds	   to	   the	  cis-­‐regulatory	  elements	  of	   slow-­‐twitch	  muscle	   genes,	   ChIP	   was	   performed.	   Pairs	   of	   primers	   were	   designed	   that	   encompass	  potential	  Sox6-­‐binding	  sites	  in	  the	  proximal	  regions	  of	  tnnc1b,	  smyhc1,	  myh7b	  and	  prox1a	  (see	  Appendix	  A6	  for	  location	  of	  primer	  pairs).	  Given	  that	  mutating	  the	  Sox6	  binding	  sites	  in	  the	  smyhc1:GFP	  promoter	  resulted	  in	  ectopic	  GFP	  expression	  in	  the	  fast-­‐twitch	  muscle	  (Chapter	   5,	   Figure	   5.8),	   primer	   pairs	   that	   encompassed	   these	   Sox6	   binding	   sites	   in	   the	  
smyhc1	   promoter	  were	   used	   as	   a	   positive	   control.	   Sox6	   ChIP-­‐seq	   analysis	   performed	   in	  mice	  has	  previously	  identified	  several	  Sox6	  binding	  sites	  in	  the	  promoters	  of	  slow-­‐twitch	  specific	   genes	   (An	   et	   al.,	   2011).	   Consequently,	   some	   primers	   pairs	   were	   designed	   to	  encompass	   the	   same	  sites	   in	   the	   zebrafish	  genes,	   to	   test	  whether	  Sox6	  binding	   could	  be	  detected	  by	  ChIP	   in	   these	  regions.	  Chromatin	  was	  extracted	   from	  both	  wild-­‐type	  AB	  and	  
UAS:sox6-­‐GFP;actin:GAL4	   embryos	   at	   30	   hpf,	   as	   significant	   differential	   expression	   of	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capture	   Sox6	   acting	   as	   a	   transcriptional	   suppressor	   of	   slow-­‐twitch	   genes.	   Ectopic	  expression	  of	   smyhc1	   in	   the	   fast-­‐muscle	  of	   Sox6	  mutants	  had	  also	  been	  observed	  at	   this	  timepoint	  (Chapter	  5,	  Figure	  5.7G),	  indicating	  that	  Sox6	  normally	  acts	  to	  repress	  this	  gene	  at	  this	  particular	  stage.	  	  ChIP	  using	   the	  GFP-­‐Trap	  did	  not	   identify	   any	  detectable	   interactions	   between	   Sox6-­‐GFP	  and	  the	  cis-­‐regulatory	  regions	  of	  the	  selected	  slow-­‐twitch	  genes	  (Figure	  6.4).	  There	  was	  no	  significant	   difference	   between	   the	   DNA	   precipitated	   from	   the	   UAS:sox6-­‐GFP;actin:GAL4	  embryos	  compared	   to	   the	  DNA	  precipitated	   from	  the	  AB	  control	  embryos,	   	   in	  any	  of	   the	  analysed	   slow-­‐twitch	  muscle	   genes,	   including	   the	   positive	   control	   smyhc1.	  As	   there	  was	  also	   no	   enrichment	   in	   the	   smyhc1	   promoter	   region	   this	   is	   thought	   to	   be	   due	   to	   either	   a	  failure	  of	  the	  GFP-­‐Trap	  ChIP	  protocol	  to	  selectively	  retain	  the	  Sox6-­‐GFP	  fusion	  protein,	  or	  dissociation	  of	  the	  Sox6-­‐GFP	  from	  its	  cognate	  DNA	  binding	  sites	  under	  the	  ChIP	  conditions	  used.	   Since	   mutating	   Sox6	   binding	   sites	   in	   the	   smyhc1:GFP	   promoter	   results	   in	   a	  derepression	   of	   smyhc1:GFP	   expression	   in	   the	   fast-­‐twitch	   muscle	   of	   30	   hpf	   embryos,	   it	  seems	   unlikely	   that	   Sox6	   is	   not	   associated	   with	   DNA	   in	   this	   region	   at	   this	   stage	   of	  development.	  	  
Figure	  6.4:	  Chromatin	  immunoprecipitation	  analysis	  of	  Sox6	  binding	  to	  cis-­‐regulatory	  
regions	  of	   slow-­‐twitch	  muscle	   specific	   genes.	   Chromatin	   from	  UAS:sox6-­‐GFP;actin:GAL4	  
and	   AB	   embryos	   was	   precipitated	   with	   a	   GFP-­‐Trap	   at	   30	   hpf.	   Sox6-­‐GFP	   is	   not	   detectably	  
associated	  with	  the	  cis-­‐regulatory	  regions	  of	  any	  of	  the	  slow-­‐twitch	  muscle	  genes	  examined.	  
Bar	  graphs	  show	  the	  mean	  value	  of	   the	   fold	  change	  between	  UAS:sox6-­‐GFP;actin:GAL4	  and	  
AB	   embryos	   normalised	   to	   the	   β-­‐actin	   gene.	   Results	   represent	   experimental	   and	   biological	  
triplicates.	  See	  Chapter	  2,	  Materials	  and	  Methods,	  section	  2.13	  Quantitative	  PCR,	  for	  the	  full	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Discussion	  	  The	  results	  described	  in	  Chapter	  4	  demonstrated	  the	  ability	  of	  the	  Sox6-­‐GFP	  fusion	  protein	  to	   repress	   expression	   of	   slow-­‐twitch	   specific	   genes.	   Chromatin	   Immunoprecipitation	  (ChIP)	   was	   therefore	   used	   to	   analyse	   whether	   Sox6	   binds	   to	   chromatin	   encompassing	  slow-­‐twitch	   muscle	   gene	   promoters.	   ChIP	   can	   be	   a	   convenient	   and	   effective	   assay	   to	  determine	   whether	   a	   protein	   directly	   binds	   to	   a	   particular	   DNA	   sequence.	   In	   order	   to	  successfully	   carry	   out	   this	   procedure,	   an	   antibody	   is	   needed	   that	   specifically	   recognises	  the	  protein	  of	   interest.	   Two	  ways	   to	   validate	   that	   an	   antibody	   specifically	   recognises	   its	  epitope,	  are	  Western	  Blot	  analysis	  and	  whole-­‐mount	  immunohistochemistry.	  Both	  of	  these	  methods	   were	   therefore	   utilised	   in	   order	   to	   try	   to	   identify	   a	   Sox6-­‐specific	   antibody.	  Neither	   of	   the	   pre-­‐existing,	   commercially	   available	   antibodies	   recognised	   Sox6	   protein	  either	  in	  Western	  blotting	  or	  whole-­‐mount	  immunohistochemistry.	  This	  is	  likely	  to	  be	  due	  to	   the	   fact	   that	   these	   antibodies	   had	   been	   designed	   to	   detect	   mouse	   and	   human	   Sox6	  proteins,	   and	   therefore	   there	   was	   not	   enough	   sequence	   similarity	   between	   the	  human/mouse	   epitopes	   and	   the	   corresponding	   zebrafish	   sequences	   within	   the	   Sox6	  polypeptide,	  for	  the	  antibody	  to	  cross-­‐react	  with	  zebrafish	  Sox6.	  Therefore,	  it	  was	  decided	  that	   a	   Sox6	   antibody	   specific	   for	   zebrafish	   Sox6	   protein	  might	   be	   necessary	   in	   order	   to	  perform	   ChIP	   analysis.	   Polyclonal	   Sox6	   antibodies	   were	   generated	   by	   two	   different	  companies,	   Sdix	   and	   Absea,	   using	   the	   same	   His-­‐tagged	   zebrafish	   Sox6	   fusion	   protein.	  Whilst	   the	   two	   Sox6	   antibodies	   generated	   by	   Sdix	   did	   not	   recognise	   Sox6	   protein	   in	  immunohistochemistry	  and	  western	  blot	  analysis,	  the	  Sox6	  antibody	  generated	  by	  Absea,	  did	   exhibit	   specificity	   for	   fast-­‐twitch	   muscle	   nuclei.	   Polyclonal	   antibodies	   are	   prone	   to	  batch-­‐variability,	   as	   was	   observed	   with	   the	   three	   Sox6	   antibodies	   generated	   using	   the	  same	   zebrafish	   Sox-­‐6	   fusion	   protein,	   making	   them	   less	   than	   ideal	   for	   use	   in	   ChIP	  experiments.	   Another	   potential	   problem	   when	   using	   polyclonal	   antibodies	   is	   the	   high	  amount	   of	   background	   cross-­‐reactivity	   they	  often	   exhibit.	  Although	   the	   Sox6M1	   (Absea)	  antibody	   appeared	   to	   be	   specific	   in	   the	   immunohistochemistry	   analysis,	   Western	   blot	  analysis	   revealed	   that	   the	   antibody	   recognised	   numerous	   proteins,	   with	   the	   suspected	  Sox6	   band,	   also	   present	   in	   sox6-­‐/-­‐	  mutants,	   indicating	   that	   this	   band	   did	   not	   correspond	  solely	   Sox6	   protein.	   The	   Sox6M1	   antibody	   also	   failed	   to	   specifically	   pull-­‐down	   Sox6	  protein	  from	  cross-­‐linked	  chromatin,	  indicating	  that	  this	  antibody	  was	  unsuitable	  for	  use	  in	  ChIP	  analysis.	  For	  this	  reason	  an	  alternative	  approach	  was	  designed,	  utilising	  the	  GFP-­‐Trap,	   which	   specifically	   pulls	   down	   GFP	   from	   protein	   extracts	   (Dubin	   et	   al,	   2010;	  Rothbauer	  et	  al.,	  2008).	  Therefore,	  this	  technique	  was	  used	  to	  selectively	  precipitate	  Sox6-­‐GFP	   from	   UAS:sox6-­‐GFP;actin:GAL4	   embryos.	   GFP-­‐Trap-­‐mediated	   immunoprecipitation	  performed	   on	   cross-­‐linked	   chromatin	   extracts	   obtained	   from	   UAS:sox6-­‐GFP;actin:GAL4	  embryos,	  followed	  by	  SDS-­‐PAGE	  and	  Western	  blot	  analysis,	  revealed	  a	  protein	  band	  at	  the	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appropriate	  size	  for	  full-­‐length	  Sox6-­‐GFP,	   if	  not	  a	   little	  too	  high,	  along	  with	  several	  other	  bands	  of	  lower	  molecular	  weight,	  which	  in	  some	  cases	  were	  stronger	  than	  the	  full-­‐length	  Sox6-­‐GFP	  band.	  Reasons	  for	  this	  are	  unknown,	  as	  no	  bands	  were	  observed	  from	  the	  GFP-­‐Trap	  mediated	  pull	   down	  of	   cross-­‐linked	   chromatin	   extracts	   from	  AB	   embryos,	   but	   it	   is	  possible	  that	  these	  smaller	  bands	  represent	  proteolytic	  fragments	  of	  the	  Sox6-­‐GFP	  fusion	  protein.	   The	   fact	   that	   the	   full-­‐length	   Sox6-­‐GFP	   protein	   band	   was	   slightly	   higher	   than	  predicted	   could	   be	   due	   to	   the	   presence	   of	   post-­‐translational	   modifications.	   Indeed,	   a	  recent	   report	   in	  mice	   has	   indicated	   that	   the	   E3	   ubiquitin	   ligase,	   Trip12,	   recognises	   and	  polyubiquitinates	  Sox6,	  regulating	  Sox6	  protein	  levels	  in	  skeletal	  muscle	  (An	  et	  al.,	  2013).	  If	  this	  is	  also	  the	  case	  in	  fish	  this	  could	  explain	  the	  higher	  molecular	  weight	  of	  the	  expected	  protein	   band,	   but	   also	   could	   explain	   why	   there	   are	   several	   smaller	   molecular	   weight	  protein	  bands,	   as	   these	  may	   represent	   the	  degradation	  of	   the	  ubiquitin	   labelled	  protein.	  Nevertheless,	   the	   presence	   of	   a	   band	   at	   roughly	   the	   correct	   size	   in	   UAS:sox6-­‐
GFP;actin:GAL4	   extracts,	   indicated	   that	   ChIP	   experiments	   with	   the	   GFP-­‐Trap	   might	   be	  successful.	  However,	  in	  vivo	  ChIP	  using	  a	  GFP-­‐Trap	  to	  pull	  down	  the	  Sox6-­‐GFP	  fusion	  protein	  detected	  no	   interaction	   between	   Sox6	   and	   the	   selected	   cis-­‐regulatory	   regions	   of	   slow-­‐specific	  genes.	   This	   result	   might	   indicate	   that	   Sox6	   does	   not	   stably	   and	   specifically	   bind	   to	   the	  promoters	   of	   slow-­‐twitch	  muscle	   genes,	   or	   alternatively,	   it	   could	   indicate	   that	   there	   are	  some	  unanticipated	  technical	  problems	  with	  the	  Sox6-­‐GFP	  ChIP	  assay	  using	  the	  GFP-­‐Trap.	  Previous	  experiments	  indicated	  that	  Sox6	  protein	  directly	  represses	  the	  smyhc1	  promoter,	  because	  mutating	  Sox6	  sites	  in	  the	  smyhc1:GFP	  promoter	  led	  to	  the	  ectopic	  expression	  of	  GFP	  in	  fast-­‐twitch	  fibres	  (Chapter	  5	  Figure	  5.8).	  Primer	  pairs	  that	  yielded	  a	  PCR	  fragment	  encompassing	   these	  mutated	   Sox6	   binding	   sites	  were	   used	   as	   a	   positive	   control	   for	   the	  binding	  of	  Sox6	  to	  the	  smyhc1	  promoter.	  However,	  GFP-­‐Trap-­‐mediated	  pull	  down	  of	  Sox6-­‐GFP	  resulted	  in	  no	  enrichment	  of	  the	  smyhc1	  promoter,	  possibly	  due	  to	  the	  inability	  of	  the	  GFP-­‐Trap	  to	  successfully	  pull	  down	  Sox6-­‐GFP	  from	  UAS:sox6-­‐GFP;actin:GAL4	  embryos,	  or	  because	   the	  Sox6-­‐GFP	   fusion	  protein	  had	  dissociated	   from	   its	   cognate	   target	   sites	  under	  the	  conditions	  used.	  The	  protein	  band	  observed	  in	  the	  Western	  blot	  analysis	   from	  cross-­‐linked	   chromatin	   for	   the	  GFP-­‐positive	   embryos	   is	   slightly	   too	  high	   to	   label	   Sox6-­‐GFP,	   as	  the	  size	  of	  the	  expected	  protein	  band	  is	  about	  117kDA.	  There	  were	  also	  numerous	  bands	  detected	  of	   smaller	  molecular	  weight	   than	   that	  of	   the	  expected	  Sox6-­‐GFP	   fusion	  protein.	  However,	  since	  previous	  papers	  have	   indicated	  a	  high	  specificity	  of	   the	  GFP-­‐Trap	  to	  GFP	  from	  protein	  extracts	  prepared	  for	  ChIP	  analysis	  (Dubin	  et	  al.,	  2010),	  this	  could	  mean	  that	  the	   GFP-­‐Trap	   was	   failing	   to	   pull-­‐down	   Sox6-­‐GFP,	   or	   that	   the	   Sox6-­‐GFP	   fusion	   is	  dissociating	  readily	  from	  the	  chromatin	  under	  the	  conditions	  used.	  Another	  possibility	  for	  the	   failure	  of	   the	  ChIP	   experiment	   to	   identify	   any	   Sox6	  binding	   regions	  may	  be	   that	   the	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level	   of	   Sox6	   binding	   to	   slow-­‐twitch	   gene	   promoters	   in	   vivo	   is	   below	   the	   threshold	   for	  detection	   in	   the	   ChIP	   assay.	   However,	   I	   feel	   this	   latter	   possibility	   is	   unlikely,	   as	   the	  
actin:GAL4	   line	   enables	   a	   high	   level	   of	   expression	   of	   Sox6-­‐GFP	   throughout	   the	   zebrafish	  myotome.	  	  The	  primer	  pairs	  that	  were	  used	  in	  the	  ChIP	  analysis	  only	  encompassed	  small	  regions	  of	  the	   target	   gene	  promoters.	   They	  were	  designed	  based	   on	   either	   the	  presumption	   of	   the	  conservation	   of	   functional	   Sox6	   binding	   sites	   between	   zebrafish	   and	   mouse	   (An	   et	   al.,	  2011),	   the	   presence	   of	   a	   Sox6	   consensus	   sequence	   in	   the	   cis-­‐regulatory	   regions	   for	   the	  genes	   examined,	   or	   finally,	   in	   the	   case	   of	   smyhc1,	   Sox6	   sites	   that	   had	   already	   been	  determined	   as	   functional	   sites	   due	   to	   the	   mutation	   of	   these	   sites	   in	   the	   smyhc1:GFP	  transgene	  resulting	  in	  ectopic	  GFP	  expression.	  It	  may	  be	  the	  case	  that	  there	  are	  other	  Sox6	  binding	   sites	   in	   the	   regulatory	   region	  of	   the	   slow-­‐twitch	  genes	   that	  have	  been	  analysed,	  which	   lie	   outside	   of	   the	   genomic	   sequences	   that	   have	   been	   analysed	   by	   PCR,	   therefore	  ChIP-­‐seq	  analysis	  may	  be	  a	  better	  way	  to	  analysis	  the	  results	  from	  the	  ChIP	  experiment	  as	  this	   would	   allow	   a	   genome	   wide	   analysis	   of	   Sox6	   enriched	   DNA.	   However	   the	   lack	   of	  enrichment	  of	  DNA	  in	  the	  smyhc1	  promoter	  pairs	  suggests	  that	  there	  was	  an	  overall	  failure	  of	  the	  ChIP	  technique,	  rather	  than	  the	  failure	  to	  identify	  potential	  Sox6	  binding	  regions.	  	  	  Although	  the	  above	  reasons	  suggest	  that	  the	  ChIP	  experiment	  failed,	  the	  results	  may	  also	  indicate	  that	  Sox6	  represses	  these	  genes	  indirectly.	  It	   is	  possible	  that	  there	  is	  an	  indirect	  interaction	  between	  Sox6	  and	  tnnc1b,	  since	  mutation	  of	  the	  canonical	  Sox6	  sites	  in	  the	  cis-­‐regulatory	   regions	   of	   the	   tnnc1b:eGFP	   transgene,	   some	   of	   which	   are	   conserved	   in	   the	  mammalian	   orthologues	   (An	   et	   al.,	   2011),	   resulted	   in	   no	   ectopic	   GFP	   expression.	   If	   this	  were	   to	  be	   the	   case,	   this	  would	   indicate	   an	   evolutionary	  divergence	   in	   the	   regulation	  of	  this	   gene	   between	   mammals	   and	   fish,	   as	   previous	   studies	   have	   demonstrated	   the	  functional	   interaction	  of	   Sox6	  with	   these	   regulatory	   elements	   in	   the	  mouse	   tnnc1b	  gene	  (An	  et	  al.,	  2011).	  	  Overall,	   the	  results	   in	   this	  chapter	  remain	   inconclusive	  and	   further	  analysis	   is	  needed	  to	  determine	   whether	   Sox6	   directly	   inhibits	   slow-­‐twitch	   muscle	   genes	   in	   zebrafish.	   A	  perhaps	   different	   approach	   to	   ChIP	   would	   be	   advisable,	   such	   as	   an	   electrophoretic	  mobility	   shift	   assay	   (EMSA),	   given	   that	   this	   does	   not	   require	   the	   use	   of	   a	   Sox6-­‐specific	  antibody	  (Hellman	  and	  Fried,	  2007,	  Lane	  et	  al.,	  1992).	  This	  would	  give	  us	  an	  indication	  of	  whether	   Sox6	   is	   able	   to	   bind	   to	   Sox6	   binding	   sites	   located	  within	   the	   tnnc1b	  promoter.	  However	   the	  exact	   location	  of	   the	  binding	  sites	  are	   first	  needed,	  as	  short	   fragments	   that	  are	  known	  to	  interact	  with	  Sox6	  are	  needed	  to	  perform	  this	  technique.	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Current	   understanding	   of	   the	  mechanisms	   underlying	   the	   specification	   of	   muscle	   fibre-­‐type	  during	  vertebrate	  embryonic	  development	  is	  relatively	  limited,	  in	  comparison	  to	  the	  extensive	   body	   of	   knowledge	   about	   the	   mechanisms	   of	   fibre-­‐type	   switching	   in	   adult	  vertebrates	  (Bassel-­‐Duby	  and	  Olson,	  2006).	  The	  zebrafish	  provides	  us	  with	  a	  convenient	  model	   organism	   in	   which	   to	   investigate	   myogenesis,	   and	   in	   particular	   to	   elucidate	   the	  mechanisms	  of	  fibre-­‐type	  specification,	  as	  slow-­‐twitch	  and	  fast-­‐twitch	  fibres	  develop	  in	  a	  spatio-­‐temporally	  stereotyped	  manner.	  The	  results	  described	  in	  this	  thesis	  have	  advanced	  our	  understanding	  of	  the	  role	  of	  Sox6	  in	  myogenesis	  and	  identified	  functions	  of	  this	  gene	  that	  are	   specific	   to	   the	   teleost	   lineage,	   as	   compared	   to	   the	   functions	  of	   sox6	  orthologues	  other	  vertebrate	  species.	  The	   results	   of	   previous	   forward	   genetic	   screens	   in	   zebrafish	   indicate	   that	   mutation	   of	  approximately	   1	   in	   10	   of	   all	   zebrafish	   genes	   cause	   recognisable	   morphological	  abnormalities	   that	   appear	   within	   the	   first	   5	   days	   of	   development	   (Haffter	   et	   al.,	   1996,	  Solnicakrezel	  et	  al.,	  1994).	  However,	  this	  observation	  does	  not	  necessarily	  imply	  that	  the	  other	  90%	  of	  zebrafish	  genes	  are	  functionally	  redundant	  or	  irrelevant	  during	  these	  early	  stages	  of	  development,	  for	  several	  reasons.	  First,	  this	  estimate	  is	  based	  on	  morphological	  embryonic	  phenotypes	  that	  are	  readily	  visualized	  under	  the	  light	  microscope,	  and	  it	  does	  not	   take	   into	   account	   more	   subtle	   phenotypes	   that	   may	   nevertheless	   be	   embryonic	   or	  larval	   lethal.	   Second,	   if	   a	   gene	   is	   maternally	   expressed,	   its	   maternally	   deposited	  mRNA	  and/or	  protein	  may	  compensate	  for	  loss	  of	  zygotic	  gene	  function	  caused	  by	  homozygosity	  for	  a	  loss-­‐of-­‐function	  mutation.	  Third,	  many	  genes	  are	  not	  required	  until	  the	  later	  stages	  of	  development,	  therefore	  a	  phenotype	  may	  only	  be	  apparent	  after	  5dpf.	  Nevertheless,	  many	  genes	   could	   have	   functions	   that	   overlap	   or	   are	   redundant	   with	   those	   of	   closely	   related	  duplicates,	  and	  which	  could	  compensate	  for	  the	  loss	  of	  the	  mutated	  gene.	  This	  situation	  is	  relatively	  common	  in	  zebrafish	  because	  of	  the	  teleost	  whole	  genome	  duplication	  (Amores	  et	   al.,	   1998).	   The	   results	   described	   in	   this	   thesis	   indicate	   that	   sox6	   is	   not	   a	   functionally	  redundant	   gene,	   as	   loss	   of	   sox6	   function	   leads	   to	   a	   severe	   morphological	   phenotype	   in	  adults.	   As	   sox6	   mutant	   fish	   reach	   maturity,	   a	   severe	   scoliosis	   phenotype	   becomes	  apparent,	   indicating	   that	   sox6	   is	  needed	   for	  normal	  development	  and	  growth.	  Moreover,	  although	  sox6	  mutant	  embryos	  have	  no	  morphological	  phenotype,	  in	  situ	  hybridization	  has	  revealed	   aberrant	   expression	   of	   several	   slow-­‐twitch	   genes	   in	   these	  mutants.	   My	   results	  further	   indicate	   that	  sox6	   is	  not	  a	  maternally	  expressed	  gene,	  and	  unlike	   the	  situation	   in	  other	   teleosts,	   there	   is	   no	   second	   copy	   of	   sox6	   in	   the	   zebrafish	   genome.	   I	   therefore	  explored	   the	   possibility	   that	   sox6	   could	   have	   an	   overlapping	   function	   with	   that	   of	   the	  closely	  related	  sox5	  gene.	  My	  results	  indicate	  that	  sox5	  is	  not	  acting	  redundantly	  with	  sox6	  with	   regards	   to	   myogenesis,	   because	   double	   sox5-­‐/-­‐;sox6-­‐/-­‐	   mutants	   have	   no	   increase	   in	  ectopic	  expression	  of	  smyhc1	  as	  compared	  to	  sox6-­‐/-­‐	  mutants	  alone.	  However,	  it	  seems	  that	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sox5	  does	  function	  redundantly	  with	  sox6	  in	  other	  aspects	  of	  development,	  as	  sox5-­‐/-­‐;sox6-­‐/-­‐	  double	   mutant	   larvae	   exhibit	   a	   severe	   morphologically	   abnormal	   phenotype,	   whereas	  
sox5-­‐/-­‐	   and	   sox6-­‐/-­‐	   single	   mutants	   do	   not.	   This	   sox5-­‐/-­‐;sox6-­‐/-­‐	   double	   mutant	   line	   could	  therefore	  be	  utilized	  to	  decipher	  the	  distinct	  and	  overlapping	  functions	  of	  these	  genes.	  In	  mice,	  Sox6	  appears	  to	  be	  one	  of	  the	  key	  transcription	  factors	  necessary	  for	  determining	  fibre-­‐type	   fate	  during	  embryonic	  development,	  with	  a	   loss	  of	  sox6-­‐/-­‐	  resulting	   in	  a	  switch	  from	  fast-­‐twitch	  fibres	  to	  slow-­‐twitch	  fibres	  (Hagiwara	  et	  al.,	  2005;	  Hagiwara	  et	  al.,	  2007;	  An	  et	  al.,	  2011).	  However,	  my	  analysis	  revealed	  that	  although	  there	  is	  an	  increase	  in	  slow-­‐twitch-­‐specific	   genes	   in	   sox6-­‐/-­‐	   zebrafish	   mutants,	   the	   switch	   to	   the	   slow-­‐twitch	   fibre	  programme	   is	   incomplete,	   as	   ectopic	   expression	   of	   all	   slow-­‐twitch	   muscle	   genes	   is	   not	  observed	  throughout	  the	  whole	  myotome,	  fusion	  of	  fast-­‐twitch	  fibres	  still	  occurs	  normally	  and	   there	   appears	   to	   be	   no	   down-­‐regulation	   of	   fast-­‐specific	   genes,	   although	   qPCR	   is	  needed	  to	  confirm	  this.	  This	  could	  be	  because	  a	  factor	  necessary	  for	  the	  activation	  of	  the	  slow-­‐twitch	   programme	   is	   not	   present	   in	   the	   fast-­‐twitch	   domain	   of	   sox6-­‐/-­‐	  mutants,	   or	  alternatively	   it	   is	   possible	   that	   another	   repressor	   besides	   sox6	   is	   able	   to	   repress	   the	  activation	  of	  certain	  slow-­‐twitch	  genes.	  	  During	   muscle	   atrophy	   a	   decrease	   in	   miR-­‐499	   expression	   causes	   a	   concomitant	  upregulation	   of	   Sox6,	   implicating	   the	   miR-­‐499-­‐associated,	   myosin-­‐encoded	   microRNA	  network	   in	   fibre-­‐type	   plasticity	   (McCarthy	   et	   al.,	   2009).	   These	   results	   suggest	   that	   Sox6	  could	   play	   a	   role	   in	   both	   the	   development	   and	   physiology	   of	   muscle,	   and	   suggest	   that	  further	   studies	   of	   zebrafish	   sox6	   and	   its	   regulation,	   including	   its	   potential	   post-­‐transcriptional	  control	  by	  miRNAs,	  could	  provide	  useful	  new	  insights	  into	  the	  mechanisms	  regulating	  both	   the	  development	   and	   the	  physiological	   function	  of	  muscle.	   Interestingly,	  my	   results	   show	   that	   the	  adult	   zebrafish	   sox6-­‐/-­‐	  mutant	  myotome	   is	   significantly	   smaller	  and	  abnormally	  shaped	  compared	  to	  that	  of	  wild-­‐type	  siblings,	  indicating	  that	  sox6	  may	  be	  required	  for	  other	  aspects	  of	  muscle	  development,	  such	  as	  growth	  and	  maintenance	  of	  the	  myotome,	  in	  addition	  to	  its	  early	  embryonic	  role	  in	  the	  specification	  of	  fibre-­‐type	  identity.	  	  Future	  studies	  can	  utilise	  the	  tools	  generated	  in	  this	  thesis	  to	  further	  our	  understanding	  of	  myogenesis	   as	   well	   as	   other	   aspects	   of	   vertebrate	   development.	   The	   sox6	   mutant	   in	  combination	   with	   ChIP-­‐seq	   can	   be	   used	   to	   identify	   novel	   functions	   for	   Sox6	   in	  development.	  The	  combined	  use	  of	  the	  sox6	  mutant	  and	  calcium	  reporter	  proteins	  such	  as	  GCaMP	  could	  be	  used	  to	  explore	  the	  role	  of	  sox6	   in	  muscle	  physiology	  and	  could	  provide	  insights	  into	  sox6	  function	  in	  adult	  fibre-­‐type	  plasticity.	  The	  analysis	  of	  the	  sox6	  and	  sox5	  mutant	  lines	  generated	  in	  this	  thesis	  may	  reveal	  novel	  distinct	  or	  overlapping	  functions	  of	  these	   genes,	   not	   yet	   discovered	   in	   vertebrates.	   The	   importance	   of	   troponins	   in	   muscle	  contraction	  is	  highlighted	  by	  the	  fact	  that	  mutations	  in	  the	  genes	  encoding	  these	  proteins	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A2:	  Zebrafish	  tnnc1b	  gene	  sequence	  comparison	  with	  orthologues	  VISTA	  plot	  alignment	  and	  comparison	  of	  the	  zebrafish	  tnnc1b	  gene	  with	  mouse	  and	  human	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A7:	  Expression	  of	  heart-­‐specific	  troponins	  in	  sox6-­‐/-­‐	  mutant	  embryos	  
sox6	  transcripts	  have	  been	  detected	  in	  the	  heart	  tissue	  of	  mice	  and	  humans	  (Hagiwara	  et	  al.,	  2011).	  The	  loss	  of	  sox6	  in	  mutant	  mice	  results	  in	  conduction	  abnormalities	  in	  the	  heart	  and	  aberrant	  expression	  of	  heart	  specific	  muscle	  genes,	  including	  genes	  encoding	  myosin	  heavy	   chains	   and	   troponins	   (Hagiwara	   et	   al.,	   2005).	   As	  mentioned	   in	   Chapter	   1,	   unlike	  mammals,	   zebrafish	   have	   two	   slow-­‐specific	   skeletal	   muscle	   troponins,	   one	   that	   is	  specifically	   expressed	   in	   the	   heart	   (tnnc1a)	   and	  one	   that	   is	   specifically	   expressed	   in	   the	  skeletal	   slow-­‐twitch	  muscle	   (tnnc1b)	   (Sogah	   et	   al.,	   2010).	   As	   loss	   of	   sox6	   causes	   robust	  ectopic	  expression	  of	  tnnc1b	  in	  the	  fast-­‐twitch	  skeletal	  muscle,	  I	  investigated	  whether	  loss	  of	  sox6	  had	  an	  effect	  on	  the	  expression	  of	  tnnc1a.	  In	  situ	  hybridisation	  revealed	  that	  there	  is	   no	   change	   in	   the	   expression	   of	   tnnc1a	   at	   32	   hpf	   in	   sox6-­‐/-­‐	   mutants	   as	   compared	   to	  siblings.	  Similarly,	  the	  expression	  of	  two	  other	  heart	  specific	  troponins,	  tnnt2	  and	  tnni1b,	  was	  unaffected	  in	  the	  mutant	  compared	  to	  the	  sibling.	  These	  results	  suggest	  a	  divergence	  in	   the	   regulation	  of	   tnnc1a	   and	   tnnc1b,	  which	   complements	  previous	   studies	   identifying	  two	  separate	  enhancers	  for	  the	  mammalian	  Tnnc1	  gene	  that	  are	  responsible	  for	  regulating	  its	  tissue	  specific	  expression	  (Parmacek	  et	  al.,	  1994,	  Parmacek	  et	  al.,	  1992).	  One	  question	  that	   still	   needs	   to	   be	   addressed	   is	   whether	   sox6	   is	   expressed	   in	   the	   zebrafish	   heart.	  Expression	  of	  sox6	  in	  the	  heart	  has	  not	  previously	  been	  reported	  (Wang	  et	  al.,	  2011),	  and	  further	  in	  situ	  hybridisation	  analysis	  is	  required,	  since	  although	  its	  expression	  appears	  to	  be	  omitted	  from	  the	  heart	  in	  Chapter	  5	  (see	  Figure	  5.1),	  the	  images	  are	  not	  clear	  enough	  to	  make	  a	  definitive	  conclusion.	  	  	  
	  
Figure	  A5:	  The	  expression	  of	  the	  heart	  specific	  troponins	  tnnc1a,	  tnnt2	  and	  tnni1b	  is	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Abbreviations	  
	  Amp	   Ampicillin	  BAC	   Bacterial	  artificial	  chromosome	  BCIP	   5-­‐bromo-­‐4-­‐chloro-­‐3-­‐indolyl	  phosphate	  βg	  	  	   Beta-­‐globin	  bHLH	   Basic	  helix-­‐loop-­‐helix	  BMP	  	  	   Bone	  morphogenetic	  protein	  ChIP	  	  	  	  	  	  	  	  	  	   Chromatin	  immunoprecipitiation	  CKIP-­‐1	  	  	  	  	  	   Casein	  kinase	  2	  interacting	  protein-­‐1	  CNE	   Conserved	  non-­‐coding	  element	  Cm	   Chloramphenicol	  Ct	   Threshold	  cycle	  DAPI	   4’,	  6-­‐diamidino-­‐2-­‐phenylindole	  DCS	   Double	  conserved	  synteny	  DIG	   Digoxigenin	  DNase	   Deoxyribonuclease	  Dock1	   Dedicator	  of	  cytokinesis	  Dpf	   Days	  post	  fertilization	  DSG	  	  	   Disuccinimidyl	  glutarate	  
E.	  coli	   Escherichia	  coli	  Edu	   5-­‐ethynyl-­‐2’-­‐deoxyuridine	  eGFP	   Enhanced	  green	  fluorescent	  protein	  Eng	   Engrailed	  ENU	   N-­‐ethyl-­‐N-­‐nitrosourea	  EtOH	   Ethanol	  FGF8	   Fibroblast	  growth	  factor	  8	  Flp	   Flippase	  Fmyhcx	   Fast	  myosin	  heavy	  chain	  FRT	   Flippase	  recognition	  target	  GFP	   Green	  fluorescent	  protein	  HA	   Homology	  arm	  HATs	   Histone	  acetyltransferases	  HDACs	   Histone	  deacetylases	  Hh	   Hedgehog	  HMG	   High	  mobility	  group	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Hpf	   Hours	  post	  fertilization	  HRP	   Horseradish	  peroxidase	  IP	   Immunoprecipitation	  Kan	   Kanamycin	  KOH	   Potassium	  hydroxide	  MeOH	   Methanol	  MFF	   Medial	  fast	  fibre	  MO	   Morpholino	  MPs	   Muscle	  pioneers	  MRFs	   Myogenic	  regulatory	  factors	  Myf5	   Myogenic	  factor	  5	  Myh7b	   Slow	  myosin	  heavy	  chain	  7b	  Mylz2	   Myosin	  light	  chain	  2	  (Fast-­‐specific)	  Mylz10	   Myosin	  light	  chain	  10	  (Slow-­‐specific)	  MyoD	   Myoblast	  determination	  protein	  Myog	   Myogenin	  NaAc	   Sodium	  acetate	  NBT	   Nitro	  blue	  tetrazolium	  chloride	  NFAT	   Nuclear	  factor	  of	  activated	  T	  cells	  Nfix	   Nuclear	  factor	  1	  X-­‐type	  Nrd	   Narrowminded	  (Prdm1	  allele)	  PBS	   Phosphate	  buffered	  saline	  PCR	   Polymerase	  chain	  reaction	  PFA	   Paraformaldehyde	  PKA	   Protein	  kinase	  A	  POD	   Horseradish	  peroxidase	  Prdm1	   PR	  domain	  zinc-­‐finger	  protein	  1	  Prox1	   Prospero	  homeobox	  protein	  1	  Ptc	   Patched	  qPCR	   Quantitative	  polymerase	  chain	  reaction	  RNase	   Ribonuclease	  RNasin	   Ribonuclease	  inhibitor	  Ryr1a	   Ryanodine	  receptor	  1a	  (Slow-­‐specific)	  Sib	   Sibling	  SDS	   Sodium	  dodecyl	  sulfate	  Shh	   Sonic	  hedgehog	  Smo	   Smoothened	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